10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the Fiscal Year Ended December 31, 2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ to ______

Commission File Number	Exact Name of Registrant as Specified in its Charter, Principal Executive Office Address and Telephone Number	State of Incorporation	I.R.S. Employer Identification No.
001-33401	Cinemark Holdings, Inc. 3900 Dallas Parkway Plano, Texas 75093 (972) 665-1000	Delaware	20-5490327
33-47040	Cinemark USA, Inc. 3900 Dallas Parkway Plano, Texas 75093 (972) 665-1000	Texas	75-2206284

Securities registered pursuant to Section 12(b) of the Act:

	Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Cinemark Holdings, Inc. ("Holdings")	Common Stock, par value $0.001 per share	CNK	New York Stock Exchange
Cinemark USA, Inc. ("CUSA")	None	None	None

Securities registered pursuant to Section 12(g) of the Act:

Cinemark Holdings, Inc. None

Cinemark USA, Inc. None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Cinemark Holdings, Inc. Yes ☒ No ☐

Cinemark USA, Inc. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

Cinemark Holdings, Inc. Yes ☐ No ☒

Cinemark USA, Inc. Yes ☒ No ☐

(Note: As a voluntary filer, Cinemark USA, Inc. is not subject to the filing requirements of Section 13 or 15(d) of the Exchange Act.)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Cinemark Holdings, Inc. Yes ☒ No ☐

Cinemark USA, Inc. Yes ☐ No ☒

(Note: As a voluntary filer, Cinemark USA, Inc. is not subject to the filing requirements of Section 13 or 15(d) of the Exchange Act. Cinemark USA, Inc. has filed all reports pursuant to Section 13 or 15(d) of the Exchange Act during the preceding 12 months as if it was subject to such filing requirements.)

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Cinemark Holdings, Inc. Yes ☒ No ☐

Cinemark USA, Inc. Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Cinemark Holdings, Inc.
Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

Cinemark USA, Inc.
Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Cinemark Holdings, Inc. ☐

Cinemark USA, Inc. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

Cinemark Holdings, Inc. ☒

Cinemark USA, Inc. ☒

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

Cinemark Holdings, Inc. ☐

Cinemark USA, Inc. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).

Cinemark Holdings, Inc. ☐

Cinemark USA, Inc. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Cinemark Holdings, Inc. Yes ☐ No ☒

Cinemark USA, Inc. Yes ☐ No ☒

The aggregate market value of the voting and non-voting common equity owned by non-affiliates of Holdings on June 30, 2023, computed by reference to the closing price for Holdings’ common stock on the New York Stock Exchange on such date was approximately $1.7 billion (104,257,922 shares held by non-affiliates at a closing price per share of $16.50). CUSA is wholly-owned by Holdings and there is no public trading market for its equity securities, therefore CUSA is unable to calculate the aggregate market value of the voting and non-voting common equity owned by non-affiliates.

As of February 9, 2024, 121,589,633 shares of common stock of Cinemark Holdings, Inc. were issued and outstanding.

As of February 9, 2024, 1,500 shares of Class A common stock, $0.01 par value per share, and 182,648 shares of Class B common stock, no par value per share, of Cinemark USA, Inc. were outstanding and held by Cinemark Holdings, Inc.

This combined Form 10-K is separately filed by Holdings and CUSA. Information contained herein relating to any individual registrant is filed by such registrant on its own behalf. Each registrant makes no representation as to information relating to the other registrant. When this Form 10-K is incorporated by reference into any filings with the SEC made by Holdings or CUSA, as a registrant, the portions of the Form 10-K that relate to the other registrant are not incorporated by reference therein.

OMISSION OF CERTAIN INFORMATION

CUSA meets the conditions set forth in General Instruction I(1)(a) and (b) of Form 10-K and has therefore omitted the information otherwise called for by items 10-13 of Form 10-K as allowed under General Instruction I(2)(c).

DOCUMENTS INCORPORATED BY REFERENCE

Certain portions of Holdings’ definitive proxy statement, in connection with its 2024 annual meeting of stockholders, to be filed within 120 days of December 31, 2023, are incorporated by reference into Part III, Items 10-14, of this annual report on Form 10-K.

Table of Contents

		Page
Cautionary Statement Regarding Forward-Looking Statements			1
PART I
Item 1.	Business		2
Item 1A.	Risk Factors		10
Item 1B.	Unresolved Staff Comments		19
Item 1C.	Cybersecurity		19
Item 2.	Properties		20
Item 3.	Legal Proceedings		21
Item 4.	Mine Safety Disclosures		21
PART II
Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities		22
Item 6.	[Reserved]		23
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		24
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk		43
Item 8.	Financial Statements and Supplementary Data		44
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure		44
Item 9A.	Controls and Procedures		44
Item 9B.	Other Information		45
Item 9C.	Disclosure Regarding Foreign Jurisdictions that Prevent Inspections		45
PART III
Item 10.	Directors, Executive Officers and Corporate Governance		47
Item 11.	Executive Compensation		47
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters		47
Item 13.	Certain Relationships and Related Transactions, and Director Independence		47
Item 14.	Principal Accounting Fees and Services		47
PART IV
Item 15.	Exhibit and Financial Statement Schedules		47
SIGNATURES			58

Cautionary Statement Regarding Forward-Looking Statements

This combined annual report on Form 10-K includes “forward-looking statements” within the meaning of the federal securities laws, including the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Holdings is a holding company which conducts all of its operations through CUSA and its subsidiaries. The “forward-looking statements” include our current expectations, assumptions, estimates and projections about the respective business and industry of Holdings and CUSA. They include statements relating to:

•future revenue, expenses and profitability;

•currency exchange rate and inflationary impacts;

•the future development and expected growth of our business;

•projected capital expenditures;

•access to capital resources;

•attendance at movies generally or in any of the markets in which we operate;

•the number and diversity of popular movies released, the length of exclusive theatrical release windows and our ability to successfully license and exhibit popular films;

•national and international growth in our industry;

•competition from other exhibitors, alternative forms of entertainment and content delivery via streaming and other formats;

•determinations in lawsuits in which we are a party; and

•the ongoing recovery of our business and the motion picture exhibition industry from the effects of the COVID-19 pandemic and the writers’ and actors’ guilds strikes.

You can identify forward-looking statements by the use of words such as “may,” “should,” “could,” “estimates,” “predicts,” “potential,” “continue,” “anticipates,” “believes,” “plans,” “expects,” “future” and “intends” and similar expressions. These statements are neither historical facts nor guarantees of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions and are, therefore, subject to risks, inherent uncertainties and other factors, some of which are beyond our control and difficult to predict. Such risks and uncertainties could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. In evaluating forward-looking statements, you should carefully consider the risks and uncertainties described in the “Risk Factors” section in Item 1A and elsewhere in this Form 10-K. All forward-looking statements attributable to either Holdings or CUSA or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements and risk factors contained in this Form 10-K. Forward-looking statements contained in this Form 10-K reflect the views of Holdings and CUSA only as of the date of this Form 10-K. Neither Holdings nor CUSA undertake any obligation, other than as required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Cinemark Holdings, Inc. is a Delaware corporation incorporated on August 2, 2006. Cinemark USA, Inc. is a Texas corporation incorporated in 1984 and a wholly-owned subsidiary of Cinemark Holdings, Inc. Our principal executive offices are at 3900 Dallas Parkway, Plano, Texas 75093. Our telephone number is (972) 665-1000. General information about us can be found at www.cinemark.com. All annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, and any amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act are available on Holdings’ investor relations website at ir.cinemark.com free of charge under the heading "SEC Filings" as soon as reasonably practicable after such reports are filed with, or furnished to, the Securities and Exchange Commission, or the SEC. Additionally, all filings with the SEC can be accessed on the SEC's website at www.sec.gov.

Unless the context otherwise requires, all references to “we,” “our,” “us,” “the Company” or “Cinemark” relate to Cinemark Holdings, Inc. and its consolidated subsidiaries. All references to CUSA relate to Cinemark USA, Inc. and its consolidated subsidiaries.

1

PART I

Unless the context otherwise requires, all references to “we,” “our,” “us,” “the Company” or “Cinemark” relate to Cinemark Holdings, Inc. and its consolidated subsidiaries. All references to CUSA relate to Cinemark USA, Inc. and its consolidated subsidiaries. Where it is important to distinguish between the entities, the report either refers specifically to Holdings or CUSA. All references to Latin America are to Brazil, Argentina, Chile, Colombia, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Paraguay, Curacao and Ecuador. We closed our one theatre in Curacao in January 2023 and sold our Ecuador subsidiary in September 2023. Unless otherwise specified, all operating and other statistical data is as of or for the year ended December 31, 2023.

Item 1. Business

We are a leader and one of the most geographically diverse operators in the motion picture exhibition industry. As of December 31, 2023, we operated 501 theatres and 5,719 screens in the United States, or “U.S.”, and Latin America. Our U.S. circuit operated 309 theatres and 4,324 screens and our Latin America circuit operated 192 theatres and 1,395 screens across 13 countries. Our significant and diverse presence in the U.S. and Latin America has made us an important distribution channel for movie studios and other content providers. We believe our portfolio of high-quality theatres with multiple platforms provides a preferred destination for moviegoers and has contributed to our consistent industry-leading results.

As of December 31, 2023, we managed our business under two reportable operating segments: U.S. markets and international markets. See Note 22 to the consolidated financial statements.

Impact of COVID-19 Pandemic

The impact of the COVID-19 pandemic had an unprecedented effect on the theatrical exhibition industry. We temporarily closed our theatres in the U.S. and Latin America during March of 2020 at the onset of the COVID-19 outbreak. We reopened theatres as soon as local restrictions and the status of the COVID-19 pandemic would allow. All of our domestic and international theatres were reopened by the end of 2021. After reopening our theatres, we faced ongoing challenges with the significant reduction in the volume of new film releases. The industry has made significant progress in its recovery from the COVID-19 pandemic; however its ongoing recovery continues to be contingent upon several key factors, including the volume of new film content available, which has also been impacted by the recent writers’ and actors’ guild strikes, the box office performance of new film content released, the duration of the exclusive theatrical release window and evolving consumer behavior with competition from other forms of in-and-out of home entertainment.

Motion Picture Exhibition Industry Overview

Domestic

Preliminary estimates indicate that North American box office revenues were approximately $9.1 billion for 2023, up more than 21% compared with 2022 due primarily to an increase in the volume of new films released.

The following table represents the results of surveys by Motion Picture Association, or MPA, published in March 2022, and The Cinema Foundation, published in March 2023, outlining the historical trends in North American box office performance for the five-year period from 2018 through 2022. Box office performance has historically been primarily dependent on the quality, quantity and timing of film product.

	North America
	Box Office Revenue		Attendance		Average Ticket
Year	($ in billions)		(in billions)		Price
2018	$	11.9		1.30	$	9.11
2019	$	11.4		1.24	$	9.16
2020	$	2.2		0.24	$	9.37
2021	$	4.5		0.47	$	9.57
2022	$	7.5	n/a (1)		$	10.53

(1)2022 attendance figures for North America were not published.

Films released during the year ended December 31, 2023 included Barbie, The Super Mario Bros. Movie, Spider-Man: Across the Spider-Verse, Guardians of the Galaxy Vol. 3, Oppenheimer, The Little Mermaid, Ant-Man

2

and the Wasp: Quantumania, John Wick: Chapter 4, Sound of Freedom, Taylor Swift | The Eras Tour concert film, The Hunger Games: The Ballad of Songbirds and Snakes, Five Nights at Freddy’s, Wonka, and Trolls Band Together, among other films.

Films scheduled for release in 2024 include Madame Web, Dune: Part Two, Ghostbusters: Frozen Empire, Kung Fu Panda 4, The Fall Guy, Furiosa, Kingdom of the Planet of the Apes, Inside Out 2, A Quiet Place: Day One, Despicable Me 4, Deadpool 3, Joker: Folie à Deux, Venom 3, Wicked - Part I, Mufusa: The Lion King, and Sonic the Hedgehog 3, among other films.

International

Preliminary estimates for Latin American box office revenues were approximately $2.4 billion for 2023, up more than 33% compared with 2022.

Box office performance in Latin America is dependent upon the quantity, quality and timing of Hollywood film product, and to a lesser extent, local film product. The performance in Latin American markets is also impacted by political and social conditions, growing populations, and continued retail development.

Drivers of Continued Industry Success

We believe the long-term fundamentals of our industry remain intact:

Consumer Enthusiasm for Theatrical Movie-Going Remains Strong. Sustained consumer enthusiasm to view compelling films in a shared, larger-than-life, cinematic environment continues to be demonstrated across all genres of films, segments of audiences, and periods of the year. Positive box office growth, aligned with film volume recovery and record-setting results of an expansive range of titles across a wide array of film genres further underscore that experiencing captivating film content in a theatrical setting remains an important part of culture and consumer entertainment agendas.

A Theatrical Release Enhances a Film’s Promotional Impact and Overall Asset Value. Theatrical exhibition has long been the primary distribution channel for launching new major motion picture releases. A theatrical release provides an enhanced promotional platform for filmed entertainment content by heightening its exposure, increasing its perceived quality, strengthening recall, and driving greater viewing interest. Furthermore, experiencing content in a shared theatrical environment elevates emotions and engagement with stories and characters, which builds larger brands, franchises, and cultural moments. It also provides an incremental revenue stream, while strengthening performance in downstream distribution channels, including streaming, which enhances overall asset value. Based on these benefits, as well as commentary provided by our film distribution partners, we anticipate the volume of films released each year will continue to recover to historical levels.

Resilient Industry Across Technology Innovations and Economic Cycles. Theatrical movie-going remains one of the most convenient and affordable forms of out-of-home entertainment. As such, it has proven resilient to competition for consumers’ leisure spending, as well as inflationary and recessionary periods. For example, North American industry box office grew in six of the last eight recessions. Additionally, theatrical movie-going has demonstrated stable, long-term growth trends across various technological innovations, including VHS, internet, DVD and streaming.

Our Strategy

Our strategic objectives prioritize experiential consumer-based, revenue-generating, and productivity-driving initiatives, including:

Deliver an Extraordinary Guest Experience. We aim to differentiate our theatres through consistent investment in high-demand consumer amenities that provide a larger-than-life, cinematic entertainment experience with top-notch guest service. Examples of amenities include state-of-the-art sight and sound technology, premium large format auditoriums, recliners, and motion seats, as well as expansive food and beverage offerings. We believe our ongoing focus on providing an extraordinary guest experience is a primary factor of our consistent industry-leading results.

Maximize Attendance and Box Office While Expanding Revenue Opportunities. We actively focus on maximizing attendance and box office results through pricing strategies, sophisticated showtime planning, and pursuit of alternative content that appeals to a broad consumer base. We also continue to invest in strengthening and leveraging our omni-channel marketing platforms and loyalty programs to expand our audience base, increase moviegoing

3

frequency and strengthen loyalty to our brand. Additionally, we seek to drive ancillary revenue opportunities through expanding the food, beverage and merchandise products we offer, simplifying speed of service through space management improvements and online mobile ordering, and extending the availability of our offerings beyond our theatres via third-party delivery platforms. Furthermore, we look to monetize our facilities with opportunities including game rooms and private events.

Maintain a Disciplined Focus on Productivity and Profitability. We remain disciplined in our pursuit of continuous improvement, seeking opportunities to simplify processes, streamline operations, remove inefficiencies, and drive productivity. Areas of emphasis include further enhancing our workforce management tools and processes, strengthening inventory management, optimizing showtime planning, leveraging advanced sourcing strategies, and expanding automation opportunities. We continue to enhance data management and analytics to strengthen our decisions and maximize our overall potential. Furthermore, as part of our ongoing focus on profitability, we continuously optimize our footprint, assessing our global circuit to ascertain the most advantageous strategies for growth, recalibration, and strengthening of our theaters to deliver sustained long-term returns.

Competitive Strengths

We believe the following strengths have allowed us to compete effectively in the past and will continue to be our guiding principles:

Disciplined Operating Philosophy. Our operating philosophy focuses on creating an extraordinary guest experience, maintaining favorable theatre-level economics, controlling operating costs and effectively reacting to changes in economic and market conditions.

Balanced Approach to Investment and Capital Allocation. Our balanced and disciplined investment approach centers on thoughtfully reinvesting in our existing theatres, building new theatres and acquiring quality theatres that will complement our circuit. We have long believed in maintaining a strong balance sheet and ensuring our capital investments earn a solid return. This philosophy has proven to be successful for us over varying economic cycles and industry challenges. We remain disciplined with our cash management and capital resource allocation strategies, while continuing to invest in the long-term health of our circuit.

Leading Position in Our U.S. and Latin American Markets. We have a leading market share in most of the U.S. markets we serve, which includes a presence in 42 states. For the year ended December 31, 2023, we ranked either first or second, based on box office revenues, in 21 of our top 25 U.S. markets, including Dallas, the San Francisco Bay Area, Houston, Salt Lake City, Sacramento, Cleveland, Austin and Las Vegas. We were one of the first circuits to begin reopening theatres in the U.S. during 2021, gaining market share of the overall North American box office as a result. We maintained a meaningful portion of these market share gains through 2023.

We have a significant presence in major cities in Latin America, with theatres in 15 of the 20 largest metropolitan areas in Latin America as of December 31, 2023. We are the largest exhibitor in Brazil and Argentina and have significant market presence in Colombia, Peru and Chile. Our geographic diversity makes us an important global distribution channel for the movie studios. Similar to the U.S., we gained overall market share in Latin America upon reopening all of our theatres during 2021. We have retained a meaningful portion of that market share through 2023.

State-of-the-Art Theatre Circuit. We build new theatres and consistently invest in our existing theatres to maintain a state-of-the-art movie-going experience, which we believe makes our theatres preferred destinations for moviegoers in our markets. Making quality investments in our circuit will continue to be one of our primary objectives.

We offer our guests a premium large format experience through our 293 XD auditoriums, which represents the largest exhibitor-branded premium large format footprint in the world, 15 IMAX auditoriums and six ScreenX auditoriums across our worldwide circuit. Our XD auditoriums offer a premium experience utilizing the latest in digital projection and enhanced custom sound, including Barco Auro-Max 11.1 sound systems in select locations. The XD experience includes wall-to-wall screens, wrap-around sound, plush seating, reclining seats in a majority of our XD auditoriums and a maximum comfort entertainment environment for an immersive experience. The benefits of our XD auditoriums include program flexibility, as we can show the content of our choice with no additional revenue share component outside of routine film rental.

We started a multi-year project in 2022 to strategically convert our auditoriums to more energy efficient Barco RGB laser projectors, which provide greater light output than the current technology, further enhancing the

4

movie-going experience. As of December 31, 2023, we have transitioned approximately 14% of our auditoriums to the new laser projectors across our worldwide circuit.

We have incorporated Luxury Lounger heated recliner seats into all of our recent domestic new builds and have repositioned many of our existing domestic theatres to offer this premium seating feature. We currently feature these heated recliner luxury loungers in 68% of our total domestic circuit.

We also have auditoriums that offer seats with immersive cinematic motion, which we refer to as motion seats, in 335 auditoriums throughout our circuit. These motion seats are programmed in harmony with the audio and video content of the film and further immerse guests into the on-screen action.

We offer enhanced food and beverages such as gourmet pizzas, burgers, and sandwiches, and a selection of beers, wine and cocktails, all of which can be enjoyed in the comfort of the auditoriums, at a majority of our theatres. We also offer full bars or dine-in areas in many of our locations and we are continuing to expand these amenities to additional locations. In the U.S., we offer advanced mobile concession ordering at virtually all of our U.S. theatres allowing guests to pre-order select concession products and pick them up at the concession stand upon arrival or have them delivered to their seat. We also offer mobile concession ordering in all of our Latin American theatres and delivery to seats in a select number of our premier Latin American theatres.

Experienced Management. Our global management team has extensive industry experience and proven track records. Many of our key leaders have over 20 years of industry experience. Additionally, our country general managers are local citizens familiar with political, social, cultural and economic factors impacting their country, which enables them to more effectively manage the local business. Our global management team has successfully navigated us through many industry and economic cycles over the years.

Theatre Operations

As of December 31, 2023, we operated 501 theatres and 5,719 screens in 42 U.S. states and 13 Latin American countries. We opened our first theatre in the U.S. in 1984. Our domestic circuit has expanded through acquisitions and organic growth, and we currently have theatres in 104 designated market areas. We first entered Latin America when we opened a theatre in Santiago, Chile in 1993. Since then, through a focused international growth strategy, we have developed into one of the most geographically diverse theatre circuits in the region. We have balanced our risk through a diversified international portfolio, which included theatres in 15 of the 20 largest metropolitan areas in Latin America as of December 31, 2023. We are a market leader in Brazil and Argentina, where we are the largest exhibitor. We also have significant market presence in Colombia, Peru and Chile.

The following table summarizes the geographic locations of our theatre circuit as of December 31, 2023.

Country	Total Theatres		Total Screens
United States		309		4,324
Brazil		85		622
Argentina		23		199
Colombia		30		177
Chile		20		142
Central America (1)		17		114
Peru		14		113
Bolivia		1		13
Paraguay		2		15
Total (2) (3)		501		5,719

(1)Includes Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala.

(2)In January 2023, we closed our theatre in Curacao.

(3)In September 2023, we sold our Ecuador subsidiary.

Content

We offer a wide variety of content at our theatres. We monitor upcoming film releases and other content and work diligently with film distributors to license content that we believe will be most successful in our theatres. We play mainstream films from many different genres, such as animated films, family films, dramas, comedies, horror and action films. We offer content in both 2-D and 3-D formats in all of our theatres, and in many locations, we offer

5

either our own premium large format, XD or IMAX. We also offer a format that features motion seats and added sensory features.

We offer a variety of alternative entertainment content for our guests. Examples include concert, sporting and gaming events, as well as art, independent, faith-based, and multicultural foreign language films. In certain Latin American markets where we operate, we also offer local film product to our guests. Additionally, we have the functionality and technological infrastructure to live-stream events via satellite network across our portfolio of theatres in the U.S. and Latin America.

In addition, our joint venture, AC JV, LLC, with Regal Entertainment Group and AMC Entertainment, Inc. provides marketing and distribution of live and pre-recorded entertainment programming to augment theatres’ feature film schedules. AC JV, LLC, referred to as Fathom Events, is the largest distributor of documentaries and inspirational content as well as classic films and performing arts, such as the Metropolitan Opera.

Film Licensing

In the U.S., our corporate film department negotiates with film distributors to license films for each of our domestic theatres. Local film personnel in our international offices negotiate with local offices of major film distributors, local film distributors and independent content providers to license films for our international theatres. Film distributors determine film release dates and plan and fund the related film marketing campaigns, while we are responsible for booking the films at each of our theatres at the optimal showtimes for our guests.

In both our domestic and international locations, film rental fees are based on a film’s box office receipts. The majority of film rental rates are negotiated on a sliding scale formula, under which the rate is based on a standard rate matrix that is established with each content provider prior to a film’s theatrical run. We may also negotiate some film rental rates on a firm terms formula, a percentage of box office receipts negotiated prior to a film’s theatrical run, or a rate that is negotiated after a film’s theatrical run.

Food and Beverage

Concession sales are our second largest revenue source. We have expanded concession sales by enhancing our offerings and adapting to our customers’ changing preferences, as discussed below.

Product Mix. Core concession products offered at all of our theatres include various sizes and types of popcorn, soft drinks, coffees, non-carbonated drinks, candy and quickly-prepared or pre-prepared food, such as hot dogs, pizza, pretzel bites, nachos and ice cream. Our food and beverage offerings may vary in particular markets based on consumer preferences. We offer adult beverage options for our guests including beer, wine and cocktails, freshly-made signature Pizza Hut pizzas, burgers and sandwiches, as well as some healthier snack options and diverse ethnic foods based on market demographics.

We have dedicated category managers that monitor product sales, upcoming content and events, and make adjustments to product mix on a theatre-by-theatre or market-by-market basis. This approach also allows us to efficiently activate and manage both national or regional product launches and promotional initiatives to further grow food and beverage sales.

New products and promotions are introduced on a regular basis to increase concession purchase incidence from existing consumers as well as to attract new consumers. In certain international countries and in all of our domestic theatres, we offer a free loyalty program that routinely offers food and beverage promotions and rewards. Our paid subscription programs allow our guests to receive exclusive concessions discounts.

Innovation. We offer unique movie-themed merchandise to customers both in our theatres and online to enhance their experience and drive incremental revenue. Additionally, we have partnered with key strategic suppliers to create an online store that offers unique merchandise to guests across the country from the comfort of their homes. We are also the first major theatre exhibition company to partner with Door Dash, Grub Hub, and Uber Eats, to allow consumers to have our concession offerings delivered to their homes.

Theatre Design. Our theatres are designed to optimize the guest purchase experience at the concession stands to facilitate serving guests in an expedited manner. We strategically design large concession stands to heighten visibility, reduce the length of concession lines, and improve traffic flow around the concession stands. We incorporate queue lines and self-serve candy cases and bottled drink coolers at our concession stands to help provide convenience for our guests, drive impulse purchases and increase product visibility for these two core categories. We also have

6

self-service cafeteria-style concession areas in many of our domestic theatres, which allow customers to select their own food and refreshments and proceed to the cash register when they are ready. This design allows for more efficient service, and superior visibility of concession items. We also have lobby bars and VIP lounges in many domestic and international theatres.

Our proprietary mobile concessions ordering capability allows moviegoers to purchase their cinema snacks in advance and have them waiting to be picked up upon arrival or delivered directly to their seat. This functionality streamlines the guest experience, adding convenience and enhanced guest service for our customers. As of December 31, 2023, mobile concession ordering is available at virtually all of our U.S. theatres. Similarly, guests in our Latin American locations can pre-pay for select concession products online or at kiosks within the theatre and pick them up at the concession stand.

Staff Training. Employees are continually trained on proper sales techniques, food preparation and handling, and maintaining the quality of our concession product offerings. Many employees are certified in food safety protocols and in serving alcoholic beverages.

Cost Control. We negotiate prices, volume-based rebates and promotional-based rebates for concession products directly with our suppliers. Concession products are generally managed through a distribution network, with theatres placing and receiving orders directly with a distributor. We monitor inventory levels at every theatre to ensure proper stock levels are maintained to appropriately serve our guests.

Supply chain interruptions and inflationary pressures may impact costs and limit product availability. Our food and beverage costs have been especially susceptible to inflationary pressures in more recent periods, particularly for core commodities, which recently experienced elevated inflationary pressures. In an effort to mitigate these pressures, we focus on identifying alternative products sourced from a variety of suppliers as well as implementing strategic pricing actions to help offset the impact of these pressures.

Screen Advertising

Our U.S. theatres are part of the in-theatre digital network operated by National CineMedia, LLC, or NCM. NCM provides advertising to our theatres through its branded “Noovie” pre-show entertainment program and also handles certain lobby promotions and displays for our theatres. We believe that the reach, scope and digital delivery capability of NCM’s network provides an effective platform for national, regional and local advertisers to reach our audiences. We receive a monthly theatre access fee for participation in the NCM network, which includes screen rental revenue on a per patron basis and on a revenue share basis depending on the placement of the advertisement.

Throughout our international markets, we have developed our Flix Media brand that handles screen advertising functions in all of our Latin American countries. Our Flix Media marketing personnel work with local agencies and advertisers to coordinate screen advertising in our theatres as well as other theatres in our markets. In addition to screen advertising in our theatres, we continue to expand Flix Media’s services to include, among other things, alternative content, digital media and other synergistic advertising opportunities.

Marketing and Promotions

Digital Marketing. Our investment in digital marketing and customer experience over the past several years has enabled us to expand our reach to our guests, communicate with them on a consistent basis, and streamline their digital customer journey. We continue to adapt our platforms to engage movie-goers more effectively and make it as compelling and simple as possible for them to purchase their next movie ticket and concessions from us. Through both organic and paid marketing efforts, we keep our millions of guests informed through email, social media, website and mobile app updates, and advertising to promote upcoming content and keep Cinemark elevated in the moviegoer consideration set.

Transforming the digital customer journey has enabled us to more effectively reach movie-goers through targeted and refined search engine optimization, and gives the customer a better experience once they are directed to our website or app. We regularly conduct comprehensive analysis of the customer journey on our channels, making updates that reduce clicks and decrease the friction from search to ticket purchase. Ongoing enhancements result in higher traffic volume to our digital channels and increased ticket and concession purchases.

7

In an effort to more deeply engage with our guests, the visual identity and physical flow of our theatres are regularly assessed. This includes keeping all signage, merchandise, food and beverage vessels and employee attire updated and reflective of the modern experience.

Campaigns and Promotions. We market our theatres and special events, including new theatre grand openings, remodel re-openings and VIP events, using email/in-app push messaging, social media communications, digital advertising, and various forms of traditional media advertising. We exhibit previews of coming attractions and current films as part of our on-screen pre-feature program. We offer guests access to movie times, the ability to buy their tickets and reserve their seats in advance, purchase concessions in advance and purchase gift cards at our website www.cinemark.com and via our mobile applications. Guests can subscribe to our emails and push notifications to receive information about current and upcoming films and events at their preferred Cinemark theatre(s), including details about upcoming XD movies, advanced ticket sales, screenings, special events, concerts, live broadcasts, contests, promotions, and our latest concessions and merchandise offerings. We partner with film distributors on a regular basis to promote upcoming films through local, regional and national programs, many of which are exclusive to our theatres.

Social Media. In the evolution of our external communication strategy, we are meeting movie-goers where they are and ensuring we are present as they scroll throughout the day. We interact with moviegoers every day on social media platforms, such as Instagram, Facebook, Snapchat, X (formerly Twitter) and TikTok to provide advanced ticketing, promotions, and event information and to monitor and respond to guests’ questions and feedback.

Membership and Loyalty. Our domestic subscription membership program, Movie Club, offers guests a standard monthly ticket credit, member-pricing for a companion ticket and concession and other transaction discounts for their choice of a monthly or annual fixed price. Movie Club is a unique option to reward our loyal guests and allows us to stay informed of frequent moviegoers’ preferences. Movie Club includes a premium tier, Movie Club Platinum, allowing members with a high visit frequency and/or high volume of ticket purchases during the year to earn additional movie ticket credits, receive an increased concessions discount and the ability to purchase additional tickets at a discounted price.

We offer a free domestic loyalty program, Movie Fan, to our guests in the U.S. Movie Fan allows our moviegoers to earn one point for every dollar they spend. Points can then be redeemed for tickets, concession items and discounts, as well as unique and limited-edition merchandise that relate to films currently playing in our theatres. Our loyalty programs are closely monitored, and new strategies are consistently tested to incentivize consumers to prioritize visiting our theatres.

We also have membership and loyalty programs in most of our international markets that either allow customers to pay a nominal fee for an annual membership card that provides them with certain admissions and concession discounts or that allows guests to earn loyalty points for each purchase. Similar to the Movie Fan program, our points-based international programs offer discounts on movie tickets and concessions.

Our global loyalty programs put us in direct contact with our moviegoers and provide opportunities for us to partner with the studios and our suppliers through targeted promotions.

Competition

We are one of the leaders in the motion picture exhibition industry. We compete against local, regional, national and international exhibitors with respect to attracting guests, licensing films and developing new theatre sites. Our primary U.S. competitors include Regal and AMC and our primary international competitors, which vary by country, include Cinépolis, Cine Colombia, CinePlanet, Kinoplex (GSR), UCI, Royal Films and Araujo.

We are generally able to book films at our theatres without regard to the film bookings of other exhibitors. Our success in attracting guests can depend on customer service quality, location, theatre capacity, quality of projection and sound equipment, film showtime availability and ticket prices.

We compete for new theatre sites with other movie theatre exhibitors as well as other entertainment venues. Securing a potential site depends upon factors such as commercial terms, available investment resources, theatre design and capacity, revenue potential and financial stability of developers as well as exhibitors.

We face competition from other forms of out-of-home entertainment competing for the public’s leisure time and disposable income, including family entertainment centers, concerts, theme parks and sporting events. We also

8

face competition for guests from a number of alternative film distribution channels, such as streaming services, digital downloads, video on-demand and network television.

Seasonality

Our revenues have historically been seasonal, coinciding with the timing of releases of motion pictures by the major distributors. The most successful motion pictures have historically been released during summer months in the U.S., extending from May to July, and during the holiday season, extending from November through year-end. In our Latin American markets, while Hollywood content has similar release dates as in the U.S., the local holidays and seasons vary. The unexpected emergence of a hit film during other periods or the failure of an expected success at a key time could alter this seasonality trend. The timing, quantity and quality of film releases can have a significant effect on our results of operations, and the results of one quarter are not necessarily indicative of results for the next quarter or for the same period in the following year.

Corporate Operations

Our global headquarters, referred to as the Cinemark Service Center, or CSC, is located in Plano, Texas. Personnel at the CSC provide oversight and support for our domestic and international theatres and includes our executive team and department heads in charge of film licensing, food and beverage, theatre operations, theatre construction and maintenance, real estate, human resources, marketing, legal, finance, accounting, tax and information technology. Our U.S. operations are comprised of regions headed by a regional vice president. We have eight regional offices in Latin America responsible for the local management of theatres in 13 countries as of December 31, 2023 (Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala are managed out of one Central American regional office). Each regional office is headed by a general manager or a member of our international management team with additional personnel responsible for film licensing, marketing, human resources, information technology, operations and finance. We have divisional or regional chief financial officers in several of the international countries in which we operate.

Human Capital

Our business is seasonal and therefore, our headcount can vary throughout the year depending on the timing and success of movie releases. We do not have unionized employees within our domestic employee base, however many of our international locations are subject to union contracts.

We currently have approximately 17,500 employees in the U.S., approximately 21% of whom are full-time employees and 79% of whom are part-time employees. We have approximately 9,300 employees in our international markets, approximately 57% of whom are full-time employees and approximately 43% of whom are part-time employees.

In our Mission, Vision and Values Statement, our employees form the core of our Cinemark Values. We strive to (i) act with honesty and integrity, respect and care for each other, our guests, communities and partners, (ii) provide a safe environment for our global employees and guests, (iii) be the best in what we do and (iv) empower our people to make decisions and take responsibility. Guided by our Cinemark Values, we are committed to creating a company where everyone is included and respected, and where we support each other in reaching our full potential. We take pride in the fact that many of our employees, ranging from field employees to executive management, have significant tenure with the Company.

To attract and retain the most qualified talent, we offer competitive benefits, including market-competitive compensation, healthcare, paid time off, parental leave, free movie passes and in the U.S., a 401(k) retirement savings and investment plan with generous Company match. Additionally, many of our CSC employees are eligible to work a hybrid schedule. We support the continuous development of professional, technical and leadership skills of our employees by offering tuition assistance, skills development courses and leadership development training in partnership with reputable institutions.

To foster a corporate culture of transparency and collaboration, our senior management regularly conducts “town-hall” style meetings with employees to share, among other matters, the Company’s performance, business conditions and market challenges, strategies and initiatives, and to respond to employee concerns through question-and-answer sessions. Employees in the U.S. are also encouraged to provide feedback about their experience through periodic employee engagement surveys. These voluntary surveys provide overall and department-specific reports and

9

enable us to improve employee experience and culture. We aspire to provide a safe, open and accountable work environment for our employees. We also provide a hotline for all employees to report workplace concerns and violations with the option to report on an anonymous basis. We address such concerns and take appropriate actions that uphold our Cinemark Values.

In recognition and gratitude for our moviegoing communities, we strongly encourage team members to give back to the community and host periodic service days for team members. Through Cinemark Cares, we support local and national charitable organizations through monetary and product donations, or donations of employees’ time or expertise. We are a proud long-term partner of several charities and host an annual golf tournament to raise funds for these and other selected charities.

Regulations

The distribution of motion pictures is largely regulated by antitrust laws and was the subject of numerous antitrust cases in the past. The manner in which we can license films from certain major film distributors has been influenced by consent decrees and other court orders resulting from these cases. Consent decrees that bound certain major film distributors expired during 2022. These consent decrees required distributors to offer and license films to exhibitors, including Cinemark, on a theatre-by-theatre and film-by-film basis. Consequently, exhibitors have not entered into long-term arrangements with major distributors but must negotiate for licenses on a theatre-by-theatre and film-by-film basis. While the consent decrees may no longer be in effect, we are still subject to the antitrust laws, and we do not anticipate a material shift in the way films are licensed.

We are subject to various general regulations applicable to our operations including the Americans with Disabilities Act of 1990, or the ADA, and regulations promulgated by the U.S. Food and Drug Administration and certain state laws that require nutrition labels for certain menu items. Our domestic and international theatre operations are also subject to federal, state and local laws governing such matters as data privacy, wages, working conditions, citizenship, health and sanitation requirements and various business licensing and permitting.

Financial Information About Geographic Areas

We currently have operations in the U.S., Brazil, Argentina, Chile, Colombia, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, and Paraguay, which are reflected in the consolidated financial statements. See Note 22 to the consolidated financial statements for segment information and financial information by geographic area.

Item 1A. Risk Factors

An investment in Holdings’ common stock or Holdings’ or CUSA’s debt securities involves risks and uncertainties, and our actual results and future trends may differ materially from our past or projected future performance. We urge investors to consider carefully the risk factors described below in addition to the other information contained in this report, in evaluating our Company and our business. It is not possible to identify all risk factors, and additional risks and uncertainties not presently known to us or that we currently believe to be immaterial that may also materially impact our business operations.

Risks Related to Our Business, Economic, Market and Operating Conditions

A variety of uncontrollable events may disrupt our businesses, reduce guest attendance, or increase the cost or reduce the profitability of providing our products and services.

Our results of operations can be significantly and adversely affected in the U.S., Latin America or in specific regions as a result of a variety of factors beyond our control, including: health concerns (including as it was by COVID-19 and could be by future health emergencies, endemics, epidemics and pandemics); adverse weather conditions arising from short-term weather patterns or long-term climate change, including catastrophic events or natural disasters such as hurricanes, typhoons, floods, droughts, wildfires and earthquakes; international, political or military developments, including trade and other international disputes and social unrest; macroeconomic conditions, including a decline in economic activity, inflation, deflation and foreign exchange rate fluctuations; and terrorist attacks. These events and others, such as fluctuations in energy costs and computer virus attacks, intrusions, ransom ware or other widespread computing or telecommunications failures, may also damage our ability to provide our services. We may

10

have insurance coverage with respect to some, but not all, of these events. Moreover, the costs of protecting against such incidents reduces the profitability of our operations.

For example, the impact of the COVID-19 pandemic had an unprecedented impact on the theatrical exhibition industry. While the industry has made significant progress in its recovery from the COVID-19 pandemic, our industry and our business continues to be impacted by disruptions in the film production cycle. Most recently the Hollywood writers’ and actors’ guild strikes caused film production to be temporarily halted or delayed and new film releases were postponed, resulting in a reduction in the volume of new films available for theatrical exhibition. As a result, we are not currently generating attendance and revenue from admissions at levels comparable to what we had generated historically.

We obtain insurance against the risk of losses relating to some of these events, generally including certain physical damage to our property and resulting business interruption, certain injuries occurring on our property and some liabilities for alleged breach of legal responsibilities. When insurance is obtained it is subject to deductibles, exclusions, terms, conditions and limits of liability. The types and levels of coverage we obtain vary from time to time depending on our view of the likelihood of specific types and levels of loss compared to the cost of obtaining coverage for such types and levels of loss. We may experience material losses not covered by our insurance.

Our business depends on film production and performance.

Our business depends on both the availability of films for exhibition in our theatres and the success of those films in our markets. Reduced volume of film releases, poor performance of films, the disruption in the production of films due to events such as a strike by directors, writers, actors or other industry related unions or guilds, a reduction in financing options for the film distributors, a reduction in the production and marketing efforts of the film distributors to make and promote their films, or the consolidation of major film distributors could have an adverse effect on our business by resulting in fewer patrons and reduced revenue. For example, the May 2, 2023 strike by the Writers Guild of America, which lasted for almost five months, and the July 14, 2023 strike by members of SAG-AFTRA, the union representing television and movie actors, which lasted almost four months, together resulted in a decrease in film content released in 2023 and will cause a decrease in 2024 film content due to production delays that have forced studios to push films previously slated to be released in 2023 and 2024 to 2025 and 2026. Also, while the quantity of new film releases available for theatrical exhibition continued to improve in 2023 and caused the industry to further recover from the effects of the COVID-19 pandemic, the volume of film content has not reverted to historical levels. The volume of new films has not, and may not, fully recover to pre-pandemic levels which would materially impact our business. In addition, certain studios have reduced the window for video and digital releases or released films directly to alternative distribution channels such as streaming services simultaneous with a theatrical release. Studios may determine that certain types of film content will not be released for theatrical exhibition in the future and will go straight to streaming platforms, further impacting the quantity of films available.

Our results of operations fluctuate on a seasonal basis.

Our results of operations vary from period to period based upon the quantity and quality of the motion pictures that we show in our theatres. The major film distributors generally release the films they anticipate will be most successful during the summer and holiday seasons. Consequently, we typically generate higher revenue during those periods. In our Latin American markets, while Hollywood content has similar release dates as in the U.S., the local holidays and seasons vary. The unexpected emergence of a successful film during other periods or the failure of an expected success at a key time could alter this seasonality trend. Due to the dependency on the success of films released from one period to the next, results of operations for one period may not be indicative of the results for future periods.

11

A deterioration in relationships with film distributors could adversely affect our ability to obtain commercially successful films.

We rely on the film distributors to supply the films shown in our theatres. The film distribution business is highly concentrated, with six major film distributors accounting for approximately 85% of U.S. box office revenues and 45 of the top 50 grossing films during 2023. Film distributors license films to exhibitors on a theatre-by-theatre and film-by-film basis. Consequently, we cannot guarantee a supply of films by entering into long-term arrangements with major distributors. A deterioration in our relationship with any of the major film distributors could adversely affect our ability to obtain commercially successful films and to negotiate favorable licensing terms for such films, both of which could adversely affect our business and operating results.

We face intense competition for patrons and films which may adversely affect our business.

The motion picture exhibition industry is highly competitive. We compete against local, regional, national and international exhibitors in many of our markets. We compete for both patrons and licensing of films. In markets where we do not face nearby competitive theatres, there is a risk of new theatres being built. The degree of competition for patrons is dependent upon such factors as location, theatre capacity, presentation quality, film showtime and availability, customer service quality, products and amenities offered, and ticket prices. The principal competitive factors with respect to film licensing include the theatre’s location and its demographics, the condition, capacity and grossing potential of each theatre, and licensing terms. We also face competition from new concept theatres such as dine-in theatres, tavern style theatres and family entertainment centers that open in close proximity to our conventional theatres. If we are unable to attract patrons or license successful films, our business may be adversely affected.

An increase in competing forms of entertainment or the use of alternative film distribution channels may reduce movie theatre attendance and limit revenue growth.

We compete with other forms of out-of-home entertainment, such as family entertainment centers, concerts, theme parks, gaming and sporting events, for our patrons’ leisure time and disposable income. We also face competition for patrons from a number of alternative film distribution channels, such as streaming, digital downloads, video on-demand and network television. We have seen an expansion in some of these distribution channels in recent years. A significant increase in popularity of these alternative film distribution channels, competing forms of entertainment or improvements in technologies available at home could have an adverse effect on our business and results of operations.

Our results of operations may be impacted by the reduction, or elimination of, video and digital release windows.

The average video and digital release window, which represents the time that elapses from the date of a film’s theatrical release to the date a film is available for DVD, was approximately 90 days and digital purchase for ownership (also known as electronic sell-through) was approximately 74 days for several years prior to the COVID-19 pandemic. During the COVID-19 pandemic, certain studios adopted strategies that reduced, or in some cases eliminated, the release windows. While the dynamic release window has coalesced to around 45 days for major films, select studios may release certain movie titles to their own streaming platforms either simultaneously with theatrical releases or bypass theatrical releases altogether. While this trend has largely diminished in 2022 and 2023, studios may reduce or eliminate the windows for certain films. If our guests choose to wait for an in-home release rather than attend a theatre to view the film, our business and results of operations, financial condition and cash flows may be adversely impacted.

Our foreign operations are subject to adverse regulations, economic instability and currency exchange risk.

We had 192 theatres with 1,395 screens in 13 countries in Latin America as of December 31, 2023. Brazil represented approximately 7.6% of our consolidated 2023 revenue. Governmental regulation of the motion picture industry in foreign markets differs from that in the U.S. Changes in regulations affecting prices and quota systems requiring the exhibition of locally-produced films may adversely affect our international operations. Our international operations are subject to certain political, economic and other uncertainties not encountered by our domestic operations, including risks of severe economic downturns and high inflation. We also face risks of currency fluctuations, hard currency shortages and controls of foreign currency exchange and cash payments to the U.S., all of which could have an adverse effect on the results of our operations and liquidity.

Tight labor market and loss of key personnel may negatively impact our operations and operating results.

Labor shortages may affect our ability to hire and retain employees. The success of our business depends on our ability to recruit and retain our theatre staff. Without proper staffing, wait times to buy tickets and concessions

12

may be extended and operating hours may be reduced. These conditions could result in a poor guest experience, which could adversely affect future attendance. We could face similar challenges with respect to retaining corporate employees. Losing the services of one or more senior executives, or other key personnel, could adversely affect our ability to execute our business strategies and could have an adverse effect on our business, financial condition, and results of operations, especially if we were unable to timely employ a qualified replacement. Labor shortages could also result in rising wages, affecting our profits.

We are subject to impairment losses due to potential declines in the fair value of our assets.

We have a significant amount of long-lived assets. We evaluate long-lived assets for impairment at the theatre level. Therefore, if a theatre is directly and individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or condition of the areas surrounding the theatre, we may record impairment charges to reflect the decline in estimated fair value of that theatre.

We also have a significant amount of goodwill and tradename intangible assets. Declines in our stock price or market capitalization, or declines in our attendance due to increased competition, macroeconomic conditions or other factors could result in impairments of goodwill and our intangible assets.

We are subject to uncertainties relating to future expansion plans, including our ability to identify suitable acquisition candidates or new theatre site locations, and to obtain financing for such activities on favorable terms or at all.

We have expanded our operations through targeted worldwide theatre development and acquisitions. We continue to pursue a strategy of expansion that involves the development of new theatres and may involve acquisitions of existing theatres and theatre circuits both in the U.S. and internationally. There is significant competition for new site locations and for existing theatre and theatre circuit acquisition opportunities. As a result of such competition, we may not be able to acquire attractive new site locations, existing theatres or theatre circuits on terms we consider acceptable. The pace of our growth may also be impacted by delays in site development caused by other parties. Acquisitions and expansion opportunities may divert a significant amount of management’s time away from the operation of our business. Growth by acquisition also involves risks relating to difficulties in integrating the operations and personnel of acquired companies and the potential loss of key employees of acquired companies. Our potential expansion strategy may not result in improvements to our business, financial condition, profitability or cash flows. Further, our expansion programs may require financing above our existing borrowing capacity and operating cash flows. We may not be able to obtain such financing on acceptable terms, or at all.

Risks Related to Financing and Liquidity

We have substantial long-term lease and debt obligations, which may restrict our ability to fund current and future operations and that restrict our ability to enter into certain transactions.

We have significant long-term debt service obligations and long-term lease obligations. As of December 31, 2023, Holdings had $2,432.1 million in long-term debt obligations, which included $1,972.1 million of CUSA debt and excludes unamortized debt issuance costs and original issue discount. As of December 31, 2023, Holdings and CUSA had $87.8 million in finance lease obligations and $853.3 million in long-term operating lease obligations. The substantial lease and debt obligations could:

•require us to dedicate a substantial portion of our cash flows to payments on our lease and debt obligations, thereby reducing the availability of our cash flows from operations to fund working capital, capital expenditures, acquisitions and other corporate requirements and to pay dividends on Holdings’ common stock;

•impede our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions and other purposes;

•subject us to the risk of increased sensitivity to interest rate increases on our variable rate debt;

•limit our ability to invest in innovations in technology and implement new platforms or concepts in our theatres; and

13

•make us more vulnerable to adverse economic, market and industry conditions, limit our flexibility in planning for, or reacting to, changes in our business operations or to our industry overall, and place us at a disadvantage in relation to our competitors that may have lower debt levels.

Holdings’ and CUSA’s ability to make scheduled payments of principal and interest on their respective indebtedness will depend on our ability to generate positive cash flows and on our future financial results. Our ability to generate positive cash flows is subject to general economic, financial, competitive, regulatory and other factors, some of which are beyond our control. As our industry recovers from the effects of the COVID-19 pandemic and the recent writers’ and actors’ guild strikes, we may not be able to generate cash flows at historical levels, or guarantee that future borrowings will be available under our senior secured credit facility, in an amount sufficient to enable us to pay our indebtedness. If our cash flows and capital resources are insufficient to fund our lease and debt service obligations, we may be forced to reduce or delay capital expenditures, sell assets or operations, seek additional capital or restructure or refinance our indebtedness. We may not be able to take any of these actions, and these actions may not be successful or permit us to meet our scheduled debt service obligations. Certain actions may be restricted under the terms of our existing or future debt agreements, including our senior secured credit facility.

If we fail to make any required payment under the agreements governing our indebtedness or fail to comply with the financial and operating covenants contained in our debt instruments, we would be in default. As a result, our debt holders would have the ability to accelerate the repayment of our outstanding indebtedness, and the lenders under our senior secured credit facility could terminate their commitments and foreclose against the assets securing their borrowings. We could be forced into bankruptcy or liquidation. The acceleration of our indebtedness under one agreement may permit acceleration of indebtedness under other agreements that contain cross-default and cross-acceleration provisions. If our indebtedness is accelerated, we may not be able to repay our indebtedness or borrow sufficient funds to refinance it. Even if we are able to obtain new financing, it may not be on commercially reasonable terms or on terms that are acceptable to us. If our debt holders require immediate payment, we may not have sufficient assets to satisfy our obligations under our indebtedness.

A lowering or withdrawal of the ratings assigned or a change in outlook to our outstanding debt securities by rating agencies may increase our future borrowing costs and reduce our access to capital.

We are rated by nationally recognized rating agencies. The rating scales and methodologies used to derive individual ratings may vary from agency to agency. Credit ratings are issued by credit rating agencies based on evaluations of our ability to pay back our outstanding debt and the likelihood that we would default on that debt prior to its maturity. The credit ratings issued by the rating agencies represent the rating agency's evaluation of both qualitative and quantitative information for our company. The credit ratings that are issued are based on the rating agency’s judgment and experience in determining what information should be considered in giving a rating to a particular company. Ratings are always subject to change and there can be no assurance that our current ratings will remain the same for any given period of time.

Our debt currently has a non-investment grade rating, and any rating assigned could be lowered (or outlook thereof could be changed) or withdrawn entirely by a rating agency if, in that rating agency’s judgment, future circumstances relating to the basis of the rating, such as adverse changes in our business or industry, so warrant. Any future lowering of our ratings likely would make it more difficult or more expensive for us to obtain additional debt financing. In particular, our access to the capital markets may be impacted, our other funding sources may decrease, the cost of debt may increase as a result of increased interest rates or fees, and we may be required to provide additional credit assurances, including collateral, under certain contracts or arrangements.

Holdings’ inability to raise funds necessary to settle conversions of, or to repurchase, the 4.50% Convertible Senior Notes (as defined below), upon a fundamental change as described in the indenture governing the 4.50% Convertible Senior Notes, may lead to defaults under such indenture and under agreements governing our existing or future indebtedness.

If Holdings settles the 4.50% Convertible Senior Notes with cash, or by a combination of cash and shares of our common stock, upon a fundamental change as described in the indenture governing the 4.50% Convertible Senior Notes, Holdings will be required to make cash payments with respect to the 4.50% Convertible Senior Notes being converted. However, Holdings may not have enough available cash or be able to obtain financing at the time it is required to settle the 4.50% Convertible Senior Notes being surrendered or converted. In addition, Holdings’ ability to settle the 4.50% Convertible Senior Notes or to pay cash upon conversion of the 4.50% Convertible Senior Notes is limited by the agreements governing CUSA’s existing indebtedness and may also be limited by law, by regulatory

14

authority or by agreements that will govern future indebtedness. Holdings’ failure to settle the 4.50% Convertible Senior Notes at a time when the repurchase is required by the indenture governing the 4.50% Convertible Senior Notes or to pay cash payable on future conversions of the 4.50% Convertible Senior Notes as required by such indenture would constitute a default under such indenture. A default under the indenture governing the 4.50% Convertible Senior Notes or the fundamental change itself could also lead to a default under agreements governing CUSA’s existing or future indebtedness.

The conditional conversion feature of the 4.50% Convertible Senior Notes, if triggered, may adversely affect our financial condition and operating results.

In the event the conditional conversion feature of the 4.50% Convertible Senior Notes is triggered, holders of the 4.50% Convertible Senior Notes will be entitled to convert the 4.50% Convertible Senior Notes at any time during specified periods at their option. If one or more holders elect to convert their 4.50% Convertible Senior Notes, Holdings may elect to satisfy its conversion obligations by payment and delivery of a combination of cash and shares of its common stock. Settlement of this conversion obligation through the payment of cash could adversely affect Holdings’ and CUSA’s liquidity. In addition, even if holders do not elect to convert their 4.50% Convertible Senior Notes, Holdings could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the 4.50% Convertible Senior Notes as a current rather than long-term liability, which would result in a material reduction of its net working capital.

Conversion of the 4.50% Convertible Senior Notes may dilute the ownership interest of existing stockholders, or may otherwise depress the price of Holdings’ common stock.

The conversion of some or all of the 4.50% Convertible Senior Notes will dilute the ownership interests of existing stockholders to the extent Holdings delivers shares of its common stock upon conversion of any of the 4.50% Convertible Senior Notes. The 4.50% Convertible Senior Notes may from time to time in the future be convertible at the option of their holders prior to their scheduled terms under certain circumstances. Any sales in the public market of the common stock issuable upon such conversion could adversely affect prevailing market prices of its common stock. In addition, the existence of the 4.50% Convertible Senior Notes may encourage short selling by market participants because the conversion of the 4.50% Convertible Senior Notes could be used to satisfy short positions, or anticipated conversion of the 4.50% Convertible Senior Notes into shares of Holdings’ common stock could depress the price of Holdings’ common stock.

The 4.50% Convertible Senior Notes Hedge Transactions and Warrant Transactions (each as defined below) may affect the value of Holdings’ common stock.

In connection with the pricing of the 4.50% Convertible Senior Notes, Holdings entered into Hedge Transactions with, and sold Warrants (as defined below) to, Option Counterparties (as defined below). The Hedge Transactions are expected generally to reduce the potential dilution to Holdings’ common stock upon any conversion of the 4.50% Convertible Senior Notes and/or offset any cash payments Holdings is required to make in excess of the principal amount of converted 4.50% Convertible Senior Notes, as the case may be. The Warrants would separately have a dilutive effect to the extent that the market price per share of Holdings’ common stock exceeds the strike price of any Warrants on the applicable expiration dates unless, subject to the terms of the Warrants, Holdings elects to cash settle the Warrants. In addition, the Option Counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to Holdings’ common stock and/or purchasing or selling Holdings’ common stock or other securities of Holdings’ in secondary market transactions prior to the maturity of the 4.50% Convertible Senior Notes (and are likely to do so during any observation period related to a conversion of the 4.50% Convertible Senior Notes or following any repurchase of the 4.50% Convertible Senior Notes by us in connection with any fundamental change repurchase date or otherwise). This activity could also cause or avoid an increase or decrease in the market price of Holdings’ common stock.

In addition, if any such Hedge Transactions and Warrants fail to become effective, the Option Counterparties or their respective affiliates may unwind their hedge positions with respect to Holdings’ common stock, which could adversely affect the market price of its common stock. The potential effect, if any, of these transactions and activities on the market price of Holdings’ common stock will depend in part on market conditions and cannot be ascertained at this time. Any of these activities could adversely affect the value of Holdings’ common stock.

15

Holdings is subject to counterparty risk with respect to the 4.50% Convertible Senior Notes Hedge Transactions.

The Option Counterparties are financial institutions or affiliates of financial institutions, and Holdings will be subject to the risk that one or more of such Option Counterparties may default under the Hedge Transactions. Holdings’ exposure to the credit risk of the Option Counterparties will not be secured by any collateral. If any Option Counterparty becomes subject to insolvency proceedings, Holdings will become an unsecured creditor in those proceedings with a claim equal to its exposure at that time under its transactions with that counterparty. Holdings’ exposure will depend on many factors but, generally, the increase in Holdings’ exposure will be correlated to the increase in Holdings’ common stock market price and the volatility of the market price of Holdings’ common stock. In addition, upon a default by the Option Counterparty, Holdings may suffer adverse tax consequences and more dilution than it currently anticipates with respect to its common stock. Holdings can provide no assurance as to the financial stability or viability of any Option Counterparty.

A credit market crisis may adversely affect our ability to raise capital and may materially impact our operations.

Severe dislocations and liquidity disruptions in the credit markets could materially impact our ability to obtain debt financing on reasonable terms or at all. The inability to access debt financing on reasonable terms could materially impact our ability to make acquisitions, invest in technology innovations or significantly expand our business in the future.

Holdings’ ability to pay dividends may be limited or otherwise restricted.

Holdings’ ability to pay dividends is limited by its status as a holding company and the terms of CUSA’s senior notes indentures and CUSA’s senior secured credit facility, which restrict Holdings’ ability to pay dividends and the ability of certain of its subsidiaries to pay dividends, directly or indirectly, to Holdings. Under CUSA’s debt instruments, we may pay a cash dividend up to a specified amount, provided we have satisfied certain financial covenants in, and are not in default under, CUSA’s debt instruments. The declaration of future dividends on Holdings’ common stock, par value $0.001 per share, or Common Stock, will be at the discretion of Holdings’ board of directors and will depend upon many factors, including our results of operations, cash flows, financial condition, earnings, capital requirements, limitations in CUSA’s debt agreements and legal requirements. Holdings suspended its dividend in March 2020 due to the impacts of the COVID-19 pandemic and it is uncertain when Holdings will resume paying dividends.

Future sales of Holdings’ common stock may adversely affect the prevailing market price.

Future sales of substantial amounts of Holdings’ common stock in the open market and the issuance of the shares reserved for potential future issuance under Holdings’ incentive plan, in exchange for outstanding warrants, conversion of outstanding 4.50% Convertible Senior Notes, or in connection with acquisitions or other corporate events, will be dilutive to Holdings’ existing stockholders and could result in a decrease in Holdings’ stock price. Holdings cannot predict whether substantial amounts of its common stock will be sold in the open market in anticipation of, or following, any divestiture by any of its large stockholders, its directors or executive officers of their shares of common stock. Holdings can also issue shares of its common stock which are authorized but unissued and not reserved for any specific purpose without any action or approval by its stockholders.

We may not be able to generate additional revenue or continue to realize value from our investment in NCMI.

As of December 31, 2023, we owned 4.4 million shares of National Cinemedia, Inc. (“NCMI”), which represented an ownership interest in NCM of approximately 4.5%. NCMI is a holding company that serves as the sole manager of NCM. NCM comprises approximately the entire balance of NCMI’s assets, liabilities and operating cash flows. CUSA receives monthly theatre access and advertising fees under an Exhibitor Services Agreement with NCM, and CUSA is entitled to receive quarterly distributions of excess cash from NCM pursuant to NCM’s operating agreement. During the years ended December 31, 2021, 2022 and 2023, Holdings and CUSA each recorded approximately $44.1 million, $52.2 million and $53.3 million in other revenue related to NCM, respectively, and $0.3 million, $0 million and $0 million in cash distributions, respectively. On April 11, 2023, NCM filed a petition for reorganization under Chapter 11 of the United States Bankruptcy Code. NCMI continued to manage NCM, the “debtor in possession,” under the jurisdiction of the bankruptcy court and in accordance with the applicable bankruptcy laws and orders of the bankruptcy court. In general, as debtor in possession under the Bankruptcy Code, NCM was authorized to continue to operate as an ongoing business but could not engage in transactions outside the ordinary course of business without the prior approval of the bankruptcy court. On August 3, 2023, NCMI announced that it had effected a 1-for-10 reverse stock split of its common stock. NCMI’s common stock automatically began trading

16

on a split adjusted basis at the opening of the market on August 4, 2023. After giving effect to the reverse stock split, the Company owns approximately 4.4 million shares of NCMI common stock. NCM emerged from bankruptcy on August 7, 2023, and the Company’s ownership interest in NCMI was reduced to less than 5%. Distributions of excess cash from NCM to its members, including NCMI, were restricted through December 2023 in accordance with the credit agreement amendment NCM entered into with its lenders and as a result of their bankruptcy filing. NCMI also suspended its dividend.

Cinema advertising is a small component of the U.S. advertising market and therefore, NCM competes with larger, more established and well-known media platforms such as broadcast radio and television, cable and satellite television, outdoor advertising and Internet portals. In-theatre advertising may not continue to attract advertisers or NCM’s in-theatre advertising format may not continue to be received favorably by theatre patrons. If NCM is unable to continue to generate consistent advertising revenue, its results of operations may be adversely affected and our investment in NCM may be adversely impacted. Since NCM's revenues are primarily dependent on theatre attendance, future NCM revenues and future dividends from NCMI will depend on the continued recovery of the motion picture exhibition industry.

Regulatory Risks

We are subject to various government regulations which could result in substantial costs.

We are subject to various federal, state and local laws, regulations and administrative practices in the U.S. and internationally. We must comply with laws regulating, among other things, antitrust activities, employment environment, sale of concession goods, alcoholic beverages, data protection and privacy and Title III of the Americans with Disabilities Act of 1990 ("ADA") and similar state disability rights laws. Compliance with the ADA and similar disability rights laws requires us as a public accommodation to reasonably accommodate individuals with disabilities. This applies to the construction of new theatres, certain renovations, existing theatres, websites and mobile applications and presentations for the blind, deaf and hard of hearing. Changes in existing laws, regulations or administrative practices or new laws, regulations or administrative practices could have a significant impact on our business.

We may face data protection, data security, and privacy risks in connection with privacy regulation.

Strict data privacy laws regulating the collection, transmission, storage and use of employee data and consumers’ personally identifying information are evolving in the U.S. and other jurisdictions in which we operate. These laws impose compliance obligations for the collection, use, retention, security, processing, transfer and deletion of personally identifiable information of individuals and creates enhanced rights for individuals. These changes in the legal and regulatory environments in the areas of customer and employee privacy, data security, and cross-border data flows could have a material adverse effect on our business, primarily through the impairment of our marketing and transaction processing activities, the limitation on the types of information that we may collect, process and retain, the resulting costs of complying with such legal and regulatory requirements and potential monetary forfeitures and penalties for noncompliance.

We may be subject to increased labor and benefits costs.

In the U.S., we are subject to United States federal and state laws governing such matters as minimum wages, working conditions and overtime. We are also subject to union regulations in certain of our international markets, which can specify wage rates as well as minimum hours to be paid to certain employees. As federal and state minimum wage rates increase, we may need to increase not only the wages of our minimum wage employees, but also the wages paid to employees at wage rates that are above minimum wage. Labor market conditions have also recently driven increases in wages across our labor base and similar increases may continue in the future. Labor shortages, increased employee turnover and health care mandates could also increase our labor costs. This in turn could lead us to increase prices, which could impact our sales. Conversely, if competitive pressures or other factors prevent us from offsetting increased labor costs by increases in prices, our results of operations may be adversely impacted.

17

Provisions in Holdings’ corporate documents and certain of CUSA’s agreements, as well as Delaware law, may hinder a change of control.

Provisions in the Holdings amended and restated certificate of incorporation and bylaws, as well as provisions of the Delaware General Corporation Law, could discourage unsolicited proposals to acquire us. These provisions include:

•authorization of Holdings’ board of directors to issue shares of preferred stock without stockholder approval;

•a board of directors classified into three classes of directors with the directors of each class having staggered, three-year terms;

•provisions regulating the ability of Holdings’ stockholders to nominate directors for election or to bring matters for action at annual meetings of its stockholders; and

•provisions of Delaware law that restrict many business combinations and provide that directors serving on classified boards of directors, may be removed only for cause.

Certain provisions of CUSA’s 8.75% secured notes indenture, 5.25% senior notes indenture, CUSA’s 5.875% senior notes indenture and CUSA’s senior secured credit facility may have the effect of delaying or preventing future transactions involving a “change of control.” A “change of control” would require us to make an offer to the holders of each of its 8.75% Secured Notes, 5.25% Senior Notes and 5.875% Senior Notes to repurchase all of the outstanding notes at a purchase price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest to the date of purchase. A “change of control” would also be an event of default under CUSA’s senior secured credit facility.

Risks Related to Information Security and Business Disruptions

An information security incident, including a cyber security breach, and our failure to protect our electronically stored data could adversely affect our business or reputation.

We collect, use, store and maintain electronic information and data necessary to conduct our business, including confidential and proprietary information of the company, our customers, and our employees. We also rely on the availability of information technology systems to operate our business, including for communications, receiving and displaying movies, ticketing, guest services, payments, and other general operations. We rely on some of our vendors to store and process certain data and to manage, host, and/or provide some of our information technology systems. Because of the scope and complexity of our information technology systems, our reliance on vendors to provide, support and protect our systems and data, and the constantly evolving cyber-threat landscape, our information technology systems are subject to the risk of disruption, failure, unauthorized access, cyber-terrorism, human error, misuse, tampering, theft, and other cyber-attacks. These or similar events, whether accidental or intentional, could result in theft, unauthorized access or disclosure, loss, fraudulent or unlawful use of customer, employee or company data, which could harm our reputation or result in a loss of business, as well as remedial and other costs, fines, investigations, enforcement actions or lawsuits. These or similar events could also lead to an interruption in the operation of our systems resulting in business impact, including loss of business. These same factors could also affect our ability to adapt to and comply with changing regulations and contractual obligations applicable to data security and privacy, which are increasingly demanding, both in the United States and in other jurisdictions where we operate. In order to address these risks, we have adopted security measures and technology, operate a security program, and work continuously to evaluate and improve our security posture. However, the development and maintenance of these systems and programs are costly and require ongoing monitoring and updating as technologies change and efforts to overcome security measures become more sophisticated. As such, there can be no assurance that these or similar events will not occur in the future or will not have an adverse effect on our business and results of operations.

In addition to Company-specific cyber threats or events, our business and results of operations could also be impacted by cyber-related events affecting our peers and partners within the entertainment industry, as well as other retail companies. We maintain insurance designed to provide coverage for cyber risks related to what we believe to be adequate and collectible insurance in the event of the theft, loss, fraudulent or unlawful use of customer, employee or company data, but the foregoing events or future events could result in costs and business impacts which may not be covered or may be in excess of any available insurance that we may have procured. As a result, future events could have a material impact on our business and adversely affect our financial condition and results of operations.

18

Other General Risks

A failure to adapt to future technological innovations could impact our ability to compete effectively and could adversely affect our results of operations.

While we continue to invest in technological innovations, such as laser projectors and motion seats, new technological innovations continue to impact our industry. If we are unable to respond to or invest in changes in technology and the technological preferences of our customers, we may not be able to compete with other exhibitors or other entertainment venues, which could adversely affect our results of operations.

Legislative or regulatory initiatives related to global warming/climate change concerns may negatively impact our business.

Recently, there has been an increasing focus and continuous debate on global climate change including increased attention from regulatory agencies and legislative bodies. This increased focus may lead to new initiatives directed at regulating an as-yet unspecified array of environmental matters. Legislative, regulatory or other efforts in the U.S. to combat climate change could result in future increases in the cost of raw materials, taxes, transportation and utilities for our vendors and for us which would result in higher operating costs for the Company. Also, compliance of our theatres and accompanying real estate with new and revised environmental, zoning, land-use or building codes, laws, rules or regulations, could have a material and adverse effect on our business. However, we are unable to predict at this time, the potential effects, if any, that any future environmental initiatives may have on our business.

We may be subject to liability under environmental laws and regulations.

We own and operate a large number of theatres and other properties within the U.S. and internationally, which may be subject to various foreign, federal, state and local laws and regulations relating to the protection of the environment or human health. Such environmental laws and regulations include those that impose liability for the investigation and remediation of spills or releases of hazardous materials. We may incur such liability, including for any currently or formerly owned, leased or operated property, or for any site, to which we may have disposed, or arranged for the disposal of, hazardous materials or wastes. Certain of these laws and regulations may impose liability, including joint and several liability, which can result in a liable party being obliged to pay for greater than its share, regardless of fault or the legality of the original disposal. Environmental conditions relating to our properties or operations could have an adverse effect on our business and results of operations and cash flows.

Product recalls and associated costs could adversely affect our reputation and financial condition.

We may be found liable if the consumption of any of the products we sell causes illness or injury. We are also subject to recall by product manufacturers or if the food products become contaminated. Recalls could result in losses due to the cost of the recall, the destruction of the product and lost sales due to the unavailability of the product for a period of time.

Item 1B. Unresolved Staff Comments

None.

Item 1C. Cybersecurity

Risk Management and Strategy. The Company has developed an information security program to address material risks from cybersecurity threats. The program includes policies and procedures that identify how security measures and controls are developed, implemented, and maintained. Risk-based analysis and judgment, along with a recognized security framework, are used to select security controls to address risks. During this process, the following factors, among others, are considered: likelihood and severity of risk, impact on the Company and others if a risk materializes, feasibility and cost of controls, and impact of controls on operations and others. Specific controls that are used to some extent include endpoint threat detection and response (EDR), identity and access management (IAM), privileged access management (PAM), logging and monitoring involving the use of security information and event management (SIEM), multi-factor authentication (MFA), firewalls and intrusion detection and prevention, and vulnerability and patch management.

Third-party security firms are used in different capacities to provide or operate some of these controls and technology systems, including cloud-based platforms and services, as well as a security operations center. For example, third parties are used to conduct assessments, such as vulnerability scans and penetration testing. The

19

Company uses a variety of processes to address cybersecurity threats related to the use of third-party technology and services, including pre-acquisition diligence, imposition of contractual obligations, and performance monitoring.

The Company has a written incident response plan and conducts tabletop exercises to enhance incident response preparedness. Business continuity and disaster recovery plans are used to prepare for the potential for a disruption in technology we rely on. The Company is a member of an industry cybersecurity intelligence and risk sharing organization. Employees undergo security awareness training when hired and annually. The Company (or third parties it relies on) may not be able to fully, continuously, and effectively implement security controls as intended. As described above, we utilize a risk-based approach and judgment to determine the security controls to implement, and it is possible we may not implement appropriate controls if we do not recognize or underestimate a particular risk. In addition, security controls, no matter how well designed or implemented, may only mitigate and not fully eliminate risks. And events, when detected by security tools or third parties, may not always be immediately understood or acted upon.

Additionally, in Item 1A Risk Factors, under the heading of Risk Related to Information Security and Business Disruptions, forward-looking cybersecurity threats that could have a material impact on the Company are discussed. Those sections of Item 1A Risk Factors should be read in conjunction with this Item 1C Cybersecurity.

Governance. The Chief Technology Officer (CTO) is the management position with primary responsibility for the development, operation, and maintenance of our information security program. The Company’s CTO, Doug Fay, has served as the Chief Technology Officer & Sr. Vice President for Cinemark since August 2006. Mr. Fay has a background in software engineering and application architecture and has worked in the information technology field since the early 1990s. The CTO routinely reviews risks and security measures and meets monthly with the general counsel, CFO, and Global Controller to review security measures and risks. Oversight of the information security program at the Board level sits with Audit Committee. Presentations regarding security measures and risks to the Audit Committee occur semi-annually. The Company’s incident response plan defines the process for escalating incidents based on level of severity to the management team and Audit Committee.

Item 2. Properties

The following table sets forth a summary of our theatres in U.S. and international markets as of December 31, 2023:

	Leased		Owned
Segment	Theatres		Theatres
U.S.		269		40
International		192		—
Total		461		40

See also Item 1, Business – Theatre Operations, for a summary of the geographic locations for our U.S. and international theatre circuit as of December 31, 2023.

The Company conducts a significant part of its theatre operations in leased properties under noncancelable operating and finance leases with base terms generally ranging from 10 to 25 years. In addition to fixed lease payments, some of the leases provide for variable lease payments and some require the payment of taxes, insurance, common area maintenance and other costs applicable to the property. Variable lease payments include payments based on a percentage of sales over defined thresholds. Other variable lease payments include payments adjusted periodically for inflation, changes in attendance or changes in average ticket price. The Company can renew, at its option, many of its leases at defined or then market rental rates for various renewal periods. Some leases also provide for escalating rent payments throughout the lease term. See Note 4 to the consolidated financial statements for further discussion of our leases.

In addition to our theatre properties, we currently own an office building in Plano, Texas, which is our global headquarters. We lease office space in Frisco, Texas and a warehouse in McKinney, Texas. We also lease office space in seven regions in Latin America for our local office teams.

20

Item 3. Legal Proceedings

For a discussion of contingencies related to legal proceedings, see Note 21 to the consolidated financial statements, which is hereby incorporated by reference.

Item 4. Mine Safety Disclosures

Not applicable.

21

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information and Holders of Common Stock

Holdings’ common equity consists of common stock, which has traded on the New York Stock Exchange since April 24, 2007 under the symbol “CNK.”

As of December 31, 2023, there were approximately 570 holders of record of Holdings’ common stock and there were no other classes of stock issued and outstanding.

Dividend Policy

Holdings, at the discretion of its board of directors and subject to applicable law, may pay regular quarterly dividends on its common stock. The amount, if any, of the dividends to be paid in the future will depend upon our then available cash, anticipated cash needs, overall financial condition, debt agreement restrictions, forecasted earnings and cash flows, as well as other relevant factors. In March 2020, the Holdings board of directors suspended its dividend in response to the impacts of the COVID-19 pandemic. See Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operation – Liquidity and Capital Resources – Financing Activities for a discussion of dividend restrictions under CUSA’s debt agreements.

CUSA did not pay any cash dividends to Holdings during the years ended December 31, 2021, 2022 and 2023. CUSA’s ability to pay dividends is limited by the terms of its senior notes indentures and its senior secured credit facility, which restrict its ability to pay dividends and the ability of its subsidiaries to pay dividends. See Note 14 to the consolidated financial statements for further discussion of our debt agreements. The declaration of future dividends will depend upon many factors, including CUSA’s results of operations, financial condition, earnings, capital requirements, limitations in our debt agreements and legal requirements.

22

Performance Graph

We benchmark our financial performance against AMC Entertainment Holdings, Inc. (AMC) and IMAX Corporation (IMAX), the two other publicly-held companies in our industry with whom we compete for investor capital. The performance graph below sets forth the cumulative total shareholder return (assuming reinvestment of dividends) to Holdings’ stockholders during the five-year period ended December 31, 2023, as well as the corresponding returns on the S&P 500 Index and in each of AMC and IMAX. Holdings’ stock price performance shown in the graph below may not be indicative of future stock performance.

 

Purchases of Equity Securities

In the fourth quarter of 2023, Holdings purchased shares of its common stock as follows:

	Total Number of Shares Purchased (1)		Average Price Paid per Share		Total Number of Shares Purchased As Part of Publicly Announced Plans		Approximate Dollar Value of Shares that May Yet Be Purchased Under Publicly Announced Plan
October 1 through October 31		—	$	—		—		—
November 1 through November 30		17.90	$	15.42		—		—
December 1 through December 31		9.53	$	14.09		—		—
Total		27.43				—		—

(1) Represents shares of Holdings’ common stock (in thousands) repurchased by withholding shares in October, November and December of 2023 to satisfy employee tax-withholding obligations upon vesting in restricted stock and performance stock units. See Note 18 to the consolidated financial statements.

Item 6. [Reserved]

23

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cinemark Holdings, Inc. is a holding company and its wholly-owned subsidiary is Cinemark USA, Inc. Holdings consolidates CUSA and its subsidiaries for financial statement purposes, and CUSA comprises approximately the entire balance of Holdings’ assets, liabilities and operating cash flows. In addition, CUSA’s operating revenue and operating expenses comprise nearly 100% of Holdings’ revenue and operating expenses. As such, Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) that follows is for Holdings and CUSA in all material respects, unless otherwise noted. Differences between the operations and results of Holdings and CUSA are separately disclosed and explained. Where it is important to distinguish between the entities, we either refer specifically to Holdings or CUSA. Otherwise, all references to “we,” “our,” “us,” “the Company” or “Cinemark” relate to Cinemark Holdings, Inc. and its consolidated subsidiaries and all references to CUSA relate to CUSA and its consolidated subsidiaries.

The following discussion and analysis should be read in conjunction with the financial statements and accompanying notes included in this report. This discussion may contain forward-looking statements. See “Cautionary Statement Regarding Forward-Looking Statements” and “Risk Factors” for a discussion of the uncertainties and risks associated with these statements. Discussion regarding our financial condition and results of operations for 2022 compared with 2021 is included in Item 7 of the Company’s 2022 Annual Report on Form 10-K filed on February 24, 2023.

Overview

We are a leader in the motion picture exhibition industry, with theatres in the U.S., Brazil, Argentina, Chile, Colombia, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, and Paraguay. As of December 31, 2023, we managed our business under two reportable operating segments – U.S. markets and international markets. See Note 22 to the consolidated financial statements.

Impact of COVID-19 Pandemic

The impact of the COVID-19 pandemic had an unprecedented effect on the theatrical exhibition industry. We temporarily closed our theatres in the U.S. and Latin America during March of 2020 at the onset of the COVID-19 outbreak. We reopened theatres as soon as local restrictions and the status of the COVID-19 pandemic would allow. All of our domestic and international theatres were reopened by the end of 2021. After reopening our theatres, we faced ongoing challenges with the significant reduction in the volume of new film releases. The industry has made significant progress in its recovery from the COVID-19 pandemic; however its ongoing recovery continues to be contingent upon several key factors, including the volume of new film content available, which has also been impacted by the recent writers’ and actors’ guild strikes, the box office performance of new film content released, the duration of the exclusive theatrical release window and evolving consumer behavior with competition from other forms of in-and-out of home entertainment.

Revenue and Expenses

We generate revenue primarily from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rental and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals and electronic video games located in some of our theatres. We also offer alternative entertainment, such as the Metropolitan Opera, concert events, live and pre-recorded sports programs and other special events in our theatres. NCM provides our domestic theatres with various forms of in-theatre advertising. Our Flix Media subsidiaries provide screen advertising and alternative content for our international circuit and other international exhibitors.

Films released during the year ended December 31, 2023 included Barbie, The Super Mario Bros. Movie, Spider-Man: Across the Spider-Verse, Guardians of the Galaxy Vol. 3, Oppenheimer, The Little Mermaid, Ant-Man and the Wasp: Quantumania, John Wick: Chapter 4, Sound of Freedom, Taylor Swift | The Eras Tour concert film, The Hunger Games: The Ballad of Songbirds and Snakes, Five Nights at Freddy’s, Wonka, and Trolls Band Together, among other films.

Films scheduled for release in 2024 include Madame Web, Dune: Part Two, Ghostbusters: Frozen Empire, Kung Fu Panda 4, The Fall Guy, Furiosa, Kingdom of the Planet of the Apes, Inside Out 2, A Quiet Place: Day One,

24

Despicable Me 4, Deadpool 3, Joker: Folie à Deux, Venom 3, Wicked - Part I, Mufusa: The Lion King, and Sonic the Hedgehog 3, among other films.

Film rental costs are variable in nature and fluctuate with our admissions revenue. Film rental costs as a percentage of revenue are generally higher for periods in which more blockbuster films are released. The Company previously received virtual print fees (VPFs) from studios for certain of its international locations, which were included as a contra-expense in film rental and advertising costs on the consolidated statements of income. However, these costs were fully recovered during 2021, and as a result, were not received during 2022 and 2023 and will not be received in future periods. Advertising costs, which are expensed as incurred, are primarily related to expanding our reach to our guests, keeping Cinemark elevated in the moviegoer consideration set and growing loyalty. These expenses vary depending on the timing and length of such campaigns.

Concession supplies expense is variable in nature and fluctuates with our concession revenue and also product mix. Inflationary pressures, and to a lesser extent supply chain interruptions, have impacted, and may continue to impact, product costs and product availability. We source products from a variety of partners around the world to minimize supply chain interruptions and cost pressures, wherever possible.

Although salaries and wages include a fixed cost component (i.e., the minimum staffing costs to operate a theatre facility during non-peak periods), salaries and wages tend to move in relation to revenue as theatre staffing is adjusted to respond to changes in attendance. Staffing levels may vary based on the amenities offered at each location, such as full-service restaurants, bars or expanded food and beverage options. In certain international locations, staffing levels are also subject to local regulations, including minimum hour requirements. Labor market conditions and inflationary pressures have driven increases in wages across our labor base and similar increases may continue in the future.

Facility lease expense is primarily a fixed cost at the theatre level as most of our facility leases require a fixed monthly minimum rent payment. Certain leases are subject to percentage rent only, while others are subject to percentage rent in addition to their fixed monthly rent if a target annual performance level is achieved.

Utilities and other costs include both fixed and variable costs and primarily consist of utilities, property taxes, janitorial costs, credit card transaction fees, third party ticket sales commissions, repairs and maintenance expenses, security services and projection and sound equipment maintenance expenses.

General and administrative expenses to support the overall management of the Company are primarily fixed in nature with certain variable components. Fixed expenses include salaries, wages and benefits costs for our corporate office personnel, facility expenses for our corporate and other offices, software license and maintenance costs and audit fees. Some variable expenses may include incentive compensation, consulting and legal fees, supplies and other costs that are not specifically associated with the operations of our theatres.

Critical Accounting Policies and Estimates

Holdings and CUSA each prepare their consolidated financial statements in conformity with generally accepted accounting principles in the U.S., or U.S. GAAP. As such, Holdings and CUSA are each required to make certain estimates and assumptions that it believes are reasonable based upon the information available. These estimates and assumptions affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The significant accounting policies and estimates, which we believe are the most critical to aid in fully understanding and evaluating Holdings’ and CUSA’s reported consolidated financial results, include the following:

Revenue and Expense Recognition

Our patrons have the option to purchase movie tickets well in advance of a movie showtime, right before the movie showtime, or at any point in between those two timeframes depending on seat availability. We recognize such admissions revenue when the showtime for a purchased movie ticket has passed. Concession revenue is recognized when products are sold to the consumer, or if purchased in advance, once the showtime associated with the customer’s movie ticket has passed. Other revenue primarily consists of screen advertising, screen rental revenue, promotional income, studio trailer placements, revenue from electronic video games located in our theatres, and transactional fees. Except for NCM screen advertising advances (see Note 9 to the consolidated financial statements), these revenues are generally recognized when we have fulfilled our performance obligations by providing the specified services.

25

We sell gift cards and discount ticket vouchers, the proceeds from which are recorded as deferred revenue. Deferred revenue for gift cards and discount ticket vouchers is recognized when they are redeemed for concession items or, if redeemed for movie tickets, when the showtime has passed. We generally record breakage revenue on gift cards and discount ticket vouchers based on redemption activity and historical experience with unused balances.

We offer a subscription program in the U.S. whereby patrons can pay a monthly or annual fee to receive a monthly credit for use towards a future movie ticket purchase. We also offer monthly subscription fee programs in several of our international locations where customers can pay a monthly fee to receive benefits such as a free monthly ticket. We record the subscription program fees as deferred revenue and record admissions revenue when the showtime for a movie ticket purchased with a credit has passed.

We have loyalty programs in the U.S. and many of our international locations that either have a prepaid annual fee or award points to customers as purchases are made. For those loyalty programs that have a prepaid annual fee, we recognize the fee collected as other revenue on a straight-line basis over the annual membership period. For those loyalty programs that award points to customers based on their purchases, we record a portion of the original transaction proceeds as deferred revenue based on the number of reward points issued to customers and recognize the deferred revenue when the customer redeems such points. The value of loyalty points issued is based on the estimated fair value of the rewards offered. We record breakage revenue on deferred loyalty and subscription revenue generally upon the expiration of loyalty points and subscription credits, respectively, as we do not yet have sufficient historical data related to the redemption patterns of these programs to estimate breakage.

Film rental costs are based on the film licensing arrangements and accrued based on the applicable box office receipts and either; 1) a sliding scale formula, which is generally established prior to the opening of the film, 2) a firm terms formula as negotiated prior to a film’s theatrical run or 3) estimates of the final settlement rate, which occurs at the conclusion of the film’s run. Under a sliding scale formula, we pay a percentage of box office revenues using a pre-determined scale that is based upon box office performance of the film for its full theatrical run. Under a firm terms formula, we pay the distributor a percentage of box office receipts that can either be an aggregate rate for the full theatrical run or rates that decline over the term of the theatrical run. The settlement process allows for negotiation of film rental fees upon the conclusion of the film's theatrical run based upon how the film performs. Estimates are based on the expected success of a film. The success of a film can generally be determined a few weeks after a film is released when the initial box office performance of the film is known. If actual settlements are different than those estimates, film rental cost estimates are adjusted at that time.

Facility lease expense is primarily a fixed cost at the theatre level as most of our facility leases require a fixed monthly minimum rent payment. Certain of our leases are subject to monthly percentage rent only, which is accrued each month based on actual revenues. Certain of our other theatres require payment of percentage rent in addition to fixed monthly rent if an annual target revenue level is achieved. Percentage rent expense for these annual payments is estimated and recorded for these theatres on a monthly basis if the theatre’s historical performance or forecasted performance indicates that the annual target revenue level will be reached. Once actual annual percentage rent is determinable, the timing of which is based on the respective lease agreement, percentage rent expense estimates are adjusted at that time.

Theatre properties and equipment are depreciated using the straight-line method over their estimated useful lives. In estimating the useful lives of our theatre properties and equipment, we have relied upon our experience with such assets and our historical replacement period. We periodically evaluate these estimates and assumptions and adjust them as necessary. Leasehold improvements for which we pay, and to which we have title, are amortized over the lesser of their useful life or the remaining initial lease term.

Long-Lived Assets Impairment Evaluations

We review long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. We also perform a full quantitative impairment evaluation on an annual basis. We assess many factors to determine whether to impair individual theatre assets, including the following:

•actual theatre level cash flows;

•budgeted or forecasted theatre level cash flows;

•theatre property and equipment carrying values;

26

•operating lease right-of-use asset carrying values;

•the age of a recently built theatre;

•change in competitive theatres in the marketplace;

•the impact of recent theatre remodels or other substantial improvements;

•available lease renewal options; and

•other factors considered relevant in our assessment of impairment of individual theatre assets.

Long-lived assets are evaluated for impairment on a theatre level, which we believe is the lowest applicable level for which there are identifiable cash flows. The impairment evaluation is based on the estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the remaining lease period, which may include the probability of the exercise of available renewal periods for leased properties, and the lesser of twenty years or the building’s remaining useful life for owned properties. If the estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, we then compare the carrying value of the asset group (theatre) with its estimated fair value. When estimated fair value is determined to be lower than the carrying value of the asset group (theatre), the asset group (theatre) is written down to its estimated fair value. Significant judgment is involved in estimating cash flows and fair value. Fair value is determined based on a multiple of cash flows. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples.

See further discussion of our impairment evaluation policy in Note 1 of the consolidated financial statements. See a summary of the impairment charges recorded during the years ended December 31, 2021, 2022 and 2023 in Note 12 to the consolidated financial statements.

Goodwill and Intangible Assets Impairment Evaluations

We evaluate goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable. We evaluate goodwill for impairment at the reporting unit level, which is the U.S. and each of our international countries that has been allocated goodwill (we do not have goodwill recorded for all of our international locations). Under our quantitative goodwill impairment analysis, we estimate the fair value of each reporting unit and compare that to its carrying value. Fair value is estimated using (i) a market approach, which considers a multiple of cash flows for each reporting unit based upon public trading and recent transaction valuation multiples as the basis for fair value and (ii) an income approach, which uses a discounted cash flow model incorporating discount rates commensurate with the risks involved as the basis for fair value. Significant judgment including management’s estimate of future theatre level cash flows for each theatre is involved in estimating the fair value of a reporting unit. Our estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on projected operating performance of each reporting unit, recent market transactions and current industry trading multiples. Under ASC Topic 350, Goodwill, Intangibles and Other, we may perform a qualitative impairment assessment or a quantitative impairment assessment of our goodwill.

Tradename intangible assets are tested for impairment at least annually as of November 30th or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. Under ASC Topic 350, we can elect to perform a qualitative or quantitative impairment assessment for our tradename intangible assets. A quantitative tradename impairment assessment includes comparing the carrying values of tradename assets to their estimated fair value. Fair values are estimated by applying an estimated market royalty rate that could be charged for the use of our tradenames to forecasted future revenues, with an adjustment for the present value of such royalties. If the estimated fair value is less than the carrying value, the tradename intangible asset is written down to its estimated fair value. Significant judgment is involved in estimating market royalty rates and long-term revenue forecasts. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected revenue performance and industry trends. The Company’s qualitative assessment considers industry and market conditions and recent developments that may impact the revenue forecasts and other estimates as compared to its most recent quantitative assessment.

See further discussion of our impairment evaluation policy in Note 1 of the consolidated financial statements. See a summary of the impairment charges recorded during the years ended December 31, 2021, 2022 and 2023 in Note 12 to the consolidated financial statements.

27

Income Taxes

CUSA participates in the consolidated return of Holdings; however, CUSA’s provisions for income taxes are computed on a stand-alone basis. We use an asset and liability approach to financial accounting and reporting for income taxes. Deferred income taxes are provided when tax laws and financial accounting standards differ with respect to the amount of income for a year and the basis of assets and liabilities. A valuation allowance is recorded to reduce the carrying amount of deferred tax assets unless it is more likely than not that such assets will be realized. Income taxes are provided on unremitted earnings from foreign subsidiaries unless such earnings are expected to be indefinitely reinvested. Income taxes have also been provided for potential tax assessments. The evaluation of an uncertain tax position is a two-step process. The first step is recognition: We determine whether it is more likely than not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, we presume that the position would be examined by the appropriate taxing authority that would have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured at the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Differences between tax positions taken in a tax return and amounts recognized in the financial statements result in (1) a change in a liability for income taxes payable or (2) a change in an income tax refund receivable, a deferred tax asset or a deferred tax liability or both (1) and (2). We accrue interest and penalties on uncertain tax positions. See Note 20 to the consolidated financial statements for further discussion of income taxes.

Accounting for Investment in National CineMedia, Inc. and Related Agreements

We have an investment in National CineMedia, Inc., or NCMI. NCMI is a holding company and the sole manager of NCM. NCM operates a digital in-theatre network in the U.S. for providing cinema advertising. NCM comprises approximately the entire balance of NCMI’s assets, liabilities and operating cash flows. The Company entered into an Exhibitor Services Agreement, or ESA, with NCM pursuant to which NCM primarily provides screen advertising to its domestic theatres. On February 13, 2007, NCMI completed an initial public offering (“IPO”) of its common stock. In connection with the NCMI initial public offering, the Company amended its operating agreement and the ESA. At the time of the NCMI IPO and as a result of amending the ESA, the Company received approximately $174 million in cash consideration from NCM. The proceeds were recorded as deferred revenue, or NCM screen advertising advances, and are being amortized over the term of the amended and restated ESA, which expires in February 2041.

The Company also periodically receives consideration in the form of common unit adjustments from NCM. Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCMI and the Company, referred to as the Founding Members, we receive annual adjustments to the common membership units primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated by us. The common units received are recorded at estimated fair value as an increase in the Company’s investment in NCM with an offset to deferred revenue or NCM screen advertising advances. The fair value of the common units received is estimated based on the market price of NCMI common stock (Level 1 input as defined in FASB ASC Topic 820, Fair Value Measurement) at the time the common units are determined, adjusted for volatility associated with the estimated time period it would take to convert the common units and register the respective shares. The recognition of revenue related to the NCM screen advertising advances is being recognized on a straight-line basis over the term of the amended and restated ESA through February 2041.

On April 11, 2023, NCM filed a petition for reorganization under Chapter 11 of the United States Bankruptcy Code. NCMI continued to manage NCM as the “debtor in possession,” under the jurisdiction of the bankruptcy court and in accordance with the applicable bankruptcy laws and orders of the bankruptcy court. In general, as debtor in possession under the Bankruptcy Code, NCM was authorized to continue to operate as an ongoing business but could not engage in transactions outside the ordinary course of business without the prior approval of the bankruptcy court. Due to NCM’s bankruptcy proceedings, we reassessed our rights and level of influence over NCM. We determined that effective April 11, 2023, the date NCM filed its bankruptcy petition, we no longer had significant influence over NCM and therefore ceased accounting for our investment in NCMI under the equity method of accounting in the second quarter of 2023. Effective April 11, 2023, we started to account for our investment in NCMI in accordance with the guidance set forth in FASB ASC Topic 321 Investments - Equity Securities, which requires us to measure our

28

investment in common stock of NCMI at fair value and recognize unrealized holding gains and losses on our investment in earnings.

Through April 11, 2023, we accounted for our investment in NCMI under the equity method of accounting, and therefore evaluated our investment in NCMI/NCM for impairment that is other than temporary on a quarterly basis or whenever events or changes in circumstances indicated the current value of the investment may be less than its carrying value. Under ASC Topic 323, Investments - Equity Method and Joint Ventures, a loss in value of an investment that is other than a temporary decline should be recognized. Factors that are considered in evaluating whether a decline in the value of an investment is other than temporary include a severe and sustained decline in the quoted market price of an investment below the carrying value of the investment, or specific events that may adversely influence the operations of the investee in a permanent or irreversible manner. We evaluated our investment in NCMI for impairment on April 11, 2023, the date NCM filed for bankruptcy, and we did not find any indication of impairment as the share price of NCMI was above the carrying value of our investment in NCMI.

On August 3, 2023, NCMI announced that it had effected a 1-for-10 reverse stock split of its common stock. NCMI’s common stock automatically began trading on a split adjusted basis at the opening of the market on August 4, 2023. After giving effect to the reverse stock split, the Company owns approximately 4.4 million shares of NCMI common stock. NCM emerged from bankruptcy on August 7, 2023, and the Company’s ownership interest in NCMI was reduced to less than 5%. The Company no longer has the right to designate two board members to the NCMI board of directors.

See Note 9 to the consolidated financial statements for further discussion of our investment in NCMI and the related accounting.

29

Results of Operations

The following table sets forth, for the periods indicated, the amounts for certain items reflected in operating (loss) income of Holdings along with each of those items as a percentage of revenue.

	Year Ended December 31,
	2021			2022			2023
Operating data (in millions):
Revenue
Admissions	$	780.0		$	1,246.9		$	1,555.6
Concession		561.7			938.3			1,192.0
Other		168.8			269.5			319.1
Total revenue	$	1,510.5		$	2,454.7		$	3,066.7
Cost of operations (1)
Film rentals and advertising		415.0			704.4			865.7
Concession supplies		97.9			169.3			221.3
Salaries and wages		232.9			372.7			403.1
Facility lease expense		280.0			308.3			329.7
Utilities and other		282.9			407.2			466.8
General and administrative expenses		161.1			177.6			198.8
Depreciation and amortization		265.4			238.2			209.5
Impairment of long-lived assets		20.8			174.1			16.6
Restructuring costs		(1.0	)		(0.5	)		—
Loss (gain) on disposal of assets and other		8.0			(6.8	)		(7.7	)
Total cost of operations		1,763.0			2,544.5			2,703.8
Operating (loss) income	$	(252.5	)	$	(89.8	)	$	362.9
Operating data as a percentage of total Revenue:
Revenue
Admissions		51.6	%		50.8	%		50.7	%
Concession		37.2	%		38.2	%		38.9	%
Other		11.2	%		11.0	%		10.4	%
Total revenue		100.0	%		100.0	%		100.0	%
Cost of operations (2)
Film rentals and advertising		53.2	%		56.5	%		55.7	%
Concession supplies		17.4	%		18.0	%		18.6	%
Salaries and wages		15.4	%		15.2	%		13.1	%
Facility lease expense		18.5	%		12.6	%		10.8	%
Utilities and other		18.7	%		16.6	%		15.2	%
General and administrative expenses		10.7	%		7.2	%		6.5	%
Depreciation and amortization		17.6	%		9.7	%		6.8	%
Impairment of long-lived assets		1.4	%		7.1	%		0.5	%
Restructuring costs		(0.1	)%		0.0	%		0.0	%
Loss (gain) on disposal of assets and other		0.5	%		(0.3	)%		(0.3	)%
Total cost of operations		116.7	%		103.7	%		88.2	%
Operating (loss) income		(16.7	)%		(3.7	)%		11.8	%
Average screen count (3)		5,890			5,849			5,803
Revenue per average screen (in dollars)	$	256,445		$	419,675		$	528,463

(1)The only difference between components of operating income (loss) for Holdings, as presented above, and those of CUSA is incremental general and administrative expense recognized by Holdings. The following table sets forth, for the periods indicated, the amounts for general and administrative expense, total cost of operations and operating income (loss) of CUSA:

30

	Year Ended December 31,
	2021			2022			2023
Operating data (in millions):
Cost of operations
General and administrative expenses	$	158.5		$	174.6		$	195.5
Total cost of operations	$	1,760.4		$	2,541.5		$	2,700.5
Operating (loss) income	$	(249.9	)	$	(86.8	)	$	366.2

(2)All costs are expressed as a percentage of total revenue, except film rentals and advertising, which are expressed as a percentage of admissions revenue and concession supplies, which are expressed as a percentage of concession revenue.

(3)Average screen count is calculated based on the average of month end screen counts.

Comparison of Years Ended December 31, 2023 and December 31, 2022

Year ended December 31, 2022 - The North American Industry box office totaled approximately $7.5 billion during 2022 which included the carryover of Spider-Man: No Way Home and new blockbuster releases such as Top Gun: Maverick, Black Panther: Wakanda Forever, Doctor Strange in the Multiverse of Madness, Avatar: The Way of Water, Jurassic World Dominion, Minions: The Rise of Gru, The Batman, Thor: Love and Thunder, Puss in Boots: The Last Wish and Sonic the Hedgehog 2, among other films.

Year ended December 31, 2023 - The North American Industry box office generated approximately $9.1 billion during 2023, which included the carryover of Avatar: The Way of Water and Puss in Boots: The Last Wish, as well as new blockbuster releases including Barbie, The Super Mario Bros. Movie, Spider-Man: Across the Spider-Verse, Guardians of the Galaxy Vol. 3, Oppenheimer, The Little Mermaid, Ant-Man and the Wasp: Quantumania, John Wick: Chapter 4, Sound of Freedom, Taylor Swift | The Eras Tour concert film, The Hunger Games: The Ballad of Songbirds and Snakes, Five Nights at Freddy’s, Wonka, and Trolls Band Together, among other films.

Revenue. The table below, presented by reportable operating segment, summarizes our year-over-year revenue performance and certain key performance indicators that impact our revenues.

	U.S. Operating Segment			International Operating Segment					Consolidated
							Constant Currency (3)
	2023	2022	% Change	2023	2022	% Change	2023	% Change	2023	2022	% Change
Admissions revenue	$1,236.0	$1,010.2	22.4%	$319.6	$236.7	35.0%	$393.1	66.1%	$1,555.6	$1,246.9	24.8%
Concession revenue	952.0	763.0	24.8%	240.0	175.3	36.9%	296.5	69.1%	1,192.0	938.3	27.0%
Other revenue (1)	227.3	197.0	15.4%	91.8	72.5	26.6%	113.9	57.1%	319.1	269.5	18.4%
Total revenue (1)	$2,415.3	$1,970.2	22.6%	$651.4	$484.5	34.4%	$803.5	65.8%	$3,066.7	$2,454.7	24.9%
Attendance	127.7	109.3	16.8%	82.1	63.4	29.5%			209.8	172.7	21.5%
Average ticket price (2)	$9.68	$9.24	4.8%	$3.89	$3.73	4.3%	$4.79	28.4%	$7.41	$7.22	2.6%
Concession revenue per patron (2)	$7.45	$6.98	6.7%	$2.92	$2.76	5.8%	$3.61	30.8%	$5.68	$5.43	4.6%

(1)U.S. operating segment revenue includes eliminations of intercompany transactions with the international operating segment. See Note 22 to the consolidated financial statements.

(2)Average ticket price is calculated as admissions revenue divided by attendance. Concession revenue per patron is calculated as concession revenue divided by attendance.

(3)Constant currency revenue amounts, which are non-GAAP measurements, were calculated using the average exchange rate for the corresponding month for 2022. We translate the results of our international operating segment from local currencies into U.S. dollars using currency rates in effect at different points in time in accordance with U.S. GAAP. Significant changes in foreign exchange rates from one period to the next can result in meaningful variations in reported results. We are providing constant currency amounts for our international operating segment to present a period-to-period comparison of business performance that excludes the impact of foreign currency fluctuations.

•U.S. Attendance increased 16.8% to 127.7 million patrons in 2023 compared with 109.3 million patrons in 2022 due to a more consistent cadence of new film releases with broad consumer appeal and the box office success of the films released. Average ticket price increased 4.8% to $9.68 during 2023 compared with $9.24 during 2022, driven by inflationary and strategic pricing initiatives and a higher mix of alternative content that carries a higher ticket price than traditional films. Concession revenue per patron increased 6.7% to $7.45 during 2023 compared with $6.98 during 2022 primarily driven by inflationary and strategic pricing actions as well as product mix. Other revenue for 2023 increased 15.4% to $227.3 million compared with $197.0 million for 2022 primarily due to attendance growth, which drove an increase in transaction fees, as well as higher screen advertising and promotional revenue.

•International. Attendance increased 29.5% to 82.1 million patrons in 2023 compared with 63.4 million in 2022 due to a more consistent cadence of new film releases with broad consumer appeal and the box office success of the films released. Average ticket price was $3.89 as reported, $4.79 in constant currency, for 2023 compared with $3.73 for 2022. The increase in average ticket price in constant currency was primarily due to inflationary pricing actions. Concession revenue per patron was $2.92 as reported, $3.61 in constant currency, for 2023 compared with $2.76 for 2022. The increase in concession revenue per patron in constant currency was primarily

31

due to inflationary pricing actions. Other revenue for 2023 increased 26.6% to $91.8 million compared with $72.5 million for 2022 primarily due to higher attendance, which drove an increase in transaction fees, as well as higher membership, screen advertising, and promotional revenue.

Cost of Operations. The table below, presented by reportable operating segment, summarizes certain of our theatre operating costs (in millions) for the years ended December 31, 2022 and 2023.

	U.S. Operating Segment				International Operating Segment						Consolidated
	2023		2022		2023		2022		Constant Currency 2023 (1)		2023		2022
Film rentals and advertising	$	703.6	$	584.4	$	162.1	$	120.0	$	202.4	$	865.7	$	704.4
Concession supplies		169.1		130.5		52.2		38.8		64.4		221.3		169.3
Salaries and wages		333.8		314.7		69.3		58.0		88.3		403.1		372.7
Facility lease expense		246.6		250.1		83.1		58.2		95.7		329.7		308.3
Utilities and other		355.4		313.7		111.4		93.5		136.7		466.8		407.2

(1)Constant currency expense amounts, which are non-GAAP measurements, were calculated using the average exchange rates for the corresponding months for 2022. We translate the results of our international operating segment from local currencies into U.S. dollars using currency rates in effect at different points in time in accordance with U.S. GAAP. Significant changes in foreign currency exchange rates from one period to the next can result in meaningful variations in reported results. We are providing constant currency amounts for our international operating segment to present a period-to-period comparison of business performance that excludes the impact of foreign currency fluctuations.

•U.S. Film rentals and advertising costs for 2023 were 56.9% of admissions revenue compared with 57.8% for 2022 due to the mix of new film content released. Concession supplies expense for 2023 was 17.8% of concession revenue compared with 17.1% of concession revenue for 2022. The concession supplies rate for 2023 was impacted by inflationary pressures on certain concession categories and product mix, partially offset by the impact of strategic pricing initiatives on concession revenue.

Salaries and wages increased to $333.8 million compared with $314.7 million for 2022 as a result of higher attendance, expanded operating hours and wage rate increases, partially offset by labor productivity initiatives. Facility lease expense, which is primarily fixed in nature, was $246.6 million, essentially flat to 2022. Utilities and other costs increased to $355.4 million, as many of these costs, such as credit card transaction fees, repairs and maintenance, utilities costs, security costs and janitorial costs, are variable in nature and were impacted by attendance growth and inflationary pressures. Higher commissions on gift cards sold by third party retailers also contributed to the increase in utilites and other costs.

•International. Film rentals and advertising costs for 2023 were 50.7% of admissions revenue, consistent with 2022. Concession supplies expense was 21.8% of concessions revenue for 2023 compared with 22.1% of concession revenue for 2022. The decrease in the concessions supplies rate was primarily driven by the impact of strategic pricing initiatives to offset inflationary pressures.

Salaries and wages increased to $69.3 million as reported for 2023 due to wage rate increases, higher attendance, and expanded operating hours. Facility lease expense increased 42.8% to $83.1 million as reported due to higher percentage rent driven by increased revenue and the return of certain minimum rent thresholds compared with 2022. Utilities and other costs increased to $111.4 million as reported, as many of these costs, such as credit card fees and other transaction fees, repairs and maintenance, janitorial costs, utilities and screen advertising commissions, are variable in nature and were impacted by the significant increase in attendance for 2023 as well as inflationary impacts. These expenses, as reported, were also impacted by exchange rate fluctuations in each of the countries in which we operate.
 

General and Administrative Expense. General and administrative expense for Holdings increased to $198.8 million for 2023 compared with $177.6 million for 2022. General and administrative expense attributable to CUSA increased to $195.5 million for 2023 compared with $174.6 million for 2022. The increase for both Holdings and CUSA is primarily due to higher corporate headcount, higher incentive and share-based compensation, wages and benefits inflation, higher property and liability insurance, and a continued shift to cloud-based software, partially offset by lower professional fees.

Depreciation and Amortization. Depreciation and amortization expense decreased to $209.5 million for 2023 from $238.2 million for 2022 primarily due to the impairment of theatre assets during 2022 and 2023.

32

Impairment of Long-Lived Assets. We recorded asset impairment charges of $16.6 million during 2023. Long-lived asset impairment charges of approximately $15.9 million were recorded in 2023, related to certain theatres that are not showing sufficient recovery since reopening after the temporary COVID-19 related closures when compared with the rest of our theatre circuit. In addition, we recorded an impairment of $0.7 million on our investment in NCMI in the first quarter of 2023 as NCMI’s stock price was below the Company’s carrying value of NCM per common unit and due to the prolonged recovery of NCM’s business from the COVID-19 pandemic. We recorded asset impairment charges of $174.1 million during 2022. Long-lived asset impairment charges of $60.9 were recorded in 2022 primarily due to the prolonged recovery of certain theatres from the COVID-19 pandemic, and an impairment of $113.2 million was recorded for our investment in NCM as NCMI’s stock price was significantly below the Company’s carrying value of NCM per common unit and due to the prolonged recovery of NCM’s business from the COVID-19 pandemic. See Notes 9 and 12 to the consolidated financial statements.

Restructuring costs. The credit of $(0.5) million to restructuring costs during 2022 was primarily due to adjustments based on final facility lease payments for certain closed theatres as compared with recorded amounts.

Gain on Disposal of Assets and Other. A gain on disposal of assets and other of $7.7 million was recorded during 2023 compared with a gain of $6.8 million during 2022. Activity for 2023 was primarily related to the sale of our Ecuador subsidiary in September 2023, sale of excess real property, and the write-off of operating lease obligations for theatres that were closed during 2023. Activity for 2022 was primarily related to the sale of excess land parcels. See Note 8 to the consolidated financial statements for further discussion of the sale of our Ecuador subsidiary.

Interest Expense. Interest expense for Holdings, which includes amortization of debt issuance costs and original issue discount and amortization of accumulated losses for swap amendments, decreased to $150.4 million during 2023 compared with $155.3 million for 2022. The interest expense attributable to CUSA, which includes amortization of debt issue costs and original issue discount and amortization of accumulated losses for swap amendments, was $126.3 million during 2023 compared with $131.2 million for 2022. The decrease in interest expense is primarily related to the redemption of $100.0 million in principal amount of the 8.75% Secured Notes during 2023. See further discussion at Liquidity and Capital Resources - Financing Activities below.

Interest Income. Interest income for Holdings was $55.0 million during 2023 compared with $20.4 million for 2022. The interest income attributable to CUSA was $43.2 million during 2023 compared with $16.5 million for 2022. The increase in interest income was primarily due to the impact of higher interest rates earned on higher average cash and cash equivalents balances in 2023.

Loss on Debt Extinguishment and Refinancing. We recorded a loss on extinguishment and refinancing of debt of $10.7 million during 2023 related to the amendment of our Credit Agreement and the partial redemption of the 8.75% Secured Notes, including the write-off of unamortized debt issuance costs and legal and other fees paid. See further discussion at Liquidity and Capital Resources - Financing Activities below.

Foreign Currency Exchange and Other Related Loss. We recorded a foreign currency exchange and other related loss of $28.8 million during 2023 and $11.5 million during 2022. Activity for 2023 includes a $12.4 million loss on Blue Chip Swap transactions. Excluding the loss on Blue Chip Swap transactions, the foreign currency exchange loss is primarily related to currency exchange fluctuations from original transaction dates until cash settlement, See Notes 1 and 16 to the consolidated financial statements for discussion of foreign currency translation and Blue Chip Swap transactions.

Cash Distributions from DCIP. We recorded cash distributions from DCIP of $3.7 million during 2022. These distributions were in excess of the carrying value of our investment in DCIP. DCIP ceased operations in 2022.

Equity in Income (Loss) of Affiliates. Equity in income of affiliates of $3.6 million was recorded during 2023 compared with a loss of $9.3 million during 2022. The equity in income of affiliates for 2023 is due to the ongoing recovery of our equity investees' performance from the effects of the COVID-19 pandemic on the motion picture exhibition industry. See Notes 9 and 10 to the consolidated financial statements for information about our equity investments.

Unrealized Gain on Investment in NCMI. We recorded an unrealized gain on our investment in NCMI of $12.4 million during 2023 related to the mark-to-market adjustment of our investment in NCMI under the fair value basis of accounting. See Note 9 to the consolidated financial statements for information about our investment in NCMI.

Income Taxes - Holdings. An income tax expense of $29.9 million was recorded for 2023 compared with an income tax expense of $3.0 million for 2022. The effective tax rate was approximately 13.5% for 2023 compared with

33

(1.1)% for 2022. The effective tax rate for 2023 was favorably impacted by the use of certain foreign tax credits for which valuation allowances had been established in prior periods as well as the release of valuation allowances previously recorded against the net deferred tax assets in certain foreign jurisdictions. The effective tax rate for 2022 was impacted by the establishment of valuation allowances related to certain deferred tax assets. We have recorded an income tax receivable of $56.7 million at December 31, 2023 and have paid cash taxes of $22.3 million during the year ended December 31, 2023. See Note 20 to the consolidated financial statements for further discussion of income taxes.

Income Taxes - CUSA. An income tax expense of $28.4 million was recorded for 2023 compared with an income tax benefit of $(13.1) million for 2022. The effective tax rate was approximately 12.0% for 2023 compared with 5.4% for 2022. The effective tax rate for 2023 was favorably impacted by the use of certain foreign tax credits for which valuation allowances had been established in prior periods as well as the release of valuation allowances previously recorded against the net deferred tax assets in certain foreign jurisdictions. The effective tax rate for 2022 was impacted by the establishment of valuation allowances related to certain deferred tax assets. We have recorded an income tax receivable of $56.1 million at December 31, 2023 and have paid cash taxes of $22.3 million during the year ended December 31, 2023. See Note 20 to the consolidated financial statements for further discussion of income taxes.

Liquidity and Capital Resources

Operating Activities

We primarily collect our revenue in cash, mainly through box office receipts and the sale of concessions. Our revenue is generally received in cash prior to the payment of related expenses; therefore, we have an operating “float” and historically have not required traditional working capital financing. However, our working capital position will continue to fluctuate based on seasonality, the timing and volume of new film content, the timing of interest payments on our long-term debt as well as timing of payment of other operating expenses that are paid annually or semi-annually, such as property and other taxes and incentive bonuses. We believe our existing cash and expected cash flows from operations will be sufficient to meet our working capital, capital expenditures, and expected cash requirements from known contractual obligations for the next twelve months and beyond.

Cash provided by operating activities was $444.3 million for Holdings and $454.8 million for CUSA for the year ended December 31, 2023 compared with $136.0 million for Holdings and $153.4 million for CUSA for the year ended December 31, 2022. The increase in cash provided by operating activities was primarily driven by the timing and level of revenue earned during 2023 and the timing of payments to vendors for expenses during 2022 and 2023.

Investing Activities

Investing activities have been principally related to the development, remodel and acquisition of theatres. New theatre openings, remodels and acquisitions historically have been financed with internally generated cash and by debt financing, including borrowings under our senior secured credit facility. Cash used for investing activities was $131.8 million and $96.3 million for the years ended December 31, 2023 and 2022, respectively. The increase in cash used for investing activities was primarily due to higher capital expenditures in 2023, partially offset by proceeds from the sale of the Company’s Ecuador subsidiary in September 2023. The increase in capital expenditures in 2023 was due to the continued recovery of our business from the effects of the COVID-19 pandemic and execution of our capital allocation strategy.

Below is a summary of capital expenditures, disaggregated by new and existing theatres, for the periods indicated (in millions):

	Year Ended December 31,
	2022		2023
New theatres	$	33.1	$	9.1
Existing theatres		77.6		140.4
Total capital expenditures	$	110.7	$	149.5

34

We operated 501 theatres with 5,719 screens worldwide as of December 31, 2023. Theatres and screens opened and closed during the year ended December 31, 2023 were as follows:

	December 31, 2022		Built		Closed			December 31, 2023
U.S. (42 states)
Theatres		318		—		(9	)		309
Screens		4,399		—		(75	)		4,324
International (13 countries)
Theatres (1)		200		1		(9	)		192
Screens (1)		1,448		4		(57	)		1,395
Worldwide
Theatres		518		1		(18	)		501
Screens		5,847		4		(132	)		5,719

(1)International theatres and screens closed includes eight theatres and 51 screens related to the sale of the Company’s Ecuador subsidiary and the closure of our one theatre and six screens in Curacao. See Note 8 to the Company’s consolidated financial statements.

As of December 31, 2023, the following signed commitments were outstanding:

	Theatres (1)		Screens (1)		Estimated Cost (2)
Expected to open during 2024
U.S.		1		7	$	18.5
International		2		10		2.7
Total during 2024		3		17	$	21.2
Expected to open subsequent to 2024
U.S.		2		26	$	11.4
International		—		—		—
Total subsequent to 2024		2		26	$	11.4
Total commitments at December 31, 2023		5		43	$	32.6

(1)Based on the expected theatre opening date.

(2)We expect approximately $21.2 million and $11.4 million to be paid during 2024 and 2025, respectively. The timing of payments is subject to change as a result of construction timing or other delays.

Actual expenditures for continued theatre development, remodels and acquisitions are subject to change based upon the availability of attractive opportunities. During the next twelve months and the foreseeable future, we plan to fund capital expenditures for our continued development with cash flow from operations and, if needed, borrowings under our senior secured credit facility, proceeds from debt issuances, sale leaseback transactions and/or sales of excess real estate.

Financing Activities

Cash used for financing activities was $125.4 million and $52.2 million for the years ended December 31, 2023 and 2022, respectively. The increase in cash used for financing activities was primarily due to the partial redemption of the 8.75% secured notes, partially offset by the net proceeds from the refinancing of the Credit Agreement during the year ended December 31, 2023.

Holdings, at the discretion of its board of directors and subject to applicable law, may pay dividends on its common stock. The amount, if any, of the dividends to be paid in the future will depend upon available cash balances, anticipated cash needs, overall financial condition, loan agreement restrictions as discussed below, future prospects for earnings and cash flows, as well as other relevant factors. As a result of the impact of the COVID-19 pandemic, Holdings suspended its quarterly dividend to its shareholders.

We may, from time to time, seek to retire or repurchase our outstanding debt securities through cash purchases or exchanges for other securities, in open market purchases, privately negotiated transactions or otherwise. Such

35

repurchases or exchanges, if any, will depend on the availability and prices of such debt securities, prevailing market conditions, or liquidity requirements, contractual restrictions and other factors. The amounts involved may be material.

Long-term debt for Holdings and CUSA consisted of the following as of December 31, 2022 and 2023 (in millions):

	December 31,
	2022		2023
Cinemark Holdings, Inc. 4.50% convertible senior notes due 2025	$	460.0	$	460.0
Cinemark USA, Inc. term loan due 2030 (see Senior Secured Credit Facility below)		626.5		645.1
Cinemark USA, Inc. 8.75% senior secured notes due 2025		250.0		150.0
Cinemark USA, Inc. 5.875% senior notes due 2026		405.0		405.0
Cinemark USA, Inc. 5.25% senior notes due 2028		765.0		765.0
Other		10.1		7.0
Total long-term debt carrying value (1)	$	2,516.6	$	2,432.1
Less: Current portion		10.7		7.8
Less: Debt issuance costs and original issue discount, net of accumulated amortization (1)		31.9		33.0
Long-term debt, less current portion, net of unamortized debt issuance costs and original issue discount (1)	$	2,474.0	$	2,391.3

(1)The only differences between the long-term debt for Holdings, as presented above, and the long-term debt for CUSA are the $460.0 million 4.50% Convertible Senior Notes due 2025 and the related debt issuance costs. The following table sets forth, as of the periods indicated, the total long-term debt, current portion of long-term debt and debt issuance costs, net of amortization for CUSA:

	December 31,
	2022		2023
Total long-term debt carrying value	$	2,056.6	$	1,972.1
Less: Current portion		10.7		7.8
Less: Debt issuance costs and original issue discount, net of accumulated amortization		22.9		27.5
Long-term debt, less current portion, net of unamortized debt issuance costs and original issue discount	$	2,023.0	$	1,936.8

As of December 31, 2023, we had $125.0 million in available borrowing capacity on our revolving line of credit.

36

As of December 31, 2023, Holdings’ long-term debt obligations, scheduled interest payments on long-term debt, future minimum lease obligations under non-cancelable operating and finance leases, scheduled interest payments under finance leases and other obligations for each period indicated are summarized as follows:

	Payments Due by Period
	(in millions)
			Less Than						After
Contractual Obligations (1)	Total		One Year		1 - 3 Years		3 - 5 Years		5 Years
Long-term debt (2)	$	2,432.1	$	7.8	$	1,030.4	$	780.4	$	613.5
Scheduled interest payments on long-term debt (3)		539.0		144.1		220.4		152.6		21.9
Operating lease obligations (4)		1,280.0		267.2		437.0		280.4		295.4
Finance lease obligations (4)		105.0		18.0		28.4		23.5		35.1
Purchase and other commitments (5)		72.9		60.1		12.4		0.3		0.1
Liability for uncertain tax positions (6)		—		—		—		—		—
Total obligations	$	4,429.0	$	497.2	$	1,728.6	$	1,237.2	$	966.0

(1)The only differences between the contractual obligations for Holdings, as presented above, and those for CUSA are incremental long-term debt obligations and scheduled interest payments on long-term debt for Holdings. The following table sets forth, for each period indicated, the long-term debt obligations, scheduled interest payments on long-term debt, liability for uncertain tax positions and total obligations of CUSA:

	Payments Due by Period
	(in millions)
Contractual Obligations	Total		Less Than One Year		1 - 3 Years		3 - 5 Years		After 5 Years
Long-term debt (2)	$	1,972.1	$	7.8	$	570.4	$	780.4	$	613.5
Scheduled interest payments on long-term debt (3)		504.5		123.4		206.6		152.6		21.9
Liability for uncertain tax positions (6)		—		—		—		—		—
Total obligations	$	2,476.6	$	131.2	$	777.0	$	933.0	$	635.4

(2)Amounts are presented before adjusting for unamortized debt issuance costs and original issue discount.

(3)Amounts include scheduled interest payments on fixed rate and variable rate debt agreements. Estimates for the variable rate interest payments were based on interest rates in effect on December 31, 2023.

(4)Amounts include both scheduled principal and interest payments on leases commenced prior to December 31, 2023. Amounts do not include approximately $44.8 million of payments under signed lease agreements which have not commenced and the timing of which cannot be reasonably estimated. See Note 4 to the consolidated financial statements for discussion of lease obligations.

(5)Includes estimated capital expenditures associated with the construction of new theatres and other capital expenditures to which we were committed as of December 31, 2023, obligations under employment agreements, which are our only contractual human capital costs, and contractual purchase commitments.

(6)The long-term portions of Holdings’ and CUSA’s liability for uncertain tax positions of $48.0 million is not included above because we cannot make a reliable estimate of the timing of the related cash payments. There were no amounts recorded for short-term uncertain tax positions on the consolidated balance sheets of either Holdings or CUSA as of December 31, 2023.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements.

4.50% Convertible Senior Notes

On August 21, 2020, Holdings issued $460.0 million of 4.50% convertible senior notes (the "4.50% Convertible Senior Notes"). The 4.50% Convertible Senior Notes will mature on August 15, 2025, unless earlier repurchased or converted. Interest on the notes is payable on February 15 and August 15 of each year, beginning on February 15, 2021.

Holders of the 4.50% Convertible Senior Notes may convert their 4.50% Convertible Senior Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2025 only under the following circumstances: (1) during the five business day period after any five consecutive trading day period, or the measurement period, in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day; (2) if Holdings distributes to all or substantially all stockholders (i) rights options or warrants entitling them to purchase shares at a discount to the recent average trading price of its common stock (including due to a stockholder rights plan) or (ii) Holdings’ assets or securities or rights, options or warrants to purchase the same with a per share value exceeding 10% of the trading price of Holdings’ common stock, (3) upon the occurrence of specified corporate events as described further in the indenture. Beginning May 15, 2025, holders may convert their 4.50% Convertible Senior Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date, or (4) during any calendar quarter commencing after the calendar

37

quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of Holdings’ common stock for at least 20 trading days during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to $18.66 per share (130% of the initial conversion price of $14.35 per share), on each applicable trading day. Upon conversion of the 4.50% Convertible Senior Notes, Holdings will pay or deliver cash, shares of its common stock or a combination of cash and shares of its common stock, at its election.

The initial conversion rate is 69.6767 shares of Holdings’ common stock per one thousand dollars principal amount of the 4.50% Convertible Senior Notes. The conversion rate will be subject to adjustment upon the occurrence of certain events. If a make-whole fundamental change as defined in the indenture occurs prior to the maturity date, Holdings will, in certain circumstances, increase the conversion rate for a holder who elects to convert its 4.50% Convertible Senior Notes in connection with such make-whole fundamental change.

The 4.50% Convertible Notes are effectively subordinated to any of Holdings’, or its subsidiaries’, existing and future secured debt to the extent of the value of the assets securing such indebtedness, including obligations under the Credit Agreement. The 4.50% Convertible Notes are structurally subordinated to all existing and future debt and other liabilities, including trade payables, and including CUSA’s 8.75% Secured Notes due 2025, 5.25% Senior Notes due 2028 and 5.875% Senior Notes due 2026, or, collectively, CUSA’s senior notes (but excluding all obligations under the Credit Agreement which are guaranteed by Holdings). The 4.50% Convertible Notes rank equally in right of payment with all existing and future unsubordinated debt, including all obligations under the Credit Agreement, which such Credit Agreement is guaranteed by Holdings, and senior in right of payment to any future debt that is expressly subordinated in right of payment to the 4.50% Convertible Senior Notes. The 4.50% Convertible Notes are not guaranteed by any of Holdings’ subsidiaries.

Concurrently with the issuance of the 4.50% Convertible Senior Notes, Holdings entered into privately negotiated convertible note hedge transactions, or the Hedge Transactions, with one or more of the initial purchasers of the 4.50% Convertible Senior Notes or their respective affiliates, or the Option Counterparties. The Hedge Transactions cover the number of shares of our common stock that will initially underlie the aggregate amount of the 4.50% Convertible Senior Notes, subject to anti-dilution adjustments substantially similar to those applicable to the 4.50% Convertible Senior Notes. The Hedge Transactions are generally expected to reduce potential dilution to Holdings’ common stock upon any conversion of the 4.50% Convertible Senior Notes and/or offset any cash payments we may be required to make in excess of the principal amount of converted 4.50% Convertible Senior Notes, as the case may be. Concurrently with entering into the Hedge Transactions, Holdings also entered into separate privately negotiated warrant transactions with Option Counterparties, or the Warrant Transactions, whereby Holdings sold to Option Counterparties warrants to purchase (subject to the net share settlement provisions set forth therein) up to the same number of shares of Holdings common stock, subject to customary anti-dilution adjustments, or the Warrants. The Warrants could separately have a dilutive effect to the extent that the market value per share of Holdings common stock exceeds the strike price of the warrants on the applicable expiration dates unless, subject to the terms of the Warrants, Holdings elects to cash settle the Warrants. The exercise price of the Warrants is initially $22.08 and is subject to certain adjustments under the terms of the warrants. Holdings received $89.4 million in cash proceeds from the sale of Warrants, which were used along with proceeds from the 4.50% Convertible Senior Notes, to pay approximately $142.1 million to enter into the Hedge Transactions.

Together, the Hedge Transactions and the Warrants are intended to reduce the potential dilution from the conversion of the 4.50% Convertible Senior Notes. The Hedge Transactions and Warrants are recorded in equity and are not accounted for as derivatives, in accordance with applicable accounting guidance.

Senior Secured Credit Facility

On May 26, 2023, CUSA amended and restated its senior secured credit facility (the “Credit Agreement”) to provide for an aggregate principal amount of $775.0 million, consisting of a $650.0 million term loan with a maturity date of May 24, 2030 and a $125.0 million revolving credit facility with a maturity date of May 26, 2028. The term loan is subject to a springing maturity date of April 15, 2028 if CUSA’s 5.25% Senior Notes due 2028 have not been paid or refinanced as required under the Credit Agreement prior to such date. The revolving credit facility is subject to springing maturity dates of January 30, 2025, December 14, 2025 and April 15, 2028 if CUSA’s 8.75% Senior Secured Notes due 2025, 5.875% Senior Notes due 2026 and 5.25% Senior Notes due 2028 have not been paid or refinanced as required under the Credit Agreement prior to such dates, as more specifically described in the Credit Agreement.

38

CUSA used the $632.7 million net proceeds of the borrowings under the Credit Agreement to fund the $628.3 million repayment of the term loan outstanding under the Credit Agreement prior to the amendment and restatement and accrued interest thereon, and for other general corporate purposes. As of December 31, 2023, there was $645.1 outstanding under the term loan and no borrowings were outstanding under the $125.0 million revolving line of credit.

Under the Credit Agreement, quarterly principal payments of $1.6 million are due on the term loan through December 31, 2030, with a final principal payment of the remaining unpaid principal due on May 24, 2030.

The amended term loan was issued net of an original issue discount of $9.8 million. CUSA also incurred a total of approximately $10.1 million in debt issuance costs in connection with the amendment, which are reflected in the consolidated financial statements as follows: (i) $7.5 million in debt issuance costs were capitalized and are reflected as a reduction of “Long-term debt, less current portion” on the Company’s consolidated balance sheet; and (ii) $2.1 million of fees paid to lenders and $0.5 million of legal and other fees are included in “Loss on debt extinguishment and refinancing” in the Company’s consolidated statement of income for the year ended December 31, 2023. As a result of the amendment, CUSA also wrote-off $4.7 million of unamortized debt issuance costs associated with exiting lenders of the refinanced Credit Agreement.

Interest on the term loan accrues, at CUSA's option, at either (i) a rate determined by reference to the secured overnight financing rate ("SOFR") as published by CME Group Benchmark Administration Limited and identified by Barclay's Bank PLC (the Administrative Agent) as the forward-looking term rate based on SOFR for a period of 1, 3, or 6 months (depending upon the Interest Period (as defined in the Credit Agreement) chosen by CUSA) (the "Term SOFR Rate"), subject to a floor of 0.50% per annum, plus an applicable margin of 3.75% per annum, or (ii) for any day, a rate per annum equal to the greatest of (a) the Prime Rate in effect on such day, (b) the Federal Reserve Bank of New York Rate in effect on such day, plus 1/2 of 1.00% and (c) the Term SOFR Rate for a one month Interest Period, as published two U.S. Government Securities Business Days prior to such day (or if such day is not a U.S. Government Securities Business Day, the immediately preceding U.S. Government Securities Business Day), plus 1.00% (this clause (ii), the "Alternate Base Rate"), subject in the case of this clause (ii) to a floor of 1.50% per annum, plus, in the case of this clause (ii), an applicable margin of 2.75%. The average interest rate on outstanding term loan borrowings under the Credit Agreement as of December 31, 2023 was approximately 7.1% per annum, after giving effect to the interest rate swap agreements discussed below.

Interest on revolving credit loans accrues, at CUSA's option, at either (i) the Term SOFR Rate plus an applicable margin that ranges from 3.00% to 3.50% per annum, or (ii) the Alternate Base Rate, subject, in the case of this clause (ii) to a floor of 1.00% per annum, plus, in the case of this clause (ii), an applicable margin that ranges from 2.00% to 2.50%. The applicable margin with respect to revolving credit loans is a function of the Consolidated Net Senior Secured Leverage Ratio as defined in the Credit Agreement. As of December 31, 2023, the applicable margin was 3.25%, however, there were no borrowings outstanding under the revolving line of credit. In addition, CUSA is required to pay a commitment fee on the revolving line of credit that accrues at a rate ranging from 0.20% to 0.375% per annum of the daily unused portion of the revolving line of credit. The commitment fee rate is a function of the Consolidated Net Senior Secured Leverage Ratio and was 0.25% at December 31, 2023.

CUSA’s obligations under the Credit Agreement are guaranteed by Holdings and certain subsidiaries of Holdings other than CUSA (the “Other Guarantors”) and are secured by security interests in substantially all of CUSA’s, Holdings’ and the Other Guarantors’ personal property.

The Credit Agreement contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on the ability of Holdings, CUSA and their subsidiaries to: merge, consolidate, liquidate, or dissolve; sell, transfer or otherwise dispose of assets; create, incur or permit to exist certain indebtedness and liens; pay dividends, repurchase stock and make other Restricted Payments (as defined in the Credit Agreement); prepay certain indebtedness; make investments; enter into transactions with affiliates; and change the nature of their business. At any time that CUSA has revolving credit loans outstanding, it is not permitted to allow the Consolidated Net Senior Secured Leverage Ratio to exceed 3.5 to 1.0 for any period of four consecutive fiscal quarters ending on the last day of any fiscal quarter. As of December 31, 2023, there were no revolving credit loans outstanding under the revolving line of credit, and CUSA’s Consolidated Net Senior Secured Leverage Ratio was 0.3 to 1.0.

The Credit Agreement also includes customary events of default, including, among other things, payment default, covenant default, breach of representation or warranty, bankruptcy, cross-default, material ERISA events, a change of control, material money judgments and failure to maintain security interests. If an event of default occurs, all commitments under the Credit Agreement may be terminated and all obligations under the Credit Agreement could

39

be accelerated by the Lenders, causing all loans outstanding (including accrued interest and fees payable thereunder) to be declared immediately due and payable.

The Restricted Payments covenant, as defined in the Credit Agreement generally does not limit the ability of Holdings and its subsidiaries to pay dividends and make other Restricted Payments if the Consolidated Net Total Leverage Ratio (as defined in the Credit Agreement) is less than or equal to 2.75 to 1.00. If the Consolidated Net Total Leverage Ratio is greater than 2.75 to 1.00, but not greater than 5.00 to 1.00, Restricted Payments generally may be made in an aggregate amount not to exceed the Available Amount (as defined in the Credit Agreement), which is a function of CUSA’s Consolidated EBITDA minus 1.75 times its Consolidated Interest Expense (as such terms are defined in the Credit Agreement) and certain other factors as specified in the Credit Agreement. As of December 31, 2023, the Consolidated Net Total Leverage Ratio was 2.13 to 1.00 and the Available Amount was $599.1 million. In addition, the Credit Agreement contains other baskets that allow certain Restricted Payments in excess of the Applicable Amount.

We have three interest rate swap agreements that are used to hedge a portion of the interest rate risk associated with the variable interest rates on the term loan outstanding under the Credit Agreement. See Note 14 to the consolidated financial statements for discussion of the interest rate swaps.

5.875% Senior Notes

On March 16, 2021, CUSA issued $405 million aggregate principal amount of 5.875% senior notes due 2026, at par value (the “5.875% Senior Notes”). Proceeds, after payment of fees, were used to fund a cash tender offer to purchase any and all of CUSA’s 5.125% Senior Notes (the “5.125% Senior Notes”) and to redeem any of the 5.125% Senior Notes that remained outstanding after the tender offer. Interest on the 5.875% Senior Notes is payable on March 15 and September 15 of each year. The 5.875% Senior Notes mature on March 15, 2026. CUSA incurred debt issuance costs of approximately $6.0 million in connection with the issuance, which are recorded as a reduction of long-term debt on the consolidated balance sheets.

The 5.875% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of CUSA’s subsidiaries that guarantee, assume or become liable with respect to any of CUSA’s or a guarantor’s debt. The 5.875% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of CUSA’s and its guarantor’s existing and future senior debt and senior in right of payment to all of CUSA’s and its guarantors’ existing and future senior subordinated debt. The 5.875% Senior Notes and the guarantees are effectively subordinated to all of CUSA’s and its guarantor’s existing and future secured debt to the extent of the value of the collateral securing such debt, including all borrowings under CUSA’s Credit Agreement. The 5.875% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of CUSA’s subsidiaries that do not guarantee the 5.875% Senior Notes.

CUSA may redeem the 5.875% Senior Notes in whole or in part at redemption prices set forth in the indenture. Prior to March 15, 2024, CUSA may redeem the 5.875% Senior Notes in whole or in part at 102.938% of the principal amount plus accrued interest on the 5.875% Senior Notes to the date of redemption. On or after March 15, 2024, CUSA may redeem the 5.875% Senior Notes in whole or in part at 101.469% of the principal amount plus accrued and unpaid interest on the 5.875% Senior Notes to the date of redemption. On or after March 15, 2025, CUSA may redeem the 5.875% Senior Notes in whole or in part at 100% of the principal amount plus accrued and unpaid interest on the 5.875% Senior Notes to the date of redemption.

5.25% Senior Notes

On June 15, 2021, CUSA issued $765 million aggregate principal amount of 5.25% senior notes due 2028, at par value (the “5.25% Senior Notes”). Proceeds, after payment of fees, were used to redeem all of CUSA’s 4.875% $755 million aggregate principal amount of Senior Notes due 2023 (the “4.875% Senior Notes”). Interest on the 5.25% Senior Notes is payable on January 15 and July 15 of each year, beginning January 15, 2022. The 5.25% Senior Notes mature on July 15, 2028. CUSA incurred debt issuance costs of approximately $10.7 million in connection with the issuance, which are recorded as a reduction of long-term debt on the consolidated balance sheets.

The 5.25% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of CUSA’s subsidiaries that guarantee, assume or become liable with respect to any of CUSA’s or a guarantor’s debt. The 5.25% Senior Notes and the guarantees will be CUSA’s and the guarantors’ senior unsecured obligations and (i) rank equally in right of payment to CUSA’s and the guarantors’ existing and future senior debt,

40

including borrowings under CUSA’s Credit Agreement (as defined below) and CUSA’s existing senior notes, (ii) rank senior in right of payment to CUSA’s and the guarantors’ future subordinated debt, (iii) are effectively subordinated to all of CUSA’s and the guarantors’ existing and future secured debt, including all obligations under the Credit Agreement and CUSA’s 8.75% senior secured notes due 2025, in each case to the extent of the value of the collateral securing such debt, (iv) are structurally subordinated to all existing and future debt and other liabilities of CUSA’s non-guarantor subsidiaries, and (v) are structurally senior to the 4.50% convertible senior notes due 2025 issued by Holdings.

Prior to July 15, 2024, CUSA, Inc. may redeem all or any part of the 5.25% Senior Notes at its option at 100% of the principal amount plus a make-whole premium plus accrued and unpaid interest on the 5.25% Senior Notes to the date of redemption. In addition, prior to July 15, 2024, CUSA may redeem up to 40% of the aggregate principal amount of the 5.25% Senior Notes from the net proceeds of certain equity offerings at the redemption price set forth in the indenture, so long as at least 60% of the principal amount of the 5.25% Senior Notes remains outstanding immediately after each such redemption. On or after July 15, 2024, CUSA may redeem the 5.25% Senior Notes in whole or in part at redemption prices specified in the indenture.

8.75% Secured Notes

On April 20, 2020, CUSA issued $250.0 million aggregate principal amount of 8.75% senior secured notes due 2025, or the 8.75% Secured Notes. The 8.75% Secured Notes mature on May 1, 2025. Interest on the 8.75% Secured Notes is payable on May 1 and November 1 of each year.

CUSA may redeem the 8.75% Secured Notes in whole or in part at redemption prices specified in the indenture. Prior to May 1, 2024, CUSA, Inc. may redeem all or any part of the 8.75% Senior Notes at its option at 102.188% of the principal amount plus accrued and unpaid interest on the 8.75% Senior Notes to the date of redemption. On or after May 1, 2024, CUSA may redeem the 8.75% Senior Notes in whole or in part at 100% of the principal amount plus accrued and unpaid interest on the 8.75% Senior Notes to the date of redemption.

On May 1, 2023, CUSA redeemed $100.0 million in principal amount of the 8.75% Secured Notes plus accrued interest thereon for $106.6 million in cash. Following the redemption, $150.0 million in aggregate principal amount of the 8.75% Secured Notes remains outstanding. As a result of the redemption, CUSA recognized a loss on extinguishment of debt totaling $3.4 million, which includes a $2.2 million premium paid on the redemption of bonds and a $1.2 million write-off of unamortized debt issuance costs, and is reflected in “Loss on debt extinguishment and refinancing” in the Company’s consolidated statement of income for the year ended December 31, 2023.

The 8.75% Secured Notes are fully and unconditionally guaranteed on a joint and several senior basis by certain of CUSA’s subsidiaries that guarantee, assume or in any other manner become liable with respect to any of CUSA’s or its guarantors’ other debt. If CUSA cannot make payments on the 8.75% Secured Notes when they are due, CUSA guarantors must make them instead. Under certain circumstances, the guarantees may be released without action by, or the consent of, the holders of the 8.75% Secured Notes.

The indenture governing the 8.75% Secured Notes contains covenants that limit, among other things, the ability of CUSA and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. Upon a change of control, as defined in the indenture governing the 8.75% Secured Notes, CUSA would be required to make an offer to repurchase the 8.75% Secured Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 8.75% Secured Notes allows CUSA to incur additional indebtedness if it satisfies a coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances.

Additional Borrowings of International Subsidiaries

During the years ended December 31, 2020 and 2021, certain of CUSA’s international subsidiaries borrowed an aggregate of $35.8 million under various local bank loans. The bank loans outstanding as of December 31, 2022 and 2023 totaled $10.1 million and $7.0 million, respectively. The remaining bank loan outstanding at December 31,

41

2023 mature in January 2029. The current interest rate on the remaining bank loan outstanding at December 31, 2023 is 4.0%.

Covenant Compliance

The indentures governing the 5.875% Senior Notes, the 5.25% Senior Notes and the 8.75% Secured Notes ("the indentures") contain covenants that limit, among other things, the ability of CUSA and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2023, CUSA could have distributed up to approximately $3,556.8 billion to its parent company and sole stockholder, Holdings, under the terms of the indentures, subject to its available cash and other borrowing restrictions outlined in the indentures. Upon a change of control, as defined in the indentures, CUSA would be required to make an offer to repurchase the 5.875% Senior Notes, the 5.25% Senior Notes and the 8.75% Secured Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indentures allow CUSA to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and our actual ratio as of December 31, 2023 was 5.5 to 1.

See discussion of dividend restrictions and the consolidated net senior secured leverage ratio under the Credit Agreement at Senior Secured Credit Facility above.

As of December 31, 2023, we believe we were in full compliance with all agreements, including related covenants, governing our outstanding debt.

Ratings

We are rated by nationally recognized rating agencies. The rating scales and methodologies used to derive individual ratings may vary from agency to agency. Credit ratings are issued by credit rating agencies based on evaluations of our ability to pay back our outstanding debt and the likelihood that we would default on that debt prior to its maturity. The credit ratings issued by the credit rating agencies represent the credit rating agency's evaluation of both qualitative and quantitative information for the Company. The credit ratings that are issued are based on the credit rating agency’s judgment and experience in determining what information should be considered in giving a rating to a particular company. Ratings are always subject to change and there can be no assurance that our current ratings will continue for any given period of time. A downgrade of our debt ratings, depending on the extent, could increase the cost to borrow funds.

New Accounting Pronouncements

See Note 2 to the consolidated financial statements for a discussion of recently issued accounting pronouncements and their impact on our financial statements.

Seasonality

Our revenues have historically been seasonal, coinciding with the timing of releases of motion pictures by the major distributors. The most successful motion pictures have historically been released during summer months in the U.S., extending from May to July, and during the holiday season, extending from November through year-end. In our Latin American markets, while Hollywood content has similar release dates as in the U.S., the local holidays and seasons vary. The unexpected emergence of a hit film during other periods or the failure of an expected success at a key time could alter this seasonality trend. The timing, quantity and quality of film releases can have a significant effect on our results of operations, and the results of one quarter are not necessarily indicative of results for the next quarter or for the same period in the following year.

42

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

We have exposure to financial market risks, including changes in interest rates and foreign currency exchange rates.

Interest Rate Risk

The Company currently has variable rate debt. An increase or decrease in interest rates would affect its interest expense relating to this variable rate debt. At December 31, 2023, we had an aggregate of $202.1 million of variable rate debt outstanding, after giving effect to the interest rate swap agreements discussed below. Based on the interest rates in effect on the variable rate debt outstanding at December 31, 2023, a 100 basis point increase in market interest rates would increase our annual interest expense by approximately $2.0 million.

The tables below provide information about Holdings’ fixed rate and variable rate long-term debt agreements as of December 31, 2023, which includes fixed rate and variable rate long-term debt of CUSA which is guaranteed by Holdings.

Holdings Debt

	Expected Maturity for the Years Ending December 31,																Average
	(in millions)																Interest
	2024		2025		2026		2027		2028		Thereafter		Total		Fair Value		Rate
Fixed rate	$	—	$	610.0	$	405.0	$	—	$	765.0	$	450.0	$	2,230.0	$	2,258.2		5.7	%
Variable rate		7.8		7.7		7.7		7.7		7.7		163.5		202.1		202.1		8.9	%
Total debt (1)	$	7.8	$	617.7	$	412.7	$	7.7	$	772.7	$	613.5	$	2,432.1	$	2,460.3

(1)Amounts are presented before adjusting for debt issuance costs and debt discounts.

CUSA Debt

	Expected Maturity for the Years Ending December 31,																Average
	(in millions)																Interest
	2024		2025		2026		2027		2028		Thereafter		Total		Fair Value		Rate
Fixed rate	$	—	$	150.0	$	405.0	$	—	$	765.0	$	450.0	$	1,770.0	$	1,701.7		6.0	%
Variable rate		7.8		7.7		7.7		7.7		7.7		163.5		202.1		202.1		8.9	%
Total debt (1)	$	7.8	$	157.7	$	412.7	$	7.7	$	772.7	$	613.5	$	1,972.1	$	1,903.8

(1)Amounts are presented before adjusting for debt issuance costs and debt discounts.

Interest Rate Swap Agreements

All of our interest rate swap agreements qualify for cash flow hedge accounting. The fair values of the interest rate swaps are recorded on each of Holdings’ and CUSA’s consolidated balance sheets as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss. See Note 14 to the consolidated financial statements for further discussion of the interest rate swap agreements.

Below is a summary of our interest rate swap agreements as of December 31, 2023:

Notional
Amount	Pay Rate	Receive Rate	Expiration Date
$ 137.5 million	2.15%	1-Month Term SOFR	December 31, 2024
$ 137.5 million	2.08%	1-Month Term SOFR	December 31, 2024
$ 175.0 million	3.20%	1-Month Term SOFR	December 31, 2026
$ 450.0 million

Foreign Currency Exchange Rate Risk

We are also exposed to market risk arising from changes in foreign currency exchange rates as a result of our international operations. Generally, we export from the U.S. certain of the equipment and interior finish items and other operating supplies used by our international subsidiaries. A majority of the revenues and operating expenses of our international subsidiaries are transacted in the country’s local currency. U.S. GAAP requires that our subsidiaries use the currency of the primary economic environment in which they operate as their functional currency. If our subsidiaries operate in a highly inflationary economy, U.S. GAAP requires that the U.S. dollar be used as the functional currency for the subsidiary, which could impact future results of operations as reported. Currency fluctuations in the countries in which we operate result in us reporting exchange gains (losses) or foreign currency translation adjustments. Based upon our equity ownership in our international subsidiaries as of December 31, 2023, holding everything else constant, a 10% immediate, simultaneous, unfavorable change in all of the foreign currency

43

exchange rates to which we are exposed, would decrease the aggregate net book value of our investments in our international subsidiaries by approximately $67.0 million and would decrease the aggregate net income of our international subsidiaries for the year ended December 31, 2023 by $10.3 million, respectively.

We deemed Argentina to be highly inflationary beginning July 1, 2018. A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity. The financial statements of the Company’s Argentina subsidiaries has been remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters, effective beginning July 1, 2018.

During 2019, the Argentine government instituted exchange controls restricting the ability of entities and individuals to exchange Argentine pesos for foreign currencies and to remit foreign currency out of Argentina. As a result of these currency exchange controls, markets in Argentina developed a legal trading mechanism known as the Blue Chip Swap that allows entities to transfer U.S. dollars out of and into Argentina. In a Blue Chip Swap transaction, an entity buys U.S. dollar denominated securities in Argentina using Argentine pesos, and subsequently sells the securities for U.S. dollars, in Argentina, to access U.S. dollars locally, or outside Argentina, by transferring the securities abroad, prior to being sold (the latter commonly known as Blue Chip Swap Rate). The Blue Chip Swap rate is the implicit exchange rate resulting from the Blue Chip Swap transaction. The Blue Chip Swap rate can diverge significantly from Argentina’s official exchange rate. During the year ended December 31, 2023, the Company entered into Blue Chip Swap transactions that resulted in a loss of approximately $12.4 million.

Item 8. Financial Statements and Supplementary Data

The financial statements and supplementary data for Holdings and CUSA are listed on the Index on page F-1 of this Form 10-K. Such financial statements and supplementary data are included herein beginning on page F-6.

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A. Controls and Procedures

Evaluation of the Effectiveness of Disclosure Controls and Procedures

As of December 31, 2023, under the supervision and with the participation of Holdings’ and CUSA’s principal executive officer and principal financial officer, Holdings and CUSA each carried out an evaluation required by the Exchange Act of the effectiveness of the design and operation of their respective disclosure controls and procedures, as defined in Rule 13a-15(e) of the Exchange Act. Based on this evaluation, Holdings’ and CUSA’s principal executive officer and principal financial officer concluded that, as of December 31, 2023, each of Holdings’ and CUSA’s respective disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by each of Holdings and CUSA in the reports that are filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and were effective to provide reasonable assurance that such information is accumulated and communicated to Holdings’ and CUSA’s management, including Holdings’ and CUSA’s principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosures.

Changes in Internal Control over Financial Reporting

There have been no changes in Holdings’ and CUSA’s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 that occurred during the quarter ended December 31, 2023 that materially affected, or are reasonably likely to materially affect, Holdings’ and CUSA’s internal control over financial reporting.

Management’s Report on Internal Control over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) of the Exchange Act. Holdings’ and CUSA’s internal control framework and processes are designed to provide reasonable assurance to management and their respective board of directors regarding the reliability of financial reporting and the preparation of the Holdings’ and CUSA’s consolidated financial statements

44

in accordance with the accounting principles generally accepted in the U.S. Management has assessed the effectiveness of Holdings’ and CUSA’s internal control over financial reporting as of December 31, 2023 based on criteria set forth by the Committee of Sponsoring Organizations of the Commission, or COSO, in Internal Control—Integrated Framework (2013). As a result of this assessment, management concluded that, as of December 31, 2023, Holdings’ and CUSA’s internal control over financial reporting was effective.

Certifications of the Chief Executive Officer and the Chief Financial Officer for Holdings and CUSA, which are required in accordance with Rule 13a-14 of the Exchange Act, are attached as exhibits to this Annual Report. This "Controls and Procedures" section includes the information concerning the controls evaluation referred to in the certifications, and it should be read in conjunction with the certifications for a more complete understanding of the topics presented.

The Company’s independent registered public accounting firm, Deloitte & Touche LLP, which has direct access to Holdings’ board of directors through its Audit Committee, have audited the consolidated financial statements prepared by Holdings and CUSA. Their reports on the respective consolidated financial statements of Holdings and CUSA are included in Part II, Item 8, Financial Statements and Supplementary Data. Deloitte & Touche LLP has issued an attestation report on the Company’s internal control over financial reporting.

Limitations on Controls

Management for Holdings and CUSA does not expect that its disclosure controls and procedures or its internal control over financial reporting will prevent or detect all errors or fraud. Any control system, no matter how well designed and operated, is based upon certain assumptions and can provide only reasonable, not absolute, assurance that its objectives will be met. Further, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within Holdings and CUSA have been detected.

Item 9B. Other Information

During the quarter ended December 31, 2023, none of the directors or officers of the Company adopted or terminated any contract, instruction or written plan for the purchase or sale of securities of the Company that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any “non-Rule 10b5-1 trading arrangement” (as defined in the Exchange Act).

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not Applicable.

45

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the stockholders and the Board of Directors of Cinemark Holdings, Inc.

Opinion on Internal Control over Financial Reporting

We have audited the internal control over financial reporting of Cinemark Holdings, Inc. and subsidiaries (the “Company”) as of December 31, 2023, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control — Integrated Framework (2013)issued by COSO.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2023, of the Company and our report dated February 16, 2024, expressed an unqualified opinion on those financial statements.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ Deloitte & Touche LLP

Dallas, Texas

February 16, 2024

46

PART III

Item 10. Directors, Executive Officers and Corporate Governance

Incorporated by reference to Holdings’ proxy statement for its annual stockholders meeting to be held on May 15, 2024 and to be filed with the SEC within 120 days after December 31, 2023.

Item 11. Executive Compensation

Incorporated by reference to Holdings’ proxy statement for its annual stockholders meeting to be held on May 15, 2024 and to be filed with the SEC within 120 days after December 31, 2023.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Incorporated by reference to Holdings’ proxy statement for its annual stockholders meeting to be held on May 15, 2024 and to be filed with the SEC within 120 days after December 31, 2023.

Item 13. Certain Relationships and Related Transactions, and Director Independence

Incorporated by reference to Holdings’ proxy statement for its annual stockholders meeting to be held on May 15, 2024 and to be filed with the SEC within 120 days after December 31, 2023.

Item 14. Principal Accounting Fees and Services

Incorporated by reference to Holdings’ proxy statement for its annual stockholders meeting to be held on May 15, 2024 and to be filed with the SEC within 120 days after December 31, 2023.

PART IV

Item 15. Exhibit and Financial Statement Schedules

(a) Documents Filed as Part of this Report

1.The financial statement schedules and related data listed in the accompanying Index beginning on page F-1 are filed as part of this report.

2.The exhibits listed in the accompanying Index beginning on page 48 are filed as a part of this report.

(b) Exhibits

See the accompanying Index beginning on page 48.

(c) Financial Statement Schedules

Schedule I – Condensed Financial Information of Cinemark Holdings, Inc. beginning on page S-1.

Supplemental Schedules Specified by the Senior Notes Indentures

As required by the indentures governing CUSA’s 5.25% Senior Notes, 5.875% Senior Notes and 8.75% Secured Notes, collectively “the senior notes”, CUSA has included in this filing, financial information for its subsidiaries that have been designated as unrestricted subsidiaries as defined by the indentures. As required by these indentures, CUSA has included a condensed consolidating balance sheet and condensed consolidating statements of income, comprehensive income and cash flows for CUSA. These supplementary schedules, beginning on page S-6 separately identify CUSA’s restricted subsidiaries and unrestricted subsidiaries as required by the indentures.

All Schedules not identified above have been omitted because they are not required, are not applicable or the information is included in the consolidated financial statements or notes contained in this report.

47

EXHIBIT INDEX

Number	Registrant	Exhibit Title
3.1	Holdings	Second Amended and Restated Certificate of Incorporation of Cinemark Holdings, Inc. filed with the Delaware Secretary of State on April 9, 2007 (incorporated by reference to Exhibit 3.1 to Amendment No. 2 to Cinemark Holdings, Inc’s Registration Statement on Form S-1, File No. 333-140390, filed April 9, 2007).
3.2	Holdings	Second Amended and Restated Bylaws of Cinemark Holdings, Inc. dated March 27, 2023 (incorporated by reference to Exhibit 3.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed March 27, 2023).
3.3	CUSA	Amended and Restated Articles of Incorporation of Cinemark USA, Inc. dated June 3, 1992 (incorporated by reference to Exhibit 3.1 to Cinemark USA, Inc.’s Registration on Form S-4, File No. 333-162105, filed on September 24, 2009).
3.4	CUSA	Amended and Restated Bylaws of Cinemark USA, Inc., as amended (incorporated by reference to Exhibit 3.4(a) to Cinemark USA, Inc.’s Registration Statement on Form S-4, File No. 333-162105, filed on September 24, 2009).
4.1	Holdings	Description of common stock (incorporated by reference to Exhibit 4.1 to the Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 21, 2020).
4.2	Holdings	Specimen stock certificate of Cinemark Holdings, Inc. (incorporated by reference to Exhibit 4.1 to Amendment No. 2 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 9, 2007).
4.3	Holdings	Director Nomination Agreement, effective as of April 27, 2007, by and among Cinemark Holdings, Inc. and certain stockholders (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc’s Current Report on Form 8-K, File No. 001-33401, filed May 3, 2007).
4.4(a)	Holdings CUSA	Indenture, dated as of December 18, 2012, between Cinemark USA, Inc. and Wells Fargo Bank, N.A. governing the 5.125% senior notes issued thereunder (incorporated by reference to Exhibit 4.1 to Cinemark Holdings, Inc.’s Current Report on Form 8K, File No. 001-33401, filed December 20, 2012).
4.4(b)	Holdings CUSA	Form of 5.125% senior notes of Cinemark USA, Inc. (contained in the Indenture listed as Exhibit 4.4(a) above) (incorporated by reference to Exhibit 4.1 to the Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed December 20, 2012).
4.5(a)	Holdings CUSA	Indenture, dated as of May 24, 2013, between Cinemark USA, Inc. and Well Fargo Bank, N.A. governing the 4.875% Senior Notes issued thereunder (incorporated by reference to Exhibit 4.1 to Cinemark Holdings, Inc.’s Current Report on Form 8K, File No. 001-33401 filed May 28, 2013).
4.5(b)	Holdings CUSA	Form of 4.875% Senior Notes of Cinemark USA, Inc. (contained in the Indenture listed as Exhibit 4.5(a) above (incorporated by reference to Exhibit 4.1 to Cinemark Holdings, Inc.’s Current Report on Form 8K, File No. 001-33401, filed May 28, 2013).
4.6(a)	Holdings CUSA	Indenture, dated as of April 20, 2020, among Cinemark USA, Inc., the Guarantors named therein and Wells Fargo Bank, N.A., as trustee and collateral agent (incorporated by reference to Exhibit 4.1 to Cinemark Holdings, Inc.’s Current Report on Form 8K, File No. 001-33401 filed April 20, 2020).
4.6(b)	Holdings CUSA	Form of 8.750% senior secured notes of Cinemark USA, Inc. (contained in the Indenture listed as Exhibit 4.6(a) above) (incorporated by reference to Exhibit 4.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed on April 20, 2020).
4.7(a)	Holdings	Indenture, dated as of August 21, 2020, between Cinemark Holdings, Inc. and Wells Fargo Bank, N.A., as trustee (incorporated by reference to Exhibit 4.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401 filed August 24, 2020)
4.7(b)	Holdings	Form of 4.500% convertible senior notes of Cinemark Holdings, Inc. (contained in the Indenture listed as Exhibit 4.7(a) above) (incorporated by reference to Exhibit 4.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed on August 24, 2020).
4.8(a)	Holdings CUSA	Indenture, dated as of March 16, 2021, among Cinemark USA, Inc., the Guarantors named therein and Wells Fargo Bank, N.A., as trustee (incorporated by reference to Exhibit 4.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed on March 16, 2021).
4.8(b)	Holdings CUSA	Form of 5.875% senior notes of Cinemark USA, Inc. (contained in the Indenture listed as Exhibit 4.8(a) above) (incorporated by reference to Exhibit 4.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed on March 16, 2021).
4.9(a)	Holdings CUSA	Indenture, dated as of June 15, 2021, among Cinemark USA, Inc., the Guarantors named therein and Wells Fargo Bank, N.A., as trustee (incorporated by reference to Exhibit 4.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401. filed on June 15, 2021).
4.9(b)	Holdings CUSA	Form of 5.25% Senior Notes of Cinemark USA, Inc. (contained in the Indenture listed as Exhibit 4.9(a) above). (incorporated by reference to Exhibit 4.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed on June 15, 2021).
10.1(a)	Holdings CUSA	Management Agreement, dated December 10, 1993, between Laredo Theatre, Ltd. and Cinemark USA, Inc. (incorporated by reference to Exhibit 10.14(b) to Cinemark USA, Inc.’s Annual Report on Form 10-K, File No. 033-47040, filed March 31, 1994). (P)

48

10.1(b)	Holdings CUSA	First Amendment to Management Agreement of Laredo Theatre, Ltd., effective as of December 10, 2003, between CNMK Texas Properties, Ltd. (successor in interest to Cinemark USA, Inc.) and Laredo Theatre Ltd. (incorporated by reference to Exhibit 10.1(d) to Cinemark, Inc.’s Registration Statement on Form S-4, File No. 333-116292, filed June 8, 2004).
10.1(c)	Holdings CUSA	Second Amendment to Management Agreement of Laredo Theatres, Ltd., effective as of December 10, 2008, between CNMK Texas Properties, L.L.C. (Successor in interest to Cinemark USA, Inc.) and Laredo Theatre Ltd. (incorporated by reference to Exhibit 10.1(c) to the Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed March 13, 2009).
10.1(d)	Holdings CUSA	Third Amendment to Management Agreement of Laredo Theatres, Ltd., effective as of December 10, 2013, between CNMK Texas Properties, L.L.C. (Successor in interest to Cinemark USA, Inc.) and Laredo Theatre Ltd. (incorporated by reference to Exhibit 10.1(d) to the Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 24, 2016).
10.2	Holdings CUSA	License Agreement, dated December 10, 1993, between Laredo Joint Venture and Cinemark USA, Inc. (incorporated by reference to Exhibit 10.14(c) to Cinemark USA, Inc.’s Annual Report on Form 10-K, File No. 033-47040, filed March 31, 1994). (P)
10.3(a)	Holdings CUSA	Amended and Restated Credit Agreement, dated as of December 18, 2012, among Cinemark USA, Inc., Cinemark Holdings, Inc., the several banks and other financial institutions and entities from time to time parties thereto, Barclays Bank PLC, Deutsche Bank Securities Inc., Morgan Stanley Senior Funding, Inc. and Wells Fargo Securities, LLC, as joint bookrunners, Morgan Stanley Senior Funding, Inc., as syndication agent, Deutsche Bank Securities Inc., Wells Fargo Securities, Inc. and Webster Bank, N.A., as co-documentation agents, and Barclays Bank PLC, as administrative agent. (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed December 20, 2012).
10.3(b)	Holdings CUSA	Second Amendment to the Amended and Restated Credit Agreement, dated as of May 8, 2015, among Cinemark USA, Inc., Cinemark Holdings, Inc., the several banks and other financial institutions and entities from time to time parties thereto, Barclays Bank PLC as administrative agent, Barclays Bank PLC as lead arranger, Barclays, Morgan Stanley Senior Funding, Inc., Deutsche Bank Securities Inc. and Wells Fargo Securities, LLC, as joint bookrunners, J.P.Morgan Securities LLC, Webster Bank, N.A., as co-arrangers (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed May 14, 2015).
10.3(c)	Holdings CUSA	Third Amendment to the Amended and Restated Credit Agreement, dated as of June 13, 2016, among Cinemark Holdings, Inc., Cinemark USA, Inc., the several banks and other financial institutions party thereto, Barclays Bank PLC, as administrative agent, and the other agents party thereto (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed June 17, 2016).
10.3(d)	Holdings CUSA	Fourth Amendment to the Amended and Restated Credit Agreement, dated as of December 15, 2016, among Cinemark Holdings, Inc., Cinemark USA, Inc., the several banks and other financial institutions party thereto, Barclays Bank PLC, as administrative agent, and the other agents party thereto (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed December 20, 2016).
10.3(e)	Holdings CUSA	Fifth Amendment to the Amended and Restated Credit Agreement, dated as of June 16, 2017, among Cinemark Holdings, Inc., Cinemark USA, Inc., the several banks and other financial institutions party thereto, Barclays Bank PLC, as administrative agent, and the other agents party thereto (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed June 20, 2017).
10.3(f)	Holdings CUSA	Sixth Amendment to the Amended and Restated Credit Agreement, dated as of November 28, 2017, among Cinemark Holdings, Inc., Cinemark USA, Inc., the several banks and other financial institutions party thereto, Barclays Bank PLC, as administrative agent, and the other agents party thereto (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed December 4, 2017).
10.3(g)	Holdings CUSA	Seventh Amendment to the Amended and Restated Credit Agreement, dated as of March 29, 2018, among Cinemark Holdings, Inc., Cinemark USA, Inc., the several banks and other financial institutions party thereto, Barclays Bank PLC, as administrative agent, and the other agents party thereto (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed April 4, 2018).
10.3(h)	Holdings CUSA	Eighth Amendment and Waiver to the Amended and Restated Credit Agreement, dated as of April 17, 2020, by and among Cinemark Holdings, Inc., Cinemark USA, Inc., the several banks and other financial institutions party thereto, Barclays Bank PLC, as administrative agent, and the other agents party thereto (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8K, File No. 001-33401 filed April 20, 2020).
10.3(i)	Holdings CUSA	Amendment to Eighth Amendment and Waiver, dated as of August 21, 2020, by and among Cinemark Holdings, Inc., Cinemark USA, Inc., the several banks and other financial institutions party thereto, and Barclays Bank PLC, as administrative agent, and the other agents party thereto (incorporated by reference to Exhibit 10.2 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401 filed August 24, 2020).
10.3(j)	Holdings CUSA	Ninth Amendment to the Amended and Restated Credit Agreement, dated as of June 15, 2021, by and among Cinemark Holdings, Inc., Cinemark USA, Inc., the several banks and other financial institutions party thereto, Barclays Bank PLC, as administrative agent, and the other agents party thereto (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401 filed June 15, 2021).
10.3(k)	Holdings CUSA	Second Amended and Restated Credit Agreement, dated as of May 26, 2023, by and among Cinemark Holdings, Inc., Cinemark USA, Inc., the lenders from time to time parties thereto, the other agents and arrangers named therein and Barclay’s Bank PLC, as administrative agent (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s and Cinemark USA, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed May 26, 2023).

49

10.3(l)	Holdings CUSA	Guarantee and Collateral Agreement, dated as of October 5, 2006, among Cinemark Holdings, Inc., Cinemark, Inc., CNMK Holding, Inc., Cinemark USA, Inc. and each subsidiary guarantor party thereto (incorporated by reference to Exhibit 10.6 to Current Report on Form 8-K, File No. 033-47040, filed by Cinemark USA, Inc. October 12, 2006).
10.3(m)	Holdings CUSA	Reaffirmation Agreement, dated as of December 18, 2012, between Cinemark Holdings, Inc., Cinemark USA, Inc. and each subsidiary guarantor party thereto (incorporated by reference to Exhibit 10.4(c) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 28, 2013).
+10.4(a)	Holdings CUSA	Employment Agreement, dated as of December 15, 2008, between Cinemark Holdings, Inc. and Lee Roy Mitchell (incorporated by reference to Exhibit 10.5 (q) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed March 13, 2009).
+10.4(b)	Holdings CUSA	Amendment to Employment Agreement, dated as of November 12, 2014 between Cinemark Holdings, Inc. and Lee Roy Mitchell (incorporated by reference to Exhibit 10.6(h) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 27, 2015).
+10.4(c)	Holdings CUSA	Employment Agreement, dated as of June 23, 2014, by and between Cinemark Holdings, Inc. and Sean Gamble (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No.001-33401, filed June 23, 2014).
+10.4(d)	Holdings CUSA	First Amendment to Employment Agreement, dated as of July 28, 2021, by and between Cinemark Holdings, Inc. and Sean Gamble (incorporated by reference to Exhibit 10.2 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No.001-33401, filed July 28, 2021).
+10.4(e)	Holdings CUSA	Amended and Restated Employment Agreement, dated as of January 1, 2022, by and between Cinemark Holdings, Inc. and Sean Gamble (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No.001-33401, filed January 4, 2022).
+10.4(f)	Holdings CUSA	Employment Agreement, dated as of June 16, 2008, between Cinemark Holdings, Inc. and Michael Cavalier (incorporated by reference to Exhibit 10.4 to Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed August 8, 2008).
+10.4(g)	Holdings CUSA	Employment Agreement, dated as of February 15, 2010, between Cinemark Holdings, Inc. and Valmir Fernandes (incorporated by reference to Exhibit 10.5(u) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed March 10, 2010).
+10.4(h)	Holdings CUSA	Amended and Restated Employment Agreement, dated as of February 19, 2016, between Cinemark Holdings, Inc. and Mark Zoradi (incorporated by reference to Exhibit 10.6(l) to the Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 24, 2016).
+10.4(i)	Holdings CUSA	First Amendment to the Amended and Restated Employment Agreement, dated as of February 20, 2018, between Cinemark Holdings, Inc. and Mark Zoradi (incorporated by reference to Exhibit 10.l to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No.001-33401, filed February 23, 2018).
+10.4(j)	Holdings CUSA	Second Amended and Restated Employment Agreement, dated as of November 18, 2020, between Cinemark Holdings, Inc. and Mark Zoradi (incorporated by reference to Exhibit 10.l to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No.001-33401, filed November 20, 2020).
+10.4(k)	Holdings CUSA	Employment Agreement, dated as of October 7, 2021, between Cinemark Holdings, Inc. and Melissa Thomas (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No.001-33401, filed October 13, 2021).
+10.4(l)	Holdings CUSA	Termination Agreement, dated as of May 25, 2022, between Cinemark Holdings, Inc. and Lee Roy Mitchell (incorporated by reference to Exhibit 10.2 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed May 25, 2022).
+10.5(a)	Holdings	Amended and Restated Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan, dated November 19, 2020 (incorporated by reference to Exhibit 10.2 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No.001-33401, filed November 20, 2020).
+10.5(b)	Holdings	Form of Stock Option Award Agreement pursuant to the Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 4.3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-8, File No. 333-218697, filed June 13, 2017).
+10.5(c)	Holdings	Form of Performance Stock Award Agreement pursuant to the Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 4.4 to Cinemark Holdings, Inc.’s Registration Statement on Form S-8, File No. 333-218697, filed June 13, 2017).
+10.5(d)	Holdings	Form of Restricted Stock Award Agreement pursuant to the Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 4.5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-8, File No. 333-218697, filed June 13, 2017).
+10.5(e)	Holdings	Form of Performance Stock Unit Award Certificate pursuant to the Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 4.6 to Cinemark Holdings, Inc.’s Registration Statement on Form S-8, File No. 333-218697, filed June 13, 2017).
+10.5(f)	Holdings	Form of Restricted Stock Unit Award Certificate pursuant to the Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 4.7 to Cinemark Holdings, Inc.’s Registration Statement on Form S-8, File No. 333-218697, filed June 13, 2017).

50

+10.6(a)	Holdings	Form of Restricted Stock Award Agreement pursuant to the Amended and Rested Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.6(b) to Cinemark Holdings, Inc’s Annual Report on Form 10-K, File No. 001-33401 filed February 26, 2021).
+10.6(b)	Holdings	Form of Restricted Stock Award Agreement pursuant to the Amended and Restated Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (officer) (incorporated by reference to Exhibit 10.6(c) to Cinemark Holdings, Inc’s Annual Report on Form 10-K, File No. 001-33401 filed February 26, 2021).
+10.6(c)	Holdings	Form of Restricted Stock Unit Award Certificate pursuant to the Amended and Restated Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.6(d) to Cinemark Holdings, Inc’s Annual Report on Form 10-K, File No. 001-33401 filed February 26, 2021).
+10.6(d)	Holdings	Form of Restricted Stock Unit Award Certificate pursuant to the Amended and Restated Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (officer) (incorporated by reference to Exhibit 10.6(e) to Cinemark Holdings, Inc’s Annual Report on Form 10-K, File No. 001-33401 filed February 26, 2021).
+10.6(e)	Holdings	Form of Performance Stock Award Agreement pursuant to the Amended and Restated Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.6(f) to Cinemark Holdings, Inc’s Annual Report on Form 10-K, File No. 001-33401 filed February 26, 2021).
+10.6(f)	Holdings	Form of Performance Stock Award Agreement pursuant to the Amended and Restated Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (officer) (incorporated by reference to Exhibit 10.6(g) to Cinemark Holdings, Inc’s Annual Report on Form 10-K, File No. 001-33401 filed February 26, 2021).
+10.6(g)	Holdings	Form of Performance Stock Unit Award Certificate pursuant to Amended and Restated the Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.6(h) to Cinemark Holdings, Inc’s Annual Report on Form 10-K, File No. 001-33401 filed February 26, 2021)..
+10.6(h)	Holdings	Form of Performance Stock Unit Award Certificate pursuant to the Amended and Restated Cinemark Holdings, Inc. 2017 Omnibus Incentive Plan (officer) (incorporated by reference to Exhibit 10.6(i) to Cinemark Holdings, Inc’s Annual Report on Form 10-K, File No. 001-33401 filed February 26, 2021).
+10.6(i)	Holdings CUSA	Cinemark Holdings, Inc. Short-Term Incentive Plan (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed February 13, 2024).
10.7(a)	Holdings CUSA	Amended and Restated Exhibitor Services Agreement between National CineMedia, LLC and Cinemark USA, Inc., dated as of December 26, 2013 (incorporated by reference to Exhibit 10.45 to Cinemark Holdings, Inc.’s Annual Report on Form 10-K , File No. 001-33401, filed February 28, 2014).
10.7(b)	Holdings CUSA	First Amendment to Amended and Restated Exhibitor Services Agreement between National CineMedia, LLC and Cinemark USA, Inc. dated as of September 17, 2019 (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed November 5, 2019).
10.8	Holdings CUSA	Third Amended and Restated Limited Liability Company Operating Agreement, dated as of February 12, 2007, by and between Cinemark Media, Inc., American Multi-Cinema, Inc., Regal CineMedia, LLC and National CineMedia, Inc. (incorporated by reference to Exhibit 10.9 to Amendment No. 1 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed March 16, 2007).
10.9(a)	Holdings CUSA	Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Laguna 16, Elk Grove, CA (incorporated by reference to Exhibit 10.11(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.9(b)	Holdings CUSA	First Amendment, dated as of September 1, 2000, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Laguna 16, Elk Grove, CA (incorporated by reference to Exhibit 10.11(b) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.9(c)	Holdings CUSA	Second Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Laguna 16, Elk Grove, CA (incorporated by reference to Exhibit 10.11(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.9(d)	Holdings CUSA	Third Amendment, dated as of September 29, 2005, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Laguna 16, Elk Grove, CA (incorporated by reference to Exhibit 10.11(d) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.9(e)	Holdings CUSA	Fourth Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century Laguna 16, Elk Grove, CA. (incorporated by reference to Exhibit 10.10(b) of Cinemark Holdings, Inc. Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).
10.9(f)	Holdings CUSA	Fifth Amendment, dated as of January 29, 2018, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century Laguna 16, Elk Grove, CA. (incorporated by reference to Exhibit 10.5 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed January 29, 2018).
10.9(g)	Holdings CUSA	Sixth Amendment, dated as of March 31, 2020, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century Laguna 16, Elk Grove, CA (incorporated by reference to Exhibit 10.3 of Cinemark Holdings, Inc.’s. Quarterly Report on Form 10-Q, File No. 001-33401, filed June 3, 2020).

51

10.9(h)	Holdings CUSA	Seventh Amendment, dated as of July 9, 2021, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century Laguna 16, Elk Grove, CA (incorporated by reference to Exhibit 10.9(h) of Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 24, 2023).
10.10(a)	Holdings CUSA	Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 14, Folsom, CA (incorporated by reference to Exhibit 10.14(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.10(b)	Holdings CUSA	First Amendment, dated as of September 1, 2000, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 14, Folsom, CA (incorporated by reference to Exhibit 10.14(b) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.10(c)	Holdings CUSA	Second Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 14, Folsom, CA (incorporated by reference to Exhibit 10.14(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.10(d)	Holdings CUSA	Third Amendment, dated as of September 29, 2005, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 14, Folsom, CA (incorporated by reference to Exhibit 10.14(d) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.10(e)	Holdings CUSA	Fourth Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century 14, Folsom, CA. (incorporated by reference to Exhibit 10.10(c) of Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).
10.10(f)	Holdings CUSA	Fifth Amendment, dated as of January 29, 2018 to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century 14, Folsom, CA. (incorporated by reference to Exhibit 10.4 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed January 29, 2018).
10.10(g)	Holdings CUSA	Sixth Amendment, dated as of March 31, 2020, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century 14, Folsom, CA (incorporated by reference to Exhibit 10.2 of Cinemark Holdings, Inc. Quarterly Report on Form 10-Q, File No. 001-33401, filed June 3, 2020).
10.10(h)	Holdings CUSA	Seventh Amendment, dated as of July 9, 2021, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century 14, Folsom, CA.(incorporated by reference to Exhibit 10.1 of Cinemark Holdings, Inc. Quarterly Report on Form 10-Q, File No. 001-33401, filed August 6, 2021).
10.10(i)	Holdings CUSA	Eighth Amendment, dated as of December 20, 2021, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century 14, Folsom, CA.(incorporated by reference to Exhibit 10.11 of Cinemark Holdings, Inc,’s Annual Report on Form 10-K, File No. 001-33401, filed February 25, 2022).
*10.10(j)	Holdings CUSA	Ninth Amendment, dated as of June 15, 2023, to Indenture of Lease, dated as of December 1, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century 14, Folsom, CA.
10.11(a)	Holdings CUSA	Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of Nevada, Inc., as tenant, for Cinedome 12, Henderson, NV (incorporated by reference to Exhibit 10.15(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.11(b)	Holdings CUSA	First Amendment, dated as of September 1, 2000, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of Nevada, Inc., as tenant, for Cinedome 12, Henderson, NV (incorporated by reference to Exhibit 10.15(b) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.11(c)	Holdings CUSA	Second Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of Nevada, Inc., as tenant, for Cinedome 12, Henderson, NV (incorporated by reference to Exhibit 10.15(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.11(d)	Holdings CUSA	Third Amendment, dated as of September 29, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of Nevada, Inc., as tenant, for Cinedome 12, Henderson, NV (incorporated by reference to Exhibit 10.15(d) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.11(e)	Holdings CUSA	Fourth Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of Nevada, Inc., as tenant, for Cinedome 12, Henderson, NV (incorporated by reference to Exhibit 10.15(e) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).

52

10.11(f)	Holdings CUSA	Fifth Amendment to Indenture of Lease, dated as of October 5, 2012 by and between Syufy Enterprises, L.P. as landlord and Century Theatres, Inc., as tenant, for Cinedome 12, Henderson, NV. (incorporated by reference to Exhibit 10.13(f) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 27, 2015).
10.11(g)	Holdings CUSA	Sixth Amendment to Indenture of Lease, dated as of January 29, 2018 by and between Syufy Enterprises, L.P. as landlord and Century Theatres, Inc., as tenant, for Cinedome 12, Henderson, NV. (incorporated by reference to Exhibit 10.3 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed January 29, 2018).
10.11(h)	Holdings CUSA	Seventh Amendment to Indenture of Lease, dated as of July 9, 2021 by and between Syufy Enterprises, L.P. as landlord and Century Theatres, Inc., as tenant, for Cinedome 12, Henderson, NV. (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed August 6, 2021).
10.11(i)	Holdings CUSA	Eighth Amendment to Indenture of Lease, dated as of June 15, 2023 by and between Syufy Enterprises, L.P. as landlord and Century Theatres, Inc., as tenant, for Cinedome 12, Henderson, NV.
10.12(a)	Holdings CUSA	Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 8, North Hollywood, CA (incorporated by reference to Exhibit 10.17(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.12(b)	Holdings CUSA	First Amendment, dated as of September 1, 2000, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 8, North Hollywood, CA (incorporated by reference to Exhibit 10.17(b) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.12(c)	Holdings CUSA	Second Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 8, North Hollywood, CA (incorporated by reference to Exhibit 10.17(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.12(d)	Holdings CUSA	Third Amendment, dated as of September 29, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 8, North Hollywood, CA (incorporated by reference to Exhibit 10.17(d) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.12(e)	Holdings CUSA	Fourth Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 8, North Hollywood, CA (incorporated by reference to Exhibit 10.17(e) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.12(f)	Holdings CUSA	Fifth Amendment, dated as of May 1, 2014, to Indenture of Lease by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant for Century 8, North Hollywood, CA. (incorporated by reference to Exhibit 10.14(f) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 27, 2015).
10.12(g)	Holdings CUSA	Sixth Amendment, dated as of July 28, 2015, to Indenture of Lease by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant for Century 8, North Hollywood, CA (incorporated by reference to Exhibit 10.14(g) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 23, 2018).
10.12(h)	Holdings CUSA	Seventh Amendment, dated as of January 29, 2018, to Indenture of Lease by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant for Century 8, North Hollywood, CA. (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed January 29, 2018).
10.13(a)	Holdings CUSA	Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Cinema 16, Mountain View, CA (incorporated by reference to Exhibit 10.21(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.13(b)	Holdings CUSA	First Amendment, dated as of September 1, 2000, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Cinema 16, Mountain View, CA (incorporated by reference to Exhibit 10.21(b) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.13(c)	Holdings CUSA	Second Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Cinema 16, Mountain View, CA (incorporated by reference to Exhibit 10.21(c) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.13(d)	Holdings CUSA	Third Amendment, dated as of September 29, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century Cinema 16, Mountain View, CA (incorporated by reference to Exhibit 10.21(d) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.13(e)	Holdings CUSA	Fourth Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century Cinema 16, Mountain View, CA. (incorporated by reference to Exhibit 10.10(d) of Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).
10.13(f)	Holdings CUSA	Fifth Amendment, dated as of January 29, 2018, to Indenture of Lease dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for

53

		Century Cinema 16, Mountain View, CA. (incorporated by reference to Exhibit 10.2 to Cinemark Holdings, Inc.’s Current Report on Form 8—K, File No. 001-33401, filed January 29, 2018).
10.13(g)	Holdings CUSA	Sixth Amendment, dated as of March 31, 2020, to Indenture of Lease dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century Cinema 16, Mountain View, CA (incorporated by reference to Exhibit 10.1 of Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed June 3, 2020).
10.14(a)	Holdings CUSA	Lease Agreement, dated as of April 10, 1998, by and between Dyer Triangle LLC, as landlord and Century Theatres, Inc., as tenant, for Century 25 Union Landing, Union City, CA (incorporated by reference to Exhibit 10.25(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.14(b)	Holdings CUSA	First Amendment, dated as of April 15, 2005, to Lease Agreement, dated as of April 10, 1998, by and between Dyer Triangle LLC, as landlord and Century Theatres, Inc., as tenant, for Century 25 Union Landing, Union City, CA (incorporated by reference to Exhibit 10.25(b) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.14(c)	Holdings CUSA	Second Amendment, dated as of September 29, 2005, to Lease Agreement, dated as of April 10, 1998, by and between Dyer Triangle LLC, as landlord and Century Theatres, Inc., as tenant, for Century 25 Union Landing, Union City, CA (incorporated by reference to Exhibit 10.25(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.14(d)	Holdings CUSA	Third Amendment, dated as of August 5, 2006, to Lease Agreement, dated as of April 10, 1998, by and between Dyer Triangle LLC, as landlord and Century Theatres, Inc., as tenant, for Century 25 Union Landing, Union City, CA. (incorporated by reference to Exhibit 10.10(j) of Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).
10.14(e)	Holdings CUSA	Fourth Amendment, dated as of January 29, 2018, to Lease Agreement, dated as of April 10, 1998, by and between Dyer Triangle, LLC, as landlord and Century Theatres, Inc., as tenant, for Century 25 Union Landing, Union City, CA (incorporated by reference to Exhibit 10.14(e) to Cinemark Holdings Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 24, 2023).
10.15(a)	Holdings CUSA	Lease Agreement, dated as of October 1, 1996, by and between Syufy Enterprises, L.P.(succeeded by Stadium Promenade LLC), as landlord and Century Theatres, Inc., as tenant, for Century Stadium 25, Orange, CA (incorporated by reference to Exhibit 10.27(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.15(b)	Holdings CUSA	First Amendment, dated as of April 15, 2005, to Lease Agreement, dated as of October 1, 1996, by and between Syufy Enterprises, L.P. (succeeded by Stadium Promenade LLC), as landlord and Century Theatres, Inc., as tenant, for Century Stadium 25, Orange, (incorporated by reference to Exhibit 10.27(b) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.15(c)	Holdings CUSA	Second Amendment, dated as of September 29, 2005, to Lease Agreement, dated as of October 1, 1996, by and between Syufy Enterprises, L.P. (succeeded by Stadium Promenade LLC), as landlord and Century Theatres, Inc., as tenant, for Century Stadium 25, Orange, (incorporated by reference to Exhibit 10.27(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.15(d)	Holdings CUSA	Third Amendment, dated as of August 5, 2006, to Lease Agreement, dated as of October 1, 1996, by and between Stadium Promenade LLC, as landlord and Century Theatres, Inc., as tenant, for Century Stadium 25, Orange, CA. (incorporated by reference to Exhibit 10.10(h) of Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).
10.15(e)	Holdings CUSA	Fourth Amendment, dated as of August 15, 2014, to Lease Agreement, dated as of October 1, 1996, by and between Stadium Promenade LLC, as landlord and Century Theatres, Inc., as tenant, for Century Stadium 25, Orange, CA (incorporated by reference to Exhibit 10.19(e) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 23, 2018).
10.15(f)	Holdings CUSA	Fifth Amendment, dated as of August 3, 2015, to Lease Agreement, dated as of October 1, 1996, by and between Stadium Promenade LLC, as landlord and Century Theatres, Inc., as tenant, for Century Stadium 25, Orange, CA (incorporated by reference to Exhibit 10.19(f) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 23, 2018).
10.16(a)	Holdings CUSA	Indenture of Lease, dated as of July 1, 1996, by and between Synm Properties Inc. (succeeded by Syufy Properties, Inc.), as landlord and Century Theatres, Inc., as tenant, Century Rio 24, Albuquerque, NM (incorporated by reference to Exhibit 10.28(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.16(b)	Holdings CUSA	First Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of July 1, 1996, by and between Synm Properties Inc. (succeeded by Syufy Properties, Inc.), as landlord and Century Theatres, Inc., as tenant, Century Rio 24, Albuquerque, NM (incorporated by reference to Exhibit 10.28(b) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.16(c)	Holdings CUSA	Second Amendment, dated as of September 29, 2005, to Indenture of Lease, dated as of July 1, 1996, by and between Synm Properties Inc. (succeeded by Syufy Properties, Inc.), as landlord and Century Theatres, Inc., as tenant, Century Rio 24, Albuquerque, NM (incorporated by reference to Exhibit 10.28(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.16(d)	Holdings CUSA	Third Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of July 1, 1996, by and between SYNM Properties Inc. (succeeded by Syufy Properties, Inc.), as landlord and Century Theatres, Inc., as tenant, Century Rio 24, Albuquerque, NM.

54

		(incorporated by reference to Exhibit 10.10(g) of Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).
10.16(e)	Holdings CUSA	Fourth Amendment, dated as of January 29, 2018, to Indenture of Lease, dated as of July 1, 1996, by and between SYNM Properties Inc. (succeeded by Syufy Properties, Inc.), as landlord and Century Theatres, Inc., as tenant, Century Rio 24, Albuquerque, NM. (incorporated by reference to Exhibit 10.7 to Cinemark Holdings, Inc.’s Current Report on Form 8—K, File No. 001-33401, filed January 29, 2018).
10.17(a)	Holdings CUSA	Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Northridge 14, Salinas, CA (incorporated by reference to Exhibit 10.32(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.17(b)	Holdings CUSA	First Amendment, dated as of September 1, 2000, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Northridge 14, Salinas, CA (incorporated by reference to Exhibit 10.32(b) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.17(c)	Holdings CUSA	Second Amendment, dated as of October 1, 2001, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Northridge 14, Salinas, CA (incorporated by reference to Exhibit 10.32(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.17(d)	Holdings CUSA	Third Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Northridge 14, Salinas, CA. (incorporated by reference to Exhibit 10.10(m) of Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).
10.17(e)	Holdings CUSA	Fourth Amendment, dated as of August 4, 2017, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Northridge 14, Salinas, CA (incorporated by reference to Exhibit 10.23(e) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 23, 2018).
10.17(f)	Holdings CUSA	Fifth Amendment, dated as of January 29, 2018, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Northridge 14, Salinas, CA. (incorporated by reference to Exhibit 10.10 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed January 29, 2018).
10.18(a)	Holdings CUSA	Indenture of Lease, dated as of August 1, 1997, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century Park Lane 16, Reno, NV (incorporated by reference to Exhibit 10.35(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.18(b)	Holdings CUSA	First Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of August 1, 1997, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century Park Lane 16, Reno, NV (incorporated by reference to Exhibit 10.35(b) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.18(c)	Holdings CUSA	Second Amendment, dated as of September 29, 2005, to Indenture of Lease, dated as of August 1, 1997, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century Park Lane 16, Reno, NV (incorporated by reference to Exhibit 10.35(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.18(d)	Holdings CUSA	Third Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of August 1, 1997, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century Park Lane 16, Reno, NV. (incorporated by reference to Exhibit 10.10(f) of Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).
10.18(e)	Holdings CUSA	Fourth Amendment, dated as of August 8, 2017, to Indenture of Lease, dated as of August 1, 1997, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century Park Lane 16, Reno, NV (incorporated by reference to Exhibit 10.26(e) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 23, 2018).
10.18(f)	Holdings CUSA	Fifth Amendment, dated as of January 29, 2018, to Indenture of Lease, dated as of August 1, 1997, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century Park Lane 16, Reno, NV. (incorporated by reference to Exhibit 10.8 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed January 29, 2018).
10.19(a)	Holdings CUSA	Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 16, Sacramento, CA (incorporated by reference to Exhibit 10.36(a) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.19(b)	Holdings CUSA	First Amendment, dated as of September 1, 2000, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 16, Sacramento, CA (incorporated by reference to Exhibit 10.36(b) to Amendment No. 5 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 20, 2007).
10.19(c)	Holdings CUSA	Second Amendment, dated as of October 1, 2001, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 16, Sacramento, CA (incorporated

55

		by reference to Exhibit 10.36(c) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.19(d)	Holdings CUSA	Third Amendment, dated as of April 15, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 16, Sacramento, CA (incorporated by reference to Exhibit 10.36(d) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.19(e)	Holdings CUSA	Fourth Amendment, dated as of September 29, 2005, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc., as tenant, for Century 16, Sacramento, CA (incorporated by reference to Exhibit 10.36(e) to Amendment No. 3 to Cinemark Holdings, Inc.’s Registration Statement on Form S-1, File No. 333-140390, filed April 18, 2007).
10.192(f)	Holdings CUSA	Fifth Amendment, dated as of August 7, 2006, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century 16, Sacramento, CA (incorporated by reference to Exhibit 10.10(n) of Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed November 7, 2013).
10.19(g)	Holdings CUSA	Sixth Amendment, dated as of January 29, 2018, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century 16, Sacramento, CA (incorporated by reference to Exhibit 10.11 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed January 29, 2018).
10.19(h)	Holdings CUSA	Seventh Amendment, dated as of March 31, 2020, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres of California, Inc. (succeeded by Century Theatres, Inc.), as tenant, for Century 16, Sacramento, CA (incorporated by reference to Exhibit 10.4 of Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed June 3, 2020).
10.19(i)	Holdings CUSA	Eight Amendment, dated as of July 9, 2021, to Indenture of Lease, dated as of September 30, 1995, by and between Syufy Enterprises, L.P., as landlord and Century Theatres, Inc., as tenant, for Century 16, Sacramento, CA (incorporated by reference to Exhibit 10.19(i) to Cinemark Holdings Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 24, 2023).
10.20(a)	Holdings CUSA	Lease Agreement, dated as of May 26, 2015, by and between Sy Arden Way LLC, as landlord and Century Theatres, Inc., as tenant, for Howe ‘Bout Arden Center, Sacramento, CA (incorporated by reference to Exhibit 10.28(a) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 23, 2018).
10.20(b)	Holdings CUSA	Letter Agreement, dated as of February 8, 2016, to Lease Agreement, dated as of May 26, 2015, by and between Sy Arden Way LLC, as landlord and Century Theatres, Inc., as tenant, for Howe ‘Bout Arden Center, Sacramento, CA (incorporated by reference to Exhibit 10.28(b) to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 23, 2018).
10.20(c)	Holdings CUSA	First Amendment, dated as of July 9, 2021, to Lease Agreement, dated as of May 26, 2015, by and between Sy Arden Way LLC, as landlord and Century Theatres, Inc., as tenant, for Howe ‘Bout Arden Center, Sacramento, CA (incorporated by reference to Exhibit 10.1 to Cinemark Holdings Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed August 5, 2022).
10.20(d)	Holdings CUSA	Second Amendment, dated as of June 24, 2022, to Lease Agreement, dated as of May 26, 2015, by and between Sy Arden Way LLC, as landlord and Century Theatres, Inc., as tenant, for Howe ‘Bout Arden Center, Sacramento, CA (incorporated by reference to Exhibit 10.2 to Cinemark Holdings Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed August 5, 2022).
10.21	Holdings	Cinemark Holdings, Inc. Performance Bonus Plan, as amended (incorporated by reference to Appendix B to Cinemark Holdings, Inc.’s Definitive Proxy Statement, filed April 11, 2013).
+10.22	Holdings	Third Amended and Restated Non-Employee Director Compensation Policy, dated as of February 15, 2017 (incorporated by reference to Exhibit 10.30 to Cinemark Holdings, Inc.’s Annual Report on Form 10-K, File No. 001-33401, filed February 23, 2018).
10.23	Holdings CUSA	Aircraft Time Sharing Agreement, dated as of September 2, 2009, between Copper Beach Capital, LLC and Cinemark USA, Inc. (incorporated by reference to Exhibit 10.1 of Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401, filed September 8, 2009).
10.24	Holdings CUSA	Limited Liability Company Agreement of FE Concepts, LLC dated as of April 20, 2018 (incorporated by reference to Exhibit 10.1 of Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed August 8, 2018).
10.25	Holdings CUSA	Management Services Agreement by and between FE Concepts, LLC and Cinema Operations, L.L.C. dated as of April 20, 2018 (incorporated by reference to Exhibit 10.2 of Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed August 8, 2018).
10.26	Holdings CUSA	Theatre Services Agreement by and between FE Concepts, LLC and CNMK Texas Properties, LLC dated as of April 20, 2018 (incorporated by reference to Exhibit 10.3 of Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed August 8, 2018).
10.27	Holdings	Form of Call Option Transaction Confirmation (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401 filed August 24, 2020).
10.28	Holdings	Form of Warrants Confirmation (incorporated by reference to Exhibit 10.2 to Cinemark Holdings, Inc.’s Current Report on Form 8-K, File No. 001-33401 filed August 24, 2020).
*21.1	Holdings	Subsidiaries of Cinemark Holdings, Inc.
*21.2	CUSA	Subsidiaries of Cinemark USA, Inc.

56

*23.1	Holdings	Consent of Deloitte & Touche LLP.
*31.1	Holdings	Certification of Sean Gamble, Chief Executive Officer of Cinemark Holdings, Inc., pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
*31.2	Holdings	Certification of Melissa Thomas, Chief Financial Officer of Cinemark Holdings, Inc., pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
*31.3	CUSA	Certification of Sean Gamble, Chief Executive Officer of Cinemark USA, Inc., pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
*31.4	CUSA	Certification of Melissa Thomas, Chief Financial Officer of Cinemark USA, Inc., pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
*32.1	Holdings	Certification of Sean Gamble, Chief Executive Officer of Cinemark Holdings, Inc., pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002.
*32.2	Holdings	Certification of Melissa Thomas, Chief Financial Officer of Cinemark Holdings, Inc., pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002.
*32.3	CUSA	Certification of Sean Gamble, Chief Executive Officer of Cinemark USA, Inc., pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002.
*32.4	CUSA	Certification of Melissa Thomas, Chief Financial Officer of Cinemark USA, Inc., pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002.
*97.1	Holdings	Cinemark Holdings Inc.’s Clawback Policy dated as of November 16, 2023.
*101	Holdings CUSA	The following financial information from the combined Cinemark Holdings, Inc. and Cinemark USA, Inc. Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on February 16, 2024, formatted in iXBRL (Inline eXtensible Business Reporting Language), filed herewith:   (i) Cinemark Holdings, Inc. Consolidated Balance Sheets  (ii) Cinemark Holdings, Inc. Consolidated Statements of Income (Loss) (iii) Cinemark Holdings, Inc. Consolidated Statements of Comprehensive Income (Loss) (iv) Cinemark Holdings, Inc. Consolidated Statements of Equity  (v) Cinemark Holdings, Inc. Consolidated Statements of Cash Flows (vi) Cinemark USA, Inc. Consolidated Balance Sheets (vii) Cinemark USA, Inc. Consolidated Statements of Income (Loss) (viii) Cinemark USA, Inc. Consolidated Statements of Comprehensive Income (Loss) (ix) Cinemark USA, Inc. Consolidated Statements of Equity  (x) Cinemark USA, Inc. Consolidated Statements of Cash Flows (xi) Notes to Consolidated Financial Statements of Cinemark Holdings, Inc.and Cinemark USA, Inc. tagged as detailed text
*104	Holdings CUSA	Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

* Filed herewith.

+ Any management contract, compensatory plan or arrangement.

(P) Paper filing.

57

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act, each registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: February 16, 2024	CINEMARK HOLDINGS, INC CINEMARK USA, INC (Registrants)
	BY:	/s/ Sean Gamble
		Sean Gamble
		Chief Executive Officer

BY:	/s/ Melissa Thomas
	Melissa Thomas
	Chief Financial Officer

POWER OF ATTORNEY

Each person whose signature appears below hereby severally constitutes and appoints Sean Gamble and Melissa Thomas their true and lawful attorney-in-fact and agent, each with the power of substitution and resubstitution, for him or her in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K and to file the same, with accompanying exhibits and other related documents, with the Securities and Exchange Commission, and ratify and confirm all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue of said appointment.

Pursuant to the requirements of the Exchange Act, this report has been signed below by the following persons on behalf of the registrants and in the capacities and on the dates indicated.

CINEMARK HOLDINGS, INC.
Name	Title	Date
/s/ Carlos M. Sepulveda	Chairman of the Board and Director	February 16, 2024
Carlos M. Sepulveda
/s/ Sean Gamble	Chief Executive Officer and Director	February 16, 2024
Sean Gamble	(principal executive officer)
/s/ Melissa Thomas	Chief Financial Officer	February 16, 2024
Melissa Thomas	(principal financial officer)
/s/ Caren Bedard	SVP — Global Controller and Treasury	February 16, 2024
Caren Bedard	(principal accounting officer)
/s/ Darcy Antonellis	Director	February 16, 2024
Darcy Antonellis
/s/ Benjamin D. Chereskin	Director	February 16, 2024
Benjamin D. Chereskin
/s/ Nancy Loewe	Director	February 16, 2024
Nancy Loewe
/s/ Kevin Mitchell	Director	February 16, 2024
Kevin Mitchell
/s/ Steven Rosenberg	Director	February 16, 2024
Steven Rosenberg
/s/ Enrique F. Senior	Director	February 16, 2024
Enrique F. Senior
/s/ Raymond W. Syufy	Director	February 16, 2024
Raymond W. Syufy

58

/s/ Nina Vaca	Director	February 16, 2024
Nina Vaca
/s/ Mark Zoradi	Director	February 16, 2024
Mark Zoradi
CINEMARK USA, INC.
Name	Title	Date
/s/ Sean Gamble	Chief Executive Officer and Director	February 16, 2024
Sean Gamble	(principal executive officer)
/s/ Melissa Thomas	Chief Financial Officer	February 16, 2024
Melissa Thomas	(principal financial officer)

59

SUPPLEMENTAL INFORMATION TO BE FURNISHED WITH REPORTS FILED PURSUANT TO

SECTION 15(d) OF THE ACT BY REGISTRANTS WHICH HAVE NOT REGISTERED

SECURITIES PURSUANT TO SECTION 12 OF THE ACT.

No annual report or proxy material has been sent to our stockholders. An annual report and proxy material may be sent to our stockholders subsequent to the filing of this Form 10-K. We shall furnish to the SEC copies of any annual report or proxy material that is sent to our stockholders.

60

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

	Page
Report of Independent Registered Public Accounting Firm (Deloitte & Touche LLP, Dallas, TX, PCAOB ID No. 34) - Cinemark Holdings, Inc. and subsidiaries	F-2
Report of Independent Registered Public Accounting Firm (Deloitte & Touche LLP, Dallas, TX, PCAOB ID No. 34) - Cinemark USA, Inc. and subsidiaries	F-4
CINEMARK HOLDINGS, INC. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS:
Consolidated Balance Sheets, December 31, 2022 and 2023	F-6
Consolidated Statements of Income (Loss) for the Years Ended December 31, 2021, 2022 and 2023	F-7
Consolidated Statements of Comprehensive Income (Loss) for the Years Ended December 31, 2021, 2022 and 2023	F-8
Consolidated Statements of Equity for the Years Ended December 31, 2021, 2022 and 2023	F-9
Consolidated Statements of Cash Flows for the Years Ended December 31, 2021, 2022 and 2023	F-10
CINEMARK USA, INC. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS:
Consolidated Balance Sheets, December 31, 2022 and 2023	F-11
Consolidated Statements of Income (Loss) for the Years Ended December 31, 2021, 2022 and 2023	F-12
Consolidated Statements of Comprehensive Income (Loss) for the Years Ended December 31, 2021, 2022 and 2023	F-13
Consolidated Statements of Equity for the Years Ended December 31, 2021, 2022 and 2023	F-14
Consolidated Statements of Cash Flows for the Years Ended December 31, 2021, 2022 and 2023	F-15
Cinemark Holdings, Inc. and Cinemark USA, Inc. Notes to Consolidated Financial Statements	F-16

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the stockholders and the Board of Directors of Cinemark Holdings, Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Cinemark Holdings, Inc. and subsidiaries (the “Company”) as of December 31, 2023, and 2022, the related consolidated statements of income (loss), comprehensive income (loss), equity, and cash flows, for each of the three years in the period ended December 31, 2023, and the related notes and the schedules listed in the Index at Item 15 (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023, and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 16, 2024, expressed an unqualified opinion on the Company's internal control over financial reporting.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Impairment of Domestic Theatre-Level Long-Lived Assets (valuation assertion)—Refer to Notes 1 and 12 to the financial statements

Critical Audit Matter Description

The impairment evaluation of domestic long-lived assets is an assessment that begins with the Company’s monitoring of indicators of impairment on an individual theatre basis, which the Company believes is the lowest level for which there are identifiable cash flows. The Company reviews the domestic long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. The Company performed the domestic long-lived asset impairment evaluations each quarter during the year ended December 31, 2023, including a full quantitative impairment assessment for the quarter ended December 31, 2023. When performing a quantitative impairment assessment, the Company estimates undiscounted cash flows at the theatre level from continuing use through the remainder of the theatre’s estimated useful life. If the

F-2

estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, the Company then compares the carrying value of the asset group (the theatre) with its estimated fair value. The Company applies significant judgment in estimating the fair value of theatres, based on most recent theatre-level cash flows, projected theatre-level cash flows, and current industry trading multiples. When the estimated fair value is determined to be lower than the carrying value of the asset group, the asset group is written down to its estimated fair value.

We identified the valuation assertion related to the impairment of the domestic long-lived assets as a critical audit matter because of the significant judgment required by management to determine estimated undiscounted cash flows and market multiples used to derive fair values. This required a high degree of auditor judgment and an increased extent of effort when performing audit procedures to evaluate the reasonableness of management’s judgements and estimates. In addition, the likelihood of exercising lease renewal options, could have a significant impact on the amount of any domestic long-lived asset impairment charge.

How the Critical Audit Matter Was Addressed in the Audit

Our audit procedures related to management’s undiscounted cash flow analysis, including the likelihood of exercising lease renewal options, include the following, among others:

•We tested the effectiveness of the Company’s controls over domestic long-lived asset impairment evaluation.

•We tested the underlying source information and mathematical accuracy of the calculations.

•We evaluated management’s ability to forecast future theatre-level cash flows by:

–Evaluating management’s 2024 forecast of estimated future cash flows (“forecast”) assumptions including, but not limited to, the forecasted performance driven by expected film releases and projected box office results, market share, and expected theatre-level operating costs.

–Comparing management’s projected domestic cash flow forecasts with:

▪Historical cash flows and results.

▪Historical forecasted cash flow.

▪Assessment of likelihood of exercising lease renewal options through inspection of underlying lease agreements.

▪Forecast information included in analyst reports, as well as industry outlook information.

•With the assistance of our fair value specialists, we evaluated the reasonableness of the domestic market cash flow multiples by testing the source information and the mathematical accuracy of the calculations. We additionally developed a range of independent estimates compared to those assumptions used by management.

/s/ Deloitte & Touche LLP
 

Dallas, Texas

February 16, 2024

We have served as the Company's auditor since 1988.

F-3

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors of Cinemark USA, Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Cinemark USA, Inc. and subsidiaries (the “Company”) as of December 31, 2023 and 2022, the related consolidated statements of income (loss), comprehensive income (loss), equity, and cash flows, for each of the three years in the period ended December 31, 2023, and the related notes and the schedules listed in the Index at Item 15 (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Impairment of Domestic Theatre-level Long-Lived Assets (valuation assertion) – Refer to Notes 1 and 12 to the financial statements

Critical Audit Matter Description

The impairment evaluation of domestic long-lived assets is an assessment that begins with the Company’s monitoring of indicators of impairment on an individual theatre basis, which the Company believes is the lowest level for which there are identifiable cash flows. The Company reviews the domestic long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. The Company performed the domestic long-lived asset impairment evaluations each quarter during the year ended December 31, 2023, including a full quantitative impairment assessment for the quarter ended December 31, 2023. When performing a quantitative impairment assessment, the Company estimates undiscounted cash flows at the theatre level from continuing use through the remainder of the theatre’s estimated useful life. If the estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, the Company then compares the carrying value of the asset group (the theatre) with its estimated fair value. The Company applies

F-4

significant judgment in estimating the fair value of theatres, based on most recent theatre-level cash flows, projected theatre-level cash flows, and current industry trading multiples. When the estimated fair value is determined to be lower than the carrying value of the asset group, the asset group is written down to its estimated fair value.

We identified the valuation assertion related to the impairment of the domestic long-lived assets as a critical audit matter because of the significant judgment required by management to determine estimated undiscounted cash flows and market multiples used to derive fair values. This required a high degree of auditor judgment and an increased extent of effort when performing audit procedures to evaluate the reasonableness of management’s judgements and estimates. In addition, the likelihood of exercising lease renewal options, could have a significant impact on the amount of any domestic long-lived asset impairment charge.

How the Critical Audit Matter Was Addressed in the Audit

Our audit procedures related to management’s undiscounted cash flow analysis, including the likelihood of exercising lease renewal options, include the following, among others:

•We tested the effectiveness of the Company’s controls over domestic long-lived asset impairment evaluation.

•We tested the underlying source information and mathematical accuracy of the calculations.

•We evaluated management’s ability to forecast future theatre-level cash flows by:

–Evaluating management’s 2024 forecast of estimated future cash flows (“forecast”) assumptions including, but not limited to, the forecasted performance driven by expected film releases and projected box office results, market share, and expected theatre-level operating costs.

–Comparing management’s projected domestic cash flow forecasts with:

▪Historical cash flows and results.

▪Historical forecasted cash flow.

▪Assessment of likelihood of exercising lease renewal options through inspection of underlying lease agreements.

▪Forecast information included in analyst reports, as well as industry outlook information.

•With the assistance of our fair value specialists, we evaluated the reasonableness of the domestic market cash flow multiples by testing the source information and the mathematical accuracy of the calculations. We additionally developed a range of independent estimates compared to those assumptions used by management.

/s/ Deloitte & Touche LLP
 

Dallas, Texas

February 16, 2024

We have served as the Company's auditor since 1988.

F-5

PART IV - FINANCIAL INFORMATION

Item 15. Financial Statements

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(in millions, except share and per share data)

	December 31,			December 31,
	2022			2023
Assets
Current assets
Cash and cash equivalents	$	674.5		$	849.1
Inventories		23.7			23.3
Accounts receivable		69.6			80.4
Current income tax receivable		45.1			56.7
Prepaid expenses and other		50.7			50.5
Total current assets	$	863.6		$	1,060.0
Theatre properties and equipment, net		1,232.1			1,161.7
Operating lease right-of-use assets, net		1,102.7			986.4
Other long-term assets
Goodwill		1,250.9			1,251.0
Intangible assets, net		304.6			302.8
Investment in NCMI/NCM		9.6			18.1
Investments in affiliates		22.6			23.6
Deferred charges and other assets, net		31.6			33.2
Total other long-term assets		1,619.3			1,628.7
Total assets	$	4,817.7		$	4,836.8
Liabilities and equity
Current liabilities
Current portion of long-term debt	$	10.7		$	7.8
Current portion of operating lease obligations		219.3			212.5
Current portion of finance lease obligations		14.4			14.0
Current income tax payable		3.2			4.2
Accounts payable		72.2			53.3
Accrued interest		39.1			36.0
Accrued film rentals		65.1			73.8
Accrued payroll		54.5			60.1
Accrued property taxes		29.6			29.4
Accrued other current liabilities (see Note 13)		200.4			239.2
Total current liabilities		708.5			730.3
Long-term liabilities
Long-term debt, less current portion		2,474.0			2,391.3
Operating lease obligations, less current portion		970.6			853.3
Finance lease obligations, less current portion		88.0			73.8
Long-term deferred tax liability		33.7			51.7
Long-term liability for uncertain tax positions		47.9			48.0
NCM screen advertising advances		338.2			328.4
Other long-term liabilities		37.3			41.2
Total long-term liabilities		3,989.7			3,787.7
Commitments and contingencies (see Note 21)
Equity
Cinemark Holdings, Inc.'s stockholders' equity:
Common stock, $0.001 par value: 300,000,000 shares authorized, 126,082,187 shares issued and 120,403,833 shares outstanding at December 31, 2022 and 127,598,774 shares issued and 121,596,206 shares outstanding at December 31, 2023		0.1			0.1
Additional paid-in-capital		1,219.3			1,244.3
Treasury stock, 5,678,354 and 6,002,568 shares, at cost, at December 31, 2022 and December 31, 2023, respectively		(95.4	)		(98.3	)
Accumulated deficit		(660.6	)		(472.4	)
Accumulated other comprehensive loss		(353.2	)		(363.9	)
Total Cinemark Holdings, Inc.'s stockholders' equity		110.2			309.8
Noncontrolling interests		9.3			9.0
Total equity		119.5			318.8
Total liabilities and equity	$	4,817.7		$	4,836.8

The accompanying notes, as they relate to Cinemark Holdings, Inc., are an integral part of the consolidated financial statements.

F-6

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME (LOSS)

(in millions, except per share data)

	Years Ended December 31,
	2021			2022			2023
Revenue
Admissions	$	780.0		$	1,246.9		$	1,555.6
Concession		561.7			938.3			1,192.0
Other		168.8			269.5			319.1
Total revenue	$	1,510.5		$	2,454.7		$	3,066.7
Cost of operations
Film rentals and advertising		415.0			704.4			865.7
Concession supplies		97.9			169.3			221.3
Salaries and wages		232.9			372.7			403.1
Facility lease expense		280.0			308.3			329.7
Utilities and other		282.9			407.2			466.8
General and administrative expenses		161.1			177.6			198.8
Depreciation and amortization		265.4			238.2			209.5
Impairment of long-lived and other assets		20.8			174.1			16.6
Restructuring costs		(1.0	)		(0.5	)		—
Loss (gain) on disposal of assets and other		8.0			(6.8	)		(7.7	)
Total cost of operations		1,763.0			2,544.5			2,703.8
Operating (loss) income		(252.5	)		(89.8	)		362.9
Other income (expense)
Interest expense		(149.7	)		(155.3	)		(150.4	)
Interest income		6.4			20.4			55.0
Loss on debt extinguishment and refinancing		(6.5	)		—			(10.7	)
Foreign currency exchange and other related loss		(1.3	)		(11.5	)		(28.8	)
Distributions from DCIP		13.1			3.7			—
Distributions from NCM		0.1			—			—
Interest expense - NCM		(23.6	)		(23.2	)		(22.6	)
Equity in (loss) income of affiliates		(25.0	)		(9.3	)		3.6
Unrealized gain on investment in NCMI		—			—			12.4
Total other expense		(186.5	)		(175.2	)		(141.5	)
(Loss) income before income taxes		(439.0	)		(265.0	)		221.4
Income tax (benefit) expense		(16.8	)		3.0			29.9
Net (loss) income	$	(422.2	)	$	(268.0	)	$	191.5
Less: Net income attributable to noncontrolling interests		0.6			3.2			3.3
Net (loss) income attributable to Cinemark Holdings, Inc.	$	(422.8	)	$	(271.2	)	$	188.2
Weighted average shares outstanding
Basic		117.3			118.2			119.1
Diluted		117.3			118.2			152.0
(Loss) income per share attributable to Cinemark Holdings, Inc.'s common stockholders
Basic	$	(3.55	)	$	(2.26	)	$	1.55
Diluted	$	(3.55	)	$	(2.26	)	$	1.34

The accompanying notes, as they relate to Cinemark Holdings, Inc., are an integral part of the consolidated financial statements.

F-7

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(in millions)

	Years Ended December 31,
	2021			2022			2023
Net (loss) income	$	(422.2	)	$	(268.0	)	$	191.5
Other comprehensive (loss) income, net of tax
Unrealized gain (loss) due to fair value adjustments on interest rate swap agreements, net of taxes of $(0.7), $(2.8) and $1.2, and net of settlements		18.5			32.2			(9.2	)
Foreign currency translation adjustments		(18.8	)		4.6			4.9
Total other comprehensive (loss) income, net of tax		(0.3	)		36.8			(4.3	)
Total comprehensive (loss) income, net of tax		(422.5	)		(231.2	)		187.2
Comprehensive income attributable to noncontrolling interests		(0.6	)		(3.2	)		(3.3	)
Comprehensive (loss) income attributable to Cinemark Holdings, Inc.	$	(423.1	)	$	(234.4	)	$	183.9

The accompanying notes, as they relate to Cinemark Holdings, Inc., are an integral part of the consolidated financial statements.

F-8

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF EQUITY

YEARS ENDED DECEMBER 31, 2021, 2022 AND 2023

(in millions)

																				Total
														Retained			Accumulated			Cinemark
	Common Stock				Treasury Stock						Additional			Earnings/			Other			Holdings, Inc.'s
	Shares				Shares						Paid-in-			Accumulated			Comprehensive			Stockholders'			Noncontrolling			Total
	Issued		Amount		Acquired			Amount			Capital			Deficit			Loss			Equity			Interests			Equity
Balance at January 1, 2021		123.6	$	0.1		(5.1	)	$	(87.0	)	$	1,245.6		$	27.9		$	(398.7	)	$	787.9		$	11.0		$	798.9
Impact of adoption of ASU 2020-06, net of taxes of $20.3		—		—		—			—			(77.1	)		5.5			—			(71.6	)		—			(71.6	)
Issuance of restricted stock		1.3		—		—			—			—			—			—			—			—			—
Issuance of stock upon vesting of performance stock units		0.2		—		—			—			—			—			—			—			—			—
Restricted stock forfeitures and stock withholdings related to share-based awards that vested during the year ended December 31, 2021		—		—		(0.3	)		(4.1	)		—			—			—			(4.1	)		—			(4.1	)
Share-based awards compensation expense		—		—		—			—			29.3			—			—			29.3			—			29.3
Net (loss) income		—		—		—			—			—			(422.8	)		—			(422.8	)		0.6			(422.2	)
Amortization of accumulated losses for amended swap agreements		—		—		—			—			—			—			4.5			4.5			—			4.5
Other comprehensive loss		—		—		—			—			—			—			(0.3	)		(0.3	)		—			(0.3	)
Balance at December 31, 2021		125.1	$	0.1		(5.4	)	$	(91.1	)	$	1,197.8		$	(389.4	)	$	(394.5	)	$	322.9		$	11.6		$	334.5
Issuance of restricted stock		0.9		—		—			—			—			—			—			—			—			—
Issuance of stock upon vesting of performance stock units		0.1		—		—			—			—			—			—			—			—			—
Restricted stock forfeitures and stock withholdings related to share-based awards that vested during the year ended December 31, 2022		—		—		(0.3	)		(4.3	)		—			—			—			(4.3	)		—			(4.3	)
Share-based awards compensation expense		—		—		—			—			21.5			—			—			21.5			—			21.5
Net (loss) income		—		—		—			—			—			(271.2	)		—			(271.2	)		3.2			(268.0	)
Distributions to noncontrolling interests		—		—		—			—			—			—			—			—			(5.5	)		(5.5	)
Amortization of accumulated losses for amended swap agreements		—		—		—			—			—			—			4.5			4.5			—			4.5
Other comprehensive income		—		—		—			—			—			—			36.8			36.8			—			36.8
Balance at December 31, 2022		126.1	$	0.1		(5.7	)	$	(95.4	)	$	1,219.3		$	(660.6	)	$	(353.2	)	$	110.2		$	9.3		$	119.5
Issuance of restricted stock		1.4		—		—			—			—			—			—			—			—			—
Issuance of stock upon vesting of performance stock units		0.1		—		—			—			—			—			—			—			—			—
Restricted stock forfeitures and stock withholdings related to share-based awards that vested during the year ended December 31, 2023		—		—		(0.3	)		(2.9	)		—			—			—			(2.9	)		—			(2.9	)
Share-based awards compensation expense		—		—		—			—			25.0			—			—			25.0			—			25.0
Net income		—		—		—			—			—			188.2			—			188.2			3.3			191.5
Distributions to noncontrolling interests		—		—		—			—			—			—			—			—			(3.6	)		(3.6	)
Amortization of accumulated gains for amended swap agreements		—		—		—			—			—			—			(6.4	)		(6.4	)		—			(6.4	)
Other comprehensive loss		—		—		—			—			—			—			(4.3	)		(4.3	)		—			(4.3	)
Balance at December 31, 2023		127.6	$	0.1		(6.0	)	$	(98.3	)	$	1,244.3		$	(472.4	)	$	(363.9	)	$	309.8		$	9.0		$	318.8

The accompanying notes, as they relate to Cinemark Holdings, Inc., are an integral part of the consolidated financial statements.

F-9

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

	Years Ended December 31,
	2021			2022			2023
Operating activities
Net (loss) income	$	(422.2	)	$	(268.0	)	$	191.5
Adjustments to reconcile net (loss) income to cash provided by operating activities:
Depreciation		262.7			235.7			207.3
Amortization of intangible and other assets		2.7			2.5			2.2
Loss on debt extinguishment and refinancing		6.5			—			10.7
Amortization of original issue discount and debt issuance costs		10.7			10.9			10.2
Interest accrued on NCM screen advertising advances		23.6			23.2			22.6
Amortization of NCM screen advertising advances and other deferred revenue		(32.4	)		(32.5	)		(32.4	)
Amortization of accumulated losses (gains) for amended swap agreements		4.5			4.5			(6.4	)
Impairment of long-lived and other assets		20.8			174.1			16.6
Share-based awards compensation expense		29.3			21.5			25.0
Loss (gain) on disposal of assets and other		8.0			(6.8	)		(7.7	)
Unrealized gain on investment in NCMI		—			—			(12.4	)
Non-cash rent expense		(3.4	)		(10.8	)		(17.9	)
Equity in loss (income) of affiliates		25.0			9.3			(3.6	)
Deferred income tax (benefit) expense		(22.6	)		(9.3	)		10.6
Distributions from equity investees		0.2			6.9			5.7
Changes in other assets and liabilities:
Inventories		(2.9	)		(8.2	)		0.3
Accounts receivable		(43.6	)		(1.2	)		(11.5	)
Income tax receivable		118.5			1.5			(12.1	)
Prepaid expenses and other		(1.8	)		(2.3	)		(2.3	)
Deferred charges and other assets, net		0.8			(1.2	)		0.3
Accounts payable and accrued expenses		175.5			(25.1	)		45.4
Income tax payable		(6.0	)		3.2			1.0
Liabilities for uncertain tax positions		30.2			2.0			0.1
Other long-term liabilities		(17.9	)		6.1			1.1
Net cash provided by operating activities		166.2			136.0			444.3
Investing activities
Additions to theatre properties and equipment and other		(95.5	)		(110.7	)		(149.5	)
Net proceeds from sale of subsidiary		—			—			14.8
Proceeds from sale of assets and other		6.2			14.4			2.9
Net cash used for investing activities		(89.3	)		(96.3	)		(131.8	)
Financing activities
Proceeds from refinancing of senior secured credit facility		—			—			640.2
Repayment of term loan upon refinancing of senior secured credit facility		—			—			(624.9	)
Redemption of $100.0 of 8.75% Secured Notes at 102.2%		—			—			(102.2	)
Proceeds from issuance of senior notes		1,170.0			—			—
Redemption of senior notes		(1,155.0	)		—			—
Proceeds from other borrowings		13.5			—			—
Payment of debt issuance costs		(17.3	)		—			(7.5	)
Fees paid related to debt refinancing		(2.0	)		—			(2.6	)
Other repayments of long-term debt		(10.3	)		(28.1	)		(10.6	)
Restricted stock withholdings for payroll taxes		(4.1	)		(4.3	)		(2.9	)
Payments on finance leases		(14.7	)		(14.3	)		(14.4	)
Other		—			(5.5	)		(0.5	)
Net cash used for financing activities		(19.9	)		(52.2	)		(125.4	)
Effect of exchange rate changes on cash and cash equivalents		(5.0	)		(20.3	)		(12.5	)
Increase (decrease) in cash and cash equivalents		52.0			(32.8	)		174.6
Cash and cash equivalents:
Beginning of period		655.3			707.3			674.5
End of period	$	707.3		$	674.5		$	849.1

Supplemental information (see Note 19)

The accompanying notes, as they relate to Cinemark Holdings, Inc., are an integral part of the consolidated financial statements.

F-10

CINEMARK USA, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(in millions, except share and per share data)

	December 31,			December 31,
	2022			2023
Assets
Current assets
Cash and cash equivalents	$	427.3		$	612.4
Inventories		23.7			23.3
Accounts receivable		69.0			78.2
Current income tax receivable		45.1			56.1
Prepaid expenses and other		50.7			50.5
Accounts receivable from parent		53.4			58.6
Total current assets		669.2			879.1
Theatre properties and equipment, net		1,232.1			1,161.7
Operating lease right-of-use assets, net		1,102.7			986.4
Other long-term assets
Goodwill		1,250.9			1,251.0
Intangible assets, net		304.6			302.8
Investment in NCMI/NCM		9.6			18.1
Investments in affiliates		22.6			23.6
Deferred charges and other assets, net		31.6			33.2
Total other long-term assets		1,619.3			1,628.7
Total assets	$	4,623.3		$	4,655.9
Liabilities and equity
Current liabilities
Current portion of long-term debt	$	10.7		$	7.8
Current portion of operating lease obligations		219.3			212.5
Current portion of finance lease obligations		14.4			14.0
Current income tax payable		3.2			4.2
Accounts payable		72.2			53.3
Accrued interest		31.2			28.2
Accrued film rentals		65.1			73.8
Accrued payroll		54.5			60.1
Accrued property taxes		29.6			29.4
Accrued other current liabilities (see Note 13)		200.1			239.1
Total current liabilities		700.3			722.4
Long-term liabilities
Long-term debt, less current portion		2,023.0			1,936.8
Operating lease obligations, less current portion		970.6			853.3
Finance lease obligations, less current portion		88.0			73.8
Long-term deferred tax liability		36.1			51.7
Long-term liability for uncertain tax positions		47.9			48.0
NCM screen advertising advances		338.2			328.4
Other long-term liabilities		37.3			41.2
Total long-term liabilities		3,541.1			3,333.2
Commitments and contingencies (see Note 21)
Equity
Cinemark USA, Inc.'s stockholder's equity:
Class A common stock, $0.01 par value: 10,000,000 shares authorized, 1,500 shares issued and outstanding		—			—
Class B common stock, no par value: 1,000,000 shares authorized, 239,893 shares issued and 182,648 shares outstanding		49.5			49.5
Treasury stock, 57,245 Class B shares at cost		(24.2	)		(24.2	)
Additional paid-in-capital		1,479.5			1,503.3
Accumulated deficit		(775.9	)		(570.6	)
Accumulated other comprehensive loss		(356.3	)		(366.7	)
Total Cinemark USA, Inc.'s stockholder's equity		372.6			591.3
Noncontrolling interests		9.3			9.0
Total equity		381.9			600.3
Total liabilities and equity	$	4,623.3		$	4,655.9

The accompanying notes, as they relate to Cinemark USA, Inc., are an integral part of the consolidated financial statements.

F-11

CINEMARK USA, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME (LOSS)

(in millions)

	Years Ended December 31,
	2021			2022			2023
Revenue
Admissions	$	780.0		$	1,246.9		$	1,555.6
Concession		561.7			938.3			1,192.0
Other		168.8			269.5			319.1
Total revenue		1,510.5			2,454.7			3,066.7
Cost of operations
Film rentals and advertising		415.0			704.4			865.7
Concession supplies		97.9			169.3			221.3
Salaries and wages		232.9			372.7			403.1
Facility lease expense		280.0			308.3			329.7
Utilities and other		282.9			407.2			466.8
General and administrative expenses		158.5			174.6			195.5
Depreciation and amortization		265.4			238.2			209.5
Impairment of long-lived and other assets		20.8			174.1			16.6
Restructuring costs		(1.0	)		(0.5	)		—
Loss (gain) on disposal of assets and other		8.0			(6.8	)		(7.7	)
Total cost of operations		1,760.4			2,541.5			2,700.5
Operating (loss) income		(249.9	)		(86.8	)		366.2
Other income (expense)
Interest expense		(125.6	)		(131.2	)		(126.3	)
Interest income		6.3			16.5			43.2
Loss on debt extinguishment and refinancing		(6.5	)		—			(10.7	)
Foreign currency exchange and other related loss		(1.3	)		(11.5	)		(28.8	)
Distributions from DCIP		13.1			3.7			—
Distributions from NCM		0.1			—			—
Interest expense - NCM		(23.6	)		(23.2	)		(22.6	)
Equity in (loss) income of affiliates		(25.0	)		(9.3	)		3.6
Unrealized gain on investment in NCMI		—			—			12.4
Total other expense		(162.5	)		(155.0	)		(129.2	)
(Loss) income before income taxes		(412.4	)		(241.8	)		237.0
Income tax (benefit) expense		(32.3	)		(13.1	)		28.4
Net (loss) income	$	(380.1	)	$	(228.7	)	$	208.6
Less: Net income attributable to noncontrolling interests		0.6			3.2			3.3
Net (loss) income attributable to Cinemark USA, Inc.	$	(380.7	)	$	(231.9	)	$	205.3

The accompanying notes, as they relate to Cinemark USA, Inc., are an integral part of the consolidated financial statements.

F-12

CINEMARK USA, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(in millions)

	Years Ended December 31,
	2021			2022			2023
Net (loss) income	$	(380.1	)	$	(228.7	)	$	208.6
Other comprehensive (loss) income, net of tax
Unrealized gain (loss) due to fair value adjustments on interest rate swap agreements, net of taxes of $(3.3), $(3.4) and $1.5, and net of settlements		16.0			31.6			(8.9	)
Foreign currency translation adjustments		(18.8	)		4.6			4.9
Total other comprehensive (loss) income, net of tax		(2.8	)		36.2			(4.0	)
Total comprehensive (loss) income, net of tax		(382.9	)		(192.5	)		204.6
Comprehensive income attributable to noncontrolling interests		(0.6	)		(3.2	)		(3.3	)
Comprehensive (loss) income attributable to Cinemark USA, Inc.	$	(383.5	)	$	(195.7	)	$	201.3

The accompanying notes, as they relate to Cinemark USA, Inc., are an integral part of the consolidated financial statements.

F-13

CINEMARK USA, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF EQUITY

YEARS ENDED DECEMBER 31, 2021, 2022 AND 2023

(in millions)

																							Total
.	Class A				Class B															Accumulated			Cinemark
	Common Stock				Common Stock				Treasury Stock						Additional					Other			USA, Inc.'s
	Shares				Shares				Shares						Paid-in-		Accumulated			Comprehensive			Stockholder's			Noncontrolling			Total
	Issued		Amount		Issued		Amount		Acquired			Amount			Capital		Deficit			Loss			Equity			Interests			Equity
Balance at January 1, 2021		—	$	—		0.2	$	49.5		(0.1	)	$	(24.2	)	$	1,310.6	$	(163.3	)	$	(398.7	)		773.9		$	11.0			784.9
Share-based awards compensation expense		—		—		—		—		—			—			28.4		—			—			28.4			—			28.4
Contributions received from parent		—		—		—		—		—			—			120.0		—			—			120.0			—			120.0
Net (loss) income		—		—		—		—		—			—			—		(380.7	)		—			(380.7	)		0.6			(380.1	)
Amortization of accumulated losses for amended swap agreements		—		—		—		—		—			—			—		—			4.5			4.5			—			4.5
Other comprehensive loss		—		—		—		—		—			—			—		—			(2.8	)		(2.8	)		—			(2.8	)
Balance at December 31, 2021		—	$	—		0.2	$	49.5		(0.1	)	$	(24.2	)	$	1,459.0	$	(544.0	)	$	(397.0	)	$	543.3		$	11.6		$	554.9
Share-based awards compensation expense		—		—		—		—		—			—			20.5		—			—			20.5			—			20.5
Net (loss) income		—		—		—		—		—			—			—		(231.9	)		—			(231.9	)		3.2			(228.7	)
Dividends paid to noncontrolling interests		—		—		—		—		—			—			—		—			—			—			(5.5	)		(5.5	)
Amortization of accumulated losses for amended swap agreements		—		—		—		—		—			—			—		—			4.5			4.5			—			4.5
Other comprehensive income		—		—		—		—		—			—			—		—			36.2			36.2			—			36.2
Balance at December 31, 2022		—	$	—		0.2	$	49.5		(0.1	)	$	(24.2	)	$	1,479.5	$	(775.9	)	$	(356.3	)	$	372.6		$	9.3		$	381.9
Share-based awards compensation expense		—		—		—		—		—			—			23.8		—			—			23.8			—			23.8
Net income		—		—		—		—		—			—			—		205.3			—			205.3			3.3			208.6
Dividends paid to noncontrolling interests		—		—		—		—		—			—			—		—			—			—			(3.6	)		(3.6	)
Amortization of accumulated gains for amended swap agreements		—		—		—		—		—			—			—		—			(6.4	)		(6.4	)		—			(6.4	)
Other comprehensive income		—		—		—		—		—			—			—		—			(4.0	)		(4.0	)		—			(4.0	)
Balance at December 31, 2023		—	$	—		0.2	$	49.5		(0.1	)	$	(24.2	)	$	1,503.3	$	(570.6	)	$	(366.7	)	$	591.3		$	9.0		$	600.3

The accompanying notes, as they relate to Cinemark USA, Inc., are an integral part of the consolidated financial statements.

F-14

CINEMARK USA, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

	Years Ended December 31,
	2021			2022			2023
Operating activities
Net (loss) income	$	(380.1	)	$	(228.7	)	$	208.6
Adjustments to reconcile net (loss) income to cash provided by operating activities:
Depreciation		262.7			235.7			207.3
Amortization of intangible and other assets		2.7			2.5			2.2
Loss on debt extinguishment and refinancing		6.5			—			10.7
Amortization of original issue discount and debt issuance costs		7.3			7.5			6.7
Interest accrued on NCM screen advertising advances		23.6			23.2			22.6
Amortization of NCM screen advertising advances and other deferred revenue		(32.4	)		(32.5	)		(32.4	)
Amortization of accumulated losses (gains) for amended swap agreements		4.5			4.5			(6.4	)
Impairment of long-lived and other assets		20.8			174.1			16.6
Share-based awards compensation expense		28.4			20.5			23.8
Loss (gain) on disposal of assets and other		8.0			(6.8	)		(7.7	)
Unrealized gain on investment in NCMI		—			—			(12.4	)
Non-cash rent expense		(3.4	)		(10.8	)		(17.9	)
Equity in loss (income) of affiliates		25.0			9.3			(3.6	)
Deferred income tax (benefit) expense		(38.1	)		(25.4	)		8.5
Distributions from equity investees		0.2			6.9			5.7
Changes in other assets and liabilities
Inventories		(2.9	)		(8.2	)		0.3
Accounts receivable		(49.3	)		(3.0	)		(12.6	)
Income tax receivable		112.3			1.5			(11.5	)
Prepaid expenses and other		(1.8	)		(2.3	)		(2.3	)
Deferred charges and other assets, net		0.8			(1.2	)		0.3
Accounts payable and accrued expenses		175.2			(24.9	)		46.1
Income tax payable		(5.9	)		3.2			1.0
Liabilities for uncertain tax positions		30.2			2.0			0.1
Other long-term liabilities		(17.9	)		6.3			1.1
Net cash provided by operating activities		176.4			153.4			454.8
Investing activities
Additions to theatre properties and equipment and other		(95.5	)		(110.7	)		(149.5	)
Net proceeds from sale of subsidiary		—			—			14.8
Proceeds from sale of assets and other		6.2			14.4			2.9
Net cash used for investing activities		(89.3	)		(96.3	)		(131.8	)
Financing activities
Proceeds from refinancing of senior secured credit facility		—			—			640.2
Repayment of term loan upon refinancing of senior secured credit facility		—			—			(624.9	)
Redemption of $100.0 of 8.75% Secured Notes at 102.2%		—			—			(102.2	)
Proceeds from issuance of senior notes		1,170.0			—			—
Redemption of senior notes		(1,155.0	)		—			—
Proceeds from other borrowings		13.5			—			—
Payment of debt issuance costs		(17.3	)		—			(7.5	)
Fees paid related to debt refinancing		(2.0	)		—			(2.6	)
Other repayments of long-term debt		(10.3	)		(28.1	)		(10.6	)
Contributions received from parent		120.0			—			—
Restricted stock withholdings for payroll taxes		(4.1	)		(4.3	)		(2.9	)
Payments on finance leases		(14.7	)		(14.3	)		(14.4	)
Other		—			(5.5	)		(0.5	)
Net cash provided by (used for) financing activities		100.1			(52.2	)		(125.4	)
Effect of exchange rate changes on cash and cash equivalents		(5.0	)		(20.3	)		(12.5	)
Increase (decrease) in cash and cash equivalents		182.2			(15.4	)		185.1
Cash and cash equivalents:
Beginning of period		260.5			442.7			427.3
End of period	$	442.7		$	427.3		$	612.4

Supplemental information (see Note 19)

The accompanying notes, as they relate to Cinemark USA, Inc., are an integral part of the consolidated financial statements.

F-15

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

1.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Business — Cinemark Holdings, Inc. (“Holdings”) is a holding company and its wholly-owned subsidiary is Cinemark USA, Inc. (“CUSA”). Holdings consolidates CUSA and its subsidiaries for financial statement purposes, and CUSA’s operating revenue and operating expenses comprise nearly 100% of Holdings’ revenue and operating expenses. As such, the following Notes to Consolidated Financial Statements relate to Holdings and CUSA and their respective consolidated subsidiaries in all material aspects, unless otherwise noted. Where it is important to distinguish between Holdings and CUSA, specific reference is made to either Holdings or CUSA. Otherwise, all references to “we”, “our”, “us” and “the Company” relate to Cinemark Holdings, Inc. and its consolidated subsidiaries and all references to CUSA relate to CUSA and its consolidated subsidiaries. We operate in the motion picture exhibition industry, with theatres in the United States (“U.S.”) and in 13 countries in Latin America as of December 31, 2023.

Principles of Consolidation — The consolidated financial statements include the accounts of Cinemark Holdings, Inc. and its subsidiaries and Cinemark USA, Inc. and its subsidiaries. Majority-owned subsidiaries that Holdings or CUSA, as applicable, has control of are consolidated while those investments in entities of which Holdings or CUSA, as applicable, owns between 20% and 50% and does not control, but has significant influence over the investee, are accounted for under the equity method. Investments in entities of which Holdings or CUSA, as applicable, owns between 20% and 50% and does not control or have significant influence over are accounted for under the fair value method. If Holdings or CUSA cease to exercise significant influence over an equity investee, the investment is accounted for under the fair value method. Investments in entities of which Holdings or CUSA, as applicable, owns less than 20% are generally accounted for under the cost method. The results of these subsidiaries and other investees are included in the consolidated financial statements of Holdings and CUSA, as applicable, effective from their date of formation or from their date of acquisition. Intercompany balances and transactions are eliminated in consolidation.

Cash and Cash Equivalents — Cash and cash equivalents consist of operating funds held in financial institutions, petty cash held at the theatres, highly liquid investments with original maturities of three months or less when purchased and restricted cash. The Company invests its cash primarily in money market funds, certificates of deposit, commercial paper or other similar funds.

Accounts Receivable – Accounts receivable, which are recorded at net realizable value, consist primarily of receivables related to screen advertising, screen rental, receivables related to gift cards sold to third party retail locations, receivables from landlords related to theatre construction projects, rebates earned from the Company’s concession vendors and value-added and other non-income tax receivables.

Inventories — Concession inventories are stated at the lower of cost (first-in, first-out method) or net realizable value.

Theatre Properties and Equipment — Theatre properties and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets as follows:

Category	Useful Life
Buildings on owned land	40 years
Buildings on leased land	Lesser of lease term or 40 years
Land and buildings under finance leases	Lease term
Theatre furniture and equipment	3 to 15 years
Leasehold improvements	Lesser of lease term or useful life

The Company evaluates long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable (qualitative evaluation). The Company also performs a full quantitative impairment evaluation on an annual basis.

F-16

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

These qualitative and quantitative evaluations are described below:

•Quantitative approach The Company performs a quantitative evaluation at the theatre level using estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the remaining lease period, which may include the probability of the exercise of available renewal periods for leased properties, and the lesser of twenty years or the building’s remaining useful life for owned properties. If the estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, the Company then compares the carrying value of the asset group (theatre) with its estimated fair value. When estimated fair value is determined to be lower than the carrying value of the asset group (theatre), the asset group (theatre) is written down to its estimated fair value. Significant judgment, including management’s estimate of future theatre level cash flows for each theatre is involved in estimating fair value. Fair value is estimated based on a multiple of cash flows. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy, as defined by FASB ASC Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples.

•Qualitative approach The Company’s qualitative assessment considers relevant economic and market conditions, industry trading multiples and recent developments that would impact its estimates of future cash flows as compared to its most recent quantitative impairment assessment.

Goodwill and Other Intangible Assets — The Company evaluates goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable. The Company evaluates goodwill for impairment at the reporting unit level. which is the U.S. and each of its international countries that has been allocated goodwill (the Company does not have goodwill recorded for all of its international locations). Under ASC Topic 350, Goodwill, Intangibles and Other (“ASC Topic 350”), the Company can elect to perform a qualitative or a quantitative impairment assessment of our goodwill as described below:

•Quantitative approach Under a quantitative goodwill impairment analysis, the Company estimates the fair value of each reporting unit and compares it with its carrying value. Fair value is estimated using (i) a market approach, which considers a multiple of cash flows for each reporting unit based upon public trading and recent transaction valuation multiples as the basis for fair value and (ii) an income approach, which uses a discounted cash flow model incorporating discount rates commensurate with the risks involved as the basis for fair value. Significant judgment including management’s estimate of future theatre level cash flows for each theatre is involved in estimating fair value of a reporting unit. The Company’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on projected operating performance of each reporting unit, recent market transactions and current industry trading multiples.

•Qualitative approach The Company’s qualitative assessment of goodwill for each reporting unit considers economic and market conditions, industry trading multiples and the impact of recent developments that would impact the estimated fair values as determined during its most recent quantitative assessment.

Tradename intangible assets are tested for impairment at least annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. Under ASC Topic 350, the Company can elect to perform a qualitative or quantitative impairment assessment for our tradename intangible assets as described below:

•Quantitative approach The Company compares the carrying values of its tradename assets to their estimated fair values. Fair values are estimated by applying an estimated market royalty rate that could be charged for the use of the tradenames to forecasted future revenues, with an adjustment for the present value of such royalties. If the estimated fair value is less than the carrying value, the tradename intangible asset is written down to its estimated fair value. Significant judgment is involved in estimating market royalty rates and long-term revenue forecasts. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected revenue performance and industry trends.

F-17

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

•Qualitative approach The Company’s qualitative assessment considers industry and market conditions and recent developments that may impact the revenue forecasts and other estimates as compared to its most recent quantitative assessment.

The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset:

Intangible Asset	Amortization Method
Goodwill	Indefinite-lived
Tradename	Indefinite-lived and definite-lived. Definite-lived tradename asset has a remaining useful life of approximately one year.
Other intangible assets	Straight-line method over the terms of the underlying agreement. The remaining useful lives of these intangible assets is two years.

Lease Accounting — See Note 4 for discussion of the Company’s lease accounting policies.

Deferred Charges and Other Assets — Deferred charges and other assets consist of construction, lease and other deposits, equipment to be placed in service, and other assets of a long-term nature.

Self-Insurance Reserves — In the U.S., the Company is self-insured for general liability claims, which are capped at $0.3 per occurrence with no aggregate annual cap. For its international locations, the Company is fully insured for general liability claims with little or no deductibles per occurrence. Under the Company’s fully-funded deductible workers compensation insurance plan in the U.S., the Company is responsible for pre-funding claims and is responsible for claims up to $0.3 per occurrence, with an annual cap of $5.0. The Company is also self-insured for domestic medical and dental claims with a cap of $0.3 per occurrence. As of December 31, 2022 and 2023, the Company’s self-insurance reserves were $10.0 and $11.4, respectively, and are reflected in accrued other current liabilities on the consolidated balance sheets. For its international locations, the Company is fully insured for workers compensation claims. Medical and dental benefits for the Company’s international locations are covered through a government-sponsored healthcare system that is funded through employee and employer payroll tax contributions.

Revenue Recognition — See Note 5 for discussion of revenue recognition and deferred revenue.

Expenses — Film rental costs are based on the film licensing arrangements and accrued based on the applicable box office receipts and either; 1) a sliding scale formula, which is generally established with the studio prior to the opening of the film, 2) a firm terms formula as negotiated prior to a film's theatrical run or 3) estimates of the final settlement rate, which occurs at the conclusion of the film’s run. Under a sliding scale formula, the Company pays a percentage of box office revenues using a pre-determined scale that is based upon box office performance of the film for its full theatrical run. Under a firm terms formula, the Company pays the distributor a percentage of box office receipts that can either be an aggregate rate for the full theatrical run or rates that decline over the term of the theatrical run. The settlement process allows for negotiation of film rental fees upon the conclusion of the film's theatrical run based upon how the film performs. Estimates are based on the expected success of a film. The success of a film can generally be determined a few weeks after a film is released when the initial box office performance of the film is known. If actual box office performance differs from our estimates, film rental costs are adjusted accordingly throughout a film’s theatrical run.

Accounting for Share Based Awards — The Company measures the cost of employee services received in exchange for an equity award based on the fair value of the award on the date of the grant. The grant date fair value is based on Holdings’ stock price on the grant date. Such costs are recognized over the period during which an employee is required to provide service in exchange for the award (which is usually the vesting period). At the time of the grant, Holdings also estimates the number of awards that will ultimately be forfeited. Holdings also periodically estimates the number of awards that will ultimately vest based upon the achievement of pre-established Company performance targets on those awards that are both performance-based and time-based. A cumulative expense adjustment is recognized when that estimate changes. See Note 18 for discussion of Holdings’ share based awards and related compensation expense.

F-18

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

Income Taxes — The Company uses an asset and liability approach to financial accounting and reporting for income taxes. CUSA participates in the consolidated return of Holdings; however, CUSA’s provisions for income taxes is computed on a stand-alone basis. Deferred income taxes are provided when tax laws and financial accounting standards differ with respect to the amount of income for a year and the basis of assets and liabilities. A valuation allowance is recorded to reduce the carrying amount of deferred tax assets unless it is more likely than not that such assets will be realized. Income taxes are provided on unremitted earnings from foreign subsidiaries unless such earnings are expected to be indefinitely reinvested. Income taxes have also been provided for potential tax assessments. The evaluation of an uncertain tax position is a two-step process. The first step is recognition: The Company determines whether it is more likely than not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, the Company should presume that the position would be examined by the appropriate taxing authority that would have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Differences between tax positions taken in a tax return and amounts recognized in the financial statements result in (1) a change in a liability for income taxes payable or (2) a change in an income tax refund receivable, a deferred tax asset or a deferred tax liability or both (1) and (2). The Company accrues interest and penalties on its uncertain tax positions as a component of income tax expense. See further discussion in Note 20.

Segments — For the years ended December 31, 2021, 2022 and 2023, the Company managed its business under two reportable operating segments, U.S. markets and international markets. See Note 22.

Use of Estimates — The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The Company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates.

Foreign Currency Translations — The assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. dollars at current exchange rates as of the balance sheet date, and revenues and expenses are translated at average monthly exchange rates. The resulting translation adjustments are recorded in the consolidated balance sheets in accumulated other comprehensive loss. See Note 16 for a summary of the translation adjustments recorded in accumulated other comprehensive loss for the years ended December 31, 2021, 2022 and 2023. The Company recognizes foreign currency transaction gains and losses when changes in exchange rates impact transactions, other than intercompany transactions of a long-term investment nature, that have been denominated in a currency other than the functional currency.

The Company deemed Argentina to be highly inflationary beginning July 1, 2018. A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity. The financial statements of the Company’s Argentina subsidiaries have been remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters, effective beginning July 1, 2018. See further discussion in Note 16.

During 2019, the Argentine government instituted exchange controls restricting the ability of entities and individuals to exchange Argentine pesos for foreign currencies and to remit foreign currency out of Argentina. As a result of these currency exchange controls, markets in Argentina developed a legal trading mechanism known as the Blue Chip Swap that allows entities to transfer U.S. dollars out of and into Argentina. In a Blue Chip Swap transaction, an entity buys U.S. dollar denominated securities in Argentina using Argentine pesos, and subsequently sells the securities for U.S. dollars, in Argentina, to access U.S. dollars locally, or outside Argentina, by transferring the securities abroad, prior to being sold (the latter commonly known as Blue Chip Swap Rate). The Blue Chip Swap rate is the implicit exchange rate resulting from the Blue Chip Swap transaction. The Blue Chip Swap rate can diverge significantly from Argentina’s official exchange rate. See further discussion in Note 16.

F-19

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

Fair Value Measurements — According to authoritative guidance, inputs used in fair value measurements fall into three different categories; Level 1, Level 2 and Level 3. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for the asset or liability. See Note 15 for a discussion of our fair value measurements for the years ended December 31, 2021, 2022 and 2023.

Interest Rate Swaps – The Company evaluates its interest rate swap agreements, which are designated as cash flow hedges, to determine whether they are effective on a quarterly basis in accordance with ASC Topic 815, Derivatives and Hedging. The fair values of the interest rate swaps are estimated based on future estimated net cash flows considering forecasted interest rates for the terms of the interest rate swap agreements as compared to the fixed interest rates paid under the agreements. If deemed to be effective, fair value estimates are recorded on the consolidated balance sheets as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss. If the swaps are determined to not be effective, the gains or losses are recorded in interest expense on the consolidated income statement. See further discussion in Note 14.

Restructuring Charges – During the year ended December 31, 2020, the Company recorded restructuring charges based on an approved and announced restructuring plan, specifically related to headcount reductions, the permanent closure of underperforming theatres and the write-down of related theatre assets. The costs of the restructuring actions were accrued based on estimates at the time the plan was formalized. Adjustments made to restructuring charges based on actual costs incurred were recorded during the years ended December 31, 2021 and 2022. The balance of accrued and unpaid restructuring charges at December 31, 2022 and 2023 was $0. See further discussion in Note 3.

2.NEW ACCOUNTING PRONOUNCEMENTS

ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, (“ASU 2020-04”), ASU 2021-01, Reference Rate Reform (Topic 848): Scope, (“ASU 2021-01”), and ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 (“ASU 2022-06”). The purpose of ASU 2020-04 is to provide optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. More specifically, the amendments in ASU 2020-04 provide optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in ASU 2021-01 clarify that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The amendments in ASU 2022-06 deferred the sunset date of Topic 848 from December 31, 2022 to December 31, 2024, after which entities will no longer be permitted to apply the relief in Topic 848. The amendments in ASU 2020-04 and ASU 2021-01 are effective as of March 12, 2020 through December 31, 2024. The Company applied the optional relief guidance prospectively to the modification of the reference rate in its interest rate swap agreements from LIBOR to Term SOFR during the second quarter of 2023 (see Note 14). The application of the guidance did not have a material impact on the Company’s consolidated financial statements.

ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). The purpose of ASU 2023-07 is to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses to enable investors to better understand an entity’s overall performance and assess potential future cash flows. In addition, the amendments of ASU 2023-07 enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple measures of profit or loss, provide new segment disclosure requirements for entities with a single reportable segment, and contain other disclosure requirements. The amendments in ASU 2023-07 are effective for all public entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is in the process of evaluating the impact of adopting the additional disclosure requirements of ASU 2023-07.

ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). The purpose of ASU 2023-09 is to enhance the transparency and decision usefulness of income tax disclosures to provide information to better assess how an entity’s operations and related tax risks and tax planning and operational

F-20

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

opportunities affect its tax rate and prospects for future cash flows. The amendments in ASU-2023-09 require that public entities, on an annual basis, (i) disclose specific categories in the income tax rate reconciliation and (ii) provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pre-tax income or loss by the applicable statutory income tax rate). The amendments in ASU 2023-09 are effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is evaluating the impact of adopting ASU 2023-09 on its consolidated financial statements.

3.IMPACT OF THE COVID-19 PANDEMIC

The impact of the COVID-19 pandemic had an unprecedented effect on the theatrical exhibition industry. We temporarily closed our theatres in the U.S. and Latin America during March of 2020 at the onset of the COVID-19 outbreak. We reopened theatres as soon as local restrictions and the status of the COVID-19 pandemic would allow. All of our domestic and international theatres were reopened by the end of 2021. After reopening our theatres, we faced ongoing challenges with the significant reduction in the volume of new film releases. The industry has made significant progress in its recovery from the COVID-19 pandemic; however its ongoing recovery continues to be contingent upon several key factors, including the volume of new film content available, which has also been impacted by the recent writers’ and actors’ guild strikes, the box office performance of new film content released, the duration of the exclusive theatrical release window, and evolving consumer behavior with competition from other forms of in-and-out-of-home entertainment.

Government Assistance

During the years ended December 31, 2021 and 2022, the Company received an aggregate of approximately $2.8 in government assistance pursuant to (i) payroll continuation support programs under the CARES Act, (ii) various grants provided in certain states intended to cover janitorial and personal protection equipment costs incurred by the Company in response to local regulations and (iii) subsidies for certain payroll costs in certain international locations. The Company has met all applicable conditions related to the government assistance received. The government assistance received was reflected as credits to salaries and wages, utilities and other costs, and general and administrative expenses in the consolidated statements of loss.

Restructuring Charges

In 2020, Company management approved and announced a restructuring plan to realign its operations to create a more efficient cost structure (referred to herein as the “Restructuring Plan”) in response to the COVID-19 pandemic. The Restructuring Plan primarily included a headcount reduction at its domestic corporate office and the permanent closure of certain domestic and international theatres.

F-21

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

The following table summarizes activity recorded during the years ended December 31, 2021 and 2022:

	U.S. Operating Segment									International Operating Segment								Consolidated
	Employee-related Costs			Facility Closure Costs			Total Charges			Employee-related Costs		Facility Closure Costs			Total Charges			Employee-related Costs			Facility Closure Costs			Total Charges
Reserve balance at January 1, 2021	$	0.9		$	5.7		$	6.6		$	—	$	0.1		$	0.1		$	0.9		$	5.8		$	6.7
Amounts paid		(0.4	)		(3.9	)		(4.3	)		—		—			—			(0.4	)		(3.9	)		(4.3	)
Reserve adjustments (1)		(0.1	)		(0.9	)		(1.0	)		—		—			—			(0.1	)		(0.9	)		(1.0	)
Reserve balance at December 31, 2021	$	0.4		$	0.9		$	1.3		$	—	$	0.1		$	0.1		$	0.4		$	1.0		$	1.4
Amounts paid		(0.4	)		(0.5	)		(0.9	)		—		—			—			(0.4	)		(0.5	)		(0.9	)
Reserve adjustments (1)		—			(0.4	)		(0.4	)		—		(0.1	)		(0.1	)		—			(0.5	)		(0.5	)
Reserve balance at December 31, 2022	$	—		$	—		$	—		$	—	$	—		$	—		$	—		$	—		$	—

(1)Amounts were primarily adjustments based on final facility lease payments for certain closed theatres as compared with original estimates recorded.

4.LEASE ACCOUNTING

Real Estate Leases — The Company conducts a significant part of its theatre operations in leased properties under noncancelable operating and finance leases with base terms generally ranging from 10 to 25 years. In addition to fixed lease payments, some of the leases provide for variable lease payments and some require the payment of taxes, insurance, common area maintenance and other costs applicable to the property. Variable lease payments include payments based on a percentage of retail sales or a percentage of retail sales over defined thresholds. Other variable lease payments include payments adjusted periodically for inflation, changes in attendance or changes in average ticket price. The Company can renew, at its option, many of its leases at defined or then market rental rates for various renewal periods. Some leases also provide for escalating rent payments throughout the lease term. The Company also leases certain office and warehouse facilities in the U.S. and in international locations, which generally only include fixed payments. The Company recognizes fixed lease expense for the operating leases on a straight-line basis over the lease term. The Company’s real estate lease agreements do not contain any residual value guarantees or restrictive covenants.

Equipment Leases — The Company leases certain equipment under operating leases, including trash compactors and various other equipment used in the day-to-day operation of its theatres. Certain of the leases require fixed lease payments to be made over the duration of the lease term, while others are variable in nature based on usage or sales. Certain of these leases are month-to-month, while others have noncancelable terms ranging from 1 to 7 years. The Company’s equipment lease agreements do not contain any residual value guarantees or restrictive covenants.

F-22

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

The following table represents the operating and finance right-of-use assets and lease liabilities as of the periods indicated.

		As of
Leases	Classification	December 31, 2022		December 31, 2023
Assets (1)
Operating lease assets	Operating lease right-of-use assets	$	1,102.7	$	986.4
Finance lease assets	Theatre properties and equipment, net of accumulated depreciation (2)		67.8		55.7
Total lease assets		$	1,170.5	$	1,042.1
Liabilities (1)
Current
Operating	Current portion of operating lease obligations	$	219.3	$	212.5
Finance	Current portion of finance lease obligations		14.4		14.0
Noncurrent
Operating	Operating lease obligations, less current portion		970.6		853.3
Finance	Finance lease obligations, less current portion		88.0		73.8
Total lease liabilities		$	1,292.3	$	1,153.6

(1)The operating lease right-of-use assets and liabilities recorded on the Company’s consolidated balance sheets generally do not include renewal options that have not yet been exercised. The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord after consideration of market conditions and performance of the theatre.

(2)Finance lease assets are net of accumulated amortization of $62.5 and $73.9 as of December 31, 2022 and 2023, respectively.

As of December 31, 2023, the Company had signed lease agreements with total noncancelable lease payments of approximately $44.8 related to theatre leases that had not yet commenced. The timing of lease commencement is dependent on the completion of construction of the related theatre facility. Additionally, these amounts are based on estimated square footage and costs to construct each facility and may be subject to adjustment upon final completion of each construction project. In accordance with ASC Topic 842, fixed minimum lease payments related to these theatres are not included in the right-of-use assets and lease liabilities as of December 31, 2023.

The following table represents the Company’s aggregate lease costs, by lease classification, for the periods indicated.

		Year Ended December 31,
Lease Cost	Classification	2021		2022		2023
Operating lease costs
Equipment (1)	Utilities and other	$	2.3	$	4.4	$	4.1
Real Estate (1)	Facility lease expense		281.0		315.7		348.6
Total operating lease costs		$	283.3	$	320.1	$	352.7
Finance lease costs
Depreciation of leased assets	Depreciation and amortization	$	12.6	$	12.4	$	12.0
Interest on lease liabilities	Interest expense		5.9		5.3		4.9
Total finance lease costs		$	18.5	$	17.7	$	16.9

(1)Includes short-term lease payments, variable lease payments and office lease payments reflected in general and administrative expense as set forth in the following table for the periods presented:

		Year Ended December 31,
Lease Cost	Classification	2021		2022		2023
Operating lease costs
Equipment - Short-term and variable lease payments	Utilities and other	$	1.8	$	3.9	$	3.6
Real Estate - Variable lease payments (1)	Facility lease expense	$	11.8	$	36.4	$	68.3
Real Estate - Office leases	General and administrative	$	1.3	$	1.3	$	1.4

(1) Represents lease payments that are based on a change in index, such as CPI or inflation, variable payments based on revenue or attendance and variable common area maintenance costs.

F-23

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

The following table represents the maturity of lease liabilities, by lease classification, as of December 31, 2023.

	Operating		Finance
Years Ending	Leases		Leases
2024	$	267.2	$	18.0
2025		237.4		16.4
2026		199.6		12.0
2027		158.5		11.9
2028		121.9		11.6
Thereafter		295.4		35.1
Total lease payments	$	1,280.0	$	105.0
Less: Interest		214.2		17.2
Present value of lease liabilities	$	1,065.8	$	87.8

The following table represents the weighted-average remaining lease term and discount rate, disaggregated by lease classification, as of December 31, 2023.

	As of
Lease Term and Discount Rate	December 31, 2023
Weighted-average remaining lease term (years) (1)
Operating leases - equipment		3.3
Operating leases - real estate		6.4
Finance leases - equipment		2.6
Finance leases - real estate		7.6
Weighted-average discount rate (2)
Operating leases - equipment		6.3	%
Operating leases - real estate		11.5	%
Finance leases - equipment		3.6	%
Finance leases - real estate		4.9	%

(1)The lease assets and liabilities recorded on the Company’s consolidated balance sheets generally do not include renewal options that have not yet been executed. The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord after consideration of market conditions and performance of the theatre.

(2)The discount rate for each lease represents the incremental borrowing rate at which the Company would borrow funds, on a collateralized basis, over a similar term and at an amount equal to the lease payments in a similar economic environment.

The following table represents the minimum cash lease payments included in the measurement of lease liabilities and the non-cash addition of right-of-use assets for the periods presented.

	Year Ended December 31,
Other Information	2021		2022		2023
Cash paid for amounts included in the measurement of lease liabilities
Cash outflows for operating leases	$	269.7	$	279.8	$	280.8
Cash outflows for finance leases - operating activities	$	5.9	$	5.3	$	4.9
Cash outflows for finance leases - financing activities	$	14.7	$	14.3	$	14.4
Non-cash amount of leased assets obtained in exchange for:
Operating lease liabilities	$	180.1	$	114.1	$	87.0
Finance lease liabilities	$	0.7	$	—	$	—

Lessor Arrangements

Under the Company’s Exhibitor Services Agreement (“ESA”) with National CineMedia, LLC (“NCM”), the nonconsecutive periods of use of the theatre screens by NCM qualify as a lease in accordance with ASC Topic 842. See further discussion in Note 9.

F-24

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

The Company rents its theatre auditoriums for corporate meetings, screenings, education and training sessions and other private events. These rentals, which are not significant to the Company, are generally one-time events and the related revenue is reflected as other revenue on the consolidated statements of income (loss).

5.REVENUE RECOGNITION

Revenue Recognition Policy

The Company’s patrons have the option to purchase movie tickets well in advance of a movie showtime, right before the movie showtime, or at any point in between those two timeframes depending on seat availability. The Company recognizes such admissions revenue when the showtime for a purchased movie ticket has passed. Concession revenue is recognized when products are sold to the consumer, or if purchased in advance, once the showtime associated with the customer’s movie ticket has passed. Other revenue primarily consists of screen advertising, screen rental revenue, promotional income, studio trailer placements and transactional fees. Except for NCM screen advertising advances discussed below in Note 9, these revenues are generally recognized when the Company has fulfilled its performance obligations by providing the specified services.

The Company sells gift cards and discount ticket vouchers, the proceeds from which are recorded as deferred revenue. Deferred revenue for gift cards and discount ticket vouchers is recognized when they are redeemed for concession items or, if redeemed for movie tickets, when the showtime has passed. The Company generally records breakage revenue on gift cards and discount ticket vouchers based on redemption activity and historical experience with unused balances.

The Company offers a subscription program in the U.S. whereby patrons can pay a monthly or annual fee to receive a monthly credit for use towards a future movie ticket purchase. We also offer monthly subscription fee programs in several of our international locations where customers can pay a monthly fee to receive benefits such as a free monthly ticket. The Company records the subscription program fees as deferred revenue and records admissions revenue when the showtime for a movie ticket purchased with a credit has passed.

The Company has loyalty programs in the U.S. and many of its international locations that either have a prepaid annual fee or award points to customers as purchases are made. For those loyalty programs that have a prepaid annual fee, the Company recognizes the fee collected as other revenue on a straight-line basis over the annual membership period. For those loyalty programs that award points to customers based on their purchases, the Company records a portion of the original transaction proceeds as deferred revenue based on the number of reward points issued to customers and recognizes the deferred revenue when the customer redeems such points. The value of loyalty points issued is based on the estimated fair value of the rewards offered. The Company records breakage revenue generally upon the expiration of loyalty points and subscription credits as the Company does not yet have sufficient historical data related to the redemption patterns for these programs to estimate breakage.

Accounts receivable as of December 31, 2022 and 2023 included approximately $22.9 and $31.6, respectively, of receivables related to contracts with customers. The Company did not record any assets related to the costs to obtain or fulfill a contract with customers during the years ended December 31, 2022 or 2023.

Disaggregation of Revenue

The following tables present revenue for the periods indicated, disaggregated based on major type of good or service and by reportable operating segment.

	Year Ended December 31, 2023
	U.S.		International
	Operating		Operating
Major Goods/Services	Segment (1)		Segment		Consolidated
Admissions Revenue	$	1,236.0	$	319.6	$	1,555.6
Concession Revenue		952.0		240.0		1,192.0
Screen advertising, screen rental and promotional revenue		91.0		53.6		144.6
Other Revenue		136.3		38.2		174.5
Total Revenue	$	2,415.3	$	651.4	$	3,066.7

F-25

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

	Year Ended December 31, 2022
	U.S.		International
	Operating		Operating
Major Goods/Services	Segment (1)		Segment		Consolidated
Admissions Revenue	$	1,010.2	$	236.7	$	1,246.9
Concession Revenue		763.0		175.3		938.3
Screen advertising, screen rental and promotional revenue		81.7		45.3		127.0
Other Revenue		115.3		27.2		142.5
Total Revenue	$	1,970.2	$	484.5	$	2,454.7

	Year Ended December 31, 2021
	U.S.		International
	Operating		Operating
Major Goods/Services	Segment (1)		Segment		Consolidated
Admissions Revenue	$	671.7	$	108.3	$	780.0
Concession Revenue		482.8		78.9		561.7
Screen advertising, screen rental and promotional revenue		66.2		17.9		84.1
Other Revenue		72.9		11.8		84.7
Total Revenue	$	1,293.6	$	216.9	$	1,510.5

(1)U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 22 for additional information on intercompany eliminations.

The following tables present revenue for the periods indicated, disaggregated based on timing of revenue recognition (as discussed above) and by reportable segment.

	Year Ended December 31, 2023
	U.S.		International
	Operating		Operating
	Segment (1)		Segment		Consolidated
Goods and services transferred at a point in time	$	2,327.9	$	588.9	$	2,916.8
Goods and services transferred over time		87.4		62.5		149.9
Total	$	2,415.3	$	651.4	$	3,066.7

	Year Ended December 31, 2022
	U.S.		International
	Operating		Operating
	Segment (1)		Segment		Consolidated
Goods and services transferred at a point in time	$	1,856.5	$	428.3	$	2,284.8
Goods and services transferred over time		113.7		56.2		169.9
Total	$	1,970.2	$	484.5	$	2,454.7

	Year Ended December 31, 2021
	U.S.		International
	Operating		Operating
	Segment (1)		Segment		Consolidated
Goods and services transferred at a point in time	$	1,201.2	$	193.7	$	1,394.9
Goods and services transferred over time		92.4		23.2		115.6
Total	$	1,293.6	$	216.9	$	1,510.5

(1)U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 22 for additional information on intercompany eliminations.

F-26

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

Screen Advertising Advances and Other Deferred Revenue

The following table presents changes in the Company’s deferred revenue for the periods indicated:

Deferred Revenue	NCM Screen Advertising Advances (2)			Other Deferred Revenue (3)
Balance at January 1, 2022	$	346.0		$	160.3
Amounts recognized as accounts receivable		—			1.8
Cash received from customers in advance		—			241.1
Common units received from NCM (see Note 9)		1.3			—
Interest accrued related to significant financing component		23.2			—
Revenue recognized during period		(32.3	)		(206.9	)
Foreign currency translation adjustments		—			(1.4	)
Balance at December 31, 2022		338.2			194.9
Amounts recognized as accounts receivable		—			4.6
Cash received from customers in advance		—			327.4
Dispositions (1)		—			(0.4	)
Interest accrued related to significant financing component		22.6			—
Revenue recognized during period		(32.4	)		(299.5	)
Foreign currency translation adjustments		—			(5.4	)
Balance at December 31, 2023	$	328.4		$	221.6

(1)Relates to the sale of the Company’s Ecuador subsidiary. See Note 8.

(2)See Significant Financing Component in Note 9 for discussion of NCM screen advertising advances and maturity of balances as of December 31, 2023.

(3)Includes liabilities associated with outstanding gift cards and discount ticket vouchers, points or rebates outstanding under the Company’s loyalty and membership programs and revenue not yet recognized for screen advertising and other promotional activities. Amount is classified as accounts payable and accrued expenses or other long-term liabilities on the consolidated balance sheets.

The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied for other deferred revenue in the table above as of December 31, 2023 and when the Company expects to recognize this revenue.

	Year Ended December 31,
Remaining Performance Obligations	2024		2025		Thereafter		Total
Other deferred revenue	$	195.2		26.4		—	$	221.6

F-27

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

6. EARNINGS (LOSS) PER SHARE

The following table presents computations of basic and diluted earnings (loss) per share for Holdings under the two class method:

	Year Ended December 31,
	2021			2022			2023
Numerator:
Net (loss) income attributable to Cinemark Holdings, Inc.	$	(422.8	)	$	(271.2	)	$	188.2
Loss (income) allocated to participating share-based awards (1)		6.1			3.8			(3.3	)
Basic net (loss) income attributable to common stockholders	$	(416.7	)	$	(267.4	)	$	184.9
Add: Interest expense on convertible notes, net of tax (3)		—			—		$	18.2
Diluted net (loss) income attributable to common stockholders	$	(416.7	)	$	(267.4	)	$	203.1
Denominator:
Basic weighted average shares outstanding		117.3			118.2			119.1
Common equivalent shares for restricted performance stock units (2)		—			—			0.9
Common equivalent shares for convertible notes (3)		—			—			32.0
Common equivalent shares for warrants (4)		—			—			—
Diluted weighted average shares outstanding		117.3			118.2			152.0
Basic (loss) earnings per share attributable to common stockholders	$	(3.55	)	$	(2.26	)	$	1.55
Diluted (loss) earnings per share attributable to common stockholders	$	(3.55	)	$	(2.26	)	$	1.34

(1)For the years ended December 31, 2021, 2022 and 2023, a weighted average of approximately 1.7 shares, 1.7 shares and 2.1 shares of unvested restricted stock, respectively, are considered participating securities.

(2)For the years ended December 31, 2021 and 2022, approximately 0.0 and 0.4 common equivalent shares for performance stock units were excluded because they were anti-dilutive.

(3)For the years ended December 31, 2021 and 2022, diluted loss per share excludes the assumed conversion of the 4.50% Convertible Senior Notes into 32.0 shares of common stock, as they would have been anti-dilutive. See further discussion below.

(4)For all periods presented, diluted earnings (loss) per share excludes the warrants, as they would be anti-dilutive.

Share-based awards

Holdings considers its unvested share-based payment awards, which contain non-forfeitable rights to dividends, participating securities, and includes such participating securities in its computation of earnings (loss) per share pursuant to the two-class method. Basic earnings (loss) per share for the two classes of stock (common stock and unvested restricted stock) is calculated by dividing net income (loss) by the weighted average number of shares of common stock and unvested restricted stock outstanding during the reporting period. Diluted earnings (loss) per share is calculated using the weighted average number of shares of common stock plus the potentially dilutive effect of common equivalent shares outstanding determined under both the two-class method and the treasury stock method.

Convertible notes, hedges and warrants

The 4.50% Convertible Senior Notes, discussed further in Note 14, are dilutive in periods in which Holdings has net income. The impact of such dilution on earnings per share is calculated under the if-converted method, which requires that all of the shares of Holdings’ common stock issuable upon conversion of the 4.50% Convertible Senior Notes be included in the calculation of diluted EPS assuming conversion at the beginning of the reporting period.

The closing price of Holdings’ common stock did not exceed the strike price of $18.66 per share (130% of the initial exercise price of $14.35 per share) during at least 20 of the last 30 trading days of the quarter ended December 31, 2023 and, therefore, the 4.50% Convertible Senior Notes will not be convertible during the first quarter of 2024. The converted value of the 4.50% Convertible Senior Notes, based on the weighted average closing price of

F-28

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

Holdings’ common stock for 2023, exceeded the aggregate outstanding principal of the notes by $23.3 as of December 31, 2023.

As noted in Note 14, Holdings entered into hedge transactions with counterparties in connection with the issuance of the 4.50% Convertible Senior Notes. The convertible note hedge transactions cover, subject to anti-dilution adjustments substantially similar to those applicable to the 4.50% Convertible Senior Notes, the number of shares of Holdings’ common stock underlying the 4.50% Convertible Notes, which initially gives Holdings the option to purchase approximately 32.0 shares of its common stock at a price of approximately $14.35 per share. Concurrently with entering into the convertible note hedge transactions, Holdings also entered into warrant transactions with each option counterparty whereby Holdings sold to such option counterparty warrants to purchase, subject to customary anti-dilution adjustments, up to the same number of shares of Holdings’ common stock, which initially gives the option counterparties the option to purchase approximately 32.0 shares at a price of approximately $22.08 per share. The economic effect of these transactions is to effectively raise the strike price of the 4.50% Convertible Senior Notes from approximately $18.66 per share of Holdings’ common stock to approximately $22.08 per share.

7.DIVIDENDS

The Company suspended its quarterly dividend in March 2020 as a result of the COVID-19 pandemic as discussed in Note 3.

8.THEATRE PROPERTIES AND EQUIPMENT

Properties and equipment consisted of the following as of the periods presented:

	December 31,
	2022			2023
Theatre properties and equipment
Land	$	99.7		$	97.8
Buildings		528.9			530.6
Property under finance lease		130.3			129.6
Theatre furniture and equipment		1,429.5			1,432.8
Leasehold interests and improvements		1,206.9			1,300.2
Total		3,395.3			3,491.0
Less: accumulated depreciation and amortization (1)		(2,163.2	)		(2,329.3	)
Theatre properties and equipment, net	$	1,232.1		$	1,161.7

(1)Amortization of finance lease assets is included in depreciation and amortization expense on the consolidated statements of income (loss). Accumulated amortization of finance lease assets as of December 31, 2022 and 2023 was $62.5 and $73.9, respectively.

Sale of Subsidiary

During December 2022, the Company entered into a purchase and sale agreement for the sale of the stock of its Ecuador subsidiary. The Company completed the sale in September 2023 and recognized a gain of $6.9, which is reflected in “Loss (gain) on disposal of assets and other” in the Company’s consolidated statement of income for the year ended December 31, 2023. The sale of the Ecuador subsidiary did not qualify as discontinued operations since it did not represent a strategic shift in the Company’s operations that will have a major effect on its results and operations. The following table presents the carrying value of Ecuador’s significant assets and liabilities as of the periods presented:

	December 31,
	2022		2023
Theatre property and equipment, net	$	5.4	$	—
Operating lease right-of-use asset, net		2.9		—
Goodwill		4.2		—
Total assets	$	15.3	$	—
Total liabilities	$	8.5	$	—

F-29

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

The table below summarizes total revenue and operating income for the Ecuador subsidiary for the periods presented:

	Year Ended December 31,
	2022			2023
Total revenue	$	13.3		$	13.5
Operating (loss) income	$	(1.2	)	$	2.0

9.INVESTMENT IN NATIONAL CINEMEDIA, INC / NATIONAL CINEMEDIA LLC

NCM operates a digital in-theatre network in the U.S. for providing cinema advertising. The Company has an investment in NCM’s parent National CineMedia, Inc. (”NCMI”) and previously held an investment in NCM. See further discussion below under Investment in National CineMedia. The Company entered into an Exhibitor Services Agreement with NCM (“ESA”) pursuant to which NCM primarily provides screen advertising to our domestic theatres through its branded “Noovie” pre-show entertainment program. See further discussion below under Exhibitor Services Agreement.

F-30

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

Summary of Activity with NCMI/NCM

Below is a summary of activity with NCMI and NCM included in each of Holdings’ and CUSA’s consolidated financial statements for the periods indicated. See Note 5 for discussion of revenue recognition.

	Investment  in NCMI/NCM			NCM Screen Advertising Advances			Distributions from NCM (5)			Equity in Loss (3)		Other Revenue			Interest Expense - NCM		Cash Received
Balance as of January 1, 2021	$	152.0		$	(344.3	)
Receipt of common units due to annual common unit adjustment		10.2			(10.2	)		—			—		—			—		—
Screen rental revenues earned under ESA (1)		—			—			—			—		(12.0	)		—		12.0
Interest accrued related to significant financing component		—			(23.6	)		—			—		—			23.6		—
Receipt under tax receivable agreement		(0.2	)		—			(0.1	)		—		—			—		0.3
Equity in loss		(26.6	)		—			—			26.6		—			—		—
Amortization of screen advertising advances		—			32.1			—			—		(32.1	)		—		—
Balance as of and for the year ended December 31, 2021	$	135.4		$	(346.0	)	$	(0.1	)	$	26.6	$	(44.1	)	$	23.6	$	12.3
Receipt of common units due to annual common unit adjustment		1.3			(1.3	)		—			—		—			—		—
Screen rental revenues earned under ESA (1)		—			—			—			—		(19.9	)		—		19.9
Interest accrued related to significant financing component		—			(23.2	)		—			—		—			23.2		—
Equity in loss		(13.9	)		—			—			13.9		—			—		—
Impairment of investment in NCM (2)		(113.2	)		—			—			—		—			—		—
Amortization of screen advertising advances		—			32.3			—			—		(32.3	)		—		—
Balance as of and for the year ended December 31, 2022	$	9.6		$	(338.2	)	$	—		$	13.9	$	(52.2	)	$	23.2	$	19.9
Screen rental revenues earned under ESA (1)		—			—			—			—		(20.9	)		—		20.9
Interest accrued related to significant financing component		—			(22.6	)		—			—		—			22.6		—
Redemption of common units of NCM for common stock of NCMI (2)		—			—			—			—		—			—		—
Equity in loss (3)		(3.2	)		—			—			3.2		—			—		—
Impairment of investment in NCMI (4)		(0.7	)		—			—			—		—			—		—
Unrealized gain on fair market value adjustment of investment in NCMI (2)		12.4			—			—			—		—			—		—
Amortization of screen advertising advances		—			32.4			—			—		(32.4	)		—		—
Balance as of and for the year ended December 31, 2023	$	18.1		$	(328.4	)	$	—		$	3.2	$	(53.3	)	$	22.6	$	20.9

(1)Amounts include the per patron and per digital screen theatre access fees, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire were approximately $4.9, $7.5 and $8.9 for the years ended December 31, 2021, 2022 and 2023, respectively. Amounts unpaid and reflected in accounts receivable were $4.9 and $4.9 as of December 31, 2022 and 2023, respectively.

(2)See Investment in National CineMedia below.

(3)Equity in loss was recorded through April 11, 2023, the date NCM filed its bankruptcy petition, after which the Company applied the fair value accounting method as discussed below.

(4)Reflected in impairment of long-lived and other assets on the consolidated income statement for the year indicated. See further discussion at Investment in National CineMedia below.

(5)Excess cash distributions from NCM to its members were restricted through December 2023 in accordance with the credit agreement amendment NCM entered into with its lenders and as a result of their bankruptcy filing. NCMI also suspended its dividend.

F-31

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

In addition to the activity in the table above, the Company made de minimus payments to NCM during the years ended December 31, 2021, 2022 and 2023, respectively, related to certain equipment used for digital advertising, which is included in theatre furniture and equipment on the consolidated balance sheets.

Investment in National CineMedia

On February 13, 2007 NCMI, a holding company that serves as the sole manager of NCM, completed an initial public offering (“IPO”) of its common stock. NCM comprises approximately the entire balance of NCMI’s assets, liabilities and operating cash flows. In connection with the NCMI initial public offering, the Company amended its operating agreement and the ESA. At the time of the NCMI IPO and as a result of amending the ESA, the Company received approximately $174.0 in cash consideration from NCM. The proceeds were recorded as deferred revenue or NCM screen advertising advances, and are being amortized over the term of the Amended and Restated ESA or through February 2041.

As of January 1, 2023, the Company owned approximately 43.7 common units of NCM, which represented an interest in NCM of approximately 25.4%.

On February 17, 2023, the Company delivered a redemption notice to NCM pursuant to the redemption right under its operating agreement with NCM to redeem approximately 42.0 of the Company’s 43.7 common units in NCM in exchange for approximately 42.0 newly issued shares of NCMI common stock, with a redemption date of February 23, 2023 (the “Redemption”). On March 20, 2023, the Company delivered a second redemption notice to NCM to redeem the Company’s remaining 1.7 common units in NCM in exchange for 1.7 newly issued shares of NCMI common stock, with a redemption date of March 23, 2023 (collectively with the February 23, 2023 redemption, the “Redemptions”). NCMI is a holding company and the sole manager of NCM. NCM comprises approximately the entire balance of NCMI’s assets, liabilities and operating cash flows.

On April 11, 2023, NCM filed a petition for reorganization under Chapter 11 of the United States Bankruptcy Code. NCMI continued to manage NCM, the “debtor in possession,” under the jurisdiction of the bankruptcy court and in accordance with the applicable bankruptcy laws and orders of the bankruptcy court. In general, as debtor in possession under the Bankruptcy Code, NCM was authorized to continue to operate as an ongoing business but could not engage in transactions outside the ordinary course of business without the prior approval of the bankruptcy court.

Due to NCM’s bankruptcy proceedings, the Company reassessed its rights and level of influence over NCM. The Company determined that effective April 11, 2023, the date NCM filed its bankruptcy petition, it no longer had significant influence over NCM and therefore ceased accounting for its investment in NCMI under the equity method of accounting in the second quarter of 2023. During the years ended December 31, 2021 and 2022, and through April 11, 2023, the Company accounted for its investment in NCMI under the equity method of accounting, and therefore assessed its investment for other than temporary impairment during those periods. The Company recorded impairment charges totaling $113.2 and $0.7 on its investment in NCMI/NCM during the years ended December 31, 2022 and 2023, respectively, because the share price of NCMI was significantly below the Company’s carrying value of NCMI per common share and NCM’s pace of recovery from the COVID-19 pandemic lagged that of the Company and the movie theatre industry. See Note 12 for impairment expense recorded during the years ended December 31, 2021, 2022 and 2023.

On August 3, 2023, NCMI announced that it had effected a 1-for-10 reverse stock split of its common stock. NCMI’s common stock automatically began trading on a split adjusted basis at the opening of the market on August 4, 2023. After giving effect to the reverse stock split, the Company owns approximately 4.4 shares of NCMI common stock. NCM emerged from bankruptcy on August 7, 2023, and the Company’s ownership interest in NCMI was reduced to less than 5%. The Company now accounts for its investment in NCMI in accordance with the guidance set forth in FASB ASC Topic 321 Investments - Equity Securities, which requires the Company to measure its investment in common stock of NCMI at fair value and recognize unrealized holding gains and losses on its investment in earnings. The Company recognized an unrealized gain of $12.4 on its investment in NCMI in the Company’s consolidated statement of income for the year ended December 31, 2023.

F-32

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

Common Unit Adjustments

In addition to the consideration received upon the NCMI IPO and ESA modification in 2007, the Company also periodically receives consideration in the form of common units from NCM. Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCMI and the Company, annual adjustments to the common membership units are made primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated by the Company. The common units received are recorded at estimated fair value as an increase in the Company’s investment in NCM with an offset to deferred revenue or NCM screen advertising advances. Through April 11, 2023, the Company’s investment was accounted for under the equity method, with undistributed equity earnings related to its investment included as a component of earnings in equity in income of affiliates or recorded as a reduction of its investment basis depending on the tranche of common units it was related to.

During March 2023, NCM performed its annual common unit adjustment calculation under the Common Unit Adjustment Agreement. As a result of the calculation, the Company was entitled to an additional 4.8 common units of NCM. The issuance of these additional common units of NCM was stayed by NCM’s bankruptcy filing on April 11, 2023. In June 2023 the bankruptcy court issued an order cancelling the issuance of these common units of NCM and found that these common units were never issued.

Below is a summary of common units received by the Company under the Common Unit Adjustment (“CUA”) Agreement during the years ended December 31, 2021 and 2022:

Event	Date Common Units Received	Number of Common Units Received		Fair Value of Common Units Received (1)
2021 annual common unit adjustment	4/14/2021		2.3	$	10.2
2022 annual common unit adjustment	4/13/2022		0.5	$	1.3

(1) The fair value of the common units received was estimated based on the market price of NCMI common stock (Level 1 input as defined in FASB ASC Topic 820) at the time the common units were determined, adjusted for volatility associated with the estimated time period it would take to convert the common units and register the respective shares.

Exhibitor Services Agreement

As previously discussed, the Company’s domestic theatres are part of the in-theatre digital network operated by NCM, the terms of which are defined in the ESA. NCM primarily provides advertising to its theatres through its branded “Noovie” pre-show entertainment program. The Company receives a monthly theatre access fee for participation in the NCM network. Effective September 17, 2019, the Company signed an amendment to the ESA, under which the Company provided incremental advertising time to NCM, and extended the term through February 2041. At the time of the amendment, the Company determined that the amended ESA met the definition of a lease under ASC Topic 842. The Company leases nonconsecutive periods of use of its domestic theatre screens to NCM for purposes of showing third party advertising content. The lease, which is classified as an operating lease, generally requires variable lease payments based on the number of patrons attending the showtimes during which such advertising is shown. The lease agreement is considered short-term due to the fact that the nonconsecutive periods of use, or advertising time slots, are set on a weekly basis. The revenues earned under the ESA are reflected in other revenue on the consolidated income statements.

The recognition of revenue related to the NCM screen advertising advances is recorded on a straight-line basis over the new term of the amended ESA through February 2041.

	Year Ended December 31,
Remaining Maturity	2024		2025		2026		2027		2028		Thereafter		Total
NCM screen advertising advances (1)	$	10.5	$	11.2	$	12.0	$	12.8	$	13.7	$	268.2	$	328.4

(1)Amounts are net of the estimated interest to be accrued for the periods presented.

Significant Financing Component

As noted above, the Company received approximately $174.0 in cash consideration from NCM at the time of NCMI’s IPO and also periodically receives consideration in the form of common units (discussed at Common Unit

F-33

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

Adjustments above) from NCM in exchange for exclusive access to the Company’s newly opened domestic screens under the ESA. Due to the significant length of time between receiving the consideration from NCM and fulfillment of the related performance obligation, the ESA includes an implied significant financing component, as per the guidance in ASC Topic 606. The interest expense was calculated using the Company’s incremental borrowing rates at the time the cash and each tranche of common units were received from NCM, which ranged from 4.4% to 8.3%. Effective September 17, 2019, upon the Company’s evaluation and determination that ASC Topic 842 applies to the amended ESA, the Company determined it acceptable to apply the significant financing component guidance from ASC Topic 606 by analogy as the economic substance of the agreement represents a financing arrangement.

Summary Financial Information for NCMI/NCM

The tables below present summary financial information for NCMI/NCM for its fiscal periods indicated:

	Year Ended						Three Months Ended
	December 30, 2021			December 29, 2022			March 30, 2023 (1)
Revenue	$	114.6		$	249.2		$	34.9
Operating income (loss)	$	(68.6	)	$	10.9		$	(30.6	)
Net loss	$	(134.6	)	$	(69.8	)	$	(54.0	)

(1)Financial information for NCMI is presented for the latest reporting period available through which the Company accounted for its investment in NCMI under the equity method.

	As of
	December 29, 2022			March 30, 2023 (1)
Current assets	$	148.6		$	121.7
Noncurrent assets	$	628.2		$	618.5
Current liabilities	$	97.5		$	1,204.8
Noncurrent liabilities	$	1,161.6		$	67.2
Members'/Total deficit	$	(482.3	)	$	(531.8	)

(1)Financial information for NCMI is presented for the latest reporting period available through which the Company accounted for its investment in NCMI under the equity method.

10.INVESTMENTS IN AFFILIATES

Below is a summary of activity for each of the Company’s affiliates for the periods indicated:

	AC JV, LLC			DCDC		FE Concepts			Other (1)			Total
Balance at January 1, 2021	$	3.7		$	1.3	$	18.3		$	0.5		$	23.8
Equity in income		—			0.5		1.0			—			1.5
Other (1)		—			—		—			(0.1	)		(0.1	)
Balance at December 31, 2021	$	3.7		$	1.8	$	19.3		$	0.4		$	25.2
Equity in income		3.4			—		1.2			—			4.6
Cash distributions received		(2.9	)		—		(4.0	)		—			(6.9	)
Other (1)		—			—		—			(0.3	)		(0.3	)
Balance at December 31, 2022	$	4.2		$	1.8	$	16.5		$	0.1		$	22.6
Equity in income		4.9			0.3		1.6			—			6.8
Cash distributions received		(5.7	)		—		—			—			(5.7	)
Other (1)		—			—		—			(0.1	)		(0.1	)
Balance at December 31, 2023	$	3.4		$	2.1	$	18.1		$	-		$	23.6

(1)Consists primarily of mark-to-market adjustment on an investment in marketable securities.

F-34

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

AC JV, LLC

During December 2013, the Company, Regal, AMC (the “AC Founding Members”) and NCM entered into a series of agreements that resulted in the formation of AC JV, LLC (“AC”), a joint venture that owns “Fathom Events” (consisting of Fathom Events and Fathom Consumer Events) formerly operated by NCM. The Fathom Events business focuses on the marketing and distribution of live and pre-recorded entertainment programming to various theatre operators to provide additional programs to augment their feature film schedule. The Company paid event fees to AC of $6.2, $13.3 and $16.0 for the years ended December 31, 2021, 2022 and 2023, respectively, which are included in film rentals and advertising costs on the consolidated statements of income (loss) of Holdings and CUSA. Also, the Company received cash distributions of $2.9 and $5.7 during the years ended December 31, 2022 and 2023, which were recorded as a reduction in the Company’s investment in AC. The Company accounts for its investment in AC under the equity method of accounting.

Digital Cinema Distribution Coalition

The Company is a party to a joint venture with certain exhibitors and distributors called Digital Cinema Distribution Coalition (“DCDC”). DCDC operates a satellite distribution network that distributes all digital content to U.S. theatres via satellite. The Company has an approximate 14.6% ownership in DCDC. The Company paid approximately $0.6, $0.5 and $0.6 to DCDC during the years ended December 31, 2021, 2022 and 2023, respectively, related to content delivery services, which is included in film rentals and advertising costs on the consolidated statements of income (loss) of Holdings and CUSA. The Company accounts for its investment in DCDC under the equity method of accounting.

FE Concepts, LLC

During April 2018, the Company, through its wholly-owned indirect subsidiary CNMK Texas Properties, LLC (“CNMK”), formed a joint venture, FE Concepts, LLC (“FE Concepts”) with AWSR Investments, LLC (“AWSR”), an entity owned by Lee Roy Mitchell and Tandy Mitchell. In December 2019, FE Concepts opened a family entertainment center that offers bowling, gaming, movies and other amenities. The Company and AWSR each invested approximately $20 and each have a 50% voting interest in FE Concepts. The Company accounts for its investment in FE Concepts under the equity method of accounting. The Company has a theatre services agreement with FE Concepts under which it receives service fees for providing film booking and equipment monitoring services for the facility. The Company recorded $0.1, $0.1 and $0.1 of related service fees during the years ended December 31, 2021, 2022 and 2023, respectively. During the years ended December 31, 2022 and 2023, the Company received cash distributions of $4.0 and $0.0 from FE Concepts. The cash distributions received were recorded as a reduction of the Company’s investment in FE Concepts.

Additional Considerations

The Company performs a qualitative impairment analysis for each of these equity investments annually during the fourth quarter. Based on the analysis performed, no impairment was recorded for the years ended December 31, 2021, 2022 and 2023.

F-35

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

11.GOODWILL AND INTANGIBLE ASSETS, NET

The Company’s goodwill was as follows for the periods presented:

	U.S. Operating Segment		International Operating Segment			Total
Balance at December 31, 2021 (1)	$	1,182.9	$	65.9		$	1,248.8
Foreign currency translation adjustments		—		2.1			2.1
Balance at December 31, 2022 (1)	$	1,182.9	$	68.0		$	1,250.9
Disposition (2)		—	$	(4.2	)		(4.2	)
Foreign currency translation adjustments		—		4.3			4.3
Balance at December 31, 2023 (1)	$	1,182.9	$	68.1		$	1,251.0

(1)Balances are presented net of accumulated impairment losses of $214.0 for the U.S. operating segment and $43.8 for the international operating segment.

(2)Relates to the sale of the Company’s Ecuador subsidiary. See Note 8.

Intangible assets activity and balances consisted of the following for the periods indicated:

	Balance at January 1, 2022			Additions		Amortization			Foreign Currency Translation Adjustments and Other (1)			Balance at December 31, 2022
Intangible assets with finite lives:
Gross carrying amount	$	81.7		$	—	$	—		$	(4.0	)	$	77.7
Accumulated amortization		(71.0	)		—		(2.4	)		0.2			(73.2	)
Total intangible assets with finite lives, net	$	10.7		$	—	$	(2.4	)	$	(3.8	)	$	4.5
Intangible assets with indefinite lives:
Tradename and other		300.1			—		—			—			300.1
Total intangible assets, net	$	310.8		$	—	$	(2.4	)	$	(3.8	)	$	304.6

	Balance at January 1, 2023			Additions (2)		Disposals (3)			Amortization			Foreign Currency Translation Adjustments and Other (4)		Balance at December 31, 2023
Intangible assets with finite lives:
Gross carrying amount	$	77.7		$	—	$	—		$	—		$	0.1	$	77.8
Accumulated amortization		(73.2	)		—		—			(2.1	)		—		(75.3	)
Total intangible assets with finite lives, net	$	4.5		$	—	$	—		$	(2.1	)	$	0.1	$	2.5
Intangible assets with indefinite lives:
Tradename and other		300.1			0.4		(0.4	)		—			0.2		300.3
Total intangible assets, net	$	304.6		$	0.4	$	(0.4	)	$	(2.1	)	$	0.3	$	302.8

(1)Includes foreign currency translation adjustments and an impairment recorded for a U.S. intangible asset during 2022. See Note 12 for discussion of impairment evaluations performed during the year ended December 31, 2022.

(2)Amount represents licenses acquired to sell alcoholic beverages for certain locations.

(3)Relates to the sale of the Company’s Ecuador subsidiary. See Note 8.

(4)Includes foreign currency translation adjustments.

F-36

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

Estimated aggregate future amortization expense for intangible assets is as follows:

Year ended December 31, 2024	$	2.0
Year ended December 31, 2025		0.5
Year ended December 31, 2026		—
Year ended December 31, 2027		—
Year ended December 31, 2028		—
Total	$	2.5

12.IMPAIRMENT OF LONG-LIVED AND OTHER ASSETS

The Company reviews for impairment indicators related to its long-lived assets on a quarterly basis and goodwill on an annual basis or whenever events or changes in circumstances indicate the carrying amount of those assets may not be fully recoverable. The Company performed a quantitative impairment analysis on its goodwill, tradename intangible assets and other long-lived assets, including theatre properties and right-of-use assets, as of December 31, 2023. See Note 1 for a discussion of the Company’s impairment policy and a description of qualitative and quantitative impairment assessments.

Below is a summary of impairment charges for the periods indicated:

	Year Ended
	December 31,
	2021	2022	2023
U.S. segment
Theatre properties	$6.4	$19.7	$6.6
Theatre operating lease right-of-use assets	6.8	34.0	7.1
Investment in NCM (1)	—	113.2	0.7
Other	—	3.9	—
U.S. total	13.2	170.8	14.4
International segment
Theatre properties	4.0	2.2	0.7
Theatre operating lease right-of-use assets	3.2	1.1	1.5
Intangible assets, net	0.4	—	—
International total	7.6	3.3	2.2
Total impairment	$20.8	$174.1	$16.6

(1)See discussion at Investment in National CineMedia in Note 9.

For the years ended December 31, 2021, 2022 and 2023, impairment charges were primarily due to the unprecedented impact of the COVID-19 pandemic on the theatrical exhibition industry and its ongoing recovery, as discussed in Note 3.

13.ACCRUED OTHER CURRENT LIABILITIES

Accrued other current liabilities consisted of the following as of the periods presented:

	December 31,
	2022		2023
Gift card liability (1)	$	64.5	$	73.6
Subscription membership program liability (1)		58.4		77.3
Discount vouchers liability (1)		32.8		31.9
Other (2)		44.7		56.4
Total	$	200.4	$	239.2

(1)See discussion at Revenue Recognition Policy in Note 5.

(2)The only difference between accrued other current liabilities for Holdings, as presented above, and CUSA is an additional $0.3 and $0.1 in other as of December 31, 2022 and 2023, respectively.

F-37

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

14.LONG-TERM DEBT

Long-term debt of Holdings and CUSA consisted of the following for the periods presented:

	December 31,
	2022		2023
Cinemark Holdings, Inc. 4.50% convertible senior notes due 2025	$	460.0	$	460.0
Cinemark USA, Inc. term loan due 2030 (see Senior Secured Credit Facility below)		626.5		645.1
Cinemark USA, Inc. 8.75% senior secured notes due 2025		250.0		150.0
Cinemark USA, Inc. 5.875% senior notes due 2026		405.0		405.0
Cinemark USA, Inc. 5.25% senior notes due 2028		765.0		765.0
Other		10.1		7.0
Total long-term debt carrying value (1)	$	2,516.6	$	2,432.1
Less: Current portion		10.7		7.8
Less: Debt issuance costs and original issue discount, net of accumulated amortization (1)		31.9		33.0
Long-term debt, less current portion, net of unamortized debt issuance costs and original issue discount (1)	$	2,474.0	$	2,391.3

(1) The only differences between the long-term debt for Holdings, as presented above, and the long-term debt for CUSA are the $460.0 million 4.50% Convertible Senior Notes due 2025 and the related debt issuance costs. The following table sets forth, as of the periods indicated, the total long-term debt carrying value, current portion of long-term debt and debt issuance costs, net of amortization for CUSA:

	December 31,
	2022		2023
Total long-term debt carrying value	$	2,056.6	$	1,972.1
Less: Current portion		10.7		7.8
Less: Debt issuance costs, net of accumulated amortization and original issue discount		22.9		27.5
Long-term debt, less current portion, net of unamortized debt issuance costs and original issue discount	$	2,023.0	$	1,936.8

Fair Value of Long Term Debt

The Company estimates the fair value of its long-term debt primarily using quoted market prices, which fall under Level 2 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35. The carrying value of the Company’s long term debt as of December 31, 2022 and 2023 is shown in the table above. The table below presents the fair value of the Company's long-term debt as of the periods presented:

	As of
	December 31, 2022		December 31, 2023
Holdings fair value (1)	$	2,210.5	$	2,460.3
CUSA fair value	$	1,771.3	$	1,903.8

(1)The fair value of the 4.50% convertible notes was $439.2 and $556.5 as of December 31, 2022 and
2023, respectively.

4.50% Convertible Senior Notes

On August 21, 2020, Holdings issued $460.0 aggregate principal amount of 4.50% convertible senior notes due 2025 (the “4.50% Convertible Senior Notes”). The 4.50% Convertible Senior Notes will mature on August 15, 2025, unless earlier repurchased or converted in accordance with the indenture. Interest on the 4.50% Convertible Senior Notes is payable on February 15 and August 15 of each year.

Holders of the 4.50% Convertible Senior Notes may convert their 4.50% Convertible Senior Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2025 only under the following circumstances: (1) during the five business day period after any five consecutive trading day period, or the measurement period, in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of Holdings’ common stock and the conversion rate on each such trading day; (2) if Holdings distributes to all or substantially all stockholders (i) rights options or warrants entitling them to purchase shares at a discount to the recent average trading price of Holdings’ common stock (including due to a stockholder rights plan) or (ii) Holdings’ assets or securities or rights, options or

F-38

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

warrants to purchase the same with a per share value exceeding 10% of the trading price of Holdings’ stock, (3) upon the occurrence of specified corporate events as described further in the indenture, or (4) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of Holdings’ common stock for at least 20 trading days during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to $18.66 per share (130% of the initial conversion price of $14.35 per share), on each applicable trading day. Beginning May 15, 2025, holders may convert their 4.50% Convertible Senior Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date. Upon conversion of the 4.50% Convertible Senior Notes, Holdings will pay or deliver cash, shares of Holdings’ common stock or a combination of cash and shares of Holdings’ common stock, at Holdings’ election.

The initial conversion rate is 69.6767 shares of Holdings’ common stock per one thousand dollars principal amount of the 4.50% Convertible Senior Notes. The conversion rate is subject to adjustment upon the occurrence of certain events. If a make-whole fundamental change as defined in the indenture governing the 4.50% Convertible Senior Notes occurs prior to the maturity date, Holdings will, in certain circumstances, increase the conversion rate for a holder who elects to convert its 4.50% Convertible Senior Notes in connection with such make-whole fundamental change.

The 4.50% Convertible Senior Notes are effectively subordinated to any of Holdings’, or its subsidiaries’, existing and future secured debt to the extent of the value of the assets securing such indebtedness, including obligations under the Credit Agreement. The 4.50% Convertible Senior Notes are structurally subordinated to all existing and future debt and other liabilities of our subsidiaries, including trade payables, and including CUSA’s 5.125% Senior Notes, 4.875% Senior Notes and the 8.75% Secured Notes, or, collectively, CUSA’s senior notes (but excluding all obligations under the Credit Agreement which are guaranteed by Holdings). The 4.50% Convertible Senior Notes rank equally in right of payment with all of Holdings’ existing and future unsubordinated debt, including all obligations under the Credit Agreement, which such Credit Agreement is guaranteed by Holdings, and senior in right of payment to any future debt that is expressly subordinated in right of payment to the 4.50% Convertible Senior Notes. The 4.50% Convertible Notes are not guaranteed by any of Holdings’ subsidiaries.

Concurrently with the issuance of the 4.50% Convertible Senior Notes, Holdings entered into privately negotiated convertible note hedge transactions (the “Hedge Transactions”) with one or more of the initial purchasers of the 4.50% Convertible Senior Notes or their respective affiliates (the “Option Counterparties”). The Hedge Transactions cover the number of shares of Holdings’ common stock that will initially underlie the aggregate amount of the 4.50% Convertible Senior Notes, subject to anti-dilution adjustments substantially similar to those applicable to the 4.50% Convertible Senior Notes. The Hedge Transactions are generally expected to reduce potential dilution to Holdings’ common stock upon any conversion of the 4.50% Convertible Senior Notes and/or offset any cash payments Holdings may be required to make in excess of the principal amount of converted 4.50% Convertible Senior Notes, as the case may be. Concurrently with entering into the Hedge Transactions, Holdings also entered into separate privately negotiated warrant transactions with Option Counterparties whereby it sold to Option Counterparties warrants to purchase (subject to the net share settlement provisions set forth therein) up to the same number of shares of Holdings’ common stock, subject to customary anti-dilution adjustments (the “Warrant Transactions”). The warrants could separately have a dilutive effect to the extent that the market value per share of Holdings’ common stock exceeds the strike price of the warrants on the applicable expiration dates unless, subject to the terms of the warrants, Holdings elects to cash settle the warrants. The exercise price of the warrants is initially $22.08 and is subject to certain adjustments under the terms of the warrants. Holdings received $89.4 in cash proceeds from the Warrant Transactions, which were used along with proceeds from the 4.50% Convertible Senior Notes, to pay approximately $142.1 to enter into the Hedge Transactions.

Together, the Hedge Transactions and the Warrants are intended to reduce the potential dilution from the conversion of the 4.50% Convertible Senior Notes. The Hedge Transactions and Warrants are recorded in equity and are not accounted for as derivatives, in accordance with applicable accounting guidance.

Senior Secured Credit Facility

On May 26, 2023, CUSA amended and restated its senior secured credit facility (the “Credit Agreement”) to provide for an aggregate principal amount of $775.0, consisting of a $650.0 term loan with a maturity date of May 24, 2030 and a $125.0 revolving credit facility with a maturity date of May 26, 2028. The term loan is subject to a springing maturity date of April 15, 2028 if CUSA’s 5.25% Senior Notes due 2028 have not been paid or refinanced as required

F-39

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

under the Credit Agreement prior to such date. The revolving credit facility is subject to springing maturity dates of January 30, 2025, December 14, 2025 and April 15, 2028 if CUSA’s 8.75% Senior Secured Notes due 2025, 5.875% Senior Notes due 2026 and 5.25% Senior Notes due 2028 have not been paid or refinanced as required under the Credit Agreement prior to such dates, as more specifically described in the Credit Agreement.

CUSA used the $632.7 net proceeds of the borrowings under the Credit Agreement to fund the $628.3 repayment of the term loan outstanding under the Credit Agreement prior to the amendment and restatement and accrued interest thereon, and for other general corporate purposes. As of December 31, 2023, there was $645.1 outstanding under the term loan.

Under the Credit Agreement, quarterly principal payments of $1.6 are due on the term loan through December 31, 2030, with a final principal payment of the remaining unpaid principal due on May 24, 2030.

The amended term loan was issued net of an original issue discount of $9.8. CUSA also incurred a total of approximately $10.1 in debt issuance costs in connection with the amendment, which are reflected in the consolidated financial statements as follows: (i) $7.5 in debt issuance costs were capitalized and are reflected as a reduction of “Long-term debt, less current portion” on the Company’s consolidated balance sheet; and (ii) $2.1 of fees paid to lenders and $0.5 of legal and other fees are included in “Loss on debt extinguishment and refinancing” in the Company’s consolidated statement of income for the year ended December 31, 2023. As a result of the amendment, CUSA also wrote-off $4.7 of unamortized debt issuance costs associated with exiting lenders of the refinanced Credit Agreement.

Interest on the term loan accrues, at CUSA's option, at either (i) a rate determined by reference to the secured overnight financing rate ("SOFR") as published by CME Group Benchmark Administration Limited and identified by Barclay's Bank PLC (the Administrative Agent) as the forward-looking term rate based on SOFR for a period of 1, 3, or 6 months (depending upon the Interest Period (as defined in the Credit Agreement) chosen by CUSA) (the "Term SOFR Rate"), subject to a floor of 0.50% per annum, plus an applicable margin of 3.75% per annum, or (ii) for any day, a rate per annum equal to the greatest of (a) the Prime Rate in effect on such day, (b) the Federal Reserve Bank of New York Rate in effect on such day, plus 1/2 of 1.00% and (c) the Term SOFR Rate for a one month Interest Period, as published two U.S. Government Securities Business Days prior to such day (or if such day is not a U.S. Government Securities Business Day, the immediately preceding U.S. Government Securities Business Day), plus 1.00% (this clause (ii), the "Alternate Base Rate"), subject in the case of this clause (ii) to a floor of 1.50% per annum, plus, in the case of this clause (ii), an applicable margin of 2.75%. The average interest rate on outstanding term loan borrowings under the Credit Agreement as of December 31, 2023 was approximately 7.1% per annum, after giving effect to the interest rate swap agreements discussed below.

Interest on revolving credit loans accrues, at CUSA's option, at either (i) the Term SOFR Rate plus an applicable margin that ranges from 3.00% to 3.50% per annum, or (ii) the Alternate Base Rate, subject, in the case of this clause (ii) to a floor of 1.00% per annum, plus, in the case of this clause (ii), an applicable margin that ranges from 2.00% to 2.50%. The applicable margin with respect to revolving credit loans is a function of the Consolidated Net Senior Secured Leverage Ratio as defined in the Credit Agreement. As of December 31, 2023, the applicable margin was 3.25%, however, there were no borrowings outstanding under the revolving line of credit. In addition, CUSA is required to pay a commitment fee on the revolving line of credit that accrues at a rate ranging from 0.20% to 0.375% per annum of the daily unused portion of the revolving line of credit. The commitment fee rate is a function of the Consolidated Net Senior Secured Leverage Ratio and was 0.25% at December 31, 2023.

CUSA’s obligations under the Credit Agreement are guaranteed by Holdings and certain subsidiaries of Holdings other than CUSA (the “Other Guarantors”) and are secured by security interests in substantially all of CUSA’s, Holdings’ and the Other Guarantors’ personal property.

The Credit Agreement contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on the ability of Holdings, CUSA and their subsidiaries to: merge, consolidate, liquidate, or dissolve; sell, transfer or otherwise dispose of assets; create, incur or permit to exist certain indebtedness and liens; pay dividends, repurchase stock and make other Restricted Payments (as defined in the Credit Agreement); prepay certain indebtedness; make investments; enter into transactions with affiliates; and change the nature of their business. At any time that CUSA has revolving credit loans outstanding, it is not permitted to allow the Consolidated Net Senior Secured Leverage Ratio to exceed 3.5 to 1.0 for any period of four consecutive fiscal quarters ending on the last day of any fiscal quarter. As of December 31, 2023, there were no revolving credit loans outstanding under the revolving line of credit, and CUSA’s Consolidated Net Senior Secured Leverage Ratio was 0.3 to 1.0.

F-40

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

The Credit Agreement also includes customary events of default, including, among other things, payment default, covenant default, breach of representation or warranty, bankruptcy, cross-default, material ERISA events, a change of control, material money judgments and failure to maintain security interests. If an event of default occurs, all commitments under the Credit Agreement may be terminated and all obligations under the Credit Agreement could be accelerated by the Lenders, causing all loans outstanding (including accrued interest and fees payable thereunder) to be declared immediately due and payable.

The Restricted Payments covenant, as defined in the Credit Agreement generally does not limit the ability of Holdings and its subsidiaries to pay dividends and make other Restricted Payments if the Consolidated Net Total Leverage Ratio (as defined in the Credit Agreement) is less than or equal to 2.75 to 1.00. If the Consolidated Net Total Leverage Ratio is greater than 2.75 to 1.00, but not greater than 5.00 to 1.00, Restricted Payments generally may be made in an aggregate amount not to exceed the Available Amount (as defined in the Credit Agreement), which is a function of CUSA’s Consolidated EBITDA minus 1.75 times its Consolidated Interest Expense (as such terms are defined in the Credit Agreement) and certain other factors as specified in the Credit Agreement. As of December 31, 2023, the Consolidated Net Total Leverage Ratio was 2.13 to 1.00 and the Available Amount was $599.1. In addition, the Credit Agreement contains other baskets that allow certain Restricted Payments in excess of the Applicable Amount.

5.875% Senior Notes

On March 16, 2021, CUSA issued $405.0 aggregate principal amount of 5.875% senior notes due 2026, at par value (the “5.875% Senior Notes”). Proceeds, after payment of fees, were used to fund a cash tender offer to purchase any and all of CUSA’s 5.125% Senior Notes (the “5.125% Senior Notes”) and to redeem any of the 5.125% Senior Notes that remained outstanding after the tender offer. See further discussion of the tender offer below. Interest on the 5.875% Senior Notes is payable on March 15 and September 15 of each year. The 5.875% Senior Notes mature on March 15, 2026. CUSA incurred debt issuance costs of approximately $6.0 in connection with the issuance, which are recorded as a reduction of long-term debt on the consolidated balance sheet.

The 5.875% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of CUSA’s subsidiaries that guarantee, assume or become liable with respect to any of CUSA’s or a guarantor’s debt. The 5.875% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of CUSA’s and its guarantor’s existing and future senior debt and are senior in right of payment to all of CUSA’s and its guarantors’ existing and future senior subordinated debt. The 5.875% Senior Notes and the guarantees are effectively subordinated to all of CUSA’s and its guarantor’s existing and future secured debt to the extent of the value of the collateral securing such debt, including all borrowings under CUSA’s Credit Agreement. The 5.875% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of CUSA’s subsidiaries that do not guarantee the 5.875% Senior Notes.

The indenture to the 5.875% Senior Notes contains covenants that limit, among other things, the ability of CUSA and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. Upon a change of control, as defined in the indenture, CUSA would be required to make an offer to repurchase the 5.875% Senior Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 5.875% Senior Notes allows CUSA to incur additional indebtedness if we satisfy the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances.

Cinemark USA, Inc. may redeem the 5.875% Senior Notes in whole or in part at redemption prices specified in the indenture.

5.25% Senior Notes

On June 15, 2021, CUSA issued $765.0 aggregate principal amount of 5.25% senior notes due 2028, at par value (the “5.25% Senior Notes”). Proceeds, after payment of fees, were used to redeem all of CUSA’s 4.875% $755.0 aggregate principal amount of Senior Notes due 2023 (the “4.875% Senior Notes”). Interest on the 5.25% Senior Notes is payable on January 15 and July 15 of each year, beginning January 15, 2022. The 5.25% Senior Notes mature

F-41

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

on July 15, 2028. CUSA incurred debt issuance costs of approximately $10.7 in connection with the issuance, which are recorded as a reduction of long-term debt on the consolidated balance sheet.

The 5.25% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of CUSA’s subsidiaries that guarantee, assume or become liable with respect to any of CUSA’s or a guarantor’s debt. The 5.25% Senior Notes and the guarantees will be CUSA’s and the guarantors’ senior unsecured obligations and (i) rank equally in right of payment to CUSA’s and the guarantors’ existing and future senior debt, including borrowings under CUSA’s Credit Agreement (as defined below) and CUSA’s existing senior notes, (ii) rank senior in right of payment to CUSA’s and the guarantors’ future subordinated debt, (iii) are effectively subordinated to all of CUSA’s and the guarantors’ existing and future secured debt, including all obligations under the Credit Agreement and CUSA’s 8.75% senior secured notes due 2025, in each case to the extent of the value of the collateral securing such debt, (iv) are structurally subordinated to all existing and future debt and other liabilities of CUSA’s non-guarantor subsidiaries, and (v) are structurally senior to the 4.50% convertible senior notes due 2025 issued by Holdings.

The indenture to the 5.25% Senior Notes contains covenants that limit, among other things, the ability of CUSA and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. Upon a change of control, as defined in the indenture, CUSA would be required to make an offer to repurchase the 5.25% Senior Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 5.25% Senior Notes allows CUSA to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances.

Prior to July 15, 2024, CUSA may redeem all or any part of the 5.25% Senior Notes at its option at 100% of the principal amount plus a make-whole premium plus accrued and unpaid interest on the 5.25% Senior Notes to the date of redemption. On or after July 15, 2024, CUSA may redeem the 5.25% Senior Notes in whole or in part at redemption prices specified in the indenture. In addition, prior to July 15, 2024, CUSA may redeem up to 40% of the aggregate principal amount of the 5.25% Senior Notes from the net proceeds of certain equity offerings at the redemption price set forth in the indenture, so long as at least 60% of the principal amount of the 5.25% Senior Notes remains outstanding immediately after each such redemption.

8.75% Secured Notes

On April 20, 2020, CUSA issued $250.0 in aggregate principal amount of 8.75% senior secured notes due 2025 (the “8.75% Secured Notes”). The 8.75% Secured Notes mature on May 1, 2025. Interest on the 8.75% Secured Notes is payable on May 1 and November 1 of each year.

CUSA may redeem the 8.75% Secured Notes in whole or in part at redemption prices specified in the indenture. Prior to May 1, 2024, CUSA, Inc. may redeem all or any part of the 8.75% Senior Notes at its option at 102.188% of the principal amount plus accrued and unpaid interest on the 8.75% Senior Notes to the date of redemption. On or after May 1, 2024, CUSA may redeem the 8.75% Senior Notes in whole or in part at 100% of the principal amount plus accrued and unpaid interest on the 8.75% Senior Notes to the date of redemption.

On May 1, 2023, CUSA redeemed $100.0 in principal amount of the 8.75% Secured Notes plus accrued interest thereon for $106.6 in cash. Following the redemption, $150.0 in aggregate principal amount of the 8.75% Secured Notes remains outstanding. As a result of the redemption, CUSA recognized a loss on extinguishment of debt totaling $3.4, which includes a $2.2 premium paid on the redemption of bonds and a $1.2 write-off of unamortized debt issuance costs, and is reflected in “Loss on debt extinguishment and refinancing” in the Company’s consolidated statement of income for the year ended December 31, 2023.

The 8.75% Secured Notes are fully and unconditionally guaranteed on a joint and several senior basis by certain of CUSA’s subsidiaries that guarantee, assume or in any other manner become liable with respect to any of CUSA’s or its guarantors’ other debt. If CUSA cannot make payments on the 8.75% Secured Notes when they are due, CUSA’s guarantors must make them instead. Under certain circumstances, the guarantees may be released without action by, or the consent of, the holders of the 8.75% Secured Notes.

F-42

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

The indenture governing the 8.75% Secured Notes contains covenants that limit, among other things, the ability of CUSA and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. Upon a change of control, as defined in the indenture governing the 8.75% Secured Notes, CUSA would be required to make an offer to repurchase the 8.75% Secured Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 8.75% Secured Notes allows CUSA to incur additional indebtedness if it satisfies a coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances.

4.875% Senior Notes

On May 21, 2021, Cinemark USA, Inc. issued a conditional notice of optional redemption to redeem the $755.0 outstanding principal amount of the 4.875% Senior Notes. In connection therewith, CUSA deposited with Wells Fargo Bank, N.A., as Trustee for the 4.875% Senior Notes (the “Trustee”), funds sufficient to redeem all 4.875% Senior Notes remaining outstanding on June 21, 2021 (the “Redemption Date”). The redemption payment (the “Redemption Payment”) included $755.0 of outstanding principal at the redemption price equal to 100% of the principal amount plus accrued and unpaid interest thereon to the Redemption Date. Upon deposit of the Redemption Payment with the Trustee on June 15, 2021, the indenture governing the 4.875% Senior Notes was fully satisfied and discharged.

The Company recorded a loss on extinguishment of debt of $3.9, which included the write-off of $3.3 of unamortized debt issuance costs and the payment of $0.6 in legal fees during the year ended December 31, 2021.

5.125% Senior Notes

On March 16, 2021, CUSA completed a tender offer to purchase its previously outstanding 5.125% Senior Notes, of which $334.0 was tendered at the expiration of the offer. On March 16, 2021, CUSA also issued a notice of optional redemption to redeem the remaining $66.0 principal amount of the 5.125% Senior Notes. In connection therewith, CUSA deposited with Wells Fargo Bank, N.A., as Trustee for the 5.125% Senior Notes (the “Trustee”), funds sufficient to redeem all 5.125% Notes remaining outstanding on April 15, 2021 (the “Redemption Date”). The redemption payment (the “Redemption Payment”) included $66.0 of outstanding principal at the redemption price equal to 100% of the principal amount plus accrued and unpaid interest thereon to the Redemption Date. Upon deposit of the Redemption Payment with the Trustee on March 16, 2021, the indenture governing the 5.125% Senior Notes was fully satisfied and discharged.

The Company recorded a loss on extinguishment of debt of $2.6 during the year ended December 31, 2021, which included the write-off of $1.2 of unamortized debt issuance costs and the payment of $1.4 in tender and legal fees.

Additional Borrowings of International Subsidiaries

During the years ended December 31, 2020 and 2021, certain of CUSA’s international subsidiaries borrowed an aggregate of $35.8 under various local bank loans, with original maturity dates ranging between November 2022 and January 2029. During the years ended December 31, 2022 and 2023, the Company repaid $21.5 and $4.1, respectively, of these bank loans. The remaining bank loan outstanding at December 31, 2023 is for our Brazil subsidiary and matures in January 2029. The current interest rate on the remaining bank loan outstanding at December 31, 2023 is 4.0%.

Covenant Compliance

The indentures governing the 5.875% Senior Notes, the 5.25% Senior Notes and the 8.750% Secured Notes ("the indentures") contain covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2023, Cinemark USA, Inc. could have distributed up to approximately $3,556.8 to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indentures, subject to its available cash and other borrowing restrictions outlined in the

F-43

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

indentures. Upon a change of control, as defined in the indentures, Cinemark USA, Inc. would be required to make an offer to repurchase the 5.875% Senior Notes, the 5.25% Senior Notes and the 8.750% Secured Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indentures allow Cinemark USA, Inc. to incur additional indebtedness if we satisfy the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and our actual ratio as of December 31, 2023 was 5.5 to 1.

See discussion of dividend restrictions and the consolidated net senior secured leverage ratio under the Credit Agreement at Senior Secured Credit Facility above.

As of December 31, 2023, the Company believes it was in full financial compliance with all agreements, including related covenants, governing its outstanding debt.

Debt Maturity

Holdings' long-term debt, excluding unamortized debt issuance costs, at December 31, 2023 matures as follows:

2024	$	7.8
2025		617.7
2026		412.7
2027		7.7
2028		772.7
Thereafter		613.5
Total (1)	$	2,432.1

(1)The only difference between the long-term debt maturity payments for Holdings, as presented above, and those for CUSA is the $460.0 repayment of Holdings’ 4.50% Convertible Senior Notes in 2025.

Interest Rate Swap Agreements

Effective May 31, 2023, in conjunction with the amendment of its Credit Agreement, the Company amended its three then existing interest rate swap agreements to update the reference rate from LIBOR to Term SOFR, and the Company applied the optional relief provided in FASB ASC Topic 848 prospectively to account for this modification. Topic 848 provides optional expedients that allow an entity not to dedesignate an existing hedging relationship when critical terms of the agreement are modified, but rather allow an existing hedging relationship to continue when one or more of the critical terms in the existing hedging agreement change because of reference rate reform. Therefore, the Company did not dedesignate the hedging relationship due to the amendment of its existing interest rate swap agreements on May 31, 2023, and accumulated losses due to the fair value adjustments on the interest rate swaps remained in other comprehensive income.

Effective November 30, 2023, the Company amended and extended its then existing $175.0 notional amount interest rate swap agreement to extend the maturity date to December 31, 2026. Upon amending the interest rate swap agreement effective November 30, 2023, the Company determined that the interest payments hedged with the agreement are still probable to occur, therefore the gain that accumulated on the swap prior to the amendment of $5.1 is being amortized to interest expense through December 31, 2024, the original maturity date of the swap.

Approximately $4.5, $4.5 and $(6.4) was recorded in amortization of accumulated losses (gains) for amended swaps in the consolidated income statement for the years ended December 31, 2021, 2022 and 2023, respectively.

The fair values of the interest rate swaps are recorded on the Company’s consolidated balance sheets as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss. The changes in fair value are reclassified from accumulated other comprehensive loss into earnings in the same period that the hedged items affect earnings. The valuation technique used to determine fair value is the income approach and under this approach, the Company uses projected future interest rates as provided by counterparty to the interest rate swap agreement and the fixed rates that the Company is obligated to pay under the agreement. Therefore, the Company’s measurements use significant unobservable inputs, which fall in Level 2 of the U.S. GAAP hierarchy as defined by FASB ASC Topic 820-10-35.

F-44

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

Below is a summary of the Company’s interest rate swap agreements designated as cash flow hedges as of December 31, 2023:

						Estimated
						Fair Value at
Notional						December 31,
Amount			Pay Rate	Receive Rate	Expiration Date	2023 (1)
$	137.5	(2)	2.15%	1-Month Term SOFR	December 31, 2024	$	3.5
$	137.5	(3)	2.08%	1-Month Term SOFR	December 31, 2024		3.5
$	175.0		3.20%	1-Month Term SOFR	December 31, 2026		2.9
					Total	$	9.9

(1)Approximately $9.7 of the total is included in prepaid expenses and other and $0.2 is included in deferred charges on the consolidated balance sheet as of December 31, 2023.

(2)In January 2024, the Company amended and extended one of its two then existing $137.5 notional amount interest rate swap agreements to amend the pay rate to 3.17% and extend the maturity date to December 31, 2027, effective January 31, 2024.

(3)In February 2024, the Company amended and extended the second of its two then existing $137.5 notional amount interest rate swap agreements to amend the pay rate to 3.21% and extend the maturity date to December 31, 2026, effective February 29, 2024.

15.FAIR VALUE MEASUREMENTS

The Company determines fair value measurements in accordance with FASB ASC Topic 820, which establishes a fair value hierarchy under which an asset or liability is categorized based on the lowest level of input significant to its fair value measurement. The levels of input defined by FASB ASC Topic 820 are as follows:

Level 1 – quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date;

Level 2 – other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and

Level 3 – unobservable and should be used to measure fair value to the extent that observable inputs are not available.

F-45

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

Below is a summary of assets measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of the periods presented:

	As of	Carrying		Fair Value
Description	December 31,	Value		Level 1		Level 2		Level 3
Interest rate swap assets (1)	2022	$	20.4	$	—	$	20.4	$	—
Interest rate swap assets (1)	2023	$	9.9	$	—	$	9.9	$	—
Investment in NCMI (2)	2023	$	18.1	$	—	$	18.1	$	—

(1) See further discussion of interest rate swaps at Note 14.

(2) See further discussion of investment in NCMI at Note 9.

The Company also uses the market and income approach for fair value measurements on a nonrecurring basis in the impairment evaluations of its long-lived assets (see Note 1 and Note 12). Additionally, the Company uses the market approach to estimate the fair value of its long-term debt (see Note 14). There were no changes in valuation techniques during the period. There were no transfers in or out of Level 1, Level 2 or Level 3 during the years ended December 31, 2021, 2022 and 2023.

16.FOREIGN CURRENCY TRANSLATION

The accumulated other comprehensive loss account in Holdings’ stockholders’ equity of $353.2 and $363.9 and CUSA’s stockholder’s equity of $356.3 and $366.7, each at December 31, 2022 and 2023, respectively, each primarily includes cumulative foreign currency net losses of $389.8 and $384.9, at December 31, 2022 and 2023, from translating the financial statements of the Company’s international subsidiaries and the cumulative changes in fair value of the interest rate swap agreements that are designated as hedges.

As of December 31, 2023, all foreign countries where the Company has operations are non-highly inflationary, other than Argentina. In non-highly inflationary countries, the local currency is the same as the functional currency and any fluctuation in the currency results in a cumulative foreign currency translation adjustment recorded to accumulated other comprehensive loss. The Company deemed Argentina to be highly inflationary beginning July 1, 2018. A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity. The financial information of the Company’s Argentina subsidiaries has been remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters, effective beginning July 1, 2018.

During 2019, the Argentine government instituted exchange controls restricting the ability of entities and individuals to exchange Argentine pesos for foreign currencies and to remit foreign currency out of Argentina. As a result of these currency exchange controls, markets in Argentina developed a legal trading mechanism known as the Blue Chip Swap that allows entities to transfer U.S. dollars out of and into Argentina. In a Blue Chip Swap transaction, an entity buys U.S. dollar denominated securities in Argentina using Argentine pesos, and subsequently sells the securities for U.S. dollars, in Argentina, to access U.S. dollars locally, or outside of Argentina, by transferring the securities abroad, prior to being sold (the latter commonly known as Blue Chip Swap Rate). The Blue Chip Swap rate is the implicit exchange rate resulting from the Blue Chip Swap transaction. The Blue Chip Swap rate can diverge significantly from Argentina’s official exchange rate. During the year ended December 31, 2023, the Company entered into Blue Chip Swap transactions that resulted in a loss of approximately $12.4 which is reflected in “Foreign currency exchange and other related loss” in the Company’s consolidated statement of income for the year ended December 31, 2023.

F-46

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

Below is a summary of the impact of translating the financial statements of the Company’s international subsidiaries for the periods presented.

							Other Comprehensive
							Income (Loss)
	Exchange Rate as of December 31,						Year Ended December 31,
Country	2021		2022		2023		2021			2022		2023
Brazil		5.57		5.29		4.85	$	(4.7	)	$	2.7	$	5.5
Colombia		3,981.16		4,810.19		3,885.85		(0.1	)		—		1.20
Chile		852.02		852.00		879.54		(10.9	)		0.3		(3.1	)
Peru		4.02		3.81		3.75		(2.8	)		1.3		0.3
All other								(0.3	)		0.3		1.0
							$	(18.8	)	$	4.6	$	4.9

As noted above, beginning July 1, 2018, Argentina was deemed highly inflationary. The impact of translating Argentina’s financial results to U.S. dollars, subsequent to June 30, 2018, has been recorded in foreign currency exchange gain (loss) on the Company’s consolidated statements of income (loss). A foreign currency exchange gain (loss) of $0.2, $8.5, and $(24.2), excluding the impact of the Blue Chip Swap transactions noted above, was recorded for the years ended December 31, 2021, 2022 and 2023, respectively.

17.NONCONTROLLING INTERESTS IN SUBSIDIARIES

Noncontrolling interests in subsidiaries of the Company were as follows as of the periods presented:

	December 31,
	2022		2023
Cinemark Partners II	$	7.7	$	7.4
Laredo Theatres		0.2		0.3
Greeley Ltd.		0.9		0.8
Other		0.5		0.5
Total	$	9.3	$	9.0

There were no changes in the Company’s ownership interest in these subsidiaries during the years ended December 31, 2021, 2022 and 2023.

18.CAPITAL STOCK

Common Stock - Holdings

Common stockholders are entitled to vote on all matters submitted to a vote of the Holdings’ stockholders. Subject to the rights of holders of any then outstanding shares of Holdings’ preferred stock, Holdings’ common stockholders are entitled to dividends declared by Holdings’ board of directors. The shares of the Holdings’ common stock are not subject to any redemption provisions. Holdings has no issued and outstanding shares of preferred stock.

Holdings’ ability to pay dividends is effectively limited by its status as a holding company and the terms of CUSA’s indentures and senior secured credit facility, which also significantly restricts the ability of certain of CUSA’s subsidiaries to pay dividends directly or indirectly to Holdings. See Note 14 for discussion of restrictions contained within the debt agreements of CUSA.

F-47

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

Treasury Stock - Holdings

Treasury stock represents shares of common stock repurchased by Holdings and not yet retired. Holdings has applied the cost method in recording its treasury shares. Below is a summary of Holdings’ treasury stock activity for the years ended December 31, 2021, 2022 and 2023.

	Number of Treasury Shares		Cost
Balance at January 1, 2021		5.05	$	87.0
Restricted stock withholdings (1)		0.24		4.1
Restricted stock forfeitures (2)		0.06		—
Balance at December 31, 2021		5.35	$	91.1
Restricted stock withholdings (1)		0.26		4.3
Restricted stock forfeitures (2)		0.07		—
Balance at December 31, 2022		5.68	$	95.4
Restricted stock withholdings (1)		0.22		2.9
Restricted stock forfeitures (2)		0.10		—
Balance at December 31, 2023		6.00	$	98.3

(1)Holdings withheld shares as a result of the election by certain employees to satisfy their tax liabilities upon vesting in restricted stock and restricted stock units. Holdings determined the number of shares to be withheld based upon market values of the common stock of Holdings on the vest dates. Below is a summary of the range of market values per share on the vest dates for the years indicated:

	Year Ended December 31,
	2021	2022	2023
Market Values	$15.21 to $24.14	$12.11 to $18.33	$11.16 to $18.36

(2)Holdings repurchased forfeited restricted shares at a cost of $0.001 per share in accordance with the 2017 Omnibus Plan.

As of December 31, 2023, Holdings had no plans to retire any shares of its treasury stock.

Common and Preferred Stock - CUSA

CUSA has 1.5 shares (in thousands) of Class A common stock and 182.6 shares (in thousands) of Class B common stock outstanding, all of which are held by Holdings. Holders of Class A common stock have exclusive voting rights. Holders of Class B common stock have no voting rights except upon any proposed amendments to the articles of incorporation. However, they may convert their Class B common stock, at their option, to Class A common stock. In the event of any liquidation, holders of the Class A and Class B common stock will be entitled to their pro-rata share of assets remaining after any holders of preferred stock have received their preferential amounts based on their respective shares held.

CUSA has 1.0 shares of preferred stock, $1.00 par value, authorized with none issued or outstanding. The rights and preferences of preferred stock will be determined by the CUSA Board of Directors at the time of issuance.

CUSA’s ability to pay dividends is effectively limited by the terms of its indentures and its senior secured credit facility, which also significantly restricts the ability of certain of CUSA’s subsidiaries to pay dividends directly or indirectly to it. See Note 14 for a discussion of restrictions contained within CUSA’s debt agreements.

Restricted Stock

Below is a summary of restricted stock activity for the years ended December 31, 2021, 2022 and 2023:

	Year Ended					Year Ended					Year Ended
	December 31, 2021					December 31, 2022					December 31, 2023
	Shares of Restricted Stock			Weighted Average Grant Date Fair Value		Shares of Restricted Stock			Weighted Average Grant Date Fair Value		Shares of Restricted Stock			Weighted Average Grant Date Fair Value
Outstanding at January 1		1.43		$	21.11		1.99		$	21.73		1.85		$	20.64
Granted		1.24		$	21.91		0.88		$	16.40		1.38		$	12.07
Vested		(0.62	)	$	20.92		(0.95	)	$	19.13		(0.78	)	$	21.04
Forfeited		(0.06	)	$	18.96		(0.07	)	$	18.91		(0.10	)	$	16.40
Outstanding at December 31		1.99		$	21.73		1.85		$	20.64		2.35		$	15.67

F-48

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

During the year ended December 31, 2023, Holdings granted 1.4 shares of its restricted stock to certain CUSA employees and to Holdings’ directors. The fair value of the restricted stock granted was determined based on the market value of the Holdings’ common stock on the grant dates, which ranged from $11.19 to $19.07 per share for the 2023 grants. The Company assumed forfeiture rates ranging from 0% to 10% for the restricted stock awards granted in 2023. The restricted stock granted to employees vests over periods ranging from one to three years based on continued service. The recipients of restricted stock are entitled to receive non-forfeitable dividends and to vote their respective shares, however, the sale and transfer of the restricted stock is prohibited during the restriction period.

Below is a summary of restricted stock award activity recorded for the periods indicated.

	Year Ended December 31,
	2021		2022		2023
Compensation expense recognized during the period:
CUSA employees (1)	$	22.0	$	14.8	$	15.1
Holdings directors		0.9		1.0		1.2
Total recognized by Holdings	$	22.9	$	15.8	$	16.3
Fair value of vested restricted stock held by:
CUSA employees	$	9.7	$	15.3	$	9.1
Holdings directors		1.3		0.6		1.3
Holdings total	$	11.0	$	15.9	$	10.4
Income tax benefit recognized upon vesting of restricted stock awards held by:
CUSA employees	$	0.8	$	2.7	$	0.6
Holdings directors		0.3		0.1		0.3
Holdings total income tax benefit	$	1.1	$	2.8	$	0.9

(1)The former CEO of Holdings retired on December 31, 2021, and all of his outstanding unvested shares vested upon his retirement in accordance with his employment agreement. The Company recorded incremental compensation expense of $4.3 related to the accelerated vesting of these awards during the year ended December 31, 2021.

As of December 31, 2023, the estimated remaining unrecognized compensation expense related to the unvested restricted stock awards was as follows:

	Estimated
	Remaining
	Expense
CUSA employees (1)	$	17.8
Holdings directors		0.6
Total remaining - Holdings (1)	$	18.4

(1) The weighted average period over which this remaining compensation expense will be recognized by both Holdings and CUSA is approximately 1.5 years.

Performance Stock Units

Holdings granted performance awards in the form of performance stock units (“PSUs”), formerly referred to as restricted stock units, in 2020, 2022 and 2023. Based upon the terms of the award agreements, the performance stock units vest based on a combination of financial performance factors and continued service.

The financial performance factors for the performance stock units have a threshold, target and maximum level of payment opportunity and vest on a prorata basis according to the performance level achieved by the Company during the performance period against the performance goals. At the time of the performance stock unit grants, the Company assumes the financial performance target will be reached for the defined measurement period in determining the amount of compensation expense to record for such grants. If and when additional information becomes available to indicate that something other than the target level will be achieved, the Company adjusts compensation expense on a prospective basis over the remaining service period.

Grantees of performance stock units are eligible to receive a ratable portion of the common stock issuable if the achievement of the performance goals is within the targets previously noted. All performance stock units granted will be paid in the form of Holdings’ common stock if the participant continues to provide services through the third anniversary of the respective grant date. Performance stock unit award participants are eligible to receive dividend

F-49

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

equivalent payments from the grant date to the extent declared by Holdings if, and at the time, the performance stock unit awards vest.

2023 awards - During the year ended December 31, 2023, Holdings granted performance awards in the form of performance stock units. Each PSU that vests will result in the issuance of one share of Holdings’ common stock. The maximum number of shares issuable under the performance awards granted during 2023 is approximately 1.5 shares of Holdings' common stock. The grant date fair value for the units issued was determined based on the closing price of Holdings' common stock on the date of grant, which was $11.68 per share. The performance metrics for these performance awards are based upon cumulative three-year Adjusted EBITDA and consolidated cash flows, and payout levels are determined based upon the achievement of pre-established criteria for these metrics as defined in the award agreement. Based upon the terms of the award agreement, PSUs vest based on a combination of performance factors and continued service. The performance measurement period for the PSUs is three years, January 1, 2023 through December 31, 2025 and the service period ends on February 20, 2026. Below is a summary of the performance metrics and measurement period for these performance awards:

Performance Measurement Period	Three years with additional service requirement to the third anniversary of the date of the grant
Maximum Performance Target Level	200% of target level
Percentage of maximum performance stock units that vest if performance metrics meet the threshold level (1)	25% or 0.37 PSUs
Percentage of maximum performance stock units that vest if performance metrics are at target (1)	50% or 0.73 PSUs
Percentage of maximum performance stock units that vest if performance metrics are at the maximum (1)	100% or 1.47 PSUs
Most likely performance metrics outcome estimated to be achieved at the time performance stock units were issued	Target
Assumed forfeiture rate for performance stock unit awards	5%

(1)Number of PSUs that vest based on maximum amount of PSUs that could vest of 1.47.

2022 awards - During the year ended December 31, 2022, Holdings granted performance awards in the form of performance stock units. The maximum number of shares issuable under the performance awards granted during 2022 is 0.8 shares of Holdings’ common stock. The grant date fair value for the units issued during the year ended December 31, 2022 was determined based on the closing price of Holdings’ common stock on the date of grant, which was $16.65 per share. The financial performance metrics are based upon the achievement of pre-established criteria for revenue and consolidated cash flows as defined in the award agreement. Based upon the terms of the award agreement, PSUs vest based on a combination of performance factors and continued service. The performance measurement period for the financial performance metrics is one year, and there is an additional two-year service requirement.

2021 awards -There were no performance stock awards granted during the year ended December 31, 2021. During the year ended December 31, 2021, the Compensation Committee of Holdings’ Board of Directors (“Compensation Committee”) evaluated the impact of the COVID-19 pandemic on the performance metric used for the performance stock unit awards granted during 2019 and 2020 and determined that the COVID-19 pandemic significantly impacted Holdings’ ability to meet the performance metric. The Compensation Committee made a discretionary decision to certify the vest of the 2019 and 2020 performance stock unit awards at target based upon the unforeseen, external circumstances that were beyond management’s control, the projected macroeconomic conditions through 2021 and beyond, and the uncertain timing as to the recovery of the Company’s industry. The requirement to satisfy the applicable service period under the performance stock unit awards was not changed. In addition, the Compensation Committee determined that it would not be appropriate to issue performance awards during 2021 due to the aforementioned macroeconomic conditions and industry recovery. In lieu of performance stock units, the Compensation Committee granted restricted stock with a four-year vest period.

F-50

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

Below is a summary of performance stock unit activity for the periods presented:

	Year Ended December 31,
	2021		2022		2023
Number of performance stock unit awards that vested during the period		0.23		0.10		0.14
Fair value of performance stock unit awards that vested during the period	$	4.1	$	1.7	$	1.8
Accumulated dividends paid upon vesting of performance stock unit awards	$	0.1	$	0.3	$	0.2
Compensation expense recognized during the period (1)	$	6.4	$	5.7	$	8.7
Income tax benefit (expense) related to stock unit awards	$	0.7	$	—	$	(0.8	)

(1)The former CEO of Holdings retired on December 31, 2021 and all of his outstanding unvested restricted stock units vested upon his retirement in accordance with his employment agreement. Holdings recorded incremental compensation expense of $2.4 related to the accelerated vesting of these awards during the year ended December 31, 2021.

As of December 31, 2023, the estimated remaining unrecognized compensation expense related to the outstanding performance stock unit awards was $12.6. The weighted average period over which this remaining compensation expense will be recognized is approximately 1.7 years. As of December 31, 2023, Holdings had performance stock units outstanding that represented a total of 1.7 hypothetical shares of common stock, net of estimated forfeitures, reflecting actual certified performance levels, which was target for PSUs granted during 2020 and maximum performance level for PSUs granted during 2022, and an estimated performance level for the 2023 grant slightly above target.

19.SUPPLEMENTAL CASH FLOW INFORMATION

The following is provided as supplemental information to the consolidated statements of cash flows:

	Year Ended December 31,
	2021			2022			2023
Cash paid for interest by Holdings (1)	$	108.2		$	140.7		$	151.3
Cash paid for interest by CUSA	$	87.8		$	109.1		$	130.6
(Refunds received) cash paid for income taxes, net	$	(136.5	)	$	4.6		$	22.3
Cash deposited in (transferred from) restricted accounts (2)	$	11.9		$	(14.9	)	$	(10.8	)
Noncash operating activities:
Interest expense - NCM (see Note 9)	$	(23.6	)	$	(23.2	)	$	(22.6	)
Noncash investing activities:
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (3)	$	20.1		$	(3.8	)	$	5.4
Theatre properties acquired under finance leases	$	0.7		$	—		$	—
Investment in NCMI/NCM – receipt of common units (see Note 9)	$	10.2		$	1.3		$	—

(1)Includes the cash interest paid by CUSA.

(2)Represents cash deposited in (transferred out) of collateral account during the period to support the issuance of letters of credit to lenders, net of returned deposits from such accounts upon the repayment of related debt.

(3)Additions to theatre properties and equipment included in accounts payable as of December 31, 2022 and 2023 were $12.0 and $6.6 respectively.

20.INCOME TAXES

Holdings

The provision for federal and foreign income tax expense for continuing operations of Holdings consisted of the following:

	Year Ended December 31,
	2021			2022			2023
(Loss) income before income taxes:
U.S.	$	(389.2	)	$	(286.9	)	$	151.4
Foreign		(49.8	)		21.9			70.0
Total	$	(439.0	)	$	(265.0	)	$	221.4

F-51

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

Current and deferred income taxes for Holdings were as follows:

	Year Ended December 31,
	2021			2022			2023
Current:
Federal	$	4.0		$	1.9		$	2.2
Foreign		0.8			9.2			14.2
State		1.0			1.2			2.9
Total current expense		5.8			12.3			19.3
Deferred:
Federal	$	(20.2	)	$	(2.7	)	$	15.8
Foreign		0.4			(2.4	)		(5.7	)
State		(2.8	)		(4.2	)		0.5
Total deferred taxes		(22.6	)		(9.3	)		10.6
Income taxes	$	(16.8	)	$	3.0		$	29.9

A reconciliation between Holdings’ income tax expense and taxes computed by applying the applicable statutory federal income tax rate to income before income taxes is as follows:

	Year Ended December 31,
	2021			2022			2023
Computed statutory tax expense	$	(92.2	)	$	(55.7	)	$	46.5
State and local income taxes, net of federal income tax impact		(1.4	)		(2.2	)		5.4
Changes in valuation allowance		76.3			60.6			(63.9	)
Foreign tax rate differential		(4.5	)		1.3			1.4
Foreign tax credits		—			(4.0	)		(13.0	)
Changes in uncertain tax positions		7.5			1.6			(0.9	)
U.S. tax impact of foreign operations		0.8			(1.6	)		10.3
Return to provision		(5.1	)		1.4			(3.3	)
Expiration of attribute carryforwards		0.6			—			37.1
Permanent differences		5.4			4.6			8.6
Other, net		(4.2	)		(3.0	)		1.7
Income taxes	$	(16.8	)	$	3.0		$	29.9

CUSA

The provision for federal and foreign income tax expense for continuing operations of CUSA consisted of the following:

	Year Ended December 31,
	2021			2022			2023
(Loss) income before income taxes:
U.S.	$	(362.6	)	$	(263.7	)	$	167.0
Foreign		(49.8	)		21.9			70.0
Total	$	(412.4	)	$	(241.8	)	$	237.0

F-52

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

Current and deferred income taxes for CUSA were as follows:

	Year Ended December 31,
	2021			2022			2023
Current:
Federal	$	4.0		$	1.9		$	2.8
Foreign		0.8			9.2			14.2
State		1.0			1.2			2.9
Total current expense		5.8			12.3			19.9
Deferred:
Federal	$	(36.7	)	$	(16.2	)	$	13.8
Foreign		0.4			(2.4	)		(5.7	)
State		(1.8	)		(6.8	)		0.4
Total deferred taxes		(38.1	)		(25.4	)		8.5
Income taxes	$	(32.3	)	$	(13.1	)	$	28.4

A reconciliation between CUSA’s income tax expense and taxes computed by applying the applicable statutory federal income tax rate to income before income taxes is as follows:

	Year Ended December 31,
	2021			2022			2023
Computed statutory tax expense	$	(86.6	)	$	(50.8	)	$	49.8
State and local income taxes, net of federal income tax impact		(0.7	)		(4.2	)		5.9
Changes in valuation allowance		54.3			41.8			(68.6	)
Foreign tax rate differential		(4.5	)		1.3			1.4
Foreign tax credits		—			(4.0	)		(12.9	)
Changes in uncertain tax positions		5.7			1.6			(0.9	)
U.S. tax impact of foreign operations		0.8			(1.6	)		10.4
Return to provision		(3.2	)		1.2			(3.3	)
Expiration of attribute carryforwards		0.6			—			36.4
Permanent differences		5.5			4.5			8.6
Other, net		(4.2	)		(2.9	)		1.6
Income taxes	$	(32.3	)	$	(13.1	)	$	28.4

.

As of December 31, 2023, the Company will not indefinitely reinvest $2.0 of accumulated undistributed losses of its Curacao subsidiary. As of December 31, 2023, the Company had approximately $157.6 of accumulated undistributed earnings and profits which it considers to be indefinitely reinvested. Of this indefinitely reinvested amount, approximately $159.3 was subject to the one-time transition tax pursuant to the 2017 Tax Cuts and Jobs Act. Additional tax due on the repatriation of these previously-taxed earnings would generally be foreign withholding and U.S. state income taxes. The Company does not intend to repatriate these offshore earnings and profits, and therefore has not recorded any deferred taxes on such earnings. The Company considers any excess of the amount for financial reporting over the tax basis of its investment in these foreign subsidiaries to be indefinitely reinvested. At this time, the determination of deferred tax liabilities on this amount is not practicable.

F-53

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

Deferred Income Taxes

Holdings

The tax effects of significant temporary differences and tax loss and tax credit carryforwards comprising the net long-term deferred income tax liabilities for Holdings as of the periods presented consisted of the following:

	December 31,
	2022			2023
Deferred liabilities:
Theatre properties and equipment	$	76.9		$	68.4
Finance lease assets		16.0			13.3
Operating lease right-of-use assets		274.3			248.8
Intangible asset – other		49.6			55.8
Intangible asset – tradenames		68.9			69.5
Total deferred liabilities		485.7			455.8
Deferred assets:
Deferred revenue – NCM and Other		82.6			82.2
Prepaid rent		4.1			2.7
Gift cards		8.8			9.7
Investment in partnerships		5.2			1.4
Operating lease obligations		296.1			269.0
Finance lease obligations		21.6			18.6
Tax impact of items in accumulated other comprehensive income and additional paid-in-capital		16.4			13.4
Restricted stock		5.1			4.5
Accrued expenses		3.7			2.9
Other tax loss carryforwards		126.1			82.7
Other tax credit and attribute carryforwards		193.5			179.3
Other expenses, not currently deductible for tax purposes		14.9			11.7
Total deferred assets		778.1			678.1
Net deferred income tax (asset) liability before valuation allowance		(292.4	)		(222.3	)
Valuation allowance against deferred assets – non-current		326.1			266.3
Net deferred income tax liability	$	33.7		$	44.0
Net deferred tax (asset) liability – Foreign	$	4.7		$	(0.1	)
Net deferred tax liability – U.S.		29.0			44.1
Total	$	33.7		$	44.0

F-54

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

CUSA

The tax effects of significant temporary differences and tax loss and tax credit carryforwards comprising the net long-term deferred income tax liabilities for CUSA as of the periods presented consisted of the following:

	December 31,
	2022			2023
Deferred liabilities:
Theatre properties and equipment	$	76.7		$	68.2
Finance lease assets		15.9			13.2
Operating lease right-of-use assets		273.9			248.1
Intangible asset – other		49.5			55.7
Intangible asset – tradenames		68.8			69.3
Tax impact of items in accumulated other comprehensive income and additional paid-in-capital		5.3			1.4
Total deferred liabilities		490.1			455.9
Deferred assets:
Deferred revenue – NCM and Other		82.4			82.0
Prepaid rent		4.1			2.7
Gift Cards		8.8			9.7
Investment in partnerships		5.2			1.4
Operating lease obligations		295.6			268.3
Finance lease obligations		21.6			18.6
Restricted stock		4.9			4.3
Accrued expenses		3.7			2.9
Other tax loss carryforwards		122.0			80.0
Other tax credit and attribute carryforwards		174.1			149.0
Other expenses, not currently deductible for tax purposes		14.8			11.5
Total deferred assets		737.2			630.4
Net deferred income tax (asset) liability before valuation allowance		(247.1	)		(174.5	)
Valuation allowance against deferred assets – non-current		283.2			218.5
Net deferred income tax liability	$	36.1		$	44.0
Net deferred tax (asset) liability – Foreign	$	4.7		$	(0.1	)
Net deferred tax liability – U.S.		31.4			44.1
Total	$	36.1		$	44.0

Federal net operating losses and interest expense limitation carryforwards have an indefinite carryforward period. Foreign net operating losses have varying carryforward periods with some being indefinite. Similarly, state net operating losses have varying carryforward periods with some being indefinite. Foreign tax credits have a 10 year carryforward period. A majority of the Company’s foreign tax credit carryforwards expire in 2026 and 2027, with the remainder expiring in future periods.

The Company assesses the likelihood that it will be able to recover its deferred tax assets against future sources of taxable income and reduces the carrying amounts of deferred tax assets by recording a valuation allowance, if, based on all available evidence, the Company believes it is more likely than not that all or a portion of such assets will not be realized. As of the year ended December 31, 2023, the Company remained in a three-year cumulative pre-tax loss domestically and in certain foreign jurisdictions. This is heavily weighted as objectively verifiable negative evidence and, as a result, the Company is unable to include future projected earnings in assessing the recoverability of its deferred tax assets in these jurisdictions.

The Company has established a valuation allowance against certain deferred tax assets for which the ultimate realization of future benefits is uncertain. Expiring carryforwards and the required valuation allowances are adjusted annually. After application of the valuation allowances described above, the Company anticipates that no limitations will apply with respect to utilization of any of the other deferred tax assets described above.

F-55

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

The Company’s valuation allowance changed from $326.1 as of December 31, 2022 to $266.3 as of December 31, 2023. CUSA’s valuation allowance changed from $283.2 as of December 31, 2022 to $218.5 as of December 31, 2023. The decrease primarily relates to a release of valuation allowances previously recorded against certain expiring foreign tax credits and foreign loss carryforwards, as well as net deferred tax assets in certain foreign jurisdictions. The remaining valuation allowance associated with these deferred tax assets is primarily a result of not having sufficient income from deferred tax liability reversals in future periods to support the realization of the deferred tax assets. When the Company begins to generate taxable income at a normal level, the Company expects to reverse the valuation allowances with an offsetting increase to reported earnings. There is a possibility that within the next 12 months, sufficient positive evidence may become available to reach a conclusion that a portion of the valuation allowance in certain foreign jurisdictions will no longer be required.

Holdings’ valuation allowance for deferred tax assets, which includes CUSA’s valuation allowance for deferred tax assets, and CUSA’s valuation for deferred tax assets, for the periods presented were as follows:

	Valuation Allowance for Deferred Taxes
	Holdings			CUSA
Balance at January 1, 2021	$	203.6		$	203.6
Additions		69.1			52.5
Deductions		(4.3	)		(10.9	)
Currency translation		(4.3	)		(4.3	)
Balance at December 31, 2021	$	264.1		$	240.9
Additions		67.0			47.0
Deductions		(5.3	)		(4.9	)
Currency translation		0.3			0.2
Balance at December 31, 2022	$	326.1		$	283.2
Additions		16.6			5.9
Deductions		(83.0	)		(77.2	)
Currency translation		6.6			6.6
Balance at December 31, 2023	$	266.3		$	218.5

Uncertain Tax Positions

The following is a reconciliation of the total amounts of unrecognized tax benefits excluding interest and penalties for Holdings for the periods presented:

	Year Ended December 31,
	2021			2022			2023
Balance at January 1,	$	46.5		$	55.9		$	55.8
Gross increases - tax positions in prior periods		7.7			—			2.2
Gross decreases - tax positions in prior periods		(1.6	)		(0.2	)		(5.1	)
Gross increases - current period tax positions		3.4			0.1			0.2
Statute of limitations expiration		(0.1	)		—			(0.2	)
Balance at December 31,	$	55.9		$	55.8		$	52.9

The following is a reconciliation of the total amounts of unrecognized tax benefits excluding interest and penalties for CUSA for the periods presented:

	Year Ended December 31,
	2021			2022			2023
Balance at January 1,	$	46.5		$	54.0		$	53.9
Gross increases - tax positions in prior periods		5.8			—			2.2
Gross decreases - tax positions in prior periods		(1.6	)		(0.2	)		(5.1	)
Gross increases - current period tax positions		3.4			0.1			0.2
Statute of limitations expiration		(0.1	)		—			(0.2	)
Balance at December 31,	$	54.0		$	53.9		$	51.0

Holdings had $64.3 and $64.1 of unrecognized tax benefits, including interest and penalties, as of December 31, 2022 and 2023, respectively. Of these amounts, $64.3 and $64.1 represent the amount of unrecognized tax benefits that, if recognized, would impact the effective income tax rate for the years ended December 31, 2022 and 2023, respectively. CUSA had $62.5 and $62.2 of unrecognized tax benefits, including interest and penalties, as of December 31, 2022 and 2023, respectively. Of these amounts, $62.5 and $62.2 represent the amount of unrecognized

F-56

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

tax benefits that, if recognized, would impact the effective income tax rate for the years ended December 31, 2022 and 2023, respectively. Holdings and CUSA had $8.5 and $11.1 accrued for interest and penalties as of December 31, 2022 and 2023, respectively. The Company believes it is reasonably possible that its existing unrecognized tax benefits may be reduced by an amount up to $35.9 within the next 12 months as a result of resolution of examination with taxing authorities.

The Company prepares and files income tax returns based upon its interpretation of tax laws and regulations and record estimates based upon these judgments and interpretations. In the normal course of business, the Company’s income tax returns are subject to examination by various taxing authorities. Such examinations may result in future tax and interest assessments by these taxing authorities. Inherent uncertainties exist in estimates of tax contingencies due to changes in tax law resulting from legislation, regulation, and/or as concluded through the various jurisdictions' tax court systems. Significant judgment is exercised in applying complex tax laws and regulations across multiple global jurisdictions where we conduct our operations. The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, including resolutions of any related appeals or litigation processes, based upon the technical merits of the position.

The Company is no longer subject to income tax audits from the Internal Revenue Service for years before 2018. The Company is no longer subject to state income tax examinations by tax authorities in its major state jurisdictions for years before 2019. The Company is no longer subject to non-U.S. income tax examinations by tax authorities in its major non-U.S. tax jurisdictions for years before 2008.

The Company is currently under IRS audit for tax years 2019 and 2020 and is under audit in the non-U.S. tax jurisdiction of Brazil.

21.COMMITMENTS AND CONTINGENCIES

Employment Agreements — As of December 31, 2023, the Company had employment agreements with Sean Gamble, Melissa Thomas, Valmir Fernandes and Michael Cavalier. These employment agreements are subject to automatic extensions for a one year period, unless the employment agreements are terminated. The base salaries stipulated in the employment agreements are subject to review at least annually during the term of the agreements for increase (but not decrease) by the Company’s Compensation Committee. Management personnel subject to these employment agreements are eligible to receive annual cash incentive bonuses upon the Company meeting certain performance targets established by the Compensation Committee.

Retirement Savings Plan — The Company has a 401(k) retirement savings plan (“401(k) Plan”) for the benefit of all eligible U.S. based employees and makes discretionary matching contributions as determined annually in accordance with the 401(k) Plan. Employer matching contribution payments of $5.7 and $6.4 were made during the years ended December 31, 2022 and 2023, respectively. A liability of approximately $0.9 was recorded as of December 31, 2023 for employer contribution payments to be made in 2024 for the remaining amounts owed for plan year 2023.

Legal Proceedings

From time to time, the Company is involved in various legal proceedings arising from the ordinary course of its business operations, such as personal injury claims, employment matters, patent claims, landlord-tenant disputes, contractual disputes with landlords over certain termination rights or the right to discontinue rent payments due to the COVID-19 pandemic and other contractual disputes, some of which are covered by insurance. The Company believes its potential liability with respect to proceedings currently pending is not material, individually or in the aggregate, to the Company’s financial position, results of operations and cash flows.

Cinemark Holdings, Inc., et al vs Factory Mutual Insurance Company. The Company filed suit on November 18, 2020, in the District Court, 471st Judicial District, Collin County, Texas. On December 22, 2020, the case was moved to the US District Court for the Eastern District of Texas, Sherman Division. The Company submitted a claim under its property insurance policy issued by Factory Mutual Insurance Company (the “FM Policy”) for losses sustained as a result of the closure of the Company’s theatres due to the COVID-19 pandemic. Factory Mutual Insurance Company (“FM”) denied the Company’s claim. The Company is seeking damages resulting from FM’s breach of contract, FM’s bad faith conduct and a declaration of the parties’ rights under the FM Policy. The Company

F-57

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

cannot predict the outcome of this litigation. The District Court granted FM’s motion for summary judgment. The Company has appealed the District Court’s decision.

Lakeenya Neal, et al v. Cinemark Holdings, Inc., et al. This class action lawsuit was filed against the Company on December 10, 2021, in the Central District of Los Angeles County Superior Court of the State of California alleging certain violations of the Fair and Accurate Credit Transactions Act. The plaintiffs voluntarily dismissed this case.

Gerardo Rodriguez, individually and on behalf of a class of all others similarly situated vs Cinemark USA, Inc. and Cinemark Holdings, Inc., et al. This class action lawsuit was filed against the Company on February 24, 2023 in the Cook County Circuit Court in Illinois alleging violation of the Fair and Accurate Credit Transactions Act. The Company firmly maintains that the allegations are without merit and will vigorously defend itself against the lawsuit. The Company cannot predict the outcome of this litigation.

National CineMedia LLC Bankruptcy. On June 3, 2023, NCM filed an Emergency Motion for Entry of an Order (1) approving and Authorizing Debtor to Enter into and Perform Under (a) the Termination and Settlement Agreement and (b) the Network Affiliate Transaction Agreement with Regal Cinemas, Inc. (the “9019 Motion”). The 9019 Motion requested an order, among other things, that the most favored nations clause (the “MFN”) in Cinemark’s Exhibitor Services Agreement was not triggered by the Network Affiliate Transaction Agreement with Regal Cinemas, Inc. On June 14, 2023, Cinemark filed an objection to the 9019 Motion. On June 26, 2023, the bankruptcy court entered a confirmation order, which among other things, approves NCM’s assumption of Cinemark’s Exhibitor Services Agreement but fails to preserve or recognize Cinemark’s rights under the MFN with respect to the Network Affiliate Transaction Agreement. Cinemark has appealed the confirmation order in the United States District Court for the Southern District of Texas, Houston Division. The Company cannot predict the outcome of this appeal.

22.SEGMENTS - HOLDINGS

The international market and U.S. market are managed as separate reportable operating segments, with the international segment consisting of operations in Brazil, Argentina, Chile, Colombia, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia and Paraguay. The Company closed its one theatre in Curacao in January 2023 and sold the shares of its Ecuador subsidiary in September 2023. See Note 8 for a discussion of the sale of our Ecuador subsidiary. Each segment’s revenue is derived from admissions and concession sales and other ancillary revenue. Holdings uses Adjusted EBITDA, as shown in the reconciliation table below, as the primary measure of segment profit and loss to evaluate performance and allocate its resources. The Company does not report total assets by segment because that information is not used to evaluate the performance or allocate resources between segments.

Holdings revenue, Adjusted EBITDA and capital expenditures by reportable operating segment

The following table is a breakdown of selected financial information by reportable operating segment for Holdings for the periods presented:

	Year Ended December 31,
	2021			2022			2023
Revenue
U.S.	$	1,296.3		$	1,977.9		$	2,428.1
International		216.9			484.5			651.4
Eliminations		(2.7	)		(7.7	)		(12.8	)
Total Revenue	$	1,510.5		$	2,454.7		$	3,066.7
Adjusted EBITDA (1)
U.S.	$	84.2		$	255.7		$	463.9
International		(4.2	)		80.8			130.2
Total Adjusted EBITDA	$	80.0		$	336.5		$	594.1
Capital expenditures
U.S.	$	78.3		$	87.2		$	111.5
International		17.2			23.5			38.0
Total capital expenditures	$	95.5		$	110.7		$	149.5

(1)Distributions from equity investees are reported entirely within the U.S. operating segment.

F-58

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

The following table sets forth a reconciliation of net (loss) income to Adjusted EBITDA for Holdings for the periods presented:

	Year Ended December 31,
	2021			2022			2023
Net (loss) income	$	(422.2	)	$	(268.0	)	$	191.5
Add (deduct):
Income tax (benefit) expense		(16.8	)		3.0			29.9
Interest expense (1)		149.7			155.3			150.4
Other expense (income), net (2)		43.5			23.6			(19.6	)
Cash distributions from equity investees (3)		0.2			6.9			5.7
Depreciation and amortization		265.4			238.2			209.5
Impairment of long-lived and other assets		20.8			174.1			16.6
Restructuring costs		(1.0	)		(0.5	)		—
(Gain) loss on disposal of assets and other		8.0			(6.8	)		(7.7	)
Loss on debt extinguishment and refinancing		6.5			—			10.7
Non-cash rent expense		(3.4	)		(10.8	)		(17.9	)
Share-based awards compensation expense		29.3			21.5			25.0
Adjusted EBITDA	$	80.0		$	336.5		$	594.1

(1)Includes amortization of debt issuance costs, amortization of original issue discount, and amortization of accumulated (gains) losses for amended swap agreements.

(2)Includes interest income, foreign currency exchange and other related loss, interest expense – NCM and equity in income (loss) of affiliates and unrealized gain on investment in NCMI. Excludes distributions from NCM and DCIP.

(3)Reflects cash distributions received from equity investees that were recorded as a reduction of the respective investment balances (see Note 10). These distributions are reported entirely within the U.S. operating segment.

Financial Information About Geographic Area

The following table sets forth a breakdown of select financial information for Holdings by geographic area for the periods presented:

	Year Ended December 31,
	2021	2022	2023
Revenue
U.S.	$1,296.3	$1,977.9	$2,428.1
Brazil	73.5	179.0	233.4
Other international countries	143.4	305.5	418.0
Eliminations	(2.7)	(7.7)	(12.8)
Total	$1,510.5	$2,454.7	$3,066.7

	As of December 31,
	2022	2023
Theatre properties and equipment, net
U.S.	$1,075.3	$1,002.1
Brazil	49.5	54.7
Other international countries	107.3	104.9
Total	$1,232.1	$1,161.7

F-59

CINEMARK HOLDINGS, INC. AND SUBSIDIARIES AND

CINEMARK USA, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(in millions, except per share data)

23.RELATED PARTY TRANSACTIONS

A subsidiary of the Company manages a theatre for Laredo Theatres, Ltd. (“Laredo”). The Company is the sole general partner and owns 75% of the limited partnership interests of Laredo. Lone Star Theatres, Inc. owns the remaining 25% of the limited partnership interests in Laredo and is 100% owned by Mr. David Roberts, who is Lee Roy Mitchell’s son-in-law and Kevin Mitchell’s brother-in-law. Lee Roy Mitchell, our founder, owns, both directly and indirectly, approximately 8.5% of Holdings’ common stock and Kevin Mitchell is a member of Holdings’ Board of Directors. Under the agreement, management fees are paid by Laredo to the Company at a rate of 5% of annual theatre revenue. The Company recorded $0.4, $0.6 and $0.7 of management fee revenue during the years ended December 31, 2021, 2022 and 2023, respectively. All such amounts are included in each of Holdings’ and CUSA’s consolidated financial statements with the intercompany amounts eliminated in consolidation. During the years ended December 31, 2022 and 2023, the Company paid excess cash distributions of $2.7 and $1.3, respectively, to Lone Star Theatres, Inc. as required by the partnership agreement, which were recorded as a reduction of noncontrolling interests on each of Holdings’ and CUSA’s consolidated balance sheets.

Walter Hebert, Mr. Lee Roy Mitchell’s brother-in-law, previously served as the Executive Vice President – Purchasing of the Company and retired in July 2021. Mr. Hebert served as a consultant to the Company until July 2022. During the years ended December 31, 2021 and 2022, the Company paid Mr. Hebert $0.1 and $0.2 related to consulting services.

A subsidiary of the Company has an Aircraft Time Sharing Agreement with Copper Beech Capital, LLC to use, on occasion, a private aircraft owned by Copper Beech Capital, LLC. Copper Beech Capital, LLC is owned by Mr. Lee Roy Mitchell and his wife, Tandy Mitchell. The private aircraft is used by Messrs. Lee Roy and Kevin Mitchell and other executives who accompany Mr. Lee Roy Mitchell to business meetings for the Company. The Company reimburses Copper Beech Capital, LLC the actual costs of fuel usage and the expenses of the pilots, landing fees, storage fees and similar expenses incurred during the trip. The aggregate amount paid to Copper Beech Capital, LLC for the use of the aircraft was less than $0.1 for each of the years ended December 31, 2021, 2022 and 2023.

A subsidiary of the Company currently leases 12 theatres from Syufy Enterprises, LP (“Syufy”) or affiliates of Syufy. Raymond Syufy is one of Holdings’ directors and is an officer of the general partner of Syufy. For the years ended December 31, 2021, 2022 and 2023, the Company paid total rent of approximately $23.3, $22.3 and $22.1, respectively, to Syufy. CUSA also provides digital equipment support to drive-in theatres owned by Syufy. The Company recorded management fees of approximately $0.1, $0.0 and $0.0 related to these services during the years ended December 31, 2021, 2022 and 2023, respectively.

A subsidiary of the Company has a 50% voting interest in FE Concepts, a joint venture with AWSR, an entity owned by Lee Roy Mitchell and Tandy Mitchell. FE Concepts operates a family entertainment center that offers bowling, gaming, movies and other amenities. See Note 10 for further discussion. The Company has a theatre services agreement with FE Concepts under which the Company receives service fees for providing film booking and equipment monitoring services for the facility. The Company recorded services fees of approximately $0.1, $0.1 and $0.1 related to this agreement during the years ended December 31, 2021, 2022 and 2023, respectively. During the year ended December 31, 2022, the Company received cash distributions of $4.0 from FE Concepts.

F-60

SCHEDULE 1 - CONDENSED FINANCIAL INFORMATION OF CINEMARK HOLDINGS, INC.

CINEMARK HOLDINGS, INC.

PARENT COMPANY BALANCE SHEETS

(in millions, except share data)

	December 31,			December 31,
	2022			2023
Assets
Cash and cash equivalents	$	247.2		$	236.8
Interest receivable and other current assets		0.6			2.6
Investment in subsidiaries		372.5			591.2
Total assets	$	620.3		$	830.6
Liabilities and equity
Liabilities
Accrued other current liabilities, including accounts payable to subsidiaries	$	61.5		$	66.5
Long-term debt		451.0			454.4
Other long-term liabilities		(2.4	)		(0.1	)
Total liabilities		510.1			520.8
Commitments and contingencies (see Note 6)
Equity
Common stock, $0.001 par value: 300,000,000 shares authorized, 126,082,187 shares issued and 120,403,833 shares outstanding at December 31, 2022 and 127,598,774 shares issued and 121,596,206 shares outstanding at December 31, 2023		0.1			0.1
Additional paid-in-capital		1,219.3			1,244.3
Treasury stock, 5,678,354 and 6,002,568 shares, at cost, at December 31, 2022 and December 31, 2023, respectively		(95.4	)		(98.3	)
Accumulated deficit		(660.6	)		(472.4	)
Accumulated other comprehensive loss		(353.2	)		(363.9	)
Total equity		110.2			309.8
Total liabilities and equity	$	620.3		$	830.6

The accompanying notes are an integral part of the condensed financial information of Cinemark Holdings Inc.

S-1

SCHEDULE 1 - CONDENSED FINANCIAL INFORMATION OF CINEMARK HOLDINGS, INC., CONTINUED

CINEMARK HOLDINGS, INC.

PARENT COMPANY STATEMENTS OF INCOME (LOSS)

(in millions)

	Year Ended December 31,
	2021			2022			2023
Revenue	$	—		$	—		$	—
Cost of operations		2.6			2.9			3.3
Operating loss		(2.6	)		(2.9	)		(3.3	)
Interest expense		(24.1	)		(24.1	)		(24.1	)
Interest income		0.1			3.8			11.8
Loss before income taxes and equity in (loss) income of subsidiaries		(26.6	)		(23.2	)		(15.6	)
Income tax benefit (expense)		5.7			(16.1	)		(1.5	)
Equity in (loss) income of subsidiaries, net of taxes		(401.9	)		(231.9	)		205.3
Net (loss) income	$	(422.8	)	$	(271.2	)	$	188.2

The accompanying notes are an integral part of the condensed financial information of Cinemark Holdings, Inc.

S-2

SCHEDULE 1 - CONDENSED FINANCIAL INFORMATION OF CINEMARK HOLDINGS, INC., CONTINUED

CINEMARK HOLDINGS, INC.

PARENT COMPANY STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(in millions)

	Year Ended December 31,
	2021			2022			2023
Net (loss) income	$	(422.8	)	$	(271.2	)	$	188.2
Other comprehensive (loss) income, net of tax
Unrealized gain (loss) due to fair value adjustments on interest rate swap agreements, net of taxes of $(0.7), $(2.8) and $1.2, and net of settlements		18.5			32.2			(9.2	)
Foreign currency translation adjustments		(18.8	)		4.6			4.9
Total other comprehensive (loss) income, net of tax		(0.3	)		36.8			(4.3	)
Comprehensive (loss) income attributable to Cinemark Holdings, Inc.	$	(423.1	)	$	(234.4	)	$	183.9

The accompanying notes are an integral part of the condensed financial information of Cinemark Holdings Inc.

S-3

SCHEDULE 1 - CONDENSED FINANCIAL INFORMATION OF CINEMARK HOLDINGS, INC., CONTINUED

CINEMARK HOLDINGS, INC.

PARENT COMPANY STATEMENTS OF CASH FLOWS

(in millions)

	Year Ended December 31,
	2021			2022			2023
Operating Activities
Net (loss) income	$	(422.8	)	$	(271.2	)	$	188.2
Adjustments to reconcile net (loss) income to cash used for operating activities:
Share-based awards compensation expense		0.9			1.0			1.2
Amortization of debt issuance costs		3.5			3.4			3.5
Equity in loss (income) of subsidiaries		401.9			231.9			(205.3	)
Changes in other assets and liabilities		10.5			21.7			4.9
Net cash used for operating activities		(6.0	)		(13.2	)		(7.5	)
Investing Activities
Contributions to subsidiaries		(120.0	)		—			—
Net cash used for investing activities		(120.0	)		—			—
Financing Activities
Restricted stock withholdings for payroll taxes		(4.1	)		(4.3	)		(2.9	)
Net cash used for financing activities		(4.1	)		(4.3	)		(2.9	)
Decrease in cash and cash equivalents		(130.1	)		(17.5	)		(10.4	)
Cash and cash equivalents:
Beginning of period		394.8			264.7			247.2
End of period	$	264.7		$	247.2		$	236.8

The accompanying notes are an integral part of the condensed financial information of Cinemark Holdings, Inc.

S-4

SCHEDULE 1 - CONDENSED FINANCIAL INFORMATION OF CINEMARK HOLDINGS, INC., CONTINUED

CINEMARK HOLDINGS, INC.

NOTES TO PARENT COMPANY FINANCIAL STATEMENTS

(in millions, except share and per share data)

1.BASIS OF PRESENTATION

Cinemark Holdings, Inc. conducts substantially all of its operations through its subsidiaries. These statements should be read in conjunction with Cinemark Holdings Inc. and subsidiaries' consolidated financial statements and notes included elsewhere in this annual report on Form 10-K. There are significant restrictions over Cinemark Holdings, Inc.’s ability to obtain funds from its subsidiaries through dividends, loans or advances as contained in CUSA’s senior secured credit facility and the indentures to each of the 5.25% Senior Notes, the 5.875% Senior Notes and the 8.75% Secured Notes (collectively referred to herein as the “Notes”). These condensed parent company financial statements have been prepared in accordance with Rule 12-04, Schedule I of Regulation S-X, as the restricted net assets of Cinemark Holdings, Inc.’s subsidiaries under each of the debt agreements previously noted exceeds 25 percent of the consolidated net assets of Cinemark Holdings, Inc. As of December 31, 2023, the restricted net assets totaled approximately $427.8 million under the Notes. See Note 14 to the consolidated financial statements included elsewhere in this annual report on Form 10-K.

2.DIVIDEND PAYMENTS

Holdings suspended its quarterly dividend in March 2020 as a result of the COVID-19 pandemic. as discussed in Note 3 of the consolidated financial statements included elsewhere in this annual report on Form 10-K.

3.DIVIDENDS AND DISTRIBUTIONS WITH SUBSIDIARIES

During the year ended December 31, 2021, Holdings paid a distribution of $120.0 million to its subsidiary, CUSA.

4.LONG-TERM DEBT

On August 21, 2020, Holdings issued $460.0 million aggregate principal amount of 4.50% Convertible Senior Notes, which will mature on August 15, 2025. Additionally, certain of Holdings’ subsidiaries have direct outstanding debt obligations. For a discussion of the debt obligations of Holdings, see Note 14 to the consolidated financial statements included elsewhere in this annual report on Form 10-K.

5.CAPITAL STOCK

Holdings’ capital stock along with its long-term incentive plan and related activity are discussed in Note 18 of the consolidated financial statements included elsewhere in this annual report on Form 10-K.

6.COMMITMENTS AND CONTINGENCIES

Holdings has no direct commitments and contingencies, but its subsidiaries do. See Note 21 of the consolidated financial statements included elsewhere in this annual report on Form 10-K.

*****

S-5

UNAUDITED SUPPLEMENTAL SCHEDULES SPECIFIED BY THE SENIOR NOTES INDENTURES

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

DECEMBER 31, 2023

(in millions)

	Restricted		Unrestricted
	Group		Group			Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents	$	496.3	$	116.1		$	—		$	612.4
Other current assets		393.4		(115.8	)		(10.9	)		266.7
Total current assets		889.7		0.3			(10.9	)		879.1
Theatre properties and equipment, net		1,161.7		—			—			1,161.7
Operating lease right-of-use assets, net		986.4		—			—			986.4
Other assets		1,718.1		285.8			(375.2	)		1,628.7
Total assets	$	4,755.9	$	286.1		$	(386.1	)	$	4,655.9
Liabilities and equity
Current liabilities
Current portion of long-term debt	$	7.8	$	—		$	—		$	7.8
Current portion of operating lease obligations		212.5		—			—			212.5
Current portion of finance lease obligations		14.0		—			—			14.0
Current income tax payable		4.2		—			—			4.2
Accounts payable and accrued expenses		494.8		—			(10.9	)		483.9
Total current liabilities		733.3		—			(10.9	)		722.4
Long-term liabilities
Long-term debt, less current portion		2,199.0		—			(262.2	)		1,936.8
Operating lease obligations, less current portion		853.3		—			—			853.3
Finance lease obligations, less current portion		73.8		—			—			73.8
Other long-term liabilities and deferrals		468.7		0.6			—			469.3
Total long-term liabilities		3,594.8		0.6			(262.2	)		3,333.2
Commitments and contingencies
Equity		427.8		285.5			(113.0	)		600.3
Total liabilities and equity	$	4,755.9	$	286.1		$	(386.1	)	$	4,655.9

Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

S-6

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENT OF INCOME

YEAR ENDED DECEMBER 31, 2023

(in millions)

	Restricted			Unrestricted
	Group			Group			Eliminations			Consolidated
Revenue	$	3,066.7		$	—		$	—		$	3,066.7
Cost of operations
Theatre operating costs		2,286.6			—			—			2,286.6
General and administrative expenses		195.5						—			195.5
Depreciation and amortization		209.5			—			—			209.5
Impairment of long-lived assets		15.9			0.7			—			16.6
Gain on disposal of assets and other		(7.7	)					—			(7.7	)
Total cost of operations		2,699.8			0.7			—			2,700.5
Operating income (loss)		366.9			(0.7	)		—			366.2
Interest expense		(129.1	)		—			2.8			(126.3	)
Loss on debt extinguishment and refinancing		(10.7	)		—			—			(10.7	)
Equity in income of affiliates		1.6			2.0			—			3.6
Interest expense - NCM		(22.6	)		—			—			(22.6	)
Other income		9.3			20.3			(2.8	)		26.8
Total other (expense) income		(151.5	)		22.3			—			(129.2	)
Income before income taxes		215.4			21.6			—			237.0
Income tax expense		24.0			4.4			—			28.4
Net income		191.4			17.2			—			208.6
Less: Net income attributable to noncontrolling interests		3.3			—			—			3.3
Net income attributable to Cinemark USA, Inc.	$	188.1		$	17.2		$	—		$	205.3

Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

S-7

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME

(in millions)

	Restricted			Unrestricted
	Group			Group		Eliminations		Consolidated
Net income	$	191.4		$	17.2	$	—	$	208.6
Other comprehensive loss, net of tax
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $1.5, net of settlements		(8.9	)		—		—		(8.9	)
Foreign currency translation adjustments		4.9			—		—		4.9
Total other comprehensive loss, net of tax		(4.0	)		—		—		(4.0	)
Total comprehensive loss, net of tax		187.4			17.2		—		204.6
Comprehensive income attributable to noncontrolling interests		(3.3	)		—		—		(3.3	)
Comprehensive income attributable to Cinemark USA, Inc.	$	184.1		$	17.2	$	—	$	201.3

Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

S-8

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

YEAR ENDED DECEMBER 31, 2023

(in millions)

	Restricted			Unrestricted
	Group			Group			Eliminations		Consolidated
Operating activities
Net income	$	191.4		$	17.2		$	—	$	208.6
Adjustments to reconcile net income to cash provided by operating activities		219.3			4.4			—		223.7
Changes in assets and liabilities		36.5			(14.0	)		—		22.5
Net cash provided by operating activities		447.2			7.6			—		454.8
Investing activities
Additions to theatre properties and equipment		(149.5	)		—			—		(149.5	)
Net proceeds from sale of subsidiary		14.8			—			—		14.8
Proceeds from sale of assets and other		2.9			—			—		2.9
Investment and loans to affiliates		(2.3	)		2.3			—		—
Net cash (used for) provided by investing activities		(134.1	)		2.3			—		(131.8	)
Financing activities
Proceeds from refinancing of senior secured credit facility		640.2			—			—		640.2
Repayment of term loan on refinancing of senior secured credit facility		(624.9	)		—			—		(624.9	)
Redemption of $100.0 of 8.75% Secured Notes at 102.2%		(102.2	)		—			—		(102.2	)
Payment of debt issuance costs		(7.5	)		—			—		(7.5	)
Payment of fees on refinancing of senior secured credit facility		(2.6	)		—			—		(2.6	)
Other repayments of long-term debt		(10.6	)		—			—		(10.6	)
Restricted stock withholdings for payroll taxes		(2.9	)		—			—		(2.9	)
Payments on finance leases		(14.4	)		—			—		(14.4	)
Other financing activities		(0.5	)		—			—		(0.5	)
Net cash used for financing activities		(125.4	)		—			—		(125.4	)
Effect of exchange rate changes on cash and cash equivalents		(12.5	)		—			—		(12.5	)
Increase in cash and cash equivalents		175.2			9.9			—		185.1
Cash and cash equivalents:
Beginning of year		321.1			106.2			—		427.3
End of year	$	496.3		$	116.1		$	—	$	612.4

Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

S-9

EX-10.10(J)

 

 

 

 

EX-10.11(I)

 

 

 

 

EX-21.1

EXHIBIT 21.1

SUBSIDIARIES OF CINEMARK HOLDINGS, INC.

United States

Cinemark USA, Inc., a Texas corporation
Cinemark, L.L.C., a Delaware limited liability company
Sunnymead Cinema Corp., a California corporation
Cinemark Properties, Inc., a Texas corporation
Greeley Holdings, Inc., a Texas corporation
Greeley, Ltd., a Texas limited partnership

Cinemark Concessions, L.L.C., a Florida limited liability company
Cinemark International, L.L.C., a Texas limited liability company
Cinemark Mexico (USA), Inc., a Delaware corporation
Cinemark Partners I, Inc., a Texas corporation
Cinemark Partners II, Ltd., a Texas limited partnership
Cinemark Investments Corporation, a Delaware corporation
CNMK Brazil Investments, Inc., a Delaware corporation
CNMK Investments, Inc., a Delaware corporation
CNMK Texas Properties, L.L.C., a Texas limited liability company
Laredo Theatre, Ltd., a Texas limited partnership
Brasil Holdings, L.L.C., a Delaware limited liability company

Brazil Holdings II, L.L.C., a Delaware limited liability company
Cinemark Media, Inc., a Delaware corporation

Cinemark Latin America Ventures, L.L.C., a Delaware limited liability company

Cinemark Prodecine Holdings, L.L.C., a Delaware limited liability company

Century Theatres, Inc., a California corporation
Cinemark AB, Inc., a Texas Corporation

FM Delaware I, LLC, a Delaware limited liability company

FM Delaware II, LLC, a Delaware limited liability company

MI Cinemark, LLC, Texas limited liability company

ARGENTINA

Cinemark Argentina, S.R.L., an Argentine limited liability company
Prodecine S.R.L., an Argentine limited liability company
Bulnes 2215, S.R.L., an Argentine limited liability company

Cinemark Argentina Holdings, Inc., a Cayman corporation

BOCA Holdings, Inc., a Cayman corporation

Hoyts Cinema de Argentina S.A., an Argentine corporation

BRAZIL

Cinemark Brasil S.A., a Brazilian corporation

Flix Media Publicidade e Entreternimento Ltda., a Brazilian limited partnership

CANADA

Century Theatres of Canada, ULC, a Canadian corporation

CENTRAL AMERICA

Cinemark Panama, S.A., a Panamanian joint stock company
Cinemark Equity Holdings Corporation, a British Virgin Islands corporation
Cinemark Costa Rica, S.R.L., a Costa Rican limited liability company
Cinemark El Salvador, Ltda de C.V., an El Salvadorian limited liability company

Cinemark Nicaragua y Cia, Ltda., a Nicaraguan limited liability company
Cinemark Honduras S. de R.L., a Honduran limited liability company

Cinemark Guatemala Ltda., a Guatemalan limited company

Flix Media Holdings Corporation, a British Virgin Islands corporation

Flix Cinevision Honduras S.R.L, a Honduran limited liability company

Flix Cinevision Costa Rica S.R.L, a Costa Rican limited liability company

Flix Cinevision Nicaragua S.R.L, a Nicaraguan limited liability company

Flix Cinevision Guatemala S.R.L, a Guatemalan limited liability company

Flix Cinevision Panama S.R.L, a Panamanian limited liability company

Flix Cinevision El Salvador S.R.L, an El Salvadorian limited liability company

Cine Food Services S.A., a Panamanian joint stock company

Premium Food Services, S.A., a Panamanian joint stock company

CHILE

Cinemark Chile S.A., a Chilean corporation
Inversiones Cinemark, S.A., a Chilean corporation
Worldwide Invest, Inc., a British Virgin Islands corporation

Flix Media S.A., a Chilean corporation

COLOMBIA

Cinemark Colombia S.A.S., a Colombian corporation

Flix Cinevision Colombia S.A.S., a Colombian corporation

MEXICO

Cinemark Plex, S. de R.L. de C.V., a Mexican limited liability company

PERU

Cinemark del Peru S.R.L., a Peruvian limited liability company

BOLIVIA

Cinemark Bolivia, S.R.L., a Bolivian corporation

PARAGUAY

Cinemark Paraguay, S.R.L, a Paraguayan limited liability company

CURACAO

Cinemark Curacao, B.V., a Dutch Caribbean limited liability company

SPAIN

Cinemark Holdings Spain, S.L., a Spanish limited liability company

UNITED KINGDOM

Cinemark U.K. Holdings, Ltd., a United Kingdom limited partnership

EX-21.2

EXHIBIT 21.2

SUBSIDIARIES OF CINEMARK USA, INC.

United States
Cinemark, L.L.C., a Delaware limited liability company
Sunnymead Cinema Corp., a California corporation
Cinemark Properties, Inc., a Texas corporation
Greeley Holdings, Inc., a Texas corporation
Greeley, Ltd., a Texas limited partnership

Cinemark Concessions, L.L.C., a Florida limited liability company
Cinemark International, L.L.C., a Texas limited liability company
Cinemark Mexico (USA), Inc., a Delaware corporation
Cinemark Partners I, Inc., a Texas corporation
Cinemark Partners II, Ltd., a Texas limited partnership
Cinemark Investments Corporation, a Delaware corporation
CNMK Brazil Investments, Inc., a Delaware corporation
CNMK Investments, Inc., a Delaware corporation
CNMK Texas Properties, L.L.C., a Texas limited liability company
Laredo Theatre, Ltd., a Texas limited partnership
Brasil Holdings, L.L.C., a Delaware limited liability company

Brazil Holdings II, L.L.C., a Delaware limited liability company
Cinemark Media, Inc., a Delaware corporation

Cinemark Latin America Ventures, L.L.C., a Delaware limited liability company

Cinemark Prodecine Holdings, L.L.C., a Delaware limited liability company

Century Theatres, Inc., a California corporation

Cinemark AB, Inc., a Texas Corporation

FM Delaware I, LLC, a Delaware limited liability company

FM Delaware II, LLC, a Delaware limited liability company

MI Cinemark, LLC, Texas limited liability company

ARGENTINA

Cinemark Argentina, S.R.L., an Argentine limited liability company
Prodecine S.R.L., an Argentine limited liability company
Bulnes 2215, S.R.L., an Argentine limited liability company

Cinemark Argentina Holdings, Inc., a Cayman corporation

BOCA Holdings, Inc., a Cayman corporation

Hoyts Cinema de Argentina S.A., an Argentine corporation

BRAZIL

Cinemark Brasil S.A., a Brazilian corporation

Flix Media Publicidade e Entreternimento Ltda., a Brazilian limited partnership

CANADA

Century Theatres of Canada, ULC, a Canadian corporation

CENTRAL AMERICA

Cinemark Panama, S.A., a Panamanian joint stock company
Cinemark Equity Holdings Corporation, a British Virgin Islands corporation
Cinemark Costa Rica, S.R.L., a Costa Rican limited liability company
Cinemark El Salvador, Ltda de C.V., an El Salvadorian limited liability company

Cinemark Nicaragua y Cia, Ltda., a Nicaraguan limited liability company
Cinemark Honduras S. de R.L., a Honduran limited liability company

Cinemark Guatemala Ltda., a Guatemalan limited company

Flix Media Holdings Corporation, a British Virgin Islands corporation

Flix Cinevision Honduras S.R.L, a Honduran limited liability company

Flix Cinevision Costa Rica S.R.L, a Costa Rican limited liability company

Flix Cinevision Nicaragua S.R.L, a Nicaraguan limited liability company

Flix Cinevision Guatemala S.R.L, a Guatemalan limited liability company

Flix Cinevision Panama S.R.L, a Panamanian limited liability company

Flix Cinevision El Salvador S.R.L, an El Salvadorian limited liability company

Cine Food Services S.A., a Panamanian join stock company

Premium Food Services, S.A., a Panamanian joint stock company

CHILE

Cinemark Chile S.A., a Chilean corporation
Inversiones Cinemark, S.A., a Chilean corporation
Worldwide Invest, Inc., a British Virgin Islands corporation

Flix Media S.A., a Chilean corporation

COLOMBIA

Cinemark Colombia S.A.S., a Colombian corporation

Flix Cinevision Colombia S.A.S., a Colombian corporation

MEXICO

Cinemark Plex, S. de R.L. de C.V., a Mexican limited liability company

PERU

Cinemark del Peru S.R.L., a Peruvian limited liability company

BOLIVIA

Cinemark Bolivia, S.R.L., a Bolivian corporation

PARAGUAY

Cinemark Paraguay, S.R.L, a Paraguayan limited liability company

CURACAO

Cinemark Curacao, B.V., a Dutch Caribbean limited liability company

SPAIN

Cinemark Holdings Spain, S.L., a Spanish limited liability company

UNITED KINGDOM

Cinemark UK Holdings, Ltd., a United Kingdom limited partnership

EX-23.1

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement Nos. 333-146349, 333-153273, and 333-218697 on Form S-8 of our reports dated February 16, 2024, relating to the financial statements and financial statement schedule of Cinemark Holdings, Inc., and the effectiveness of Cinemark Holdings, Inc.’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of Cinemark Holdings, Inc. for the year ended December 31, 2023.

/s/ Deloitte & Touche LLP

Dallas, Texas

February 16, 2024

EX-31.1

EXHIBIT 31.1

CEO CERTIFICATION

PURSUANT TO SECTION 302 OF THE

SARBANES - OXLEY ACT OF 2002

I, Sean Gamble, certify that:

1. I have reviewed this annual report on Form 10-K of Cinemark Holdings, Inc.;

2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;

3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15 (f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	February 16, 2024
	CINEMARK HOLDINGS, INC.
By:	/s/ Sean Gamble
	Sean Gamble
	Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CFO CERTIFICATION

PURSUANT TO SECTION 302 OF THE

SARBANES - OXLEY ACT OF 2002

I, Melissa Thomas, certify that:

1.I have reviewed this annual report on Form 10-K of Cinemark Holdings, Inc.;

2.Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;

3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15 (f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

c) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	February 16, 2024
	CINEMARK HOLDINGS, INC.
By:	/s/ Melissa Thomas
	Melissa Thomas
	Chief Financial Officer

EX-31.3

EXHIBIT 31.3

CEO CERTIFICATION

PURSUANT TO SECTION 302 OF THE

SARBANES - OXLEY ACT OF 2002

I, Sean Gamble, certify that:

1. I have reviewed this annual report on Form 10-K of Cinemark USA, Inc.;

2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;

3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15 (f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	February 16, 2024
	CINEMARK USA, INC.
By:	/s/ Sean Gamble
	Sean Gamble
	Chief Executive Officer

EX-31.4

EXHIBIT 31.4

CFO CERTIFICATION

PURSUANT TO SECTION 302 OF THE

SARBANES - OXLEY ACT OF 2002

I, Melissa Thomas, certify that:

1.I have reviewed this annual report on Form 10-K of Cinemark USA, Inc.;

2.Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;

3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15 (f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

c) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	February 16, 2024
	CINEMARK USA, INC.
By:	/s/ Melissa Thomas
	Melissa Thomas
	Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CEO CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADDED BY

SECTION 906 OF THE SARBANES - OXLEY ACT OF 2002

This certification is provided pursuant to 18 U.S.C. Section 1350, as added bySection 906 of the Sarbanes-Oxley Act of 2002, and accompanies the annual report on Form 10-K (the “Form 10-K”) for the year ended December 31, 2023 of Cinemark Holdings, Inc. (the “Issuer”).

I, Sean Gamble, the Chief Executive Officer of Issuer certify that to the best of my knowledge:

(i)the Form 10-K fully complies with the requirements of section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

(ii)the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Issuer.

Dated: February 16, 2024

/s/ Sean Gamble

Sean Gamble

Chief Executive Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

EXHIBIT 32.2

CFO CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADDED BY

SECTION 906 OF THE SARBANES – OXLEY ACT OF 2002

This certification is provided pursuant to 18 U.S.C. Section 1350, as added bySection 906 of the Sarbanes-Oxley Act of 2002, and accompanies the annual report on Form 10-K (the “Form 10-K”) for the year ended December 31, 2023 of Cinemark Holdings, Inc. (the “Issuer”).

I, Melissa Thomas, the Chief Financial Officer of Issuer certify that to the best of my knowledge:

(i)the Form 10-K fully complies with the requirements of section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

(ii)the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Issuer.

Dated: February 16, 2024

/s/ Melissa Thomas

Melissa Thomas

Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.3

EXHIBIT 32.3

CEO CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADDED BY

SECTION 906 OF THE SARBANES - OXLEY ACT OF 2002

This certification is provided pursuant to 18 U.S.C. Section 1350, as added bySection 906 of the Sarbanes-Oxley Act of 2002, and accompanies the annual report on Form 10-K (the “Form 10-K”) for the year ended December 31, 2023 of Cinemark USA, Inc. (the “Issuer”).

I, Sean Gamble, the Chief Executive Officer of Issuer certify that to the best of my knowledge:

1.the Form 10-K fully complies with the requirements of section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

2.the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Issuer.

Dated: February 16, 2024

/s/ Sean Gamble

Sean Gamble

Chief Executive Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.4

EXHIBIT 32.4

CFO CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADDED BY

SECTION 906 OF THE SARBANES – OXLEY ACT OF 2002

This certification is provided pursuant to 18 U.S.C. Section 1350, as added bySection 906 of the Sarbanes-Oxley Act of 2002, and accompanies the annual report on Form 10-K (the “Form 10-K”) for the year ended December 31, 2023 of Cinemark USA, Inc. (the “Issuer”).

I, Melissa Thomas, the Chief Financial Officer of Issuer certify that to the best of my knowledge:

1.the Form 10-K fully complies with the requirements of section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

2.the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Issuer.

Dated: February 16, 2024

/s/ Melissa Thomas

Melissa Thomas

Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-97.1

Exhibit 97.1

CINEMARK HOLDINGS, INC.

CLAWBACK POLICY

Introduction

The Board of Directors (the "Board") of Cinemark Holdings, Inc. (the “Company”) believes that it is in the best interests of the Company and its shareholders to reinforce our culture that emphasizes integrity and accountability and that reinforces the Company's pay-for-performance compensation philosophy. The Board has therefore adopted this policy which provides for the recoupment of certain executive compensation in the event of an accounting restatement resulting from material noncompliance with financial reporting requirements under the federal securities laws (the "Policy"). This Policy is designed to comply with and shall be interpreted to be consistent with Section 10D of the Securities Exchange Act of 1934 (the "Exchange Act"), Rule 10D-1 promulgated under the Exchange Act (“Rule 10D-1”) and Section 303A.14 of the New York Stock Exchange Listed Company Manual or the standards of any other national securities exchange on which the Company's securities are listed (the “Listing Standards”).

Administration

This Policy shall be administered by the Board or, if so designated by the Board, the Compensation Committee (the “Administrator”), in which case references herein to the Board or Administrator shall be deemed references to the Compensation Committee. The Administrator is authorized to interpret and construe this Policy and to make all determinations necessary, appropriate or advisable for the administration of this Policy. Any determinations made by the Administrator, shall be final and binding on all affected individuals and need not be uniform with respect to each individual covered by the Policy. In the administration of this Policy, the Administrator is authorized and directed to consult with the full Board or such other committees of the Board, such as the Audit Committee or the Compensation Committee, as may be necessary or appropriate as to matters within the scope of such other committee’s responsibility and authority. Subject to any limitation at applicable law, the Administrator may authorize and empower any officer or employee of the Company to take any and all actions necessary or appropriate to carry out the purpose and intent of this Policy (other than with respect to any recovery under this Policy involving such officer or employee).

Covered Employee

This Policy applies to the Company's current and former executive officers, as determined by the Administrator in accordance with the Exchange Act, Rule 10D-1, and the Listing Standards, and such other senior executives or employees who may from time to time be deemed subject to the Policy by the Administrator in consultation with the Chief Executive Officer or the Chief Financial Officer in connection with the annual incentive award process ("Covered Employees").

Recoupment; Accounting Restatement

In the event the Company is required to prepare an accounting restatement of its financial statements due to the Company's material noncompliance with any financial reporting requirement under the securities laws, the Administrator will require reimbursement or forfeiture of any excess Incentive Compensation received by any Covered Employee during the three completed fiscal years immediately preceding the date on which the Company is required to prepare an accounting restatement, as well as any transition period (that results from a change in the Company’s fiscal

year) within or immediately following those three completed fiscal years (except that a transition period that comprises a period of at least nine months shall count as a completed fiscal year). The “date on which the Company is required to prepare an accounting restatement” is the earlier to occur of (a) the date the Board or appropriate committee of the Board concludes, or reasonably should have concluded, that the Company is required to prepare an accounting restatement or (b) the date a court, regulator or other legally authorized body directs the Company to prepare an accounting restatement, in each case regardless of if or when the restated financial statements are filed. This Policy applies to Incentive Compensation received by a Covered Employee (a) after beginning services as a Covered Employee; (b) if that person served as a Covered Employee at any time during the performance period for such Incentive-Based Compensation; and (c) while the Company had a listed class of securities on a national securities exchange.

Incentive Compensation

For purposes of this Policy, Incentive Compensation means any of the following; provided that, such compensation is granted, earned, or vested based wholly or in part on the attainment of a financial reporting measure:

•Annual bonuses and other short- and long-term cash incentives

•Stock options

•Stock appreciation rights

•Restricted stock

•Restricted stock units

•Performance shares

•Performance units

Financial reporting measures include, but are not limited to, the following:

•Company stock price

•Total shareholder return

•Revenues

•Net income

•Earnings before interest, taxes, depreciation, and amortization (EBITDA)

•Adjusted EBITDA

November 16, 2023

•Funds from operations

•Liquidity measures such as working capital, operating cash flow, or free cash flow

•Return measures such as return on invested capital, return on assets or internal rate of return

•Earnings measures such as earnings per share

Excess Incentive Compensation: Amount Subject to Recovery

The amount to be recovered will be the excess of the Incentive Compensation received by the Covered Employee based on the erroneous data over the Incentive Compensation that would have been paid to the Covered Employee had it been based on the restated results, as determined by the Board. Incentive Compensation is “received” for purposes of this Policy in the Company’s fiscal period during which the financial reporting measure specified in the Incentive Compensation award is attained, even if the payment or grant of such Incentive Compensation occurs after the end of that period.

If the Board cannot determine the amount of excess Incentive Compensation received by the Covered Employee directly from the information in the accounting restatement, then it will make its determination based on a reasonable estimate of the effect of the accounting restatement. For example, for Incentive Compensation based on stock price or Total Stockholder Return (“TSR”): (a) the Administrator shall determine the amount of excess Incentive Compensation based on a reasonable estimate of the effect of the accounting restatement on the stock price or TSR upon which the Incentive Compensation was received; and (b) the Company shall maintain documentation of the determination of that reasonable estimate and provide such documentation to the New York Stock Exchange (“NYSE”).

Method of Recoupment

The Administrator will determine, in its sole discretion, the method for recouping Incentive Compensation hereunder which may include, without limitation:

(a) requiring reimbursement of cash Incentive Compensation previously paid;

(b) seeking recovery of any gain realized on the vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based awards;

(c) offsetting the recouped amount from any compensation otherwise owed by the Company to the Covered Employee;

(d) cancelling outstanding vested or unvested equity awards; and/or

(e) taking any other remedial and recovery action permitted by law, as determined by the Board.

November 16, 2023

No Indemnification

Notwithstanding the terms of any indemnification or insurance policy or any contractual arrangement with any Covered Employee that may be interpreted to the contrary, the Company shall not indemnify any Covered Employees against the loss of any incorrectly awarded Incentive Compensation, including any payment or reimbursement for the cost of third-party insurance purchased by any Covered Employee to fund potential clawback obligations under this Policy.

Interpretation

The Administrator is authorized to interpret and construe this Policy and to make all determinations necessary, appropriate, or advisable for the administration of this Policy. It is intended that this Policy be interpreted in a manner that is consistent with the requirements of the Exchange Act, Rule 10D-1 and the Listing Standards. Any members of the Administrator, and any other members of the Board or any officers or employees of the Company who assist in the administration of this Policy, shall not be personally liable for any action, determination or interpretation made with respect to this Policy and shall be fully indemnified by the Company to the fullest extent under applicable law and Company policy with respect to any such action, determination or interpretation. The foregoing sentence shall not limit any other rights to indemnification of the members of the Administrator, the Board, or officers or employees who assist the Administrator under applicable law or Company policy.

Effective Date

This Policy shall be effective as of the date it is adopted by the Board (the "Effective Date") and shall apply to Incentive Compensation that is approved, awarded or granted to Covered Employees on or after that date, but not later than the effective date of the Listing Standards.

Amendment; Termination

The Board may amend this Policy from time to time in its discretion and shall amend this Policy as it deems necessary to reflect regulations adopted by the Securities and Exchange Commission under Section 10D of the Exchange Act and to comply with any rules or standards adopted by a national securities exchange on which the Company's securities are listed. The Board may terminate this Policy at any time.

Other Recoupment Rights

The Board intends that this Policy will be applied to the fullest extent of the law. The Board may require that any employment agreement, equity award agreement, or similar agreement entered into on or after the Effective Date shall, as a condition to the grant of any benefit thereunder, require a Covered Employee to agree to abide by the terms of this Policy. Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment that may be available to the Company pursuant to the terms of any similar policy in any employment agreement, equity award agreement, or similar agreement and any other legal remedies available to the Company. Nothing contained in this Policy, and no recoupment or recovery as contemplated by this Policy, shall limit any claims, damages or other legal remedies

November 16, 2023

the Company or any of its affiliates may have against a Covered Employee arising out of or resulting from any actions or omissions by the Covered Employee.

Impracticability

The Board shall recover any excess Incentive Compensation in accordance with this Policy unless such recovery would be impracticable, as determined by the Board in accordance with Rule 10D1 of the Exchange Act and the Listing Standards.

Successors

This Policy shall be binding and enforceable against all Covered Employees and their beneficiaries, heirs, executors, administrators or other legal representatives.

Exhibit Filing Requirement

A copy of this Policy and any amendments thereto shall be posted on the Company’s website and filed as an exhibit to the Company’s annual report on Form 10-K.

November 16, 2023

Acknowledgment

I, the undersigned, agree and acknowledge that I am fully bound by, and subject to, all of the terms and conditions of the Cinemark Holdings, Inc. Clawback Policy (as may be amended, restated, supplemented or otherwise modified from time to time, the “Policy”). In the event of any inconsistency between the Policy and the terms of any employment agreement to which I am a party, or the terms of any compensation plan, program or agreement under which any compensation has been granted, awarded, earned or paid, the terms of the Policy shall govern. In the event it is determined by the Administrator that any amounts granted, awarded, earned or paid to me must be forfeited or reimbursed to the Company, I will promptly take any action necessary to effectuate such forfeiture and/or reimbursement. Any capitalized terms used in this Acknowledgment without definition shall have the meaning set forth in the Policy.

By: __________________________

Name _________________________

Title __________________________

Date __________________________

XML

Document and Entity Information - USD ($)
$ in Billions

12 Months Ended

Dec. 31, 2023

Feb. 09, 2024

Jun. 30, 2023

Dec. 31, 2022

Entity Information [Line Items]

Document Type

10-K

Amendment Flag

false

Document Period End Date

Dec. 31, 2023

Document Fiscal Year Focus

2023

Document Fiscal Period Focus

FY

Entity Registrant Name

Cinemark Holdings, Inc.

Entity Central Index Key

0001385280

Current Fiscal Year End Date

--12-31

Entity Filer Category

Large Accelerated Filer

Entity Emerging Growth Company

false

Entity Small Business

false

Entity Current Reporting Status

Yes

Entity Interactive Data Current

Yes

Entity Shell Company

false

Entity File Number

001-33401

Entity Tax Identification Number

20-5490327

Entity Address, Address Line One

3900 Dallas Parkway

Entity Address, City or Town

Plano

Entity Address, State or Province

TX

Entity Address, Postal Zip Code

75093

City Area Code

(972)

Local Phone Number

665-1000

Entity Incorporation, State or Country Code

DE

Document Annual Report

true

Document Transition Report

false

Title of Each Class

Common Stock, par value $0.001 per share

Trading Symbol(s)

CNK

Name of each exchange on which registered

NYSE

Document Financial Statement Error Correction [Flag]

false

Entity Public Float

$ 1.7

Entity Well-known Seasoned Issuer

Yes

Entity Voluntary Filers

No

ICFR Auditor Attestation Flag

true

Documents Incorporated by Reference

Certain portions of Holdings’ definitive proxy statement, in connection with its 2024 annual meeting of stockholders, to be filed within 120 days of December 31, 2023, are incorporated by reference into Part III, Items 10-14, of this annual report on Form 10-K.

Auditor Name

Deloitte & Touche LLP

Auditor Firm ID

34

Auditor Location

Dallas, Texas

CUSA [Member]

Entity Information [Line Items]

Entity Registrant Name

Cinemark USA, Inc.

Entity Filer Category

Non-accelerated Filer

Entity Emerging Growth Company

false

Entity Small Business

false

Entity Current Reporting Status

No

Entity Interactive Data Current

Yes

Entity Shell Company

false

Entity File Number

33-47040

Entity Tax Identification Number

75-2206284

Entity Address, Address Line One

3900 Dallas Parkway

Entity Address, City or Town

Plano

Entity Address, State or Province

TX

Entity Address, Postal Zip Code

75093

City Area Code

(972)

Local Phone Number

665-1000

Entity Incorporation, State or Country Code

TX

Document Financial Statement Error Correction [Flag]

false

Entity Well-known Seasoned Issuer

No

Entity Voluntary Filers

Yes

ICFR Auditor Attestation Flag

true

Auditor Name

Deloitte & Touche LLP

Auditor Firm ID

34

Auditor Location

Dallas, Texas

CUSA [Member] | Class A Common Stock

Entity Information [Line Items]

Entity Common Stock, Shares Outstanding

1,500

Common stock, shares issued

1,500

1,500

Common stock, shares outstanding

1,500

1,500

CUSA [Member] | Class B Common Stock

Entity Information [Line Items]

Entity Common Stock, Shares Outstanding

182,648

Common stock, shares issued

239,893

239,893

Common stock, shares outstanding

182,648

182,648

CNK [Member]

Entity Information [Line Items]

Common stock, shares issued

127,598,774

121,589,633

126,082,187

Common stock, shares outstanding

121,596,206

120,403,833

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions		Dec. 31, 2023	Dec. 31, 2022
Current assets
Theatre properties and equipment, net		$ 1,161.7	$ 1,232.1
Operating lease right-of-use assets, net	[1]	986.4	1,102.7
Other long-term assets
Goodwill	[2]	1,251.0	1,250.9
Intangible assets, net		302.8	304.6
Current liabilities
Current portion of operating lease obligations	[1]	212.5	219.3
Current portion of finance lease obligations	[1]	14.0	14.4
Accrued other current liabilities (see Note 13)		239.2	200.4
Long-term liabilities
Operating lease obligations, less current portion	[1]	853.3	970.6
Finance lease obligations, less current portion	[1]	73.8	88.0
Commitments and contingencies (see Note 21)
Cinemark Holdings, Inc.'s stockholders' equity:
Treasury stock shares		(98.3)	(95.4)
Noncontrolling interests		9.0	9.3
CUSA
Current assets
Cash and cash equivalents		612.4	427.3
Inventories		23.3	23.7
Accounts receivable		78.2	69.0
Current income tax receivable		56.1	45.1
Prepaid expenses and other		50.5	50.7
Accounts receivable from parent		58.6	53.4
Total current assets		879.1	669.2
Theatre properties and equipment, net		1,161.7	1,232.1
Operating lease right-of-use assets, net		986.4	1,102.7
Other long-term assets
Goodwill		1,251.0	1,250.9
Intangible assets, net		302.8	304.6
Investments in affiliates		23.6	22.6
Deferred charges and other assets, net		33.2	31.6
Total other long-term assets		1,628.7	1,619.3
Total assets		4,655.9	4,623.3
Current liabilities
Current portion of long-term debt		7.8	10.7
Current portion of operating lease obligations		212.5	219.3
Current portion of finance lease obligations		14.0	14.4
Current income tax payable		4.2	3.2
Accounts payable		53.3	72.2
Accrued interest		28.2	31.2
Accrued film rentals		73.8	65.1
Accrued payroll		60.1	54.5
Accrued property taxes		29.4	29.6
Accrued other current liabilities (see Note 13)		239.1	200.1
Total current liabilities		722.4	700.3
Long-term liabilities
Long-term debt, less current portion		1,936.8	2,023.0
Operating lease obligations, less current portion		853.3	970.6
Finance lease obligations, less current portion		73.8	88.0
Long-term deferred tax liability		51.7	36.1
Long-term liability for uncertain tax positions		48.0	47.9
NCM screen advertising advances		328.4	338.2
Other long-term liabilities		41.2	37.3
Total long-term liabilities		3,333.2	3,541.1
Commitments and contingencies (see Note 21)
Cinemark Holdings, Inc.'s stockholders' equity:
Additional paid-in-capital		1,503.3	1,479.5
Treasury stock shares		(24.2)	(24.2)
Accumulated deficit		(570.6)	(775.9)
Accumulated other comprehensive loss		(366.7)	(356.3)
Total equity		591.3	372.6
Noncontrolling interests		9.0	9.3
Total equity		600.3	381.9
Total liabilities and equity		4,655.9	4,623.3
CUSA | Class A Common Stock
Cinemark Holdings, Inc.'s stockholders' equity:
Common stock value		0.0	0.0
CUSA | Class B Common Stock
Cinemark Holdings, Inc.'s stockholders' equity:
Common stock value		49.5	49.5
CNK [Member]
Current assets
Cash and cash equivalents		849.1	674.5
Inventories		23.3	23.7
Accounts receivable		80.4	69.6
Current income tax receivable		56.7	45.1
Prepaid expenses and other		50.5
Accounts receivable from parent			50.7
Total current assets		1,060.0	863.6
Theatre properties and equipment, net		1,161.7	1,232.1
Operating lease right-of-use assets, net		986.4	1,102.7
Other long-term assets
Goodwill		1,251.0	1,250.9
Intangible assets, net		302.8	304.6
Investments in affiliates		23.6	22.6
Deferred charges and other assets, net		33.2	31.6
Total other long-term assets		1,628.7	1,619.3
Total assets		4,836.8	4,817.7
Current liabilities
Current portion of long-term debt		7.8	10.7
Current portion of operating lease obligations		212.5	219.3
Current portion of finance lease obligations		14.0	14.4
Current income tax payable		4.2	3.2
Accounts payable		53.3	72.2
Accrued interest		36.0	39.1
Accrued film rentals		73.8	65.1
Accrued payroll		60.1	54.5
Accrued property taxes		29.4	29.6
Accrued other current liabilities (see Note 13)		239.2	200.4
Total current liabilities		730.3	708.5
Long-term liabilities
Long-term debt, less current portion	[3]	2,391.3	2,474.0
Operating lease obligations, less current portion		853.3	970.6
Finance lease obligations, less current portion		73.8	88.0
Long-term deferred tax liability		51.7	33.7
Long-term liability for uncertain tax positions		48.0	47.9
Other long-term liabilities		41.2	37.3
Total long-term liabilities		3,787.7	3,989.7
Commitments and contingencies (see Note 21)
Cinemark Holdings, Inc.'s stockholders' equity:
Common stock value		0.1	0.1
Additional paid-in-capital		1,244.3	1,219.3
Treasury stock shares		(98.3)	(95.4)
Accumulated deficit		(472.4)	(660.6)
Accumulated other comprehensive loss		(363.9)	(353.2)
Total equity		309.8	110.2
Noncontrolling interests		9.0	9.3
Total equity		318.8	119.5
Total liabilities and equity		4,836.8	4,817.7
NCM | CUSA
Other long-term assets
Investment in NCMI/NCM		18.1	9.6
NCM | CNK [Member]
Other long-term assets
Investment in NCMI/NCM		18.1	9.6
Long-term liabilities
NCM screen advertising advances		$ 328.4	$ 338.2

[1] The operating lease right-of-use assets and liabilities recorded on the Company’s consolidated balance sheets generally do not include renewal options that have not yet been exercised.

[2] Balances are presented net of accumulated impairment losses of $214.0 for the U.S. operating segment and $43.8 for the international operating segment.

[3] The only differences between the long-term debt for Holdings, as presented above, and the long-term debt for CUSA are the $460.0 million 4.50% Convertible Senior Notes due 2025 and the related debt issuance costs.

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions		Dec. 31, 2023	Dec. 31, 2022
Accumulated depreciation and amortization	[1]	$ 2,329.3	$ 2,163.2
CUSA [Member]
Treasury stock		57,245	57,245
CUSA [Member] | Class A Common Stock
Common stock, par value		$ 0.01	$ 0.01
Common stock, shares authorized		10,000,000	10,000,000
Common stock, shares issued		1,500	1,500
Common stock, shares outstanding		1,500	1,500
CUSA [Member] | Class B Common Stock
Common stock, par value		$ 0	$ 0
Common stock, shares authorized		1,000,000	1,000,000
Common stock, shares issued		239,893	239,893
Common stock, shares outstanding		182,648	182,648
CNK [Member]
Common stock, par value		$ 0.001	$ 0.001
Common stock, shares authorized		300,000,000	300,000,000
Common stock, shares issued		127,598,774	126,082,187
Common stock, shares outstanding		121,596,206	120,403,833
Treasury stock		6,002,568	5,678,354

[1] Amortization of finance lease assets is included in depreciation and amortization expense on the consolidated statements of income (loss). Accumulated amortization of finance lease assets as of December 31, 2022 and 2023 was $62.5 and $73.9, respectively.

XML

CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($) shares in Millions, $ in Millions		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenue
Total revenue		$ 3,066.7	$ 2,454.7	$ 1,510.5
Cost of operations
Depreciation and amortization		209.5	238.2	265.4
Impairment of long-lived and other assets		16.6	174.1	20.8
Restructuring costs		0.0	(0.5)	(1.0)
Other income (expense)
Interest expense	[1]	150.4	155.3	149.7
Loss on debt extinguishment and refinancing		10.7	0.0	6.5
Interest expense - NCM		(22.6)	(23.2)	(23.6)
Total		221.4	(265.0)	(439.0)
Income tax (benefit) expense		29.9	3.0	(16.8)
Net (loss) income		191.5	(268.0)	(422.2)
Less: Net income attributable to noncontrolling interests		3.3
Net (loss) income attributable to Cinemark Holdings, Inc.		$ 188.2	$ (271.2)	$ (422.8)
Weighted average shares outstanding
Basic		119.1	118.2	117.3
Diluted		152.0	118.2	117.3
(Loss) income per share attributable to Cinemark Holdings, Inc.'s common stockholders
Basic		$ 1.55	$ (2.26)	$ (3.55)
Diluted		$ 1.34	$ (2.26)	$ (3.55)
CUSA [Member]
Revenue
Total revenue		$ 3,066.7	$ 2,454.7	$ 1,510.5
Cost of operations
Film rentals and advertising		865.7	704.4	415.0
Concession supplies		221.3	169.3	97.9
Salaries and wages		403.1	372.7	232.9
Facility lease expense		329.7	308.3	280.0
Utilities and other		466.8	407.2	282.9
General and administrative expenses		195.5	174.6	158.5
Depreciation and amortization		209.5	238.2	265.4
Impairment of long-lived and other assets		16.6	174.1	20.8
Restructuring costs		0.0	(0.5)	(1.0)
Loss (gain) on disposal of assets and other		(7.7)	(6.8)	8.0
Total cost of operations		2,700.5	2,541.5	1,760.4
Operating (loss) income		366.2	(86.8)	(249.9)
Other income (expense)
Interest expense		(126.3)	(131.2)	(125.6)
Interest income		43.2	16.5	6.3
Loss on debt extinguishment and refinancing		(10.7)	0.0	(6.5)
Foreign currency exchange and other related loss		(28.8)	(11.5)	(1.3)
Equity in income of affiliates		3.6	(9.3)	(25.0)
Unrealized gain on investment in NCMI		12.4	0.0	0.0
Total other (expense) income		(129.2)	(155.0)	(162.5)
Total		237.0	(241.8)	(412.4)
Income tax (benefit) expense		28.4	(13.1)	(32.3)
Net (loss) income		208.6	(228.7)	(380.1)
Less: Net income attributable to noncontrolling interests		3.3	3.2	0.6
Net (loss) income attributable to Cinemark Holdings, Inc.		205.3	(231.9)	(380.7)
CNK [Member]
Revenue
Total revenue		3,066.7	2,454.7	1,510.5
Cost of operations
Film rentals and advertising		865.7	704.4	415.0
Concession supplies		221.3	169.3	97.9
Salaries and wages		403.1	372.7	232.9
Facility lease expense		329.7	308.3	280.0
Utilities and other		466.8	407.2	282.9
General and administrative expenses		198.8	177.6	161.1
Depreciation and amortization		209.5	238.2	265.4
Impairment of long-lived and other assets		16.6	174.1	20.8
Restructuring costs		0.0	(0.5)	(1.0)
Loss (gain) on disposal of assets and other		(7.7)	(6.8)	8.0
Total cost of operations		2,703.8	2,544.5	1,763.0
Operating (loss) income		362.9	(89.8)	(252.5)
Other income (expense)
Interest expense		(150.4)	(155.3)	(149.7)
Interest income		55.0	20.4	6.4
Loss on debt extinguishment and refinancing		(10.7)	0.0	(6.5)
Foreign currency exchange and other related loss		(28.8)	(11.5)	(1.3)
Equity in income of affiliates		3.6	(9.3)	(25.0)
Unrealized gain on investment in NCMI		12.4	0.0	0.0
Total other (expense) income		(141.5)	(175.2)	(186.5)
Total		221.4	(265.0)	(439.0)
Income tax (benefit) expense		29.9	3.0	(16.8)
Net (loss) income		191.5	(268.0)	(422.2)
Less: Net income attributable to noncontrolling interests		3.3	3.2	0.6
Net (loss) income attributable to Cinemark Holdings, Inc.		$ 188.2	$ (271.2)	$ (422.8)
Weighted average shares outstanding
Basic		119.1	118.2	117.3
Diluted		152.0	118.2	117.3
(Loss) income per share attributable to Cinemark Holdings, Inc.'s common stockholders
Basic		$ 1.55	$ (2.26)	$ (3.55)
Diluted		$ 1.34	$ (2.26)	$ (3.55)
NCM | CUSA [Member]
Other income (expense)
Distributions from NCM		$ 0.0	$ 0.0	$ 0.1
Interest expense - NCM		(22.6)	(23.2)	(23.6)
NCM | CNK [Member]
Other income (expense)
Distributions from NCM		0.0	0.0	0.1
Interest expense - NCM		(22.6)	(23.2)	(23.6)
DCIP | CUSA [Member]
Other income (expense)
Distributions from DCIP		0.0	3.7	13.1
DCIP | CNK [Member]
Other income (expense)
Distributions from DCIP		0.0	3.7	13.1
Admissions | CUSA [Member]
Revenue
Total revenue		1,555.6	1,246.9	780.0
Admissions | CNK [Member]
Revenue
Total revenue		1,555.6	1,246.9	780.0
Concession
Revenue
Total revenue		1,192.0	938.3	561.7
Concession | CUSA [Member]
Revenue
Total revenue		1,192.0	938.3	561.7
Concession | CNK [Member]
Revenue
Total revenue		1,192.0	938.3	561.7
Other | CUSA [Member]
Revenue
Total revenue		319.1	269.5	168.8
Other | CNK [Member]
Revenue
Total revenue		$ 319.1	$ 269.5	$ 168.8

[1] Includes amortization of debt issuance costs, amortization of original issue discount, and amortization of accumulated (gains) losses for amended swap agreements.

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Net (loss) income	$ 191.5	$ (268.0)	$ (422.2)
Other comprehensive income (loss), net of tax
Foreign currency translation adjustments	4.9	4.6	(18.8)
CUSA [Member]
Net (loss) income	208.6	(228.7)	(380.1)
Other comprehensive income (loss), net of tax
Unrealized gain (loss) due to fair value adjustments on interest rate swap agreements, net of taxes and settlements	(8.9)	31.6	16.0
Foreign currency translation adjustments	4.9	4.6	(18.8)
Total other comprehensive (loss) income, net of tax	(4.0)	36.2	(2.8)
Total comprehensive (loss) income, net of tax	204.6	(192.5)	(382.9)
Comprehensive income attributable to noncontrolling interests	(3.3)	(3.2)	(0.6)
Comprehensive (loss) income attributable to Cinemark, Inc.	201.3	(195.7)	(383.5)
CNK [Member]
Net (loss) income	191.5	(268.0)	(422.2)
Other comprehensive income (loss), net of tax
Unrealized gain (loss) due to fair value adjustments on interest rate swap agreements, net of taxes and settlements	(9.2)	32.2	18.5
Foreign currency translation adjustments	4.9	4.6	(18.8)
Total other comprehensive (loss) income, net of tax	(4.3)	36.8	(0.3)
Total comprehensive (loss) income, net of tax	187.2	(231.2)	(422.5)
Comprehensive income attributable to noncontrolling interests	(3.3)	(3.2)	(0.6)
Comprehensive (loss) income attributable to Cinemark, Inc.	$ 183.9	$ (234.4)	$ (423.1)

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
CUSA [Member]
Unrealized loss due to fair value adjustments on interest rate swap agreements, taxes	$ 1.5	$ (3.4)	$ (3.3)
CNK [Member]
Unrealized loss due to fair value adjustments on interest rate swap agreements, taxes	$ 1.2	$ (2.8)	$ (0.7)

XML

CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Millions		Total	CUSA [Member]	CUSA	CNK [Member]	Common Stock CUSA [Member] Class B Common Stock	Common Stock CNK [Member]	Treasury Stock Preferred CUSA [Member]	Treasury Stock Preferred CNK [Member]	Additional Paid-in- Capital CUSA [Member]	Additional Paid-in- Capital CNK [Member]	Retained Earnings CUSA [Member]	Retained Earnings CNK [Member]	Accumulated Other Comprehensive Loss CUSA [Member]	Accumulated Other Comprehensive Loss CNK [Member]	Total Cinemark Holdings, Inc.'s Stockholders' Equity CUSA [Member]	Total Cinemark Holdings, Inc.'s Stockholders' Equity CNK [Member]	Noncontrolling Interests CUSA [Member]	Noncontrolling Interests CNK [Member]
Balance at Dec. 31, 2020			$ 784.9		$ 798.9	$ 49.5	$ 0.1	$ (24.2)	$ (87.0)	$ 1,310.6	$ 1,245.6	$ (163.3)	$ 27.9	$ (398.7)	$ (398.7)	$ 773.9	$ 787.9	$ 11.0	$ 11.0
Balance (in shares) at Dec. 31, 2020						200,000	123,600,000	(100,000)	(5,100,000)
Impact of adoption of ASU 2020-06, net of tax | ASU 2020-06					(71.6)						(77.1)		5.5				(71.6)
Issuance of restricted stock (in shares)							1,300,000
Issuance of stock share upon vesting of performance stock units							200,000
Restricted stock forfeitures and stock withholdings related to share based awards that vested during the year	[1]	$ (4.1)
Restricted stock forfeitures					(4.1)				$ (4.1)								(4.1)
Restricted stock forfeitures and stock withholdings related to share based awards that vested during the year (in shares)									(300,000)
Share based awards compensation expense			28.4		29.3					28.4	29.3					28.4	29.3
Contributions received from parent			120.0							120.0						120.0
Net (loss) income		(422.2)	(380.1)		(422.2)							(380.7)	(422.8)			(380.7)	(422.8)	0.6	0.6
Amortization of accumulated losses for amended swap agreements			4.5		4.5									4.5	4.5	4.5	4.5
Other comprehensive income (loss)			(2.8)		(0.3)									(2.8)	(0.3)	(2.8)	(0.3)
Balance at Dec. 31, 2021			554.9		334.5	$ 49.5	$ 0.1	$ (24.2)	$ (91.1)	1,459.0	1,197.8	(544.0)	(389.4)	(397.0)	(394.5)	543.3	322.9	11.6	11.6
Balance (in shares) at Dec. 31, 2021						200,000	125.1	(100,000)	(5.4)
Issuance of restricted stock (in shares)							900,000
Issuance of stock share upon vesting of performance stock units							100,000
Restricted stock forfeitures and stock withholdings related to share based awards that vested during the year	[1]	(4.3)
Restricted stock forfeitures					(4.3)				$ (4.3)								(4.3)
Restricted stock forfeitures and stock withholdings related to share based awards that vested during the year (in shares)									(300,000)
Share based awards compensation expense			20.5		21.5					20.5	21.5					20.5	21.5
Contributions received from parent			0.0
Distributions to noncontrolling interests			(5.5)															(5.5)
Stock issued during period value Distributions to noncontrolling interests					(5.5)														(5.5)
Net (loss) income		(268.0)	(228.7)		(268.0)							(231.9)	(271.2)			(231.9)	(271.2)	3.2	3.2
Amortization of accumulated losses for amended swap agreements			4.5		4.5									4.5	4.5	4.5	4.5
Other comprehensive income (loss)			36.2		36.8									36.2	36.8	36.2	36.8
Balance at Dec. 31, 2022			381.9	$ 381.9	119.5	$ 49.5	$ 0.1	$ (24.2)	$ (95.4)	1,479.5	1,219.3	(775.9)	(660.6)	(356.3)	(353.2)	372.6	110.2	9.3	9.3
Balance (in shares) at Dec. 31, 2022						200,000	126.1	(100,000)	(5.7)
Issuance of restricted stock (in shares)							1,400,000
Issuance of stock share upon vesting of performance stock units							100,000
Restricted stock forfeitures and stock withholdings related to share based awards that vested during the year	[1]	(2.9)
Restricted stock forfeitures					(2.9)				$ (2.9)								(2.9)
Restricted stock forfeitures and stock withholdings related to share based awards that vested during the year (in shares)									(300,000)
Share based awards compensation expense			23.8		25.0					23.8	25.0					23.8	25.0
Contributions received from parent			0.0
Distributions to noncontrolling interests			(3.6)															(3.6)
Stock issued during period value Distributions to noncontrolling interests					(3.6)														(3.6)
Net (loss) income		$ 191.5	208.6		191.5							205.3	188.2			205.3	188.2	3.3	3.3
Amortization of accumulated losses for amended swap agreements			(6.4)		(6.4)									(6.4)	(6.4)	(6.4)	(6.4)
Other comprehensive income (loss)			(4.0)		(4.3)									(4.0)	(4.3)	(4.0)	4.3
Balance at Dec. 31, 2023			$ 600.3	$ 600.3	$ 318.8	$ 49.5	$ 0.1	$ (24.2)	$ (98.3)	$ 1,503.3	$ 1,244.3	$ (570.6)	$ (472.4)	$ (366.7)	$ (363.9)	$ 591.3	$ 309.8	$ 9.0	$ 9.0
Balance (in shares) at Dec. 31, 2023						200,000	127,600,000	(100,000)	(6,000,000)

[1] Holdings withheld shares as a result of the election by certain employees to satisfy their tax liabilities upon vesting in restricted stock and restricted stock units. Holdings determined the number of shares to be withheld based upon market values of the common stock of Holdings on the vest dates. Below is a summary of the range of market values per share on the vest dates for the years indicated:

XML

CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical) $ in Millions	12 Months Ended
	Dec. 31, 2021 USD ($)
CNK [Member]
Cumulative effect of change in accounting principle, taxes	$ 20.3

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Operating activities
Net (loss) income	$ 191.5	$ (268.0)	$ (422.2)
Adjustments to reconcile net (loss) income to cash provided by operating activities:
Loss on debt extinguishment and refinancing	(10.7)	0.0	(6.5)
Impairment of long-lived and other assets	16.6	174.1	20.8
Share based awards compensation expense	25.0	21.5	29.3
Non-cash rent expense	(17.9)	(10.8)	(3.4)
Deferred income tax (benefit) expense	10.6	(9.3)	(22.6)
Financing activities
Payments on finance leases	(14.4)	(14.3)	(14.7)
CUSA [Member]
Operating activities
Net (loss) income	208.6	(228.7)	(380.1)
Adjustments to reconcile net (loss) income to cash provided by operating activities:
Depreciation	207.3	235.7	262.7
Amortization of intangible and other assets	2.2	2.5	2.7
Loss on debt extinguishment and refinancing	10.7	0.0	6.5
Amortization of debt issuance costs	6.7	7.5	7.3
Amortization of accumulated losses (gains) for amended swap agreements	(6.4)	4.5	4.5
Impairment of long-lived and other assets	16.6	174.1	20.8
Share based awards compensation expense	23.8	20.5	28.4
Loss (gain) on disposal of assets and other	(7.7)	(6.8)	8.0
Unrealized gain on investment in NCMI	(12.4)	0.0	0.0
Non-cash rent expense	(17.9)	(10.8)	(3.4)
Equity in loss (income) of affiliates	(3.6)	9.3	25.0
Deferred income tax (benefit) expense	8.5	(25.4)	(38.1)
Distributions from equity investees	5.7	6.9	0.2
Changes in other assets and liabilities:
Inventories	0.3	(8.2)	(2.9)
Accounts receivable	(12.6)	(3.0)	(49.3)
Income tax receivable	(11.5)	1.5	112.3
Prepaid expenses and other	(2.3)	(2.3)	(1.8)
Deferred charges and other assets, net	0.3	(1.2)	0.8
Accounts payable and accrued expenses	46.1	(24.9)	175.2
Income tax payable	1.0	3.2	(5.9)
Liabilities for uncertain tax positions	(0.1)	2.0	30.2
Other long-term liabilities	1.1	6.3	(17.9)
Net cash provided by operating activities	454.8	153.4	176.4
Investing activities
Additions to theatre properties and equipment and other	(149.5)	(110.7)	(95.5)
Net proceeds from sale of subsidiary	14.8	0.0	0.0
Proceeds from sale of assets and other	2.9	14.4	6.2
Net cash (used for) provided by investing activities	(131.8)	(96.3)	(89.3)
Financing activities
Proceeds from refinancing of senior secured credit facility	640.2	0.0	0.0
Repayment of term loan upon refinancing of senior secured credit facility	(624.9)	0.0	0.0
Redemption of $100.0 of 8.75% Secured Notes at 102.2%	(102.2)	0.0	0.0
Proceeds from issuance of senior notes	0.0	0.0	1,170.0
Redemption of senior notes	0.0	0.0	(1,155.0)
Proceeds from other borrowings	0.0	0.0	13.5
Payment of debt issuance costs	(7.5)	0.0	(17.3)
Fees paid related to debt refinancing	(2.6)	0.0	(2.0)
Other repayments of long-term debt	(10.6)	(28.1)	(10.3)
Contributions received from parent	0.0	0.0	120.0
Restricted stock withholdings for payroll taxes	(2.9)	(4.3)	(4.1)
Payments on finance leases	(14.4)	(14.3)	(14.7)
Other	(0.5)	(5.5)	0.0
Net cash used for financing activities	(125.4)	(52.2)	100.1
Effect of exchange rate changes on cash and cash equivalents	(12.5)	(20.3)	(5.0)
Increase (decrease) in cash and cash equivalents	185.1	(15.4)	182.2
Cash and cash equivalents:
Beginning of period	427.3	442.7	260.5
End of period	612.4	427.3	442.7
CNK [Member]
Operating activities
Net (loss) income	191.5	(268.0)	(422.2)
Adjustments to reconcile net (loss) income to cash provided by operating activities:
Depreciation	207.3	235.7	262.7
Amortization of intangible and other assets	2.2	2.5	2.7
Loss on debt extinguishment and refinancing	10.7	0.0	6.5
Amortization of debt issuance costs	10.2	10.9	10.7
Amortization of accumulated losses (gains) for amended swap agreements	(6.4)	4.5	4.5
Impairment of long-lived and other assets	16.6	174.1	20.8
Share based awards compensation expense	25.0	21.5	29.3
Loss (gain) on disposal of assets and other	(7.7)	(6.8)	8.0
Unrealized gain on investment in NCMI	(12.4)	0.0	0.0
Non-cash rent expense	(17.9)	(10.8)	(3.4)
Equity in loss (income) of affiliates	(3.6)	9.3	25.0
Deferred income tax (benefit) expense	10.6	(9.3)	(22.6)
Distributions from equity investees	5.7	6.9	0.2
Changes in other assets and liabilities:
Inventories	0.3	(8.2)	(2.9)
Accounts receivable	(11.5)	(1.2)	(43.6)
Income tax receivable	(12.1)	1.5	118.5
Prepaid expenses and other	(2.3)	(2.3)	(1.8)
Deferred charges and other assets, net	0.3	(1.2)	0.8
Accounts payable and accrued expenses	45.4	(25.1)	175.5
Income tax payable	1.0	3.2	(6.0)
Liabilities for uncertain tax positions	(0.1)	2.0	30.2
Other long-term liabilities	1.1	6.1	(17.9)
Net cash provided by operating activities	444.3	136.0	166.2
Investing activities
Additions to theatre properties and equipment and other	(149.5)	(110.7)	(95.5)
Net proceeds from sale of subsidiary	14.8	0.0	0.0
Proceeds from sale of assets and other	2.9	14.4	6.2
Net cash (used for) provided by investing activities	(131.8)	(96.3)	(89.3)
Financing activities
Proceeds from refinancing of senior secured credit facility	640.2	0.0	0.0
Repayment of term loan upon refinancing of senior secured credit facility	(624.9)	0.0	0.0
Redemption of $100.0 of 8.75% Secured Notes at 102.2%	(102.2)	0.0	0.0
Proceeds from issuance of senior notes	0.0	0.0	1,170.0
Redemption of senior notes	0.0	0.0	(1,155.0)
Proceeds from other borrowings	0.0	0.0	13.5
Payment of debt issuance costs	(7.5)	0.0	(17.3)
Fees paid related to debt refinancing	(2.6)	0.0	(2.0)
Other repayments of long-term debt	(10.6)	(28.1)	(10.3)
Restricted stock withholdings for payroll taxes	(2.9)	(4.3)	(4.1)
Payments on finance leases	(14.4)	(14.3)	(14.7)
Other	(0.5)	(5.5)	0.0
Net cash used for financing activities	(125.4)	(52.2)	(19.9)
Effect of exchange rate changes on cash and cash equivalents	(12.5)	(20.3)	(5.0)
Increase (decrease) in cash and cash equivalents	174.6	(32.8)	52.0
Cash and cash equivalents:
Beginning of period	674.5	707.3	655.3
End of period	849.1	674.5	707.3
NCM | CUSA [Member]
Adjustments to reconcile net (loss) income to cash provided by operating activities:
Interest accrued on NCM screen advertising advances	22.6	23.2	23.6
Amortization of NCM screen advertising advances and other deferred revenues	(32.4)	(32.5)	(32.4)
NCM | CNK [Member]
Adjustments to reconcile net (loss) income to cash provided by operating activities:
Interest accrued on NCM screen advertising advances	22.6	23.2	23.6
Amortization of NCM screen advertising advances and other deferred revenues	(32.4)	(32.5)	(32.4)
NCMI [Member] | CUSA [Member]
Adjustments to reconcile net (loss) income to cash provided by operating activities:
Unrealized gain on investment in NCMI	12.4	0.0	0.0
NCMI [Member] | CNK [Member]
Adjustments to reconcile net (loss) income to cash provided by operating activities:
Unrealized gain on investment in NCMI	$ (12.4)	$ 0.0	$ 0.0

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - 8.75% Secured Notes $ in Millions	May 01, 2023 USD ($)
Debt instrument, face amount	$ 100.0
CNK [Member]
Debt instrument, face amount	$ 100.0
Debt instrument, redemption price, percentage	102.20%
CUSA [Member]
Debt instrument, face amount	$ 100.0
Debt instrument, redemption price, percentage	102.20%

XML

Pay vs Performance Disclosure - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Pay vs Performance Disclosure
Net Income (Loss)	$ 188.2	$ (271.2)	$ (422.8)

XML

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Dec. 31, 2023

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

1.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Business — Cinemark Holdings, Inc. (“Holdings”) is a holding company and its wholly-owned subsidiary is Cinemark USA, Inc. (“CUSA”). Holdings consolidates CUSA and its subsidiaries for financial statement purposes, and CUSA’s operating revenue and operating expenses comprise nearly 100% of Holdings’ revenue and operating expenses. As such, the following Notes to Consolidated Financial Statements relate to Holdings and CUSA and their respective consolidated subsidiaries in all material aspects, unless otherwise noted. Where it is important to distinguish between Holdings and CUSA, specific reference is made to either Holdings or CUSA. Otherwise, all references to “we”, “our”, “us” and “the Company” relate to Cinemark Holdings, Inc. and its consolidated subsidiaries and all references to CUSA relate to CUSA and its consolidated subsidiaries. We operate in the motion picture exhibition industry, with theatres in the United States (“U.S.”) and in 13 countries in Latin America as of December 31, 2023.

Principles of Consolidation — The consolidated financial statements include the accounts of Cinemark Holdings, Inc. and its subsidiaries and Cinemark USA, Inc. and its subsidiaries. Majority-owned subsidiaries that Holdings or CUSA, as applicable, has control of are consolidated while those investments in entities of which Holdings or CUSA, as applicable, owns between 20% and 50% and does not control, but has significant influence over the investee, are accounted for under the equity method. Investments in entities of which Holdings or CUSA, as applicable, owns between 20% and 50% and does not control or have significant influence over are accounted for under the fair value method. If Holdings or CUSA cease to exercise significant influence over an equity investee, the investment is accounted for under the fair value method. Investments in entities of which Holdings or CUSA, as applicable, owns less than 20% are generally accounted for under the cost method. The results of these subsidiaries and other investees are included in the consolidated financial statements of Holdings and CUSA, as applicable, effective from their date of formation or from their date of acquisition. Intercompany balances and transactions are eliminated in consolidation.

Cash and Cash Equivalents — Cash and cash equivalents consist of operating funds held in financial institutions, petty cash held at the theatres, highly liquid investments with original maturities of three months or less when purchased and restricted cash. The Company invests its cash primarily in money market funds, certificates of deposit, commercial paper or other similar funds.

Accounts Receivable – Accounts receivable, which are recorded at net realizable value, consist primarily of receivables related to screen advertising, screen rental, receivables related to gift cards sold to third party retail locations, receivables from landlords related to theatre construction projects, rebates earned from the Company’s concession vendors and value-added and other non-income tax receivables.

Inventories — Concession inventories are stated at the lower of cost (first-in, first-out method) or net realizable value.

Theatre Properties and Equipment — Theatre properties and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets as follows:

Category	Useful Life
Buildings on owned land	40 years
Buildings on leased land	Lesser of lease term or 40 years
Land and buildings under finance leases	Lease term
Theatre furniture and equipment	3 to 15 years
Leasehold improvements	Lesser of lease term or useful life

The Company evaluates long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable (qualitative evaluation). The Company also performs a full quantitative impairment evaluation on an annual basis.

These qualitative and quantitative evaluations are described below:

•Quantitative approach The Company performs a quantitative evaluation at the theatre level using estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the remaining lease period, which may include the probability of the exercise of available renewal periods for leased properties, and the lesser of twenty years or the building’s remaining useful life for owned properties. If the estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, the Company then compares the carrying value of the asset group (theatre) with its estimated fair value. When estimated fair value is determined to be lower than the carrying value of the asset group (theatre), the asset group (theatre) is written down to its estimated fair value. Significant judgment, including management’s estimate of future theatre level cash flows for each theatre is involved in estimating fair value. Fair value is estimated based on a multiple of cash flows. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy, as defined by FASB ASC Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples.

•Qualitative approach The Company’s qualitative assessment considers relevant economic and market conditions, industry trading multiples and recent developments that would impact its estimates of future cash flows as compared to its most recent quantitative impairment assessment.

Goodwill and Other Intangible Assets — The Company evaluates goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable. The Company evaluates goodwill for impairment at the reporting unit level. which is the U.S. and each of its international countries that has been allocated goodwill (the Company does not have goodwill recorded for all of its international locations). Under ASC Topic 350, Goodwill, Intangibles and Other (“ASC Topic 350”), the Company can elect to perform a qualitative or a quantitative impairment assessment of our goodwill as described below:

•Quantitative approach Under a quantitative goodwill impairment analysis, the Company estimates the fair value of each reporting unit and compares it with its carrying value. Fair value is estimated using (i) a market approach, which considers a multiple of cash flows for each reporting unit based upon public trading and recent transaction valuation multiples as the basis for fair value and (ii) an income approach, which uses a discounted cash flow model incorporating discount rates commensurate with the risks involved as the basis for fair value. Significant judgment including management’s estimate of future theatre level cash flows for each theatre is involved in estimating fair value of a reporting unit. The Company’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on projected operating performance of each reporting unit, recent market transactions and current industry trading multiples.

•Qualitative approach The Company’s qualitative assessment of goodwill for each reporting unit considers economic and market conditions, industry trading multiples and the impact of recent developments that would impact the estimated fair values as determined during its most recent quantitative assessment.

Tradename intangible assets are tested for impairment at least annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. Under ASC Topic 350, the Company can elect to perform a qualitative or quantitative impairment assessment for our tradename intangible assets as described below:

•Quantitative approach The Company compares the carrying values of its tradename assets to their estimated fair values. Fair values are estimated by applying an estimated market royalty rate that could be charged for the use of the tradenames to forecasted future revenues, with an adjustment for the present value of such royalties. If the estimated fair value is less than the carrying value, the tradename intangible asset is written down to its estimated fair value. Significant judgment is involved in estimating market royalty rates and long-term revenue forecasts. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected revenue performance and industry trends.

•Qualitative approach The Company’s qualitative assessment considers industry and market conditions and recent developments that may impact the revenue forecasts and other estimates as compared to its most recent quantitative assessment.

The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset:

Intangible Asset	Amortization Method
Goodwill	Indefinite-lived
Tradename	Indefinite-lived and definite-lived. Definite-lived tradename asset has a remaining useful life of approximately one year.
Other intangible assets	Straight-line method over the terms of the underlying agreement. The remaining useful lives of these intangible assets is two years.

Lease Accounting — See Note 4 for discussion of the Company’s lease accounting policies.

Deferred Charges and Other Assets — Deferred charges and other assets consist of construction, lease and other deposits, equipment to be placed in service, and other assets of a long-term nature.

Self-Insurance Reserves — In the U.S., the Company is self-insured for general liability claims, which are capped at $0.3 per occurrence with no aggregate annual cap. For its international locations, the Company is fully insured for general liability claims with little or no deductibles per occurrence. Under the Company’s fully-funded deductible workers compensation insurance plan in the U.S., the Company is responsible for pre-funding claims and is responsible for claims up to $0.3 per occurrence, with an annual cap of $5.0. The Company is also self-insured for domestic medical and dental claims with a cap of $0.3 per occurrence. As of December 31, 2022 and 2023, the Company’s self-insurance reserves were $10.0 and $11.4, respectively, and are reflected in accrued other current liabilities on the consolidated balance sheets. For its international locations, the Company is fully insured for workers compensation claims. Medical and dental benefits for the Company’s international locations are covered through a government-sponsored healthcare system that is funded through employee and employer payroll tax contributions.

Revenue Recognition — See Note 5 for discussion of revenue recognition and deferred revenue.

Expenses — Film rental costs are based on the film licensing arrangements and accrued based on the applicable box office receipts and either; 1) a sliding scale formula, which is generally established with the studio prior to the opening of the film, 2) a firm terms formula as negotiated prior to a film's theatrical run or 3) estimates of the final settlement rate, which occurs at the conclusion of the film’s run. Under a sliding scale formula, the Company pays a percentage of box office revenues using a pre-determined scale that is based upon box office performance of the film for its full theatrical run. Under a firm terms formula, the Company pays the distributor a percentage of box office receipts that can either be an aggregate rate for the full theatrical run or rates that decline over the term of the theatrical run. The settlement process allows for negotiation of film rental fees upon the conclusion of the film's theatrical run based upon how the film performs. Estimates are based on the expected success of a film. The success of a film can generally be determined a few weeks after a film is released when the initial box office performance of the film is known. If actual box office performance differs from our estimates, film rental costs are adjusted accordingly throughout a film’s theatrical run.

Accounting for Share Based Awards — The Company measures the cost of employee services received in exchange for an equity award based on the fair value of the award on the date of the grant. The grant date fair value is based on Holdings’ stock price on the grant date. Such costs are recognized over the period during which an employee is required to provide service in exchange for the award (which is usually the vesting period). At the time of the grant, Holdings also estimates the number of awards that will ultimately be forfeited. Holdings also periodically estimates the number of awards that will ultimately vest based upon the achievement of pre-established Company performance targets on those awards that are both performance-based and time-based. A cumulative expense adjustment is recognized when that estimate changes. See Note 18 for discussion of Holdings’ share based awards and related compensation expense.

Income Taxes — The Company uses an asset and liability approach to financial accounting and reporting for income taxes. CUSA participates in the consolidated return of Holdings; however, CUSA’s provisions for income taxes is computed on a stand-alone basis. Deferred income taxes are provided when tax laws and financial accounting standards differ with respect to the amount of income for a year and the basis of assets and liabilities. A valuation allowance is recorded to reduce the carrying amount of deferred tax assets unless it is more likely than not that such assets will be realized. Income taxes are provided on unremitted earnings from foreign subsidiaries unless such earnings are expected to be indefinitely reinvested. Income taxes have also been provided for potential tax assessments. The evaluation of an uncertain tax position is a two-step process. The first step is recognition: The Company determines whether it is more likely than not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, the Company should presume that the position would be examined by the appropriate taxing authority that would have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Differences between tax positions taken in a tax return and amounts recognized in the financial statements result in (1) a change in a liability for income taxes payable or (2) a change in an income tax refund receivable, a deferred tax asset or a deferred tax liability or both (1) and (2). The Company accrues interest and penalties on its uncertain tax positions as a component of income tax expense. See further discussion in Note 20.

Segments — For the years ended December 31, 2021, 2022 and 2023, the Company managed its business under two reportable operating segments, U.S. markets and international markets. See Note 22.

Use of Estimates — The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The Company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates.

Foreign Currency Translations — The assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. dollars at current exchange rates as of the balance sheet date, and revenues and expenses are translated at average monthly exchange rates. The resulting translation adjustments are recorded in the consolidated balance sheets in accumulated other comprehensive loss. See Note 16 for a summary of the translation adjustments recorded in accumulated other comprehensive loss for the years ended December 31, 2021, 2022 and 2023. The Company recognizes foreign currency transaction gains and losses when changes in exchange rates impact transactions, other than intercompany transactions of a long-term investment nature, that have been denominated in a currency other than the functional currency.

The Company deemed Argentina to be highly inflationary beginning July 1, 2018. A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity. The financial statements of the Company’s Argentina subsidiaries have been remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters, effective beginning July 1, 2018. See further discussion in Note 16.

During 2019, the Argentine government instituted exchange controls restricting the ability of entities and individuals to exchange Argentine pesos for foreign currencies and to remit foreign currency out of Argentina. As a result of these currency exchange controls, markets in Argentina developed a legal trading mechanism known as the Blue Chip Swap that allows entities to transfer U.S. dollars out of and into Argentina. In a Blue Chip Swap transaction, an entity buys U.S. dollar denominated securities in Argentina using Argentine pesos, and subsequently sells the securities for U.S. dollars, in Argentina, to access U.S. dollars locally, or outside Argentina, by transferring the securities abroad, prior to being sold (the latter commonly known as Blue Chip Swap Rate). The Blue Chip Swap rate is the implicit exchange rate resulting from the Blue Chip Swap transaction. The Blue Chip Swap rate can diverge significantly from Argentina’s official exchange rate. See further discussion in Note 16.

Fair Value Measurements — According to authoritative guidance, inputs used in fair value measurements fall into three different categories; Level 1, Level 2 and Level 3. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for the asset or liability. See Note 15 for a discussion of our fair value measurements for the years ended December 31, 2021, 2022 and 2023.

Interest Rate Swaps – The Company evaluates its interest rate swap agreements, which are designated as cash flow hedges, to determine whether they are effective on a quarterly basis in accordance with ASC Topic 815, Derivatives and Hedging. The fair values of the interest rate swaps are estimated based on future estimated net cash flows considering forecasted interest rates for the terms of the interest rate swap agreements as compared to the fixed interest rates paid under the agreements. If deemed to be effective, fair value estimates are recorded on the consolidated balance sheets as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss. If the swaps are determined to not be effective, the gains or losses are recorded in interest expense on the consolidated income statement. See further discussion in Note 14.

Restructuring Charges – During the year ended December 31, 2020, the Company recorded restructuring charges based on an approved and announced restructuring plan, specifically related to headcount reductions, the permanent closure of underperforming theatres and the write-down of related theatre assets. The costs of the restructuring actions were accrued based on estimates at the time the plan was formalized. Adjustments made to restructuring charges based on actual costs incurred were recorded during the years ended December 31, 2021 and 2022. The balance of accrued and unpaid restructuring charges at December 31, 2022 and 2023 was $0. See further discussion in Note 3.

XML

NEW ACCOUNTING PRONOUNCEMENTS

12 Months Ended

Dec. 31, 2023

Accounting Changes and Error Corrections [Abstract]

NEW ACCOUNTING PRONOUNCEMENTS

2.NEW ACCOUNTING PRONOUNCEMENTS

ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, (“ASU 2020-04”), ASU 2021-01, Reference Rate Reform (Topic 848): Scope, (“ASU 2021-01”), and ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 (“ASU 2022-06”). The purpose of ASU 2020-04 is to provide optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. More specifically, the amendments in ASU 2020-04 provide optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in ASU 2021-01 clarify that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The amendments in ASU 2022-06 deferred the sunset date of Topic 848 from December 31, 2022 to December 31, 2024, after which entities will no longer be permitted to apply the relief in Topic 848. The amendments in ASU 2020-04 and ASU 2021-01 are effective as of March 12, 2020 through December 31, 2024. The Company applied the optional relief guidance prospectively to the modification of the reference rate in its interest rate swap agreements from LIBOR to Term SOFR during the second quarter of 2023 (see Note 14). The application of the guidance did not have a material impact on the Company’s consolidated financial statements.

ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). The purpose of ASU 2023-07 is to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses to enable investors to better understand an entity’s overall performance and assess potential future cash flows. In addition, the amendments of ASU 2023-07 enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple measures of profit or loss, provide new segment disclosure requirements for entities with a single reportable segment, and contain other disclosure requirements. The amendments in ASU 2023-07 are effective for all public entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is in the process of evaluating the impact of adopting the additional disclosure requirements of ASU 2023-07.

ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). The purpose of ASU 2023-09 is to enhance the transparency and decision usefulness of income tax disclosures to provide information to better assess how an entity’s operations and related tax risks and tax planning and operational

opportunities affect its tax rate and prospects for future cash flows. The amendments in ASU-2023-09 require that public entities, on an annual basis, (i) disclose specific categories in the income tax rate reconciliation and (ii) provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pre-tax income or loss by the applicable statutory income tax rate). The amendments in ASU 2023-09 are effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is evaluating the impact of adopting ASU 2023-09 on its consolidated financial statements.

XML

IMPACT OF THE COVID-19 PANDEMIC

12 Months Ended

Dec. 31, 2023

Unusual or Infrequent Items, or Both [Abstract]

Impact of The COVID-19 Pandemic

3.IMPACT OF THE COVID-19 PANDEMIC

The impact of the COVID-19 pandemic had an unprecedented effect on the theatrical exhibition industry. We temporarily closed our theatres in the U.S. and Latin America during March of 2020 at the onset of the COVID-19 outbreak. We reopened theatres as soon as local restrictions and the status of the COVID-19 pandemic would allow. All of our domestic and international theatres were reopened by the end of 2021. After reopening our theatres, we faced ongoing challenges with the significant reduction in the volume of new film releases. The industry has made significant progress in its recovery from the COVID-19 pandemic; however its ongoing recovery continues to be contingent upon several key factors, including the volume of new film content available, which has also been impacted by the recent writers’ and actors’ guild strikes, the box office performance of new film content released, the duration of the exclusive theatrical release window, and evolving consumer behavior with competition from other forms of in-and-out-of-home entertainment.

Government Assistance

During the years ended December 31, 2021 and 2022, the Company received an aggregate of approximately $2.8 in government assistance pursuant to (i) payroll continuation support programs under the CARES Act, (ii) various grants provided in certain states intended to cover janitorial and personal protection equipment costs incurred by the Company in response to local regulations and (iii) subsidies for certain payroll costs in certain international locations. The Company has met all applicable conditions related to the government assistance received. The government assistance received was reflected as credits to salaries and wages, utilities and other costs, and general and administrative expenses in the consolidated statements of loss.

Restructuring Charges

In 2020, Company management approved and announced a restructuring plan to realign its operations to create a more efficient cost structure (referred to herein as the “Restructuring Plan”) in response to the COVID-19 pandemic. The Restructuring Plan primarily included a headcount reduction at its domestic corporate office and the permanent closure of certain domestic and international theatres.

The following table summarizes activity recorded during the years ended December 31, 2021 and 2022:

	U.S. Operating Segment									International Operating Segment								Consolidated
	Employee-related Costs			Facility Closure Costs			Total Charges			Employee-related Costs		Facility Closure Costs			Total Charges			Employee-related Costs			Facility Closure Costs			Total Charges
Reserve balance at January 1, 2021	$	0.9		$	5.7		$	6.6		$	—	$	0.1		$	0.1		$	0.9		$	5.8		$	6.7
Amounts paid		(0.4	)		(3.9	)		(4.3	)		—		—			—			(0.4	)		(3.9	)		(4.3	)
Reserve adjustments (1)		(0.1	)		(0.9	)		(1.0	)		—		—			—			(0.1	)		(0.9	)		(1.0	)
Reserve balance at December 31, 2021	$	0.4		$	0.9		$	1.3		$	—	$	0.1		$	0.1		$	0.4		$	1.0		$	1.4
Amounts paid		(0.4	)		(0.5	)		(0.9	)		—		—			—			(0.4	)		(0.5	)		(0.9	)
Reserve adjustments (1)		—			(0.4	)		(0.4	)		—		(0.1	)		(0.1	)		—			(0.5	)		(0.5	)
Reserve balance at December 31, 2022	$	—		$	—		$	—		$	—	$	—		$	—		$	—		$	—		$	—

Amounts were primarily adjustments based on final facility lease payments for certain closed theatres as compared with original estimates recorded.

XML

LEASE ACCOUNTING

12 Months Ended

Dec. 31, 2023

Leases [Abstract]

Lease Accounting

4.LEASE ACCOUNTING

Real Estate Leases — The Company conducts a significant part of its theatre operations in leased properties under noncancelable operating and finance leases with base terms generally ranging from 10 to 25 years. In addition to fixed lease payments, some of the leases provide for variable lease payments and some require the payment of taxes, insurance, common area maintenance and other costs applicable to the property. Variable lease payments include payments based on a percentage of retail sales or a percentage of retail sales over defined thresholds. Other variable lease payments include payments adjusted periodically for inflation, changes in attendance or changes in average ticket price. The Company can renew, at its option, many of its leases at defined or then market rental rates for various renewal periods. Some leases also provide for escalating rent payments throughout the lease term. The Company also leases certain office and warehouse facilities in the U.S. and in international locations, which generally only include fixed payments. The Company recognizes fixed lease expense for the operating leases on a straight-line basis over the lease term. The Company’s real estate lease agreements do not contain any residual value guarantees or restrictive covenants.

Equipment Leases — The Company leases certain equipment under operating leases, including trash compactors and various other equipment used in the day-to-day operation of its theatres. Certain of the leases require fixed lease payments to be made over the duration of the lease term, while others are variable in nature based on usage or sales. Certain of these leases are month-to-month, while others have noncancelable terms ranging from 1 to 7 years. The Company’s equipment lease agreements do not contain any residual value guarantees or restrictive covenants.

The following table represents the operating and finance right-of-use assets and lease liabilities as of the periods indicated.

		As of
Leases	Classification	December 31, 2022		December 31, 2023
Assets (1)
Operating lease assets	Operating lease right-of-use assets	$	1,102.7	$	986.4
Finance lease assets	Theatre properties and equipment, net of accumulated depreciation (2)		67.8		55.7
Total lease assets		$	1,170.5	$	1,042.1
Liabilities (1)
Current
Operating	Current portion of operating lease obligations	$	219.3	$	212.5
Finance	Current portion of finance lease obligations		14.4		14.0
Noncurrent
Operating	Operating lease obligations, less current portion		970.6		853.3
Finance	Finance lease obligations, less current portion		88.0		73.8
Total lease liabilities		$	1,292.3	$	1,153.6

(1)The operating lease right-of-use assets and liabilities recorded on the Company’s consolidated balance sheets generally do not include renewal options that have not yet been exercised. The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord after consideration of market conditions and performance of the theatre.

(2)Finance lease assets are net of accumulated amortization of $62.5 and $73.9 as of December 31, 2022 and 2023, respectively.

As of December 31, 2023, the Company had signed lease agreements with total noncancelable lease payments of approximately $44.8 related to theatre leases that had not yet commenced. The timing of lease commencement is dependent on the completion of construction of the related theatre facility. Additionally, these amounts are based on estimated square footage and costs to construct each facility and may be subject to adjustment upon final completion of each construction project. In accordance with ASC Topic 842, fixed minimum lease payments related to these theatres are not included in the right-of-use assets and lease liabilities as of December 31, 2023.

The following table represents the Company’s aggregate lease costs, by lease classification, for the periods indicated.

		Year Ended December 31,
Lease Cost	Classification	2021		2022		2023
Operating lease costs
Equipment (1)	Utilities and other	$	2.3	$	4.4	$	4.1
Real Estate (1)	Facility lease expense		281.0		315.7		348.6
Total operating lease costs		$	283.3	$	320.1	$	352.7
Finance lease costs
Depreciation of leased assets	Depreciation and amortization	$	12.6	$	12.4	$	12.0
Interest on lease liabilities	Interest expense		5.9		5.3		4.9
Total finance lease costs		$	18.5	$	17.7	$	16.9

(1)Includes short-term lease payments, variable lease payments and office lease payments reflected in general and administrative expense as set forth in the following table for the periods presented:

		Year Ended December 31,
Lease Cost	Classification	2021		2022		2023
Operating lease costs
Equipment - Short-term and variable lease payments	Utilities and other	$	1.8	$	3.9	$	3.6
Real Estate - Variable lease payments (1)	Facility lease expense	$	11.8	$	36.4	$	68.3
Real Estate - Office leases	General and administrative	$	1.3	$	1.3	$	1.4

(1) Represents lease payments that are based on a change in index, such as CPI or inflation, variable payments based on revenue or attendance and variable common area maintenance costs.

The following table represents the maturity of lease liabilities, by lease classification, as of December 31, 2023.

	Operating		Finance
Years Ending	Leases		Leases
2024	$	267.2	$	18.0
2025		237.4		16.4
2026		199.6		12.0
2027		158.5		11.9
2028		121.9		11.6
Thereafter		295.4		35.1
Total lease payments	$	1,280.0	$	105.0
Less: Interest		214.2		17.2
Present value of lease liabilities	$	1,065.8	$	87.8

The following table represents the weighted-average remaining lease term and discount rate, disaggregated by lease classification, as of December 31, 2023.

	As of
Lease Term and Discount Rate	December 31, 2023
Weighted-average remaining lease term (years) (1)
Operating leases - equipment		3.3
Operating leases - real estate		6.4
Finance leases - equipment		2.6
Finance leases - real estate		7.6
Weighted-average discount rate (2)
Operating leases - equipment		6.3	%
Operating leases - real estate		11.5	%
Finance leases - equipment		3.6	%
Finance leases - real estate		4.9	%

(1)The lease assets and liabilities recorded on the Company’s consolidated balance sheets generally do not include renewal options that have not yet been executed. The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord after consideration of market conditions and performance of the theatre.

(2)The discount rate for each lease represents the incremental borrowing rate at which the Company would borrow funds, on a collateralized basis, over a similar term and at an amount equal to the lease payments in a similar economic environment.

The following table represents the minimum cash lease payments included in the measurement of lease liabilities and the non-cash addition of right-of-use assets for the periods presented.

	Year Ended December 31,
Other Information	2021		2022		2023
Cash paid for amounts included in the measurement of lease liabilities
Cash outflows for operating leases	$	269.7	$	279.8	$	280.8
Cash outflows for finance leases - operating activities	$	5.9	$	5.3	$	4.9
Cash outflows for finance leases - financing activities	$	14.7	$	14.3	$	14.4
Non-cash amount of leased assets obtained in exchange for:
Operating lease liabilities	$	180.1	$	114.1	$	87.0
Finance lease liabilities	$	0.7	$	—	$	—

Lessor Arrangements

Under the Company’s Exhibitor Services Agreement (“ESA”) with National CineMedia, LLC (“NCM”), the nonconsecutive periods of use of the theatre screens by NCM qualify as a lease in accordance with ASC Topic 842. See further discussion in Note 9.

The Company rents its theatre auditoriums for corporate meetings, screenings, education and training sessions and other private events. These rentals, which are not significant to the Company, are generally one-time events and the related revenue is reflected as other revenue on the consolidated statements of income (loss).

XML

REVENUE RECOGNITION

12 Months Ended

Dec. 31, 2023

Revenue from Contract with Customer [Abstract]

REVENUE RECOGNITION

5.REVENUE RECOGNITION

Revenue Recognition Policy

The Company’s patrons have the option to purchase movie tickets well in advance of a movie showtime, right before the movie showtime, or at any point in between those two timeframes depending on seat availability. The Company recognizes such admissions revenue when the showtime for a purchased movie ticket has passed. Concession revenue is recognized when products are sold to the consumer, or if purchased in advance, once the showtime associated with the customer’s movie ticket has passed. Other revenue primarily consists of screen advertising, screen rental revenue, promotional income, studio trailer placements and transactional fees. Except for NCM screen advertising advances discussed below in Note 9, these revenues are generally recognized when the Company has fulfilled its performance obligations by providing the specified services.

The Company sells gift cards and discount ticket vouchers, the proceeds from which are recorded as deferred revenue. Deferred revenue for gift cards and discount ticket vouchers is recognized when they are redeemed for concession items or, if redeemed for movie tickets, when the showtime has passed. The Company generally records breakage revenue on gift cards and discount ticket vouchers based on redemption activity and historical experience with unused balances.

The Company offers a subscription program in the U.S. whereby patrons can pay a monthly or annual fee to receive a monthly credit for use towards a future movie ticket purchase. We also offer monthly subscription fee programs in several of our international locations where customers can pay a monthly fee to receive benefits such as a free monthly ticket. The Company records the subscription program fees as deferred revenue and records admissions revenue when the showtime for a movie ticket purchased with a credit has passed.

The Company has loyalty programs in the U.S. and many of its international locations that either have a prepaid annual fee or award points to customers as purchases are made. For those loyalty programs that have a prepaid annual fee, the Company recognizes the fee collected as other revenue on a straight-line basis over the annual membership period. For those loyalty programs that award points to customers based on their purchases, the Company records a portion of the original transaction proceeds as deferred revenue based on the number of reward points issued to customers and recognizes the deferred revenue when the customer redeems such points. The value of loyalty points issued is based on the estimated fair value of the rewards offered. The Company records breakage revenue generally upon the expiration of loyalty points and subscription credits as the Company does not yet have sufficient historical data related to the redemption patterns for these programs to estimate breakage.

Accounts receivable as of December 31, 2022 and 2023 included approximately $22.9 and $31.6, respectively, of receivables related to contracts with customers. The Company did not record any assets related to the costs to obtain or fulfill a contract with customers during the years ended December 31, 2022 or 2023.

Disaggregation of Revenue

The following tables present revenue for the periods indicated, disaggregated based on major type of good or service and by reportable operating segment.

	Year Ended December 31, 2023
	U.S.		International
	Operating		Operating
Major Goods/Services	Segment (1)		Segment		Consolidated
Admissions Revenue	$	1,236.0	$	319.6	$	1,555.6
Concession Revenue		952.0		240.0		1,192.0
Screen advertising, screen rental and promotional revenue		91.0		53.6		144.6
Other Revenue		136.3		38.2		174.5
Total Revenue	$	2,415.3	$	651.4	$	3,066.7

	Year Ended December 31, 2022
	U.S.		International
	Operating		Operating
Major Goods/Services	Segment (1)		Segment		Consolidated
Admissions Revenue	$	1,010.2	$	236.7	$	1,246.9
Concession Revenue		763.0		175.3		938.3
Screen advertising, screen rental and promotional revenue		81.7		45.3		127.0
Other Revenue		115.3		27.2		142.5
Total Revenue	$	1,970.2	$	484.5	$	2,454.7

	Year Ended December 31, 2021
	U.S.		International
	Operating		Operating
Major Goods/Services	Segment (1)		Segment		Consolidated
Admissions Revenue	$	671.7	$	108.3	$	780.0
Concession Revenue		482.8		78.9		561.7
Screen advertising, screen rental and promotional revenue		66.2		17.9		84.1
Other Revenue		72.9		11.8		84.7
Total Revenue	$	1,293.6	$	216.9	$	1,510.5

(1)U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 22 for additional information on intercompany eliminations.

The following tables present revenue for the periods indicated, disaggregated based on timing of revenue recognition (as discussed above) and by reportable segment.

	Year Ended December 31, 2023
	U.S.		International
	Operating		Operating
	Segment (1)		Segment		Consolidated
Goods and services transferred at a point in time	$	2,327.9	$	588.9	$	2,916.8
Goods and services transferred over time		87.4		62.5		149.9
Total	$	2,415.3	$	651.4	$	3,066.7

	Year Ended December 31, 2022
	U.S.		International
	Operating		Operating
	Segment (1)		Segment		Consolidated
Goods and services transferred at a point in time	$	1,856.5	$	428.3	$	2,284.8
Goods and services transferred over time		113.7		56.2		169.9
Total	$	1,970.2	$	484.5	$	2,454.7

	Year Ended December 31, 2021
	U.S.		International
	Operating		Operating
	Segment (1)		Segment		Consolidated
Goods and services transferred at a point in time	$	1,201.2	$	193.7	$	1,394.9
Goods and services transferred over time		92.4		23.2		115.6
Total	$	1,293.6	$	216.9	$	1,510.5

(1)U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 22 for additional information on intercompany eliminations.

Screen Advertising Advances and Other Deferred Revenue

The following table presents changes in the Company’s deferred revenue for the periods indicated:

Deferred Revenue	NCM Screen Advertising Advances (2)			Other Deferred Revenue (3)
Balance at January 1, 2022	$	346.0		$	160.3
Amounts recognized as accounts receivable		—			1.8
Cash received from customers in advance		—			241.1
Common units received from NCM (see Note 9)		1.3			—
Interest accrued related to significant financing component		23.2			—
Revenue recognized during period		(32.3	)		(206.9	)
Foreign currency translation adjustments		—			(1.4	)
Balance at December 31, 2022		338.2			194.9
Amounts recognized as accounts receivable		—			4.6
Cash received from customers in advance		—			327.4
Dispositions (1)		—			(0.4	)
Interest accrued related to significant financing component		22.6			—
Revenue recognized during period		(32.4	)		(299.5	)
Foreign currency translation adjustments		—			(5.4	)
Balance at December 31, 2023	$	328.4		$	221.6

(1)Relates to the sale of the Company’s Ecuador subsidiary. See Note 8.

(2)See Significant Financing Component in Note 9 for discussion of NCM screen advertising advances and maturity of balances as of December 31, 2023.

(3)Includes liabilities associated with outstanding gift cards and discount ticket vouchers, points or rebates outstanding under the Company’s loyalty and membership programs and revenue not yet recognized for screen advertising and other promotional activities. Amount is classified as accounts payable and accrued expenses or other long-term liabilities on the consolidated balance sheets.

The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied for other deferred revenue in the table above as of December 31, 2023 and when the Company expects to recognize this revenue.

	Year Ended December 31,
Remaining Performance Obligations	2024		2025		Thereafter		Total
Other deferred revenue	$	195.2		26.4		—	$	221.6

XML

EARNINGS (LOSS) PER SHARE

12 Months Ended

Dec. 31, 2023

Earnings Per Share [Abstract]

EARNINGS (LOSS) PER SHARE

6. EARNINGS (LOSS) PER SHARE

The following table presents computations of basic and diluted earnings (loss) per share for Holdings under the two class method:

	Year Ended December 31,
	2021			2022			2023
Numerator:
Net (loss) income attributable to Cinemark Holdings, Inc.	$	(422.8	)	$	(271.2	)	$	188.2
Loss (income) allocated to participating share-based awards (1)		6.1			3.8			(3.3	)
Basic net (loss) income attributable to common stockholders	$	(416.7	)	$	(267.4	)	$	184.9
Add: Interest expense on convertible notes, net of tax (3)		—			—		$	18.2
Diluted net (loss) income attributable to common stockholders	$	(416.7	)	$	(267.4	)	$	203.1
Denominator:
Basic weighted average shares outstanding		117.3			118.2			119.1
Common equivalent shares for restricted performance stock units (2)		—			—			0.9
Common equivalent shares for convertible notes (3)		—			—			32.0
Common equivalent shares for warrants (4)		—			—			—
Diluted weighted average shares outstanding		117.3			118.2			152.0
Basic (loss) earnings per share attributable to common stockholders	$	(3.55	)	$	(2.26	)	$	1.55
Diluted (loss) earnings per share attributable to common stockholders	$	(3.55	)	$	(2.26	)	$	1.34

(1)For the years ended December 31, 2021, 2022 and 2023, a weighted average of approximately 1.7 shares, 1.7 shares and 2.1 shares of unvested restricted stock, respectively, are considered participating securities.

(2)For the years ended December 31, 2021 and 2022, approximately 0.0 and 0.4 common equivalent shares for performance stock units were excluded because they were anti-dilutive.

(3)For the years ended December 31, 2021 and 2022, diluted loss per share excludes the assumed conversion of the 4.50% Convertible Senior Notes into 32.0 shares of common stock, as they would have been anti-dilutive. See further discussion below.

(4)For all periods presented, diluted earnings (loss) per share excludes the warrants, as they would be anti-dilutive.

Share-based awards

Holdings considers its unvested share-based payment awards, which contain non-forfeitable rights to dividends, participating securities, and includes such participating securities in its computation of earnings (loss) per share pursuant to the two-class method. Basic earnings (loss) per share for the two classes of stock (common stock and unvested restricted stock) is calculated by dividing net income (loss) by the weighted average number of shares of common stock and unvested restricted stock outstanding during the reporting period. Diluted earnings (loss) per share is calculated using the weighted average number of shares of common stock plus the potentially dilutive effect of common equivalent shares outstanding determined under both the two-class method and the treasury stock method.

Convertible notes, hedges and warrants

The 4.50% Convertible Senior Notes, discussed further in Note 14, are dilutive in periods in which Holdings has net income. The impact of such dilution on earnings per share is calculated under the if-converted method, which requires that all of the shares of Holdings’ common stock issuable upon conversion of the 4.50% Convertible Senior Notes be included in the calculation of diluted EPS assuming conversion at the beginning of the reporting period.

The closing price of Holdings’ common stock did not exceed the strike price of $18.66 per share (130% of the initial exercise price of $14.35 per share) during at least 20 of the last 30 trading days of the quarter ended December 31, 2023 and, therefore, the 4.50% Convertible Senior Notes will not be convertible during the first quarter of 2024. The converted value of the 4.50% Convertible Senior Notes, based on the weighted average closing price of

Holdings’ common stock for 2023, exceeded the aggregate outstanding principal of the notes by $23.3 as of December 31, 2023.

As noted in Note 14, Holdings entered into hedge transactions with counterparties in connection with the issuance of the 4.50% Convertible Senior Notes. The convertible note hedge transactions cover, subject to anti-dilution adjustments substantially similar to those applicable to the 4.50% Convertible Senior Notes, the number of shares of Holdings’ common stock underlying the 4.50% Convertible Notes, which initially gives Holdings the option to purchase approximately 32.0 shares of its common stock at a price of approximately $14.35 per share. Concurrently with entering into the convertible note hedge transactions, Holdings also entered into warrant transactions with each option counterparty whereby Holdings sold to such option counterparty warrants to purchase, subject to customary anti-dilution adjustments, up to the same number of shares of Holdings’ common stock, which initially gives the option counterparties the option to purchase approximately 32.0 shares at a price of approximately $22.08 per share. The economic effect of these transactions is to effectively raise the strike price of the 4.50% Convertible Senior Notes from approximately $18.66 per share of Holdings’ common stock to approximately $22.08 per share.

XML

DIVIDENDS

12 Months Ended

Dec. 31, 2023

Supplemental Cash Flow Elements [Abstract]

DIVIDENDS

7.DIVIDENDS

The Company suspended its quarterly dividend in March 2020 as a result of the COVID-19 pandemic as discussed in Note 3.

XML

THEATRE PROPERTIES AND EQUIPMENT

12 Months Ended

Dec. 31, 2023

Property, Plant and Equipment, Net [Abstract]

THEATRE PROPERTIES AND EQUIPMENT

8.THEATRE PROPERTIES AND EQUIPMENT

Properties and equipment consisted of the following as of the periods presented:

	December 31,
	2022			2023
Theatre properties and equipment
Land	$	99.7		$	97.8
Buildings		528.9			530.6
Property under finance lease		130.3			129.6
Theatre furniture and equipment		1,429.5			1,432.8
Leasehold interests and improvements		1,206.9			1,300.2
Total		3,395.3			3,491.0
Less: accumulated depreciation and amortization (1)		(2,163.2	)		(2,329.3	)
Theatre properties and equipment, net	$	1,232.1		$	1,161.7

(1)Amortization of finance lease assets is included in depreciation and amortization expense on the consolidated statements of income (loss). Accumulated amortization of finance lease assets as of December 31, 2022 and 2023 was $62.5 and $73.9, respectively.

Sale of Subsidiary

During December 2022, the Company entered into a purchase and sale agreement for the sale of the stock of its Ecuador subsidiary. The Company completed the sale in September 2023 and recognized a gain of $6.9, which is reflected in “Loss (gain) on disposal of assets and other” in the Company’s consolidated statement of income for the year ended December 31, 2023. The sale of the Ecuador subsidiary did not qualify as discontinued operations since it did not represent a strategic shift in the Company’s operations that will have a major effect on its results and operations. The following table presents the carrying value of Ecuador’s significant assets and liabilities as of the periods presented:

	December 31,
	2022		2023
Theatre property and equipment, net	$	5.4	$	—
Operating lease right-of-use asset, net		2.9		—
Goodwill		4.2		—
Total assets	$	15.3	$	—
Total liabilities	$	8.5	$	—

The table below summarizes total revenue and operating income for the Ecuador subsidiary for the periods presented:

	Year Ended December 31,
	2022			2023
Total revenue	$	13.3		$	13.5
Operating (loss) income	$	(1.2	)	$	2.0

XML

INVESTMENT IN NATIONAL CINEMEDIA, INC/ NATIONAL CINEMEDIA LLC

12 Months Ended

Dec. 31, 2023

NCM

INVESTMENT IN NATIONAL CINEMEDIA, INC / NATIONAL CINEMEDIA LLC

9.INVESTMENT IN NATIONAL CINEMEDIA, INC / NATIONAL CINEMEDIA LLC

NCM operates a digital in-theatre network in the U.S. for providing cinema advertising. The Company has an investment in NCM’s parent National CineMedia, Inc. (”NCMI”) and previously held an investment in NCM. See further discussion below under Investment in National CineMedia. The Company entered into an Exhibitor Services Agreement with NCM (“ESA”) pursuant to which NCM primarily provides screen advertising to our domestic theatres through its branded “Noovie” pre-show entertainment program. See further discussion below under Exhibitor Services Agreement.

Summary of Activity with NCMI/NCM

Below is a summary of activity with NCMI and NCM included in each of Holdings’ and CUSA’s consolidated financial statements for the periods indicated. See Note 5 for discussion of revenue recognition.

	Investment  in NCMI/NCM			NCM Screen Advertising Advances			Distributions from NCM (5)			Equity in Loss (3)		Other Revenue			Interest Expense - NCM		Cash Received
Balance as of January 1, 2021	$	152.0		$	(344.3	)
Receipt of common units due to annual common unit adjustment		10.2			(10.2	)		—			—		—			—		—
Screen rental revenues earned under ESA (1)		—			—			—			—		(12.0	)		—		12.0
Interest accrued related to significant financing component		—			(23.6	)		—			—		—			23.6		—
Receipt under tax receivable agreement		(0.2	)		—			(0.1	)		—		—			—		0.3
Equity in loss		(26.6	)		—			—			26.6		—			—		—
Amortization of screen advertising advances		—			32.1			—			—		(32.1	)		—		—
Balance as of and for the year ended December 31, 2021	$	135.4		$	(346.0	)	$	(0.1	)	$	26.6	$	(44.1	)	$	23.6	$	12.3
Receipt of common units due to annual common unit adjustment		1.3			(1.3	)		—			—		—			—		—
Screen rental revenues earned under ESA (1)		—			—			—			—		(19.9	)		—		19.9
Interest accrued related to significant financing component		—			(23.2	)		—			—		—			23.2		—
Equity in loss		(13.9	)		—			—			13.9		—			—		—
Impairment of investment in NCM (2)		(113.2	)		—			—			—		—			—		—
Amortization of screen advertising advances		—			32.3			—			—		(32.3	)		—		—
Balance as of and for the year ended December 31, 2022	$	9.6		$	(338.2	)	$	—		$	13.9	$	(52.2	)	$	23.2	$	19.9
Screen rental revenues earned under ESA (1)		—			—			—			—		(20.9	)		—		20.9
Interest accrued related to significant financing component		—			(22.6	)		—			—		—			22.6		—
Redemption of common units of NCM for common stock of NCMI (2)		—			—			—			—		—			—		—
Equity in loss (3)		(3.2	)		—			—			3.2		—			—		—
Impairment of investment in NCMI (4)		(0.7	)		—			—			—		—			—		—
Unrealized gain on fair market value adjustment of investment in NCMI (2)		12.4			—			—			—		—			—		—
Amortization of screen advertising advances		—			32.4			—			—		(32.4	)		—		—
Balance as of and for the year ended December 31, 2023	$	18.1		$	(328.4	)	$	—		$	3.2	$	(53.3	)	$	22.6	$	20.9

(1)Amounts include the per patron and per digital screen theatre access fees, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire were approximately $4.9, $7.5 and $8.9 for the years ended December 31, 2021, 2022 and 2023, respectively. Amounts unpaid and reflected in accounts receivable were $4.9 and $4.9 as of December 31, 2022 and 2023, respectively.

(2)See Investment in National CineMedia below.

(3)Equity in loss was recorded through April 11, 2023, the date NCM filed its bankruptcy petition, after which the Company applied the fair value accounting method as discussed below.

(4)Reflected in impairment of long-lived and other assets on the consolidated income statement for the year indicated. See further discussion at Investment in National CineMedia below.

(5)Excess cash distributions from NCM to its members were restricted through December 2023 in accordance with the credit agreement amendment NCM entered into with its lenders and as a result of their bankruptcy filing. NCMI also suspended its dividend.

In addition to the activity in the table above, the Company made de minimus payments to NCM during the years ended December 31, 2021, 2022 and 2023, respectively, related to certain equipment used for digital advertising, which is included in theatre furniture and equipment on the consolidated balance sheets.

Investment in National CineMedia

On February 13, 2007 NCMI, a holding company that serves as the sole manager of NCM, completed an initial public offering (“IPO”) of its common stock. NCM comprises approximately the entire balance of NCMI’s assets, liabilities and operating cash flows. In connection with the NCMI initial public offering, the Company amended its operating agreement and the ESA. At the time of the NCMI IPO and as a result of amending the ESA, the Company received approximately $174.0 in cash consideration from NCM. The proceeds were recorded as deferred revenue or NCM screen advertising advances, and are being amortized over the term of the Amended and Restated ESA or through February 2041.

As of January 1, 2023, the Company owned approximately 43.7 common units of NCM, which represented an interest in NCM of approximately 25.4%.

On February 17, 2023, the Company delivered a redemption notice to NCM pursuant to the redemption right under its operating agreement with NCM to redeem approximately 42.0 of the Company’s 43.7 common units in NCM in exchange for approximately 42.0 newly issued shares of NCMI common stock, with a redemption date of February 23, 2023 (the “Redemption”). On March 20, 2023, the Company delivered a second redemption notice to NCM to redeem the Company’s remaining 1.7 common units in NCM in exchange for 1.7 newly issued shares of NCMI common stock, with a redemption date of March 23, 2023 (collectively with the February 23, 2023 redemption, the “Redemptions”). NCMI is a holding company and the sole manager of NCM. NCM comprises approximately the entire balance of NCMI’s assets, liabilities and operating cash flows.

On April 11, 2023, NCM filed a petition for reorganization under Chapter 11 of the United States Bankruptcy Code. NCMI continued to manage NCM, the “debtor in possession,” under the jurisdiction of the bankruptcy court and in accordance with the applicable bankruptcy laws and orders of the bankruptcy court. In general, as debtor in possession under the Bankruptcy Code, NCM was authorized to continue to operate as an ongoing business but could not engage in transactions outside the ordinary course of business without the prior approval of the bankruptcy court.

Due to NCM’s bankruptcy proceedings, the Company reassessed its rights and level of influence over NCM. The Company determined that effective April 11, 2023, the date NCM filed its bankruptcy petition, it no longer had significant influence over NCM and therefore ceased accounting for its investment in NCMI under the equity method of accounting in the second quarter of 2023. During the years ended December 31, 2021 and 2022, and through April 11, 2023, the Company accounted for its investment in NCMI under the equity method of accounting, and therefore assessed its investment for other than temporary impairment during those periods. The Company recorded impairment charges totaling $113.2 and $0.7 on its investment in NCMI/NCM during the years ended December 31, 2022 and 2023, respectively, because the share price of NCMI was significantly below the Company’s carrying value of NCMI per common share and NCM’s pace of recovery from the COVID-19 pandemic lagged that of the Company and the movie theatre industry. See Note 12 for impairment expense recorded during the years ended December 31, 2021, 2022 and 2023.

On August 3, 2023, NCMI announced that it had effected a 1-for-10 reverse stock split of its common stock. NCMI’s common stock automatically began trading on a split adjusted basis at the opening of the market on August 4, 2023. After giving effect to the reverse stock split, the Company owns approximately 4.4 shares of NCMI common stock. NCM emerged from bankruptcy on August 7, 2023, and the Company’s ownership interest in NCMI was reduced to less than 5%. The Company now accounts for its investment in NCMI in accordance with the guidance set forth in FASB ASC Topic 321 Investments - Equity Securities, which requires the Company to measure its investment in common stock of NCMI at fair value and recognize unrealized holding gains and losses on its investment in earnings. The Company recognized an unrealized gain of $12.4 on its investment in NCMI in the Company’s consolidated statement of income for the year ended December 31, 2023.

Common Unit Adjustments

In addition to the consideration received upon the NCMI IPO and ESA modification in 2007, the Company also periodically receives consideration in the form of common units from NCM. Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCMI and the Company, annual adjustments to the common membership units are made primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated by the Company. The common units received are recorded at estimated fair value as an increase in the Company’s investment in NCM with an offset to deferred revenue or NCM screen advertising advances. Through April 11, 2023, the Company’s investment was accounted for under the equity method, with undistributed equity earnings related to its investment included as a component of earnings in equity in income of affiliates or recorded as a reduction of its investment basis depending on the tranche of common units it was related to.

During March 2023, NCM performed its annual common unit adjustment calculation under the Common Unit Adjustment Agreement. As a result of the calculation, the Company was entitled to an additional 4.8 common units of NCM. The issuance of these additional common units of NCM was stayed by NCM’s bankruptcy filing on April 11, 2023. In June 2023 the bankruptcy court issued an order cancelling the issuance of these common units of NCM and found that these common units were never issued.

Below is a summary of common units received by the Company under the Common Unit Adjustment (“CUA”) Agreement during the years ended December 31, 2021 and 2022:

Event	Date Common Units Received	Number of Common Units Received		Fair Value of Common Units Received (1)
2021 annual common unit adjustment	4/14/2021		2.3	$	10.2
2022 annual common unit adjustment	4/13/2022		0.5	$	1.3

(1) The fair value of the common units received was estimated based on the market price of NCMI common stock (Level 1 input as defined in FASB ASC Topic 820) at the time the common units were determined, adjusted for volatility associated with the estimated time period it would take to convert the common units and register the respective shares.

Exhibitor Services Agreement

As previously discussed, the Company’s domestic theatres are part of the in-theatre digital network operated by NCM, the terms of which are defined in the ESA. NCM primarily provides advertising to its theatres through its branded “Noovie” pre-show entertainment program. The Company receives a monthly theatre access fee for participation in the NCM network. Effective September 17, 2019, the Company signed an amendment to the ESA, under which the Company provided incremental advertising time to NCM, and extended the term through February 2041. At the time of the amendment, the Company determined that the amended ESA met the definition of a lease under ASC Topic 842. The Company leases nonconsecutive periods of use of its domestic theatre screens to NCM for purposes of showing third party advertising content. The lease, which is classified as an operating lease, generally requires variable lease payments based on the number of patrons attending the showtimes during which such advertising is shown. The lease agreement is considered short-term due to the fact that the nonconsecutive periods of use, or advertising time slots, are set on a weekly basis. The revenues earned under the ESA are reflected in other revenue on the consolidated income statements.

The recognition of revenue related to the NCM screen advertising advances is recorded on a straight-line basis over the new term of the amended ESA through February 2041.

	Year Ended December 31,
Remaining Maturity	2024		2025		2026		2027		2028		Thereafter		Total
NCM screen advertising advances (1)	$	10.5	$	11.2	$	12.0	$	12.8	$	13.7	$	268.2	$	328.4

(1)Amounts are net of the estimated interest to be accrued for the periods presented.

Significant Financing Component

As noted above, the Company received approximately $174.0 in cash consideration from NCM at the time of NCMI’s IPO and also periodically receives consideration in the form of common units (discussed at Common Unit

Adjustments above) from NCM in exchange for exclusive access to the Company’s newly opened domestic screens under the ESA. Due to the significant length of time between receiving the consideration from NCM and fulfillment of the related performance obligation, the ESA includes an implied significant financing component, as per the guidance in ASC Topic 606. The interest expense was calculated using the Company’s incremental borrowing rates at the time the cash and each tranche of common units were received from NCM, which ranged from 4.4% to 8.3%. Effective September 17, 2019, upon the Company’s evaluation and determination that ASC Topic 842 applies to the amended ESA, the Company determined it acceptable to apply the significant financing component guidance from ASC Topic 606 by analogy as the economic substance of the agreement represents a financing arrangement.

Summary Financial Information for NCMI/NCM

The tables below present summary financial information for NCMI/NCM for its fiscal periods indicated:

	Year Ended						Three Months Ended
	December 30, 2021			December 29, 2022			March 30, 2023 (1)
Revenue	$	114.6		$	249.2		$	34.9
Operating income (loss)	$	(68.6	)	$	10.9		$	(30.6	)
Net loss	$	(134.6	)	$	(69.8	)	$	(54.0	)

(1)Financial information for NCMI is presented for the latest reporting period available through which the Company accounted for its investment in NCMI under the equity method.

	As of
	December 29, 2022			March 30, 2023 (1)
Current assets	$	148.6		$	121.7
Noncurrent assets	$	628.2		$	618.5
Current liabilities	$	97.5		$	1,204.8
Noncurrent liabilities	$	1,161.6		$	67.2
Members'/Total deficit	$	(482.3	)	$	(531.8	)

(1)Financial information for NCMI is presented for the latest reporting period available through which the Company accounted for its investment in NCMI under the equity method.

XML

INVESTMENTS IN AFFILIATES

12 Months Ended

Dec. 31, 2023

Financial Support for Nonconsolidated Legal Entity [Abstract]

INVESTMENTS IN AFFILIATES

10.INVESTMENTS IN AFFILIATES

Below is a summary of activity for each of the Company’s affiliates for the periods indicated:

	AC JV, LLC			DCDC		FE Concepts			Other (1)			Total
Balance at January 1, 2021	$	3.7		$	1.3	$	18.3		$	0.5		$	23.8
Equity in income		—			0.5		1.0			—			1.5
Other (1)		—			—		—			(0.1	)		(0.1	)
Balance at December 31, 2021	$	3.7		$	1.8	$	19.3		$	0.4		$	25.2
Equity in income		3.4			—		1.2			—			4.6
Cash distributions received		(2.9	)		—		(4.0	)		—			(6.9	)
Other (1)		—			—		—			(0.3	)		(0.3	)
Balance at December 31, 2022	$	4.2		$	1.8	$	16.5		$	0.1		$	22.6
Equity in income		4.9			0.3		1.6			—			6.8
Cash distributions received		(5.7	)		—		—			—			(5.7	)
Other (1)		—			—		—			(0.1	)		(0.1	)
Balance at December 31, 2023	$	3.4		$	2.1	$	18.1		$	-		$	23.6

(1)Consists primarily of mark-to-market adjustment on an investment in marketable securities.

AC JV, LLC

During December 2013, the Company, Regal, AMC (the “AC Founding Members”) and NCM entered into a series of agreements that resulted in the formation of AC JV, LLC (“AC”), a joint venture that owns “Fathom Events” (consisting of Fathom Events and Fathom Consumer Events) formerly operated by NCM. The Fathom Events business focuses on the marketing and distribution of live and pre-recorded entertainment programming to various theatre operators to provide additional programs to augment their feature film schedule. The Company paid event fees to AC of $6.2, $13.3 and $16.0 for the years ended December 31, 2021, 2022 and 2023, respectively, which are included in film rentals and advertising costs on the consolidated statements of income (loss) of Holdings and CUSA. Also, the Company received cash distributions of $2.9 and $5.7 during the years ended December 31, 2022 and 2023, which were recorded as a reduction in the Company’s investment in AC. The Company accounts for its investment in AC under the equity method of accounting.

Digital Cinema Distribution Coalition

The Company is a party to a joint venture with certain exhibitors and distributors called Digital Cinema Distribution Coalition (“DCDC”). DCDC operates a satellite distribution network that distributes all digital content to U.S. theatres via satellite. The Company has an approximate 14.6% ownership in DCDC. The Company paid approximately $0.6, $0.5 and $0.6 to DCDC during the years ended December 31, 2021, 2022 and 2023, respectively, related to content delivery services, which is included in film rentals and advertising costs on the consolidated statements of income (loss) of Holdings and CUSA. The Company accounts for its investment in DCDC under the equity method of accounting.

FE Concepts, LLC

During April 2018, the Company, through its wholly-owned indirect subsidiary CNMK Texas Properties, LLC (“CNMK”), formed a joint venture, FE Concepts, LLC (“FE Concepts”) with AWSR Investments, LLC (“AWSR”), an entity owned by Lee Roy Mitchell and Tandy Mitchell. In December 2019, FE Concepts opened a family entertainment center that offers bowling, gaming, movies and other amenities. The Company and AWSR each invested approximately $20 and each have a 50% voting interest in FE Concepts. The Company accounts for its investment in FE Concepts under the equity method of accounting. The Company has a theatre services agreement with FE Concepts under which it receives service fees for providing film booking and equipment monitoring services for the facility. The Company recorded $0.1, $0.1 and $0.1 of related service fees during the years ended December 31, 2021, 2022 and 2023, respectively. During the years ended December 31, 2022 and 2023, the Company received cash distributions of $4.0 and $0.0 from FE Concepts. The cash distributions received were recorded as a reduction of the Company’s investment in FE Concepts.

Additional Considerations

The Company performs a qualitative impairment analysis for each of these equity investments annually during the fourth quarter. Based on the analysis performed, no impairment was recorded for the years ended December 31, 2021, 2022 and 2023

XML

GOODWILL AND OTHER INTANGIBLE ASSETS - NET

12 Months Ended

Dec. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND INTANGIBLE ASSETS, NET

11.GOODWILL AND INTANGIBLE ASSETS, NET

The Company’s goodwill was as follows for the periods presented:

	U.S. Operating Segment		International Operating Segment			Total
Balance at December 31, 2021 (1)	$	1,182.9	$	65.9		$	1,248.8
Foreign currency translation adjustments		—		2.1			2.1
Balance at December 31, 2022 (1)	$	1,182.9	$	68.0		$	1,250.9
Disposition (2)		—	$	(4.2	)		(4.2	)
Foreign currency translation adjustments		—		4.3			4.3
Balance at December 31, 2023 (1)	$	1,182.9	$	68.1		$	1,251.0

(1)Balances are presented net of accumulated impairment losses of $214.0 for the U.S. operating segment and $43.8 for the international operating segment.

(2)Relates to the sale of the Company’s Ecuador subsidiary. See Note 8.

Intangible assets activity and balances consisted of the following for the periods indicated:

	Balance at January 1, 2022			Additions		Amortization			Foreign Currency Translation Adjustments and Other (1)			Balance at December 31, 2022
Intangible assets with finite lives:
Gross carrying amount	$	81.7		$	—	$	—		$	(4.0	)	$	77.7
Accumulated amortization		(71.0	)		—		(2.4	)		0.2			(73.2	)
Total intangible assets with finite lives, net	$	10.7		$	—	$	(2.4	)	$	(3.8	)	$	4.5
Intangible assets with indefinite lives:
Tradename and other		300.1			—		—			—			300.1
Total intangible assets, net	$	310.8		$	—	$	(2.4	)	$	(3.8	)	$	304.6

	Balance at January 1, 2023			Additions (2)		Disposals (3)			Amortization			Foreign Currency Translation Adjustments and Other (4)		Balance at December 31, 2023
Intangible assets with finite lives:
Gross carrying amount	$	77.7		$	—	$	—		$	—		$	0.1	$	77.8
Accumulated amortization		(73.2	)		—		—			(2.1	)		—		(75.3	)
Total intangible assets with finite lives, net	$	4.5		$	—	$	—		$	(2.1	)	$	0.1	$	2.5
Intangible assets with indefinite lives:
Tradename and other		300.1			0.4		(0.4	)		—			0.2		300.3
Total intangible assets, net	$	304.6		$	0.4	$	(0.4	)	$	(2.1	)	$	0.3	$	302.8

(1)Includes foreign currency translation adjustments and an impairment recorded for a U.S. intangible asset during 2022. See Note 12 for discussion of impairment evaluations performed during the year ended December 31, 2022.

(2)Amount represents licenses acquired to sell alcoholic beverages for certain locations.

(3)Relates to the sale of the Company’s Ecuador subsidiary. See Note 8.

(4)Includes foreign currency translation adjustments.

Estimated aggregate future amortization expense for intangible assets is as follows:

Year ended December 31, 2024	$	2.0
Year ended December 31, 2025		0.5
Year ended December 31, 2026		—
Year ended December 31, 2027		—
Year ended December 31, 2028		—
Total	$	2.5

XML

IMPAIRMENT OF LONG-LIVED AND OTHER ASSETS

12 Months Ended

Dec. 31, 2023

Impairment or Disposal of Tangible Assets Disclosure [Abstract]

IMPAIRMENT OF LONG-LIVED AND OTHER ASSETS

12.IMPAIRMENT OF LONG-LIVED AND OTHER ASSETS

The Company reviews for impairment indicators related to its long-lived assets on a quarterly basis and goodwill on an annual basis or whenever events or changes in circumstances indicate the carrying amount of those assets may not be fully recoverable. The Company performed a quantitative impairment analysis on its goodwill, tradename intangible assets and other long-lived assets, including theatre properties and right-of-use assets, as of December 31, 2023. See Note 1 for a discussion of the Company’s impairment policy and a description of qualitative and quantitative impairment assessments.

Below is a summary of impairment charges for the periods indicated:

	Year Ended
	December 31,
	2021	2022	2023
U.S. segment
Theatre properties	$6.4	$19.7	$6.6
Theatre operating lease right-of-use assets	6.8	34.0	7.1
Investment in NCM (1)	—	113.2	0.7
Other	—	3.9	—
U.S. total	13.2	170.8	14.4
International segment
Theatre properties	4.0	2.2	0.7
Theatre operating lease right-of-use assets	3.2	1.1	1.5
Intangible assets, net	0.4	—	—
International total	7.6	3.3	2.2
Total impairment	$20.8	$174.1	$16.6

(1)See discussion at Investment in National CineMedia in Note 9.

For the years ended December 31, 2021, 2022 and 2023, impairment charges were primarily due to the unprecedented impact of the COVID-19 pandemic on the theatrical exhibition industry and its ongoing recovery, as discussed in Note 3.

XML

ACCRUED OTHER CURRENT LIABILITIES

12 Months Ended

Dec. 31, 2023

Payables and Accruals [Abstract]

ACCRUED OTHER CURRENT LIABILITIES

13.ACCRUED OTHER CURRENT LIABILITIES

Accrued other current liabilities consisted of the following as of the periods presented:

	December 31,
	2022		2023
Gift card liability (1)	$	64.5	$	73.6
Subscription membership program liability (1)		58.4		77.3
Discount vouchers liability (1)		32.8		31.9
Other (2)		44.7		56.4
Total	$	200.4	$	239.2

(1)See discussion at Revenue Recognition Policy in Note 5.

(2)The only difference between accrued other current liabilities for Holdings, as presented above, and CUSA is an additional $0.3 and $0.1 in other as of December 31, 2022 and 2023, respectively.

XML

LONG-TERM DEBT

12 Months Ended

Dec. 31, 2023

Debt Disclosure [Abstract]

Long-Term Debt

14.LONG-TERM DEBT

Long-term debt of Holdings and CUSA consisted of the following for the periods presented:

	December 31,
	2022		2023
Cinemark Holdings, Inc. 4.50% convertible senior notes due 2025	$	460.0	$	460.0
Cinemark USA, Inc. term loan due 2030 (see Senior Secured Credit Facility below)		626.5		645.1
Cinemark USA, Inc. 8.75% senior secured notes due 2025		250.0		150.0
Cinemark USA, Inc. 5.875% senior notes due 2026		405.0		405.0
Cinemark USA, Inc. 5.25% senior notes due 2028		765.0		765.0
Other		10.1		7.0
Total long-term debt carrying value (1)	$	2,516.6	$	2,432.1
Less: Current portion		10.7		7.8
Less: Debt issuance costs and original issue discount, net of accumulated amortization (1)		31.9		33.0
Long-term debt, less current portion, net of unamortized debt issuance costs and original issue discount (1)	$	2,474.0	$	2,391.3

(1) The only differences between the long-term debt for Holdings, as presented above, and the long-term debt for CUSA are the $460.0 million 4.50% Convertible Senior Notes due 2025 and the related debt issuance costs. The following table sets forth, as of the periods indicated, the total long-term debt carrying value, current portion of long-term debt and debt issuance costs, net of amortization for CUSA:

	December 31,
	2022		2023
Total long-term debt carrying value	$	2,056.6	$	1,972.1
Less: Current portion		10.7		7.8
Less: Debt issuance costs, net of accumulated amortization and original issue discount		22.9		27.5
Long-term debt, less current portion, net of unamortized debt issuance costs and original issue discount	$	2,023.0	$	1,936.8

Fair Value of Long Term Debt

The Company estimates the fair value of its long-term debt primarily using quoted market prices, which fall under Level 2 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35. The carrying value of the Company’s long term debt as of December 31, 2022 and 2023 is shown in the table above. The table below presents the fair value of the Company's long-term debt as of the periods presented:

	As of
	December 31, 2022		December 31, 2023
Holdings fair value (1)	$	2,210.5	$	2,460.3
CUSA fair value	$	1,771.3	$	1,903.8

(1)The fair value of the 4.50% convertible notes was $439.2 and $556.5 as of December 31, 2022 and
2023, respectively.

4.50% Convertible Senior Notes

On August 21, 2020, Holdings issued $460.0 aggregate principal amount of 4.50% convertible senior notes due 2025 (the “4.50% Convertible Senior Notes”). The 4.50% Convertible Senior Notes will mature on August 15, 2025, unless earlier repurchased or converted in accordance with the indenture. Interest on the 4.50% Convertible Senior Notes is payable on February 15 and August 15 of each year.

Holders of the 4.50% Convertible Senior Notes may convert their 4.50% Convertible Senior Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2025 only under the following circumstances: (1) during the five business day period after any five consecutive trading day period, or the measurement period, in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of Holdings’ common stock and the conversion rate on each such trading day; (2) if Holdings distributes to all or substantially all stockholders (i) rights options or warrants entitling them to purchase shares at a discount to the recent average trading price of Holdings’ common stock (including due to a stockholder rights plan) or (ii) Holdings’ assets or securities or rights, options or

warrants to purchase the same with a per share value exceeding 10% of the trading price of Holdings’ stock, (3) upon the occurrence of specified corporate events as described further in the indenture, or (4) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of Holdings’ common stock for at least 20 trading days during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to $18.66 per share (130% of the initial conversion price of $14.35 per share), on each applicable trading day. Beginning May 15, 2025, holders may convert their 4.50% Convertible Senior Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date. Upon conversion of the 4.50% Convertible Senior Notes, Holdings will pay or deliver cash, shares of Holdings’ common stock or a combination of cash and shares of Holdings’ common stock, at Holdings’ election.

The initial conversion rate is 69.6767 shares of Holdings’ common stock per one thousand dollars principal amount of the 4.50% Convertible Senior Notes. The conversion rate is subject to adjustment upon the occurrence of certain events. If a make-whole fundamental change as defined in the indenture governing the 4.50% Convertible Senior Notes occurs prior to the maturity date, Holdings will, in certain circumstances, increase the conversion rate for a holder who elects to convert its 4.50% Convertible Senior Notes in connection with such make-whole fundamental change.

The 4.50% Convertible Senior Notes are effectively subordinated to any of Holdings’, or its subsidiaries’, existing and future secured debt to the extent of the value of the assets securing such indebtedness, including obligations under the Credit Agreement. The 4.50% Convertible Senior Notes are structurally subordinated to all existing and future debt and other liabilities of our subsidiaries, including trade payables, and including CUSA’s 5.125% Senior Notes, 4.875% Senior Notes and the 8.75% Secured Notes, or, collectively, CUSA’s senior notes (but excluding all obligations under the Credit Agreement which are guaranteed by Holdings). The 4.50% Convertible Senior Notes rank equally in right of payment with all of Holdings’ existing and future unsubordinated debt, including all obligations under the Credit Agreement, which such Credit Agreement is guaranteed by Holdings, and senior in right of payment to any future debt that is expressly subordinated in right of payment to the 4.50% Convertible Senior Notes. The 4.50% Convertible Notes are not guaranteed by any of Holdings’ subsidiaries.

Concurrently with the issuance of the 4.50% Convertible Senior Notes, Holdings entered into privately negotiated convertible note hedge transactions (the “Hedge Transactions”) with one or more of the initial purchasers of the 4.50% Convertible Senior Notes or their respective affiliates (the “Option Counterparties”). The Hedge Transactions cover the number of shares of Holdings’ common stock that will initially underlie the aggregate amount of the 4.50% Convertible Senior Notes, subject to anti-dilution adjustments substantially similar to those applicable to the 4.50% Convertible Senior Notes. The Hedge Transactions are generally expected to reduce potential dilution to Holdings’ common stock upon any conversion of the 4.50% Convertible Senior Notes and/or offset any cash payments Holdings may be required to make in excess of the principal amount of converted 4.50% Convertible Senior Notes, as the case may be. Concurrently with entering into the Hedge Transactions, Holdings also entered into separate privately negotiated warrant transactions with Option Counterparties whereby it sold to Option Counterparties warrants to purchase (subject to the net share settlement provisions set forth therein) up to the same number of shares of Holdings’ common stock, subject to customary anti-dilution adjustments (the “Warrant Transactions”). The warrants could separately have a dilutive effect to the extent that the market value per share of Holdings’ common stock exceeds the strike price of the warrants on the applicable expiration dates unless, subject to the terms of the warrants, Holdings elects to cash settle the warrants. The exercise price of the warrants is initially $22.08 and is subject to certain adjustments under the terms of the warrants. Holdings received $89.4 in cash proceeds from the Warrant Transactions, which were used along with proceeds from the 4.50% Convertible Senior Notes, to pay approximately $142.1 to enter into the Hedge Transactions.

Together, the Hedge Transactions and the Warrants are intended to reduce the potential dilution from the conversion of the 4.50% Convertible Senior Notes. The Hedge Transactions and Warrants are recorded in equity and are not accounted for as derivatives, in accordance with applicable accounting guidance.

Senior Secured Credit Facility

On May 26, 2023, CUSA amended and restated its senior secured credit facility (the “Credit Agreement”) to provide for an aggregate principal amount of $775.0, consisting of a $650.0 term loan with a maturity date of May 24, 2030 and a $125.0 revolving credit facility with a maturity date of May 26, 2028. The term loan is subject to a springing maturity date of April 15, 2028 if CUSA’s 5.25% Senior Notes due 2028 have not been paid or refinanced as required

under the Credit Agreement prior to such date. The revolving credit facility is subject to springing maturity dates of January 30, 2025, December 14, 2025 and April 15, 2028 if CUSA’s 8.75% Senior Secured Notes due 2025, 5.875% Senior Notes due 2026 and 5.25% Senior Notes due 2028 have not been paid or refinanced as required under the Credit Agreement prior to such dates, as more specifically described in the Credit Agreement.

CUSA used the $632.7 net proceeds of the borrowings under the Credit Agreement to fund the $628.3 repayment of the term loan outstanding under the Credit Agreement prior to the amendment and restatement and accrued interest thereon, and for other general corporate purposes. As of December 31, 2023, there was $645.1 outstanding under the term loan.

Under the Credit Agreement, quarterly principal payments of $1.6 are due on the term loan through December 31, 2030, with a final principal payment of the remaining unpaid principal due on May 24, 2030.

The amended term loan was issued net of an original issue discount of $9.8. CUSA also incurred a total of approximately $10.1 in debt issuance costs in connection with the amendment, which are reflected in the consolidated financial statements as follows: (i) $7.5 in debt issuance costs were capitalized and are reflected as a reduction of “Long-term debt, less current portion” on the Company’s consolidated balance sheet; and (ii) $2.1 of fees paid to lenders and $0.5 of legal and other fees are included in “Loss on debt extinguishment and refinancing” in the Company’s consolidated statement of income for the year ended December 31, 2023. As a result of the amendment, CUSA also wrote-off $4.7 of unamortized debt issuance costs associated with exiting lenders of the refinanced Credit Agreement.

Interest on the term loan accrues, at CUSA's option, at either (i) a rate determined by reference to the secured overnight financing rate ("SOFR") as published by CME Group Benchmark Administration Limited and identified by Barclay's Bank PLC (the Administrative Agent) as the forward-looking term rate based on SOFR for a period of 1, 3, or 6 months (depending upon the Interest Period (as defined in the Credit Agreement) chosen by CUSA) (the "Term SOFR Rate"), subject to a floor of 0.50% per annum, plus an applicable margin of 3.75% per annum, or (ii) for any day, a rate per annum equal to the greatest of (a) the Prime Rate in effect on such day, (b) the Federal Reserve Bank of New York Rate in effect on such day, plus 1/2 of 1.00% and (c) the Term SOFR Rate for a one month Interest Period, as published two U.S. Government Securities Business Days prior to such day (or if such day is not a U.S. Government Securities Business Day, the immediately preceding U.S. Government Securities Business Day), plus 1.00% (this clause (ii), the "Alternate Base Rate"), subject in the case of this clause (ii) to a floor of 1.50% per annum, plus, in the case of this clause (ii), an applicable margin of 2.75%. The average interest rate on outstanding term loan borrowings under the Credit Agreement as of December 31, 2023 was approximately 7.1% per annum, after giving effect to the interest rate swap agreements discussed below.

Interest on revolving credit loans accrues, at CUSA's option, at either (i) the Term SOFR Rate plus an applicable margin that ranges from 3.00% to 3.50% per annum, or (ii) the Alternate Base Rate, subject, in the case of this clause (ii) to a floor of 1.00% per annum, plus, in the case of this clause (ii), an applicable margin that ranges from 2.00% to 2.50%. The applicable margin with respect to revolving credit loans is a function of the Consolidated Net Senior Secured Leverage Ratio as defined in the Credit Agreement. As of December 31, 2023, the applicable margin was 3.25%, however, there were no borrowings outstanding under the revolving line of credit. In addition, CUSA is required to pay a commitment fee on the revolving line of credit that accrues at a rate ranging from 0.20% to 0.375% per annum of the daily unused portion of the revolving line of credit. The commitment fee rate is a function of the Consolidated Net Senior Secured Leverage Ratio and was 0.25% at December 31, 2023.

CUSA’s obligations under the Credit Agreement are guaranteed by Holdings and certain subsidiaries of Holdings other than CUSA (the “Other Guarantors”) and are secured by security interests in substantially all of CUSA’s, Holdings’ and the Other Guarantors’ personal property.

The Credit Agreement contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on the ability of Holdings, CUSA and their subsidiaries to: merge, consolidate, liquidate, or dissolve; sell, transfer or otherwise dispose of assets; create, incur or permit to exist certain indebtedness and liens; pay dividends, repurchase stock and make other Restricted Payments (as defined in the Credit Agreement); prepay certain indebtedness; make investments; enter into transactions with affiliates; and change the nature of their business. At any time that CUSA has revolving credit loans outstanding, it is not permitted to allow the Consolidated Net Senior Secured Leverage Ratio to exceed 3.5 to 1.0 for any period of four consecutive fiscal quarters ending on the last day of any fiscal quarter. As of December 31, 2023, there were no revolving credit loans outstanding under the revolving line of credit, and CUSA’s Consolidated Net Senior Secured Leverage Ratio was 0.3 to 1.0.

The Credit Agreement also includes customary events of default, including, among other things, payment default, covenant default, breach of representation or warranty, bankruptcy, cross-default, material ERISA events, a change of control, material money judgments and failure to maintain security interests. If an event of default occurs, all commitments under the Credit Agreement may be terminated and all obligations under the Credit Agreement could be accelerated by the Lenders, causing all loans outstanding (including accrued interest and fees payable thereunder) to be declared immediately due and payable.

The Restricted Payments covenant, as defined in the Credit Agreement generally does not limit the ability of Holdings and its subsidiaries to pay dividends and make other Restricted Payments if the Consolidated Net Total Leverage Ratio (as defined in the Credit Agreement) is less than or equal to 2.75 to 1.00. If the Consolidated Net Total Leverage Ratio is greater than 2.75 to 1.00, but not greater than 5.00 to 1.00, Restricted Payments generally may be made in an aggregate amount not to exceed the Available Amount (as defined in the Credit Agreement), which is a function of CUSA’s Consolidated EBITDA minus 1.75 times its Consolidated Interest Expense (as such terms are defined in the Credit Agreement) and certain other factors as specified in the Credit Agreement. As of December 31, 2023, the Consolidated Net Total Leverage Ratio was 2.13 to 1.00 and the Available Amount was $599.1. In addition, the Credit Agreement contains other baskets that allow certain Restricted Payments in excess of the Applicable Amount.

5.875% Senior Notes

On March 16, 2021, CUSA issued $405.0 aggregate principal amount of 5.875% senior notes due 2026, at par value (the “5.875% Senior Notes”). Proceeds, after payment of fees, were used to fund a cash tender offer to purchase any and all of CUSA’s 5.125% Senior Notes (the “5.125% Senior Notes”) and to redeem any of the 5.125% Senior Notes that remained outstanding after the tender offer. See further discussion of the tender offer below. Interest on the 5.875% Senior Notes is payable on March 15 and September 15 of each year. The 5.875% Senior Notes mature on March 15, 2026. CUSA incurred debt issuance costs of approximately $6.0 in connection with the issuance, which are recorded as a reduction of long-term debt on the consolidated balance sheet.

The 5.875% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of CUSA’s subsidiaries that guarantee, assume or become liable with respect to any of CUSA’s or a guarantor’s debt. The 5.875% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of CUSA’s and its guarantor’s existing and future senior debt and are senior in right of payment to all of CUSA’s and its guarantors’ existing and future senior subordinated debt. The 5.875% Senior Notes and the guarantees are effectively subordinated to all of CUSA’s and its guarantor’s existing and future secured debt to the extent of the value of the collateral securing such debt, including all borrowings under CUSA’s Credit Agreement. The 5.875% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of CUSA’s subsidiaries that do not guarantee the 5.875% Senior Notes.

The indenture to the 5.875% Senior Notes contains covenants that limit, among other things, the ability of CUSA and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. Upon a change of control, as defined in the indenture, CUSA would be required to make an offer to repurchase the 5.875% Senior Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 5.875% Senior Notes allows CUSA to incur additional indebtedness if we satisfy the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances.

Cinemark USA, Inc. may redeem the 5.875% Senior Notes in whole or in part at redemption prices specified in the indenture.

5.25% Senior Notes

On June 15, 2021, CUSA issued $765.0 aggregate principal amount of 5.25% senior notes due 2028, at par value (the “5.25% Senior Notes”). Proceeds, after payment of fees, were used to redeem all of CUSA’s 4.875% $755.0 aggregate principal amount of Senior Notes due 2023 (the “4.875% Senior Notes”). Interest on the 5.25% Senior Notes is payable on January 15 and July 15 of each year, beginning January 15, 2022. The 5.25% Senior Notes mature

on July 15, 2028. CUSA incurred debt issuance costs of approximately $10.7 in connection with the issuance, which are recorded as a reduction of long-term debt on the consolidated balance sheet.

The 5.25% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of CUSA’s subsidiaries that guarantee, assume or become liable with respect to any of CUSA’s or a guarantor’s debt. The 5.25% Senior Notes and the guarantees will be CUSA’s and the guarantors’ senior unsecured obligations and (i) rank equally in right of payment to CUSA’s and the guarantors’ existing and future senior debt, including borrowings under CUSA’s Credit Agreement (as defined below) and CUSA’s existing senior notes, (ii) rank senior in right of payment to CUSA’s and the guarantors’ future subordinated debt, (iii) are effectively subordinated to all of CUSA’s and the guarantors’ existing and future secured debt, including all obligations under the Credit Agreement and CUSA’s 8.75% senior secured notes due 2025, in each case to the extent of the value of the collateral securing such debt, (iv) are structurally subordinated to all existing and future debt and other liabilities of CUSA’s non-guarantor subsidiaries, and (v) are structurally senior to the 4.50% convertible senior notes due 2025 issued by Holdings.

The indenture to the 5.25% Senior Notes contains covenants that limit, among other things, the ability of CUSA and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. Upon a change of control, as defined in the indenture, CUSA would be required to make an offer to repurchase the 5.25% Senior Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 5.25% Senior Notes allows CUSA to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances.

Prior to July 15, 2024, CUSA may redeem all or any part of the 5.25% Senior Notes at its option at 100% of the principal amount plus a make-whole premium plus accrued and unpaid interest on the 5.25% Senior Notes to the date of redemption. On or after July 15, 2024, CUSA may redeem the 5.25% Senior Notes in whole or in part at redemption prices specified in the indenture. In addition, prior to July 15, 2024, CUSA may redeem up to 40% of the aggregate principal amount of the 5.25% Senior Notes from the net proceeds of certain equity offerings at the redemption price set forth in the indenture, so long as at least 60% of the principal amount of the 5.25% Senior Notes remains outstanding immediately after each such redemption.

8.75% Secured Notes

On April 20, 2020, CUSA issued $250.0 in aggregate principal amount of 8.75% senior secured notes due 2025 (the “8.75% Secured Notes”). The 8.75% Secured Notes mature on May 1, 2025. Interest on the 8.75% Secured Notes is payable on May 1 and November 1 of each year.

CUSA may redeem the 8.75% Secured Notes in whole or in part at redemption prices specified in the indenture. Prior to May 1, 2024, CUSA, Inc. may redeem all or any part of the 8.75% Senior Notes at its option at 102.188% of the principal amount plus accrued and unpaid interest on the 8.75% Senior Notes to the date of redemption. On or after May 1, 2024, CUSA may redeem the 8.75% Senior Notes in whole or in part at 100% of the principal amount plus accrued and unpaid interest on the 8.75% Senior Notes to the date of redemption.

On May 1, 2023, CUSA redeemed $100.0 in principal amount of the 8.75% Secured Notes plus accrued interest thereon for $106.6 in cash. Following the redemption, $150.0 in aggregate principal amount of the 8.75% Secured Notes remains outstanding. As a result of the redemption, CUSA recognized a loss on extinguishment of debt totaling $3.4, which includes a $2.2 premium paid on the redemption of bonds and a $1.2 write-off of unamortized debt issuance costs, and is reflected in “Loss on debt extinguishment and refinancing” in the Company’s consolidated statement of income for the year ended December 31, 2023.

The 8.75% Secured Notes are fully and unconditionally guaranteed on a joint and several senior basis by certain of CUSA’s subsidiaries that guarantee, assume or in any other manner become liable with respect to any of CUSA’s or its guarantors’ other debt. If CUSA cannot make payments on the 8.75% Secured Notes when they are due, CUSA’s guarantors must make them instead. Under certain circumstances, the guarantees may be released without action by, or the consent of, the holders of the 8.75% Secured Notes.

The indenture governing the 8.75% Secured Notes contains covenants that limit, among other things, the ability of CUSA and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. Upon a change of control, as defined in the indenture governing the 8.75% Secured Notes, CUSA would be required to make an offer to repurchase the 8.75% Secured Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indenture governing the 8.75% Secured Notes allows CUSA to incur additional indebtedness if it satisfies a coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances.

4.875% Senior Notes

On May 21, 2021, Cinemark USA, Inc. issued a conditional notice of optional redemption to redeem the $755.0 outstanding principal amount of the 4.875% Senior Notes. In connection therewith, CUSA deposited with Wells Fargo Bank, N.A., as Trustee for the 4.875% Senior Notes (the “Trustee”), funds sufficient to redeem all 4.875% Senior Notes remaining outstanding on June 21, 2021 (the “Redemption Date”). The redemption payment (the “Redemption Payment”) included $755.0 of outstanding principal at the redemption price equal to 100% of the principal amount plus accrued and unpaid interest thereon to the Redemption Date. Upon deposit of the Redemption Payment with the Trustee on June 15, 2021, the indenture governing the 4.875% Senior Notes was fully satisfied and discharged.

The Company recorded a loss on extinguishment of debt of $3.9, which included the write-off of $3.3 of unamortized debt issuance costs and the payment of $0.6 in legal fees during the year ended December 31, 2021.

5.125% Senior Notes

On March 16, 2021, CUSA completed a tender offer to purchase its previously outstanding 5.125% Senior Notes, of which $334.0 was tendered at the expiration of the offer. On March 16, 2021, CUSA also issued a notice of optional redemption to redeem the remaining $66.0 principal amount of the 5.125% Senior Notes. In connection therewith, CUSA deposited with Wells Fargo Bank, N.A., as Trustee for the 5.125% Senior Notes (the “Trustee”), funds sufficient to redeem all 5.125% Notes remaining outstanding on April 15, 2021 (the “Redemption Date”). The redemption payment (the “Redemption Payment”) included $66.0 of outstanding principal at the redemption price equal to 100% of the principal amount plus accrued and unpaid interest thereon to the Redemption Date. Upon deposit of the Redemption Payment with the Trustee on March 16, 2021, the indenture governing the 5.125% Senior Notes was fully satisfied and discharged.

The Company recorded a loss on extinguishment of debt of $2.6 during the year ended December 31, 2021, which included the write-off of $1.2 of unamortized debt issuance costs and the payment of $1.4 in tender and legal fees.

Additional Borrowings of International Subsidiaries

During the years ended December 31, 2020 and 2021, certain of CUSA’s international subsidiaries borrowed an aggregate of $35.8 under various local bank loans, with original maturity dates ranging between November 2022 and January 2029. During the years ended December 31, 2022 and 2023, the Company repaid $21.5 and $4.1, respectively, of these bank loans. The remaining bank loan outstanding at December 31, 2023 is for our Brazil subsidiary and matures in January 2029. The current interest rate on the remaining bank loan outstanding at December 31, 2023 is 4.0%.

Covenant Compliance

The indentures governing the 5.875% Senior Notes, the 5.25% Senior Notes and the 8.750% Secured Notes ("the indentures") contain covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2023, Cinemark USA, Inc. could have distributed up to approximately $3,556.8 to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indentures, subject to its available cash and other borrowing restrictions outlined in the

indentures. Upon a change of control, as defined in the indentures, Cinemark USA, Inc. would be required to make an offer to repurchase the 5.875% Senior Notes, the 5.25% Senior Notes and the 8.750% Secured Notes at a price equal to 101% of the aggregate principal amount outstanding plus accrued and unpaid interest, if any, through the date of repurchase. The indentures allow Cinemark USA, Inc. to incur additional indebtedness if we satisfy the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and our actual ratio as of December 31, 2023 was 5.5 to 1.

See discussion of dividend restrictions and the consolidated net senior secured leverage ratio under the Credit Agreement at Senior Secured Credit Facility above.

As of December 31, 2023, the Company believes it was in full financial compliance with all agreements, including related covenants, governing its outstanding debt.

Debt Maturity

Holdings' long-term debt, excluding unamortized debt issuance costs, at December 31, 2023 matures as follows:

2024	$	7.8
2025		617.7
2026		412.7
2027		7.7
2028		772.7
Thereafter		613.5
Total (1)	$	2,432.1

(1)The only difference between the long-term debt maturity payments for Holdings, as presented above, and those for CUSA is the $460.0 repayment of Holdings’ 4.50% Convertible Senior Notes in 2025.

Interest Rate Swap Agreements

Effective May 31, 2023, in conjunction with the amendment of its Credit Agreement, the Company amended its three then existing interest rate swap agreements to update the reference rate from LIBOR to Term SOFR, and the Company applied the optional relief provided in FASB ASC Topic 848 prospectively to account for this modification. Topic 848 provides optional expedients that allow an entity not to dedesignate an existing hedging relationship when critical terms of the agreement are modified, but rather allow an existing hedging relationship to continue when one or more of the critical terms in the existing hedging agreement change because of reference rate reform. Therefore, the Company did not dedesignate the hedging relationship due to the amendment of its existing interest rate swap agreements on May 31, 2023, and accumulated losses due to the fair value adjustments on the interest rate swaps remained in other comprehensive income.

Effective November 30, 2023, the Company amended and extended its then existing $175.0 notional amount interest rate swap agreement to extend the maturity date to December 31, 2026. Upon amending the interest rate swap agreement effective November 30, 2023, the Company determined that the interest payments hedged with the agreement are still probable to occur, therefore the gain that accumulated on the swap prior to the amendment of $5.1 is being amortized to interest expense through December 31, 2024, the original maturity date of the swap.

Approximately $4.5, $4.5 and $(6.4) was recorded in amortization of accumulated losses (gains) for amended swaps in the consolidated income statement for the years ended December 31, 2021, 2022 and 2023, respectively.

The fair values of the interest rate swaps are recorded on the Company’s consolidated balance sheets as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss. The changes in fair value are reclassified from accumulated other comprehensive loss into earnings in the same period that the hedged items affect earnings. The valuation technique used to determine fair value is the income approach and under this approach, the Company uses projected future interest rates as provided by counterparty to the interest rate swap agreement and the fixed rates that the Company is obligated to pay under the agreement. Therefore, the Company’s measurements use significant unobservable inputs, which fall in Level 2 of the U.S. GAAP hierarchy as defined by FASB ASC Topic 820-10-35.

Below is a summary of the Company’s interest rate swap agreements designated as cash flow hedges as of December 31, 2023:

						Estimated
						Fair Value at
Notional						December 31,
Amount			Pay Rate	Receive Rate	Expiration Date	2023 (1)
$	137.5	(2)	2.15%	1-Month Term SOFR	December 31, 2024	$	3.5
$	137.5	(3)	2.08%	1-Month Term SOFR	December 31, 2024		3.5
$	175.0		3.20%	1-Month Term SOFR	December 31, 2026		2.9
					Total	$	9.9

(1)Approximately $9.7 of the total is included in prepaid expenses and other and $0.2 is included in deferred charges on the consolidated balance sheet as of December 31, 2023.

(2)In January 2024, the Company amended and extended one of its two then existing $137.5 notional amount interest rate swap agreements to amend the pay rate to 3.17% and extend the maturity date to December 31, 2027, effective January 31, 2024.

(3)In February 2024, the Company amended and extended the second of its two then existing $137.5 notional amount interest rate swap agreements to amend the pay rate to 3.21% and extend the maturity date to December 31, 2026, effective February 29, 2024.

XML

FAIR VALUE MEASUREMENTS

12 Months Ended

Dec. 31, 2023

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

15.FAIR VALUE MEASUREMENTS

The Company determines fair value measurements in accordance with FASB ASC Topic 820, which establishes a fair value hierarchy under which an asset or liability is categorized based on the lowest level of input significant to its fair value measurement. The levels of input defined by FASB ASC Topic 820 are as follows:

Level 1 – quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date;

Level 2 – other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and

Level 3 – unobservable and should be used to measure fair value to the extent that observable inputs are not available.

Below is a summary of assets measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of the periods presented:

	As of	Carrying		Fair Value
Description	December 31,	Value		Level 1		Level 2		Level 3
Interest rate swap assets (1)	2022	$	20.4	$	—	$	20.4	$	—
Interest rate swap assets (1)	2023	$	9.9	$	—	$	9.9	$	—
Investment in NCMI (2)	2023	$	18.1	$	—	$	18.1	$	—

(1) See further discussion of interest rate swaps at Note 14.

(2) See further discussion of investment in NCMI at Note 9.

The Company also uses the market and income approach for fair value measurements on a nonrecurring basis in the impairment evaluations of its long-lived assets (see Note 1 and Note 12). Additionally, the Company uses the market approach to estimate the fair value of its long-term debt (see Note 14). There were no changes in valuation techniques during the period. There were no transfers in or out of Level 1, Level 2 or Level 3 during the years ended December 31, 2021, 2022 and 2023.

XML

FOREIGN CURRENCY TRANSLATION

12 Months Ended

Dec. 31, 2023

Foreign Currency [Abstract]

FOREIGN CURRENCY TRANSLATION

16.FOREIGN CURRENCY TRANSLATION

The accumulated other comprehensive loss account in Holdings’ stockholders’ equity of $353.2 and $363.9 and CUSA’s stockholder’s equity of $356.3 and $366.7, each at December 31, 2022 and 2023, respectively, each primarily includes cumulative foreign currency net losses of $389.8 and $384.9, at December 31, 2022 and 2023, from translating the financial statements of the Company’s international subsidiaries and the cumulative changes in fair value of the interest rate swap agreements that are designated as hedges.

As of December 31, 2023, all foreign countries where the Company has operations are non-highly inflationary, other than Argentina. In non-highly inflationary countries, the local currency is the same as the functional currency and any fluctuation in the currency results in a cumulative foreign currency translation adjustment recorded to accumulated other comprehensive loss. The Company deemed Argentina to be highly inflationary beginning July 1, 2018. A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity. The financial information of the Company’s Argentina subsidiaries has been remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters, effective beginning July 1, 2018.

During 2019, the Argentine government instituted exchange controls restricting the ability of entities and individuals to exchange Argentine pesos for foreign currencies and to remit foreign currency out of Argentina. As a result of these currency exchange controls, markets in Argentina developed a legal trading mechanism known as the Blue Chip Swap that allows entities to transfer U.S. dollars out of and into Argentina. In a Blue Chip Swap transaction, an entity buys U.S. dollar denominated securities in Argentina using Argentine pesos, and subsequently sells the securities for U.S. dollars, in Argentina, to access U.S. dollars locally, or outside of Argentina, by transferring the securities abroad, prior to being sold (the latter commonly known as Blue Chip Swap Rate). The Blue Chip Swap rate is the implicit exchange rate resulting from the Blue Chip Swap transaction. The Blue Chip Swap rate can diverge significantly from Argentina’s official exchange rate. During the year ended December 31, 2023, the Company entered into Blue Chip Swap transactions that resulted in a loss of approximately $12.4 which is reflected in “Foreign currency exchange and other related loss” in the Company’s consolidated statement of income for the year ended December 31, 2023.

Below is a summary of the impact of translating the financial statements of the Company’s international subsidiaries for the periods presented.

							Other Comprehensive
							Income (Loss)
	Exchange Rate as of December 31,						Year Ended December 31,
Country	2021		2022		2023		2021			2022		2023
Brazil		5.57		5.29		4.85	$	(4.7	)	$	2.7	$	5.5
Colombia		3,981.16		4,810.19		3,885.85		(0.1	)		—		1.20
Chile		852.02		852.00		879.54		(10.9	)		0.3		(3.1	)
Peru		4.02		3.81		3.75		(2.8	)		1.3		0.3
All other								(0.3	)		0.3		1.0
							$	(18.8	)	$	4.6	$	4.9

As noted above, beginning July 1, 2018, Argentina was deemed highly inflationary. The impact of translating Argentina’s financial results to U.S. dollars, subsequent to June 30, 2018, has been recorded in foreign currency exchange gain (loss) on the Company’s consolidated statements of income (loss). A foreign currency exchange gain (loss) of $0.2, $8.5, and $(24.2), excluding the impact of the Blue Chip Swap transactions noted above, was recorded for the years ended December 31, 2021, 2022 and 2023, respectively.

XML

NONCONTROLLING INTERESTS IN SUBSIDIARIES

12 Months Ended

Dec. 31, 2023

Noncontrolling Interest [Abstract]

NONCONTROLLING INTERESTS IN SUBSIDIARIES

17.NONCONTROLLING INTERESTS IN SUBSIDIARIES

Noncontrolling interests in subsidiaries of the Company were as follows as of the periods presented:

	December 31,
	2022		2023
Cinemark Partners II	$	7.7	$	7.4
Laredo Theatres		0.2		0.3
Greeley Ltd.		0.9		0.8
Other		0.5		0.5
Total	$	9.3	$	9.0

There were no changes in the Company’s ownership interest in these subsidiaries during the years ended December 31, 2021, 2022 and 2023.

XML

CAPITAL STOCK

12 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement [Abstract]

CAPITAL STOCK

18.CAPITAL STOCK

Common Stock - Holdings

Common stockholders are entitled to vote on all matters submitted to a vote of the Holdings’ stockholders. Subject to the rights of holders of any then outstanding shares of Holdings’ preferred stock, Holdings’ common stockholders are entitled to dividends declared by Holdings’ board of directors. The shares of the Holdings’ common stock are not subject to any redemption provisions. Holdings has no issued and outstanding shares of preferred stock.

Holdings’ ability to pay dividends is effectively limited by its status as a holding company and the terms of CUSA’s indentures and senior secured credit facility, which also significantly restricts the ability of certain of CUSA’s subsidiaries to pay dividends directly or indirectly to Holdings. See Note 14 for discussion of restrictions contained within the debt agreements of CUSA.

Treasury Stock - Holdings

Treasury stock represents shares of common stock repurchased by Holdings and not yet retired. Holdings has applied the cost method in recording its treasury shares. Below is a summary of Holdings’ treasury stock activity for the years ended December 31, 2021, 2022 and 2023.

	Number of Treasury Shares		Cost
Balance at January 1, 2021		5.05	$	87.0
Restricted stock withholdings (1)		0.24		4.1
Restricted stock forfeitures (2)		0.06		—
Balance at December 31, 2021		5.35	$	91.1
Restricted stock withholdings (1)		0.26		4.3
Restricted stock forfeitures (2)		0.07		—
Balance at December 31, 2022		5.68	$	95.4
Restricted stock withholdings (1)		0.22		2.9
Restricted stock forfeitures (2)		0.10		—
Balance at December 31, 2023		6.00	$	98.3

(1)Holdings withheld shares as a result of the election by certain employees to satisfy their tax liabilities upon vesting in restricted stock and restricted stock units. Holdings determined the number of shares to be withheld based upon market values of the common stock of Holdings on the vest dates. Below is a summary of the range of market values per share on the vest dates for the years indicated:

	Year Ended December 31,
	2021	2022	2023
Market Values	$15.21 to $24.14	$12.11 to $18.33	$11.16 to $18.36

(2)Holdings repurchased forfeited restricted shares at a cost of $0.001 per share in accordance with the 2017 Omnibus Plan.

As of December 31, 2023, Holdings had no plans to retire any shares of its treasury stock.

Common and Preferred Stock - CUSA

CUSA has 1.5 shares (in thousands) of Class A common stock and 182.6 shares (in thousands) of Class B common stock outstanding, all of which are held by Holdings. Holders of Class A common stock have exclusive voting rights. Holders of Class B common stock have no voting rights except upon any proposed amendments to the articles of incorporation. However, they may convert their Class B common stock, at their option, to Class A common stock. In the event of any liquidation, holders of the Class A and Class B common stock will be entitled to their pro-rata share of assets remaining after any holders of preferred stock have received their preferential amounts based on their respective shares held.

CUSA has 1.0 shares of preferred stock, $1.00 par value, authorized with none issued or outstanding. The rights and preferences of preferred stock will be determined by the CUSA Board of Directors at the time of issuance.

CUSA’s ability to pay dividends is effectively limited by the terms of its indentures and its senior secured credit facility, which also significantly restricts the ability of certain of CUSA’s subsidiaries to pay dividends directly or indirectly to it. See Note 14 for a discussion of restrictions contained within CUSA’s debt agreements.

Restricted Stock

Below is a summary of restricted stock activity for the years ended December 31, 2021, 2022 and 2023:

	Year Ended					Year Ended					Year Ended
	December 31, 2021					December 31, 2022					December 31, 2023
	Shares of Restricted Stock			Weighted Average Grant Date Fair Value		Shares of Restricted Stock			Weighted Average Grant Date Fair Value		Shares of Restricted Stock			Weighted Average Grant Date Fair Value
Outstanding at January 1		1.43		$	21.11		1.99		$	21.73		1.85		$	20.64
Granted		1.24		$	21.91		0.88		$	16.40		1.38		$	12.07
Vested		(0.62	)	$	20.92		(0.95	)	$	19.13		(0.78	)	$	21.04
Forfeited		(0.06	)	$	18.96		(0.07	)	$	18.91		(0.10	)	$	16.40
Outstanding at December 31		1.99		$	21.73		1.85		$	20.64		2.35		$	15.67

During the year ended December 31, 2023, Holdings granted 1.4 shares of its restricted stock to certain CUSA employees and to Holdings’ directors. The fair value of the restricted stock granted was determined based on the market value of the Holdings’ common stock on the grant dates, which ranged from $11.19 to $19.07 per share for the 2023 grants. The Company assumed forfeiture rates ranging from 0% to 10% for the restricted stock awards granted in 2023. The restricted stock granted to employees vests over periods ranging from one to three years based on continued service. The recipients of restricted stock are entitled to receive non-forfeitable dividends and to vote their respective shares, however, the sale and transfer of the restricted stock is prohibited during the restriction period.

Below is a summary of restricted stock award activity recorded for the periods indicated.

	Year Ended December 31,
	2021		2022		2023
Compensation expense recognized during the period:
CUSA employees (1)	$	22.0	$	14.8	$	15.1
Holdings directors		0.9		1.0		1.2
Total recognized by Holdings	$	22.9	$	15.8	$	16.3
Fair value of vested restricted stock held by:
CUSA employees	$	9.7	$	15.3	$	9.1
Holdings directors		1.3		0.6		1.3
Holdings total	$	11.0	$	15.9	$	10.4
Income tax benefit recognized upon vesting of restricted stock awards held by:
CUSA employees	$	0.8	$	2.7	$	0.6
Holdings directors		0.3		0.1		0.3
Holdings total income tax benefit	$	1.1	$	2.8	$	0.9

(1)The former CEO of Holdings retired on December 31, 2021, and all of his outstanding unvested shares vested upon his retirement in accordance with his employment agreement. The Company recorded incremental compensation expense of $4.3 related to the accelerated vesting of these awards during the year ended December 31, 2021.

As of December 31, 2023, the estimated remaining unrecognized compensation expense related to the unvested restricted stock awards was as follows:

	Estimated
	Remaining
	Expense
CUSA employees (1)	$	17.8
Holdings directors		0.6
Total remaining - Holdings (1)	$	18.4

(1) The weighted average period over which this remaining compensation expense will be recognized by both Holdings and CUSA is approximately 1.5 years.

Performance Stock Units

Holdings granted performance awards in the form of performance stock units (“PSUs”), formerly referred to as restricted stock units, in 2020, 2022 and 2023. Based upon the terms of the award agreements, the performance stock units vest based on a combination of financial performance factors and continued service.

The financial performance factors for the performance stock units have a threshold, target and maximum level of payment opportunity and vest on a prorata basis according to the performance level achieved by the Company during the performance period against the performance goals. At the time of the performance stock unit grants, the Company assumes the financial performance target will be reached for the defined measurement period in determining the amount of compensation expense to record for such grants. If and when additional information becomes available to indicate that something other than the target level will be achieved, the Company adjusts compensation expense on a prospective basis over the remaining service period.

Grantees of performance stock units are eligible to receive a ratable portion of the common stock issuable if the achievement of the performance goals is within the targets previously noted. All performance stock units granted will be paid in the form of Holdings’ common stock if the participant continues to provide services through the third anniversary of the respective grant date. Performance stock unit award participants are eligible to receive dividend

equivalent payments from the grant date to the extent declared by Holdings if, and at the time, the performance stock unit awards vest.

2023 awards - During the year ended December 31, 2023, Holdings granted performance awards in the form of performance stock units. Each PSU that vests will result in the issuance of one share of Holdings’ common stock. The maximum number of shares issuable under the performance awards granted during 2023 is approximately 1.5 shares of Holdings' common stock. The grant date fair value for the units issued was determined based on the closing price of Holdings' common stock on the date of grant, which was $11.68 per share. The performance metrics for these performance awards are based upon cumulative three-year Adjusted EBITDA and consolidated cash flows, and payout levels are determined based upon the achievement of pre-established criteria for these metrics as defined in the award agreement. Based upon the terms of the award agreement, PSUs vest based on a combination of performance factors and continued service. The performance measurement period for the PSUs is three years, January 1, 2023 through December 31, 2025 and the service period ends on February 20, 2026. Below is a summary of the performance metrics and measurement period for these performance awards:

Performance Measurement Period	Three years with additional service requirement to the third anniversary of the date of the grant
Maximum Performance Target Level	200% of target level
Percentage of maximum performance stock units that vest if performance metrics meet the threshold level (1)	25% or 0.37 PSUs
Percentage of maximum performance stock units that vest if performance metrics are at target (1)	50% or 0.73 PSUs
Percentage of maximum performance stock units that vest if performance metrics are at the maximum (1)	100% or 1.47 PSUs
Most likely performance metrics outcome estimated to be achieved at the time performance stock units were issued	Target
Assumed forfeiture rate for performance stock unit awards	5%

(1)Number of PSUs that vest based on maximum amount of PSUs that could vest of 1.47.

2022 awards - During the year ended December 31, 2022, Holdings granted performance awards in the form of performance stock units. The maximum number of shares issuable under the performance awards granted during 2022 is 0.8 shares of Holdings’ common stock. The grant date fair value for the units issued during the year ended December 31, 2022 was determined based on the closing price of Holdings’ common stock on the date of grant, which was $16.65 per share. The financial performance metrics are based upon the achievement of pre-established criteria for revenue and consolidated cash flows as defined in the award agreement. Based upon the terms of the award agreement, PSUs vest based on a combination of performance factors and continued service. The performance measurement period for the financial performance metrics is one year, and there is an additional two-year service requirement.

2021 awards -There were no performance stock awards granted during the year ended December 31, 2021. During the year ended December 31, 2021, the Compensation Committee of Holdings’ Board of Directors (“Compensation Committee”) evaluated the impact of the COVID-19 pandemic on the performance metric used for the performance stock unit awards granted during 2019 and 2020 and determined that the COVID-19 pandemic significantly impacted Holdings’ ability to meet the performance metric. The Compensation Committee made a discretionary decision to certify the vest of the 2019 and 2020 performance stock unit awards at target based upon the unforeseen, external circumstances that were beyond management’s control, the projected macroeconomic conditions through 2021 and beyond, and the uncertain timing as to the recovery of the Company’s industry. The requirement to satisfy the applicable service period under the performance stock unit awards was not changed. In addition, the Compensation Committee determined that it would not be appropriate to issue performance awards during 2021 due to the aforementioned macroeconomic conditions and industry recovery. In lieu of performance stock units, the Compensation Committee granted restricted stock with a four-year vest period.

Below is a summary of performance stock unit activity for the periods presented:

	Year Ended December 31,
	2021		2022		2023
Number of performance stock unit awards that vested during the period		0.23		0.10		0.14
Fair value of performance stock unit awards that vested during the period	$	4.1	$	1.7	$	1.8
Accumulated dividends paid upon vesting of performance stock unit awards	$	0.1	$	0.3	$	0.2
Compensation expense recognized during the period (1)	$	6.4	$	5.7	$	8.7
Income tax benefit (expense) related to stock unit awards	$	0.7	$	—	$	(0.8	)

(1)The former CEO of Holdings retired on December 31, 2021 and all of his outstanding unvested restricted stock units vested upon his retirement in accordance with his employment agreement. Holdings recorded incremental compensation expense of $2.4 related to the accelerated vesting of these awards during the year ended December 31, 2021.

As of December 31, 2023, the estimated remaining unrecognized compensation expense related to the outstanding performance stock unit awards was $12.6. The weighted average period over which this remaining compensation expense will be recognized is approximately 1.7 years. As of December 31, 2023, Holdings had performance stock units outstanding that represented a total of 1.7 hypothetical shares of common stock, net of estimated forfeitures, reflecting actual certified performance levels, which was target for PSUs granted during 2020 and maximum performance level for PSUs granted during 2022, and an estimated performance level for the 2023 grant slightly above target.

XML

SUPPLEMENTAL CASH FLOW INFORMATION

12 Months Ended

Dec. 31, 2023

Supplemental Cash Flow Elements [Abstract]

SUPPLEMENTAL CASH FLOW INFORMATION

19.SUPPLEMENTAL CASH FLOW INFORMATION

The following is provided as supplemental information to the consolidated statements of cash flows:

	Year Ended December 31,
	2021			2022			2023
Cash paid for interest by Holdings (1)	$	108.2		$	140.7		$	151.3
Cash paid for interest by CUSA	$	87.8		$	109.1		$	130.6
(Refunds received) cash paid for income taxes, net	$	(136.5	)	$	4.6		$	22.3
Cash deposited in (transferred from) restricted accounts (2)	$	11.9		$	(14.9	)	$	(10.8	)
Noncash operating activities:
Interest expense - NCM (see Note 9)	$	(23.6	)	$	(23.2	)	$	(22.6	)
Noncash investing activities:
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (3)	$	20.1		$	(3.8	)	$	5.4
Theatre properties acquired under finance leases	$	0.7		$	—		$	—
Investment in NCMI/NCM – receipt of common units (see Note 9)	$	10.2		$	1.3		$	—

(1)Includes the cash interest paid by CUSA.

(2)Represents cash deposited in (transferred out) of collateral account during the period to support the issuance of letters of credit to lenders, net of returned deposits from such accounts upon the repayment of related debt.

(3)Additions to theatre properties and equipment included in accounts payable as of December 31, 2022 and 2023 were $12.0 and $6.6 respectively.

XML

INCOME TAXES

12 Months Ended

Dec. 31, 2023

Income Tax Disclosure [Abstract]

INCOME TAXES

20.INCOME TAXES

Holdings

The provision for federal and foreign income tax expense for continuing operations of Holdings consisted of the following:

	Year Ended December 31,
	2021			2022			2023
(Loss) income before income taxes:
U.S.	$	(389.2	)	$	(286.9	)	$	151.4
Foreign		(49.8	)		21.9			70.0
Total	$	(439.0	)	$	(265.0	)	$	221.4

Current and deferred income taxes for Holdings were as follows:

	Year Ended December 31,
	2021			2022			2023
Current:
Federal	$	4.0		$	1.9		$	2.2
Foreign		0.8			9.2			14.2
State		1.0			1.2			2.9
Total current expense		5.8			12.3			19.3
Deferred:
Federal	$	(20.2	)	$	(2.7	)	$	15.8
Foreign		0.4			(2.4	)		(5.7	)
State		(2.8	)		(4.2	)		0.5
Total deferred taxes		(22.6	)		(9.3	)		10.6
Income taxes	$	(16.8	)	$	3.0		$	29.9

A reconciliation between Holdings’ income tax expense and taxes computed by applying the applicable statutory federal income tax rate to income before income taxes is as follows:

	Year Ended December 31,
	2021			2022			2023
Computed statutory tax expense	$	(92.2	)	$	(55.7	)	$	46.5
State and local income taxes, net of federal income tax impact		(1.4	)		(2.2	)		5.4
Changes in valuation allowance		76.3			60.6			(63.9	)
Foreign tax rate differential		(4.5	)		1.3			1.4
Foreign tax credits		—			(4.0	)		(13.0	)
Changes in uncertain tax positions		7.5			1.6			(0.9	)
U.S. tax impact of foreign operations		0.8			(1.6	)		10.3
Return to provision		(5.1	)		1.4			(3.3	)
Expiration of attribute carryforwards		0.6			—			37.1
Permanent differences		5.4			4.6			8.6
Other, net		(4.2	)		(3.0	)		1.7
Income taxes	$	(16.8	)	$	3.0		$	29.9

CUSA

The provision for federal and foreign income tax expense for continuing operations of CUSA consisted of the following:

	Year Ended December 31,
	2021			2022			2023
(Loss) income before income taxes:
U.S.	$	(362.6	)	$	(263.7	)	$	167.0
Foreign		(49.8	)		21.9			70.0
Total	$	(412.4	)	$	(241.8	)	$	237.0

Current and deferred income taxes for CUSA were as follows:

	Year Ended December 31,
	2021			2022			2023
Current:
Federal	$	4.0		$	1.9		$	2.8
Foreign		0.8			9.2			14.2
State		1.0			1.2			2.9
Total current expense		5.8			12.3			19.9
Deferred:
Federal	$	(36.7	)	$	(16.2	)	$	13.8
Foreign		0.4			(2.4	)		(5.7	)
State		(1.8	)		(6.8	)		0.4
Total deferred taxes		(38.1	)		(25.4	)		8.5
Income taxes	$	(32.3	)	$	(13.1	)	$	28.4

A reconciliation between CUSA’s income tax expense and taxes computed by applying the applicable statutory federal income tax rate to income before income taxes is as follows:

	Year Ended December 31,
	2021			2022			2023
Computed statutory tax expense	$	(86.6	)	$	(50.8	)	$	49.8
State and local income taxes, net of federal income tax impact		(0.7	)		(4.2	)		5.9
Changes in valuation allowance		54.3			41.8			(68.6	)
Foreign tax rate differential		(4.5	)		1.3			1.4
Foreign tax credits		—			(4.0	)		(12.9	)
Changes in uncertain tax positions		5.7			1.6			(0.9	)
U.S. tax impact of foreign operations		0.8			(1.6	)		10.4
Return to provision		(3.2	)		1.2			(3.3	)
Expiration of attribute carryforwards		0.6			—			36.4
Permanent differences		5.5			4.5			8.6
Other, net		(4.2	)		(2.9	)		1.6
Income taxes	$	(32.3	)	$	(13.1	)	$	28.4

.

As of December 31, 2023, the Company will not indefinitely reinvest $2.0 of accumulated undistributed losses of its Curacao subsidiary. As of December 31, 2023, the Company had approximately $157.6 of accumulated undistributed earnings and profits which it considers to be indefinitely reinvested. Of this indefinitely reinvested amount, approximately $159.3 was subject to the one-time transition tax pursuant to the 2017 Tax Cuts and Jobs Act. Additional tax due on the repatriation of these previously-taxed earnings would generally be foreign withholding and U.S. state income taxes. The Company does not intend to repatriate these offshore earnings and profits, and therefore has not recorded any deferred taxes on such earnings. The Company considers any excess of the amount for financial reporting over the tax basis of its investment in these foreign subsidiaries to be indefinitely reinvested. At this time, the determination of deferred tax liabilities on this amount is not practicable.

Deferred Income Taxes

Holdings

The tax effects of significant temporary differences and tax loss and tax credit carryforwards comprising the net long-term deferred income tax liabilities for Holdings as of the periods presented consisted of the following:

	December 31,
	2022			2023
Deferred liabilities:
Theatre properties and equipment	$	76.9		$	68.4
Finance lease assets		16.0			13.3
Operating lease right-of-use assets		274.3			248.8
Intangible asset – other		49.6			55.8
Intangible asset – tradenames		68.9			69.5
Total deferred liabilities		485.7			455.8
Deferred assets:
Deferred revenue – NCM and Other		82.6			82.2
Prepaid rent		4.1			2.7
Gift cards		8.8			9.7
Investment in partnerships		5.2			1.4
Operating lease obligations		296.1			269.0
Finance lease obligations		21.6			18.6
Tax impact of items in accumulated other comprehensive income and additional paid-in-capital		16.4			13.4
Restricted stock		5.1			4.5
Accrued expenses		3.7			2.9
Other tax loss carryforwards		126.1			82.7
Other tax credit and attribute carryforwards		193.5			179.3
Other expenses, not currently deductible for tax purposes		14.9			11.7
Total deferred assets		778.1			678.1
Net deferred income tax (asset) liability before valuation allowance		(292.4	)		(222.3	)
Valuation allowance against deferred assets – non-current		326.1			266.3
Net deferred income tax liability	$	33.7		$	44.0
Net deferred tax (asset) liability – Foreign	$	4.7		$	(0.1	)
Net deferred tax liability – U.S.		29.0			44.1
Total	$	33.7		$	44.0

CUSA

The tax effects of significant temporary differences and tax loss and tax credit carryforwards comprising the net long-term deferred income tax liabilities for CUSA as of the periods presented consisted of the following:

	December 31,
	2022			2023
Deferred liabilities:
Theatre properties and equipment	$	76.7		$	68.2
Finance lease assets		15.9			13.2
Operating lease right-of-use assets		273.9			248.1
Intangible asset – other		49.5			55.7
Intangible asset – tradenames		68.8			69.3
Tax impact of items in accumulated other comprehensive income and additional paid-in-capital		5.3			1.4
Total deferred liabilities		490.1			455.9
Deferred assets:
Deferred revenue – NCM and Other		82.4			82.0
Prepaid rent		4.1			2.7
Gift Cards		8.8			9.7
Investment in partnerships		5.2			1.4
Operating lease obligations		295.6			268.3
Finance lease obligations		21.6			18.6
Restricted stock		4.9			4.3
Accrued expenses		3.7			2.9
Other tax loss carryforwards		122.0			80.0
Other tax credit and attribute carryforwards		174.1			149.0
Other expenses, not currently deductible for tax purposes		14.8			11.5
Total deferred assets		737.2			630.4
Net deferred income tax (asset) liability before valuation allowance		(247.1	)		(174.5	)
Valuation allowance against deferred assets – non-current		283.2			218.5
Net deferred income tax liability	$	36.1		$	44.0
Net deferred tax (asset) liability – Foreign	$	4.7		$	(0.1	)
Net deferred tax liability – U.S.		31.4			44.1
Total	$	36.1		$	44.0

Federal net operating losses and interest expense limitation carryforwards have an indefinite carryforward period. Foreign net operating losses have varying carryforward periods with some being indefinite. Similarly, state net operating losses have varying carryforward periods with some being indefinite. Foreign tax credits have a 10 year carryforward period. A majority of the Company’s foreign tax credit carryforwards expire in 2026 and 2027, with the remainder expiring in future periods.

The Company assesses the likelihood that it will be able to recover its deferred tax assets against future sources of taxable income and reduces the carrying amounts of deferred tax assets by recording a valuation allowance, if, based on all available evidence, the Company believes it is more likely than not that all or a portion of such assets will not be realized. As of the year ended December 31, 2023, the Company remained in a three-year cumulative pre-tax loss domestically and in certain foreign jurisdictions. This is heavily weighted as objectively verifiable negative evidence and, as a result, the Company is unable to include future projected earnings in assessing the recoverability of its deferred tax assets in these jurisdictions.

The Company has established a valuation allowance against certain deferred tax assets for which the ultimate realization of future benefits is uncertain. Expiring carryforwards and the required valuation allowances are adjusted annually. After application of the valuation allowances described above, the Company anticipates that no limitations will apply with respect to utilization of any of the other deferred tax assets described above.

The Company’s valuation allowance changed from $326.1 as of December 31, 2022 to $266.3 as of December 31, 2023. CUSA’s valuation allowance changed from $283.2 as of December 31, 2022 to $218.5 as of December 31, 2023. The decrease primarily relates to a release of valuation allowances previously recorded against certain expiring foreign tax credits and foreign loss carryforwards, as well as net deferred tax assets in certain foreign jurisdictions. The remaining valuation allowance associated with these deferred tax assets is primarily a result of not having sufficient income from deferred tax liability reversals in future periods to support the realization of the deferred tax assets. When the Company begins to generate taxable income at a normal level, the Company expects to reverse the valuation allowances with an offsetting increase to reported earnings. There is a possibility that within the next 12 months, sufficient positive evidence may become available to reach a conclusion that a portion of the valuation allowance in certain foreign jurisdictions will no longer be required.

Holdings’ valuation allowance for deferred tax assets, which includes CUSA’s valuation allowance for deferred tax assets, and CUSA’s valuation for deferred tax assets, for the periods presented were as follows:

	Valuation Allowance for Deferred Taxes
	Holdings			CUSA
Balance at January 1, 2021	$	203.6		$	203.6
Additions		69.1			52.5
Deductions		(4.3	)		(10.9	)
Currency translation		(4.3	)		(4.3	)
Balance at December 31, 2021	$	264.1		$	240.9
Additions		67.0			47.0
Deductions		(5.3	)		(4.9	)
Currency translation		0.3			0.2
Balance at December 31, 2022	$	326.1		$	283.2
Additions		16.6			5.9
Deductions		(83.0	)		(77.2	)
Currency translation		6.6			6.6
Balance at December 31, 2023	$	266.3		$	218.5

Uncertain Tax Positions

The following is a reconciliation of the total amounts of unrecognized tax benefits excluding interest and penalties for Holdings for the periods presented:

	Year Ended December 31,
	2021			2022			2023
Balance at January 1,	$	46.5		$	55.9		$	55.8
Gross increases - tax positions in prior periods		7.7			—			2.2
Gross decreases - tax positions in prior periods		(1.6	)		(0.2	)		(5.1	)
Gross increases - current period tax positions		3.4			0.1			0.2
Statute of limitations expiration		(0.1	)		—			(0.2	)
Balance at December 31,	$	55.9		$	55.8		$	52.9

The following is a reconciliation of the total amounts of unrecognized tax benefits excluding interest and penalties for CUSA for the periods presented:

	Year Ended December 31,
	2021			2022			2023
Balance at January 1,	$	46.5		$	54.0		$	53.9
Gross increases - tax positions in prior periods		5.8			—			2.2
Gross decreases - tax positions in prior periods		(1.6	)		(0.2	)		(5.1	)
Gross increases - current period tax positions		3.4			0.1			0.2
Statute of limitations expiration		(0.1	)		—			(0.2	)
Balance at December 31,	$	54.0		$	53.9		$	51.0

Holdings had $64.3 and $64.1 of unrecognized tax benefits, including interest and penalties, as of December 31, 2022 and 2023, respectively. Of these amounts, $64.3 and $64.1 represent the amount of unrecognized tax benefits that, if recognized, would impact the effective income tax rate for the years ended December 31, 2022 and 2023, respectively. CUSA had $62.5 and $62.2 of unrecognized tax benefits, including interest and penalties, as of December 31, 2022 and 2023, respectively. Of these amounts, $62.5 and $62.2 represent the amount of unrecognized

tax benefits that, if recognized, would impact the effective income tax rate for the years ended December 31, 2022 and 2023, respectively. Holdings and CUSA had $8.5 and $11.1 accrued for interest and penalties as of December 31, 2022 and 2023, respectively. The Company believes it is reasonably possible that its existing unrecognized tax benefits may be reduced by an amount up to $35.9 within the next 12 months as a result of resolution of examination with taxing authorities.

The Company prepares and files income tax returns based upon its interpretation of tax laws and regulations and record estimates based upon these judgments and interpretations. In the normal course of business, the Company’s income tax returns are subject to examination by various taxing authorities. Such examinations may result in future tax and interest assessments by these taxing authorities. Inherent uncertainties exist in estimates of tax contingencies due to changes in tax law resulting from legislation, regulation, and/or as concluded through the various jurisdictions' tax court systems. Significant judgment is exercised in applying complex tax laws and regulations across multiple global jurisdictions where we conduct our operations. The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, including resolutions of any related appeals or litigation processes, based upon the technical merits of the position.

The Company is no longer subject to income tax audits from the Internal Revenue Service for years before 2018. The Company is no longer subject to state income tax examinations by tax authorities in its major state jurisdictions for years before 2019. The Company is no longer subject to non-U.S. income tax examinations by tax authorities in its major non-U.S. tax jurisdictions for years before 2008.

The Company is currently under IRS audit for tax years 2019 and 2020 and is under audit in the non-U.S. tax jurisdiction of Brazil.

XML

COMMITMENTS AND CONTINGENCIES

12 Months Ended

Dec. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

21.COMMITMENTS AND CONTINGENCIES

Employment Agreements — As of December 31, 2023, the Company had employment agreements with Sean Gamble, Melissa Thomas, Valmir Fernandes and Michael Cavalier. These employment agreements are subject to automatic extensions for a one year period, unless the employment agreements are terminated. The base salaries stipulated in the employment agreements are subject to review at least annually during the term of the agreements for increase (but not decrease) by the Company’s Compensation Committee. Management personnel subject to these employment agreements are eligible to receive annual cash incentive bonuses upon the Company meeting certain performance targets established by the Compensation Committee.

Retirement Savings Plan — The Company has a 401(k) retirement savings plan (“401(k) Plan”) for the benefit of all eligible U.S. based employees and makes discretionary matching contributions as determined annually in accordance with the 401(k) Plan. Employer matching contribution payments of $5.7 and $6.4 were made during the years ended December 31, 2022 and 2023, respectively. A liability of approximately $0.9 was recorded as of December 31, 2023 for employer contribution payments to be made in 2024 for the remaining amounts owed for plan year 2023.

Legal Proceedings

From time to time, the Company is involved in various legal proceedings arising from the ordinary course of its business operations, such as personal injury claims, employment matters, patent claims, landlord-tenant disputes, contractual disputes with landlords over certain termination rights or the right to discontinue rent payments due to the COVID-19 pandemic and other contractual disputes, some of which are covered by insurance. The Company believes its potential liability with respect to proceedings currently pending is not material, individually or in the aggregate, to the Company’s financial position, results of operations and cash flows.

Cinemark Holdings, Inc., et al vs Factory Mutual Insurance Company. The Company filed suit on November 18, 2020, in the District Court, 471st Judicial District, Collin County, Texas. On December 22, 2020, the case was moved to the US District Court for the Eastern District of Texas, Sherman Division. The Company submitted a claim under its property insurance policy issued by Factory Mutual Insurance Company (the “FM Policy”) for losses sustained as a result of the closure of the Company’s theatres due to the COVID-19 pandemic. Factory Mutual Insurance Company (“FM”) denied the Company’s claim. The Company is seeking damages resulting from FM’s breach of contract, FM’s bad faith conduct and a declaration of the parties’ rights under the FM Policy. The Company

cannot predict the outcome of this litigation. The District Court granted FM’s motion for summary judgment. The Company has appealed the District Court’s decision.

Lakeenya Neal, et al v. Cinemark Holdings, Inc., et al. This class action lawsuit was filed against the Company on December 10, 2021, in the Central District of Los Angeles County Superior Court of the State of California alleging certain violations of the Fair and Accurate Credit Transactions Act. The plaintiffs voluntarily dismissed this case.

Gerardo Rodriguez, individually and on behalf of a class of all others similarly situated vs Cinemark USA, Inc. and Cinemark Holdings, Inc., et al. This class action lawsuit was filed against the Company on February 24, 2023 in the Cook County Circuit Court in Illinois alleging violation of the Fair and Accurate Credit Transactions Act. The Company firmly maintains that the allegations are without merit and will vigorously defend itself against the lawsuit. The Company cannot predict the outcome of this litigation.

National CineMedia LLC Bankruptcy. On June 3, 2023, NCM filed an Emergency Motion for Entry of an Order (1) approving and Authorizing Debtor to Enter into and Perform Under (a) the Termination and Settlement Agreement and (b) the Network Affiliate Transaction Agreement with Regal Cinemas, Inc. (the “9019 Motion”). The 9019 Motion requested an order, among other things, that the most favored nations clause (the “MFN”) in Cinemark’s Exhibitor Services Agreement was not triggered by the Network Affiliate Transaction Agreement with Regal Cinemas, Inc. On June 14, 2023, Cinemark filed an objection to the 9019 Motion. On June 26, 2023, the bankruptcy court entered a confirmation order, which among other things, approves NCM’s assumption of Cinemark’s Exhibitor Services Agreement but fails to preserve or recognize Cinemark’s rights under the MFN with respect to the Network Affiliate Transaction Agreement. Cinemark has appealed the confirmation order in the United States District Court for the Southern District of Texas, Houston Division. The Company cannot predict the outcome of this appeal.

XML

SEGMENTS - HOLDINGS

12 Months Ended

Dec. 31, 2023

Segment Reporting [Abstract]

Segments - Holdings

22.SEGMENTS - HOLDINGS

The international market and U.S. market are managed as separate reportable operating segments, with the international segment consisting of operations in Brazil, Argentina, Chile, Colombia, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia and Paraguay. The Company closed its one theatre in Curacao in January 2023 and sold the shares of its Ecuador subsidiary in September 2023. See Note 8 for a discussion of the sale of our Ecuador subsidiary. Each segment’s revenue is derived from admissions and concession sales and other ancillary revenue. Holdings uses Adjusted EBITDA, as shown in the reconciliation table below, as the primary measure of segment profit and loss to evaluate performance and allocate its resources. The Company does not report total assets by segment because that information is not used to evaluate the performance or allocate resources between segments.

Holdings revenue, Adjusted EBITDA and capital expenditures by reportable operating segment

The following table is a breakdown of selected financial information by reportable operating segment for Holdings for the periods presented:

	Year Ended December 31,
	2021			2022			2023
Revenue
U.S.	$	1,296.3		$	1,977.9		$	2,428.1
International		216.9			484.5			651.4
Eliminations		(2.7	)		(7.7	)		(12.8	)
Total Revenue	$	1,510.5		$	2,454.7		$	3,066.7
Adjusted EBITDA (1)
U.S.	$	84.2		$	255.7		$	463.9
International		(4.2	)		80.8			130.2
Total Adjusted EBITDA	$	80.0		$	336.5		$	594.1
Capital expenditures
U.S.	$	78.3		$	87.2		$	111.5
International		17.2			23.5			38.0
Total capital expenditures	$	95.5		$	110.7		$	149.5

(1)Distributions from equity investees are reported entirely within the U.S. operating segment.

The following table sets forth a reconciliation of net (loss) income to Adjusted EBITDA for Holdings for the periods presented:

	Year Ended December 31,
	2021			2022			2023
Net (loss) income	$	(422.2	)	$	(268.0	)	$	191.5
Add (deduct):
Income tax (benefit) expense		(16.8	)		3.0			29.9
Interest expense (1)		149.7			155.3			150.4
Other expense (income), net (2)		43.5			23.6			(19.6	)
Cash distributions from equity investees (3)		0.2			6.9			5.7
Depreciation and amortization		265.4			238.2			209.5
Impairment of long-lived and other assets		20.8			174.1			16.6
Restructuring costs		(1.0	)		(0.5	)		—
(Gain) loss on disposal of assets and other		8.0			(6.8	)		(7.7	)
Loss on debt extinguishment and refinancing		6.5			—			10.7
Non-cash rent expense		(3.4	)		(10.8	)		(17.9	)
Share-based awards compensation expense		29.3			21.5			25.0
Adjusted EBITDA	$	80.0		$	336.5		$	594.1

(1)Includes amortization of debt issuance costs, amortization of original issue discount, and amortization of accumulated (gains) losses for amended swap agreements.

(2)Includes interest income, foreign currency exchange and other related loss, interest expense – NCM and equity in income (loss) of affiliates and unrealized gain on investment in NCMI. Excludes distributions from NCM and DCIP.

(3)Reflects cash distributions received from equity investees that were recorded as a reduction of the respective investment balances (see Note 10). These distributions are reported entirely within the U.S. operating segment.

Financial Information About Geographic Area

The following table sets forth a breakdown of select financial information for Holdings by geographic area for the periods presented:

	Year Ended December 31,
	2021	2022	2023
Revenue
U.S.	$1,296.3	$1,977.9	$2,428.1
Brazil	73.5	179.0	233.4
Other international countries	143.4	305.5	418.0
Eliminations	(2.7)	(7.7)	(12.8)
Total	$1,510.5	$2,454.7	$3,066.7

	As of December 31,
	2022	2023
Theatre properties and equipment, net
U.S.	$1,075.3	$1,002.1
Brazil	49.5	54.7
Other international countries	107.3	104.9
Total	$1,232.1	$1,161.7

XML

RELATED PARTY TRANSACTIONS

12 Months Ended

Dec. 31, 2023

Related Party Transactions [Abstract]

Related Party Transactions

23.RELATED PARTY TRANSACTIONS

A subsidiary of the Company manages a theatre for Laredo Theatres, Ltd. (“Laredo”). The Company is the sole general partner and owns 75% of the limited partnership interests of Laredo. Lone Star Theatres, Inc. owns the remaining 25% of the limited partnership interests in Laredo and is 100% owned by Mr. David Roberts, who is Lee Roy Mitchell’s son-in-law and Kevin Mitchell’s brother-in-law. Lee Roy Mitchell, our founder, owns, both directly and indirectly, approximately 8.5% of Holdings’ common stock and Kevin Mitchell is a member of Holdings’ Board of Directors. Under the agreement, management fees are paid by Laredo to the Company at a rate of 5% of annual theatre revenue. The Company recorded $0.4, $0.6 and $0.7 of management fee revenue during the years ended December 31, 2021, 2022 and 2023, respectively. All such amounts are included in each of Holdings’ and CUSA’s consolidated financial statements with the intercompany amounts eliminated in consolidation. During the years ended December 31, 2022 and 2023, the Company paid excess cash distributions of $2.7 and $1.3, respectively, to Lone Star Theatres, Inc. as required by the partnership agreement, which were recorded as a reduction of noncontrolling interests on each of Holdings’ and CUSA’s consolidated balance sheets.

Walter Hebert, Mr. Lee Roy Mitchell’s brother-in-law, previously served as the Executive Vice President – Purchasing of the Company and retired in July 2021. Mr. Hebert served as a consultant to the Company until July 2022. During the years ended December 31, 2021 and 2022, the Company paid Mr. Hebert $0.1 and $0.2 related to consulting services.

A subsidiary of the Company has an Aircraft Time Sharing Agreement with Copper Beech Capital, LLC to use, on occasion, a private aircraft owned by Copper Beech Capital, LLC. Copper Beech Capital, LLC is owned by Mr. Lee Roy Mitchell and his wife, Tandy Mitchell. The private aircraft is used by Messrs. Lee Roy and Kevin Mitchell and other executives who accompany Mr. Lee Roy Mitchell to business meetings for the Company. The Company reimburses Copper Beech Capital, LLC the actual costs of fuel usage and the expenses of the pilots, landing fees, storage fees and similar expenses incurred during the trip. The aggregate amount paid to Copper Beech Capital, LLC for the use of the aircraft was less than $0.1 for each of the years ended December 31, 2021, 2022 and 2023.

A subsidiary of the Company currently leases 12 theatres from Syufy Enterprises, LP (“Syufy”) or affiliates of Syufy. Raymond Syufy is one of Holdings’ directors and is an officer of the general partner of Syufy. For the years ended December 31, 2021, 2022 and 2023, the Company paid total rent of approximately $23.3, $22.3 and $22.1, respectively, to Syufy. CUSA also provides digital equipment support to drive-in theatres owned by Syufy. The Company recorded management fees of approximately $0.1, $0.0 and $0.0 related to these services during the years ended December 31, 2021, 2022 and 2023, respectively.

A subsidiary of the Company has a 50% voting interest in FE Concepts, a joint venture with AWSR, an entity owned by Lee Roy Mitchell and Tandy Mitchell. FE Concepts operates a family entertainment center that offers bowling, gaming, movies and other amenities. See Note 10 for further discussion. The Company has a theatre services agreement with FE Concepts under which the Company receives service fees for providing film booking and equipment monitoring services for the facility. The Company recorded services fees of approximately $0.1, $0.1 and $0.1 related to this agreement during the years ended December 31, 2021, 2022 and 2023, respectively. During the year ended December 31, 2022, the Company received cash distributions of $4.0 from FE Concepts.

XML

CONDENSED FINANCIAL INFORMATION OF REGISTRANT

12 Months Ended

Dec. 31, 2023

Condensed Financial Information Disclosure [Abstract]

CONDENSED FINANCIAL INFORMATION OF REGISTRANT

CINEMARK HOLDINGS, INC.

PARENT COMPANY BALANCE SHEETS

(in millions, except share data)

	December 31,			December 31,
	2022			2023
Assets
Cash and cash equivalents	$	247.2		$	236.8
Interest receivable and other current assets		0.6			2.6
Investment in subsidiaries		372.5			591.2
Total assets	$	620.3		$	830.6
Liabilities and equity
Liabilities
Accrued other current liabilities, including accounts payable to subsidiaries	$	61.5		$	66.5
Long-term debt		451.0			454.4
Other long-term liabilities		(2.4	)		(0.1	)
Total liabilities		510.1			520.8
Commitments and contingencies (see Note 6)
Equity
Common stock, $0.001 par value: 300,000,000 shares authorized, 126,082,187 shares issued and 120,403,833 shares outstanding at December 31, 2022 and 127,598,774 shares issued and 121,596,206 shares outstanding at December 31, 2023		0.1			0.1
Additional paid-in-capital		1,219.3			1,244.3
Treasury stock, 5,678,354 and 6,002,568 shares, at cost, at December 31, 2022 and December 31, 2023, respectively		(95.4	)		(98.3	)
Accumulated deficit		(660.6	)		(472.4	)
Accumulated other comprehensive loss		(353.2	)		(363.9	)
Total equity		110.2			309.8
Total liabilities and equity	$	620.3		$	830.6

The accompanying notes are an integral part of the condensed financial information of Cinemark Holdings Inc.

CINEMARK HOLDINGS, INC.

PARENT COMPANY STATEMENTS OF INCOME (LOSS)

(in millions)

	Year Ended December 31,
	2021			2022			2023
Revenue	$	—		$	—		$	—
Cost of operations		2.6			2.9			3.3
Operating loss		(2.6	)		(2.9	)		(3.3	)
Interest expense		(24.1	)		(24.1	)		(24.1	)
Interest income		0.1			3.8			11.8
Loss before income taxes and equity in (loss) income of subsidiaries		(26.6	)		(23.2	)		(15.6	)
Income tax benefit (expense)		5.7			(16.1	)		(1.5	)
Equity in (loss) income of subsidiaries, net of taxes		(401.9	)		(231.9	)		205.3
Net (loss) income	$	(422.8	)	$	(271.2	)	$	188.2

The accompanying notes are an integral part of the condensed financial information of Cinemark Holdings, Inc.

CINEMARK HOLDINGS, INC.

PARENT COMPANY STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(in millions)

	Year Ended December 31,
	2021			2022			2023
Net (loss) income	$	(422.8	)	$	(271.2	)	$	188.2
Other comprehensive (loss) income, net of tax
Unrealized gain (loss) due to fair value adjustments on interest rate swap agreements, net of taxes of $(0.7), $(2.8) and $1.2, and net of settlements		18.5			32.2			(9.2	)
Foreign currency translation adjustments		(18.8	)		4.6			4.9
Total other comprehensive (loss) income, net of tax		(0.3	)		36.8			(4.3	)
Comprehensive (loss) income attributable to Cinemark Holdings, Inc.	$	(423.1	)	$	(234.4	)	$	183.9

The accompanying notes are an integral part of the condensed financial information of Cinemark Holdings Inc.

CINEMARK HOLDINGS, INC.

PARENT COMPANY STATEMENTS OF CASH FLOWS

(in millions)

	Year Ended December 31,
	2021			2022			2023
Operating Activities
Net (loss) income	$	(422.8	)	$	(271.2	)	$	188.2
Adjustments to reconcile net (loss) income to cash used for operating activities:
Share-based awards compensation expense		0.9			1.0			1.2
Amortization of debt issuance costs		3.5			3.4			3.5
Equity in loss (income) of subsidiaries		401.9			231.9			(205.3	)
Changes in other assets and liabilities		10.5			21.7			4.9
Net cash used for operating activities		(6.0	)		(13.2	)		(7.5	)
Investing Activities
Contributions to subsidiaries		(120.0	)		—			—
Net cash used for investing activities		(120.0	)		—			—
Financing Activities
Restricted stock withholdings for payroll taxes		(4.1	)		(4.3	)		(2.9	)
Net cash used for financing activities		(4.1	)		(4.3	)		(2.9	)
Decrease in cash and cash equivalents		(130.1	)		(17.5	)		(10.4	)
Cash and cash equivalents:
Beginning of period		394.8			264.7			247.2
End of period	$	264.7		$	247.2		$	236.8

The accompanying notes are an integral part of the condensed financial information of Cinemark Holdings, Inc.

CINEMARK HOLDINGS, INC.

NOTES TO PARENT COMPANY FINANCIAL STATEMENTS

(in millions, except share and per share data)

1.BASIS OF PRESENTATION

Cinemark Holdings, Inc. conducts substantially all of its operations through its subsidiaries. These statements should be read in conjunction with Cinemark Holdings Inc. and subsidiaries' consolidated financial statements and notes included elsewhere in this annual report on Form 10-K. There are significant restrictions over Cinemark Holdings, Inc.’s ability to obtain funds from its subsidiaries through dividends, loans or advances as contained in CUSA’s senior secured credit facility and the indentures to each of the 5.25% Senior Notes, the 5.875% Senior Notes and the 8.75% Secured Notes (collectively referred to herein as the “Notes”). These condensed parent company financial statements have been prepared in accordance with Rule 12-04, Schedule I of Regulation S-X, as the restricted net assets of Cinemark Holdings, Inc.’s subsidiaries under each of the debt agreements previously noted exceeds 25 percent of the consolidated net assets of Cinemark Holdings, Inc. As of December 31, 2023, the restricted net assets totaled approximately $427.8 million under the Notes. See Note 14 to the consolidated financial statements included elsewhere in this annual report on Form 10-K.

2.DIVIDEND PAYMENTS

Holdings suspended its quarterly dividend in March 2020 as a result of the COVID-19 pandemic. as discussed in Note 3 of the consolidated financial statements included elsewhere in this annual report on Form 10-K.

3.DIVIDENDS AND DISTRIBUTIONS WITH SUBSIDIARIES

During the year ended December 31, 2021, Holdings paid a distribution of $120.0 million to its subsidiary, CUSA.

4.LONG-TERM DEBT

On August 21, 2020, Holdings issued $460.0 million aggregate principal amount of 4.50% Convertible Senior Notes, which will mature on August 15, 2025. Additionally, certain of Holdings’ subsidiaries have direct outstanding debt obligations. For a discussion of the debt obligations of Holdings, see Note 14 to the consolidated financial statements included elsewhere in this annual report on Form 10-K.

5.CAPITAL STOCK

Holdings’ capital stock along with its long-term incentive plan and related activity are discussed in Note 18 of the consolidated financial statements included elsewhere in this annual report on Form 10-K.

6.COMMITMENTS AND CONTINGENCIES

Holdings has no direct commitments and contingencies, but its subsidiaries do. See Note 21 of the consolidated financial statements included elsewhere in this annual report on Form 10-K.

XML

CONSOLIDATING FINANCIAL INFORMATION OF SUBSIDIARIES

12 Months Ended

Dec. 31, 2023

Condensed Financial Information Disclosure [Abstract]

CONSOLIDATING FINANCIAL INFORMATION OF SUBSIDIARIES

UNAUDITED SUPPLEMENTAL SCHEDULES SPECIFIED BY THE SENIOR NOTES INDENTURES

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEET

DECEMBER 31, 2023

(in millions)

	Restricted		Unrestricted
	Group		Group			Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents	$	496.3	$	116.1		$	—		$	612.4
Other current assets		393.4		(115.8	)		(10.9	)		266.7
Total current assets		889.7		0.3			(10.9	)		879.1
Theatre properties and equipment, net		1,161.7		—			—			1,161.7
Operating lease right-of-use assets, net		986.4		—			—			986.4
Other assets		1,718.1		285.8			(375.2	)		1,628.7
Total assets	$	4,755.9	$	286.1		$	(386.1	)	$	4,655.9
Liabilities and equity
Current liabilities
Current portion of long-term debt	$	7.8	$	—		$	—		$	7.8
Current portion of operating lease obligations		212.5		—			—			212.5
Current portion of finance lease obligations		14.0		—			—			14.0
Current income tax payable		4.2		—			—			4.2
Accounts payable and accrued expenses		494.8		—			(10.9	)		483.9
Total current liabilities		733.3		—			(10.9	)		722.4
Long-term liabilities
Long-term debt, less current portion		2,199.0		—			(262.2	)		1,936.8
Operating lease obligations, less current portion		853.3		—			—			853.3
Finance lease obligations, less current portion		73.8		—			—			73.8
Other long-term liabilities and deferrals		468.7		0.6			—			469.3
Total long-term liabilities		3,594.8		0.6			(262.2	)		3,333.2
Commitments and contingencies
Equity		427.8		285.5			(113.0	)		600.3
Total liabilities and equity	$	4,755.9	$	286.1		$	(386.1	)	$	4,655.9

Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENT OF INCOME

YEAR ENDED DECEMBER 31, 2023

(in millions)

	Restricted			Unrestricted
	Group			Group			Eliminations			Consolidated
Revenue	$	3,066.7		$	—		$	—		$	3,066.7
Cost of operations
Theatre operating costs		2,286.6			—			—			2,286.6
General and administrative expenses		195.5						—			195.5
Depreciation and amortization		209.5			—			—			209.5
Impairment of long-lived assets		15.9			0.7			—			16.6
Gain on disposal of assets and other		(7.7	)					—			(7.7	)
Total cost of operations		2,699.8			0.7			—			2,700.5
Operating income (loss)		366.9			(0.7	)		—			366.2
Interest expense		(129.1	)		—			2.8			(126.3	)
Loss on debt extinguishment and refinancing		(10.7	)		—			—			(10.7	)
Equity in income of affiliates		1.6			2.0			—			3.6
Interest expense - NCM		(22.6	)		—			—			(22.6	)
Other income		9.3			20.3			(2.8	)		26.8
Total other (expense) income		(151.5	)		22.3			—			(129.2	)
Income before income taxes		215.4			21.6			—			237.0
Income tax expense		24.0			4.4			—			28.4
Net income		191.4			17.2			—			208.6
Less: Net income attributable to noncontrolling interests		3.3			—			—			3.3
Net income attributable to Cinemark USA, Inc.	$	188.1		$	17.2		$	—		$	205.3

Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME

(in millions)

	Restricted			Unrestricted
	Group			Group		Eliminations		Consolidated
Net income	$	191.4		$	17.2	$	—	$	208.6
Other comprehensive loss, net of tax
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $1.5, net of settlements		(8.9	)		—		—		(8.9	)
Foreign currency translation adjustments		4.9			—		—		4.9
Total other comprehensive loss, net of tax		(4.0	)		—		—		(4.0	)
Total comprehensive loss, net of tax		187.4			17.2		—		204.6
Comprehensive income attributable to noncontrolling interests		(3.3	)		—		—		(3.3	)
Comprehensive income attributable to Cinemark USA, Inc.	$	184.1		$	17.2	$	—	$	201.3

Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

CINEMARK USA, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

YEAR ENDED DECEMBER 31, 2023

(in millions)

	Restricted			Unrestricted
	Group			Group			Eliminations		Consolidated
Operating activities
Net income	$	191.4		$	17.2		$	—	$	208.6
Adjustments to reconcile net income to cash provided by operating activities		219.3			4.4			—		223.7
Changes in assets and liabilities		36.5			(14.0	)		—		22.5
Net cash provided by operating activities		447.2			7.6			—		454.8
Investing activities
Additions to theatre properties and equipment		(149.5	)		—			—		(149.5	)
Net proceeds from sale of subsidiary		14.8			—			—		14.8
Proceeds from sale of assets and other		2.9			—			—		2.9
Investment and loans to affiliates		(2.3	)		2.3			—		—
Net cash (used for) provided by investing activities		(134.1	)		2.3			—		(131.8	)
Financing activities
Proceeds from refinancing of senior secured credit facility		640.2			—			—		640.2
Repayment of term loan on refinancing of senior secured credit facility		(624.9	)		—			—		(624.9	)
Redemption of $100.0 of 8.75% Secured Notes at 102.2%		(102.2	)		—			—		(102.2	)
Payment of debt issuance costs		(7.5	)		—			—		(7.5	)
Payment of fees on refinancing of senior secured credit facility		(2.6	)		—			—		(2.6	)
Other repayments of long-term debt		(10.6	)		—			—		(10.6	)
Restricted stock withholdings for payroll taxes		(2.9	)		—			—		(2.9	)
Payments on finance leases		(14.4	)		—			—		(14.4	)
Other financing activities		(0.5	)		—			—		(0.5	)
Net cash used for financing activities		(125.4	)		—			—		(125.4	)
Effect of exchange rate changes on cash and cash equivalents		(12.5	)		—			—		(12.5	)
Increase in cash and cash equivalents		175.2			9.9			—		185.1
Cash and cash equivalents:
Beginning of year		321.1			106.2			—		427.3
End of year	$	496.3		$	116.1		$	—	$	612.4

Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

12 Months Ended

Dec. 31, 2023

Accounting Policies [Abstract]

Business

Business — Cinemark Holdings, Inc. (“Holdings”) is a holding company and its wholly-owned subsidiary is Cinemark USA, Inc. (“CUSA”). Holdings consolidates CUSA and its subsidiaries for financial statement purposes, and CUSA’s operating revenue and operating expenses comprise nearly 100% of Holdings’ revenue and operating expenses. As such, the following Notes to Consolidated Financial Statements relate to Holdings and CUSA and their respective consolidated subsidiaries in all material aspects, unless otherwise noted. Where it is important to distinguish between Holdings and CUSA, specific reference is made to either Holdings or CUSA. Otherwise, all references to “we”, “our”, “us” and “the Company” relate to Cinemark Holdings, Inc. and its consolidated subsidiaries and all references to CUSA relate to CUSA and its consolidated subsidiaries. We operate in the motion picture exhibition industry, with theatres in the United States (“U.S.”) and in 13 countries in Latin America as of December 31, 2023.

Principles of Consolidation

Principles of Consolidation — The consolidated financial statements include the accounts of Cinemark Holdings, Inc. and its subsidiaries and Cinemark USA, Inc. and its subsidiaries. Majority-owned subsidiaries that Holdings or CUSA, as applicable, has control of are consolidated while those investments in entities of which Holdings or CUSA, as applicable, owns between 20% and 50% and does not control, but has significant influence over the investee, are accounted for under the equity method. Investments in entities of which Holdings or CUSA, as applicable, owns between 20% and 50% and does not control or have significant influence over are accounted for under the fair value method. If Holdings or CUSA cease to exercise significant influence over an equity investee, the investment is accounted for under the fair value method. Investments in entities of which Holdings or CUSA, as applicable, owns less than 20% are generally accounted for under the cost method. The results of these subsidiaries and other investees are included in the consolidated financial statements of Holdings and CUSA, as applicable, effective from their date of formation or from their date of acquisition. Intercompany balances and transactions are eliminated in consolidation.

Cash and Cash Equivalents

Cash and Cash Equivalents — Cash and cash equivalents consist of operating funds held in financial institutions, petty cash held at the theatres, highly liquid investments with original maturities of three months or less when purchased and restricted cash. The Company invests its cash primarily in money market funds, certificates of deposit, commercial paper or other similar funds.

Accounts Receivable

Accounts Receivable – Accounts receivable, which are recorded at net realizable value, consist primarily of receivables related to screen advertising, screen rental, receivables related to gift cards sold to third party retail locations, receivables from landlords related to theatre construction projects, rebates earned from the Company’s concession vendors and value-added and other non-income tax receivables.

Inventories

Inventories — Concession inventories are stated at the lower of cost (first-in, first-out method) or net realizable value.

Theatre Properties and Equipment

Theatre Properties and Equipment — Theatre properties and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets as follows:

Category	Useful Life
Buildings on owned land	40 years
Buildings on leased land	Lesser of lease term or 40 years
Land and buildings under finance leases	Lease term
Theatre furniture and equipment	3 to 15 years
Leasehold improvements	Lesser of lease term or useful life

The Company evaluates long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable (qualitative evaluation). The Company also performs a full quantitative impairment evaluation on an annual basis.

These qualitative and quantitative evaluations are described below:

•Quantitative approach The Company performs a quantitative evaluation at the theatre level using estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the remaining lease period, which may include the probability of the exercise of available renewal periods for leased properties, and the lesser of twenty years or the building’s remaining useful life for owned properties. If the estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, the Company then compares the carrying value of the asset group (theatre) with its estimated fair value. When estimated fair value is determined to be lower than the carrying value of the asset group (theatre), the asset group (theatre) is written down to its estimated fair value. Significant judgment, including management’s estimate of future theatre level cash flows for each theatre is involved in estimating fair value. Fair value is estimated based on a multiple of cash flows. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy, as defined by FASB ASC Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples.

•Qualitative approach The Company’s qualitative assessment considers relevant economic and market conditions, industry trading multiples and recent developments that would impact its estimates of future cash flows as compared to its most recent quantitative impairment assessment.

Goodwill and Other Intangible Assets

Goodwill and Other Intangible Assets — The Company evaluates goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable. The Company evaluates goodwill for impairment at the reporting unit level. which is the U.S. and each of its international countries that has been allocated goodwill (the Company does not have goodwill recorded for all of its international locations). Under ASC Topic 350, Goodwill, Intangibles and Other (“ASC Topic 350”), the Company can elect to perform a qualitative or a quantitative impairment assessment of our goodwill as described below:

•Quantitative approach Under a quantitative goodwill impairment analysis, the Company estimates the fair value of each reporting unit and compares it with its carrying value. Fair value is estimated using (i) a market approach, which considers a multiple of cash flows for each reporting unit based upon public trading and recent transaction valuation multiples as the basis for fair value and (ii) an income approach, which uses a discounted cash flow model incorporating discount rates commensurate with the risks involved as the basis for fair value. Significant judgment including management’s estimate of future theatre level cash flows for each theatre is involved in estimating fair value of a reporting unit. The Company’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on projected operating performance of each reporting unit, recent market transactions and current industry trading multiples.

•Qualitative approach The Company’s qualitative assessment of goodwill for each reporting unit considers economic and market conditions, industry trading multiples and the impact of recent developments that would impact the estimated fair values as determined during its most recent quantitative assessment.

Tradename intangible assets are tested for impairment at least annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. Under ASC Topic 350, the Company can elect to perform a qualitative or quantitative impairment assessment for our tradename intangible assets as described below:

•Quantitative approach The Company compares the carrying values of its tradename assets to their estimated fair values. Fair values are estimated by applying an estimated market royalty rate that could be charged for the use of the tradenames to forecasted future revenues, with an adjustment for the present value of such royalties. If the estimated fair value is less than the carrying value, the tradename intangible asset is written down to its estimated fair value. Significant judgment is involved in estimating market royalty rates and long-term revenue forecasts. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected revenue performance and industry trends.

•Qualitative approach The Company’s qualitative assessment considers industry and market conditions and recent developments that may impact the revenue forecasts and other estimates as compared to its most recent quantitative assessment.

The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset:

Intangible Asset	Amortization Method
Goodwill	Indefinite-lived
Tradename	Indefinite-lived and definite-lived. Definite-lived tradename asset has a remaining useful life of approximately one year.
Other intangible assets	Straight-line method over the terms of the underlying agreement. The remaining useful lives of these intangible assets is two years.

Lease Accounting

Lease Accounting — See Note 4 for discussion of the Company’s lease accounting policies.

Deferred Charges and Other Assets

Deferred Charges and Other Assets — Deferred charges and other assets consist of construction, lease and other deposits, equipment to be placed in service, and other assets of a long-term nature.

Self-Insurance Reserves

Self-Insurance Reserves — In the U.S., the Company is self-insured for general liability claims, which are capped at $0.3 per occurrence with no aggregate annual cap. For its international locations, the Company is fully insured for general liability claims with little or no deductibles per occurrence. Under the Company’s fully-funded deductible workers compensation insurance plan in the U.S., the Company is responsible for pre-funding claims and is responsible for claims up to $0.3 per occurrence, with an annual cap of $5.0. The Company is also self-insured for domestic medical and dental claims with a cap of $0.3 per occurrence. As of December 31, 2022 and 2023, the Company’s self-insurance reserves were $10.0 and $11.4, respectively, and are reflected in accrued other current liabilities on the consolidated balance sheets. For its international locations, the Company is fully insured for workers compensation claims. Medical and dental benefits for the Company’s international locations are covered through a government-sponsored healthcare system that is funded through employee and employer payroll tax contributions.

Revenue and Expense Recognition

Revenue Recognition — See Note 5 for discussion of revenue recognition and deferred revenue.

Expenses — Film rental costs are based on the film licensing arrangements and accrued based on the applicable box office receipts and either; 1) a sliding scale formula, which is generally established with the studio prior to the opening of the film, 2) a firm terms formula as negotiated prior to a film's theatrical run or 3) estimates of the final settlement rate, which occurs at the conclusion of the film’s run. Under a sliding scale formula, the Company pays a percentage of box office revenues using a pre-determined scale that is based upon box office performance of the film for its full theatrical run. Under a firm terms formula, the Company pays the distributor a percentage of box office receipts that can either be an aggregate rate for the full theatrical run or rates that decline over the term of the theatrical run. The settlement process allows for negotiation of film rental fees upon the conclusion of the film's theatrical run based upon how the film performs. Estimates are based on the expected success of a film. The success of a film can generally be determined a few weeks after a film is released when the initial box office performance of the film is known. If actual box office performance differs from our estimates, film rental costs are adjusted accordingly throughout a film’s theatrical run.

Accounting for Share Based Awards

Accounting for Share Based Awards — The Company measures the cost of employee services received in exchange for an equity award based on the fair value of the award on the date of the grant. The grant date fair value is based on Holdings’ stock price on the grant date. Such costs are recognized over the period during which an employee is required to provide service in exchange for the award (which is usually the vesting period). At the time of the grant, Holdings also estimates the number of awards that will ultimately be forfeited. Holdings also periodically estimates the number of awards that will ultimately vest based upon the achievement of pre-established Company performance targets on those awards that are both performance-based and time-based. A cumulative expense adjustment is recognized when that estimate changes. See Note 18 for discussion of Holdings’ share based awards and related compensation expense.

Income Taxes

Income Taxes — The Company uses an asset and liability approach to financial accounting and reporting for income taxes. CUSA participates in the consolidated return of Holdings; however, CUSA’s provisions for income taxes is computed on a stand-alone basis. Deferred income taxes are provided when tax laws and financial accounting standards differ with respect to the amount of income for a year and the basis of assets and liabilities. A valuation allowance is recorded to reduce the carrying amount of deferred tax assets unless it is more likely than not that such assets will be realized. Income taxes are provided on unremitted earnings from foreign subsidiaries unless such earnings are expected to be indefinitely reinvested. Income taxes have also been provided for potential tax assessments. The evaluation of an uncertain tax position is a two-step process. The first step is recognition: The Company determines whether it is more likely than not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, the Company should presume that the position would be examined by the appropriate taxing authority that would have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Differences between tax positions taken in a tax return and amounts recognized in the financial statements result in (1) a change in a liability for income taxes payable or (2) a change in an income tax refund receivable, a deferred tax asset or a deferred tax liability or both (1) and (2). The Company accrues interest and penalties on its uncertain tax positions as a component of income tax expense. See further discussion in Note 20.

Segments

Segments — For the years ended December 31, 2021, 2022 and 2023, the Company managed its business under two reportable operating segments, U.S. markets and international markets. See Note 22.

Use of Estimates

Use of Estimates — The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The Company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates.

Foreign Currency Translations

Foreign Currency Translations — The assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. dollars at current exchange rates as of the balance sheet date, and revenues and expenses are translated at average monthly exchange rates. The resulting translation adjustments are recorded in the consolidated balance sheets in accumulated other comprehensive loss. See Note 16 for a summary of the translation adjustments recorded in accumulated other comprehensive loss for the years ended December 31, 2021, 2022 and 2023. The Company recognizes foreign currency transaction gains and losses when changes in exchange rates impact transactions, other than intercompany transactions of a long-term investment nature, that have been denominated in a currency other than the functional currency.

The Company deemed Argentina to be highly inflationary beginning July 1, 2018. A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity. The financial statements of the Company’s Argentina subsidiaries have been remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters, effective beginning July 1, 2018. See further discussion in Note 16.

During 2019, the Argentine government instituted exchange controls restricting the ability of entities and individuals to exchange Argentine pesos for foreign currencies and to remit foreign currency out of Argentina. As a result of these currency exchange controls, markets in Argentina developed a legal trading mechanism known as the Blue Chip Swap that allows entities to transfer U.S. dollars out of and into Argentina. In a Blue Chip Swap transaction, an entity buys U.S. dollar denominated securities in Argentina using Argentine pesos, and subsequently sells the securities for U.S. dollars, in Argentina, to access U.S. dollars locally, or outside Argentina, by transferring the securities abroad, prior to being sold (the latter commonly known as Blue Chip Swap Rate). The Blue Chip Swap rate is the implicit exchange rate resulting from the Blue Chip Swap transaction. The Blue Chip Swap rate can diverge significantly from Argentina’s official exchange rate. See further discussion in Note 16.

Fair Value Measurements

Fair Value Measurements — According to authoritative guidance, inputs used in fair value measurements fall into three different categories; Level 1, Level 2 and Level 3. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for the asset or liability. See Note 15 for a discussion of our fair value measurements for the years ended December 31, 2021, 2022 and 2023.

Interest Rate Swaps

Interest Rate Swaps – The Company evaluates its interest rate swap agreements, which are designated as cash flow hedges, to determine whether they are effective on a quarterly basis in accordance with ASC Topic 815, Derivatives and Hedging. The fair values of the interest rate swaps are estimated based on future estimated net cash flows considering forecasted interest rates for the terms of the interest rate swap agreements as compared to the fixed interest rates paid under the agreements. If deemed to be effective, fair value estimates are recorded on the consolidated balance sheets as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss. If the swaps are determined to not be effective, the gains or losses are recorded in interest expense on the consolidated income statement. See further discussion in Note 14.

Restructuring Charges

Restructuring Charges – During the year ended December 31, 2020, the Company recorded restructuring charges based on an approved and announced restructuring plan, specifically related to headcount reductions, the permanent closure of underperforming theatres and the write-down of related theatre assets. The costs of the restructuring actions were accrued based on estimates at the time the plan was formalized. Adjustments made to restructuring charges based on actual costs incurred were recorded during the years ended December 31, 2021 and 2022. The balance of accrued and unpaid restructuring charges at December 31, 2022 and 2023 was $0. See further discussion in Note 3.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Dec. 31, 2023

Accounting Policies [Abstract]

Summary Of Estimated Useful Life of Assets

Depreciation is recorded using the straight-line method over the estimated useful lives of the assets as follows:

Category	Useful Life
Buildings on owned land	40 years
Buildings on leased land	Lesser of lease term or 40 years
Land and buildings under finance leases	Lease term
Theatre furniture and equipment	3 to 15 years
Leasehold improvements	Lesser of lease term or useful life

Summary Of Intangible Assets and Amortization Method

The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset:

Intangible Asset	Amortization Method
Goodwill	Indefinite-lived
Tradename	Indefinite-lived and definite-lived. Definite-lived tradename asset has a remaining useful life of approximately one year.
Other intangible assets	Straight-line method over the terms of the underlying agreement. The remaining useful lives of these intangible assets is two years.

XML

IMPACT OF THE COVID-19 PANDEMIC (Tables)

12 Months Ended

Dec. 31, 2023

Unusual Or Infrequent Item [Line Items]

Schedule of Restructuring Plan

The following table summarizes activity recorded during the years ended December 31, 2021 and 2022:

	U.S. Operating Segment									International Operating Segment								Consolidated
	Employee-related Costs			Facility Closure Costs			Total Charges			Employee-related Costs		Facility Closure Costs			Total Charges			Employee-related Costs			Facility Closure Costs			Total Charges
Reserve balance at January 1, 2021	$	0.9		$	5.7		$	6.6		$	—	$	0.1		$	0.1		$	0.9		$	5.8		$	6.7
Amounts paid		(0.4	)		(3.9	)		(4.3	)		—		—			—			(0.4	)		(3.9	)		(4.3	)
Reserve adjustments (1)		(0.1	)		(0.9	)		(1.0	)		—		—			—			(0.1	)		(0.9	)		(1.0	)
Reserve balance at December 31, 2021	$	0.4		$	0.9		$	1.3		$	—	$	0.1		$	0.1		$	0.4		$	1.0		$	1.4
Amounts paid		(0.4	)		(0.5	)		(0.9	)		—		—			—			(0.4	)		(0.5	)		(0.9	)
Reserve adjustments (1)		—			(0.4	)		(0.4	)		—		(0.1	)		(0.1	)		—			(0.5	)		(0.5	)
Reserve balance at December 31, 2022	$	—		$	—		$	—		$	—	$	—		$	—		$	—		$	—		$	—

Amounts were primarily adjustments based on final facility lease payments for certain closed theatres as compared with original estimates recorded.

XML

LEASE ACCOUNTING (Tables)

12 Months Ended

Dec. 31, 2023

Leases [Abstract]

Schedule of Operating and Finance Right-of-Use Assets and Lease Liabilities

The following table represents the operating and finance right-of-use assets and lease liabilities as of the periods indicated.

		As of
Leases	Classification	December 31, 2022		December 31, 2023
Assets (1)
Operating lease assets	Operating lease right-of-use assets	$	1,102.7	$	986.4
Finance lease assets	Theatre properties and equipment, net of accumulated depreciation (2)		67.8		55.7
Total lease assets		$	1,170.5	$	1,042.1
Liabilities (1)
Current
Operating	Current portion of operating lease obligations	$	219.3	$	212.5
Finance	Current portion of finance lease obligations		14.4		14.0
Noncurrent
Operating	Operating lease obligations, less current portion		970.6		853.3
Finance	Finance lease obligations, less current portion		88.0		73.8
Total lease liabilities		$	1,292.3	$	1,153.6

(1)The operating lease right-of-use assets and liabilities recorded on the Company’s consolidated balance sheets generally do not include renewal options that have not yet been exercised. The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord after consideration of market conditions and performance of the theatre.

(2)Finance lease assets are net of accumulated amortization of $62.5 and $73.9 as of December 31, 2022 and 2023, respectively.

Schedule of Aggregate Lease Costs by Lease Classification

The following table represents the Company’s aggregate lease costs, by lease classification, for the periods indicated.

		Year Ended December 31,
Lease Cost	Classification	2021		2022		2023
Operating lease costs
Equipment (1)	Utilities and other	$	2.3	$	4.4	$	4.1
Real Estate (1)	Facility lease expense		281.0		315.7		348.6
Total operating lease costs		$	283.3	$	320.1	$	352.7
Finance lease costs
Depreciation of leased assets	Depreciation and amortization	$	12.6	$	12.4	$	12.0
Interest on lease liabilities	Interest expense		5.9		5.3		4.9
Total finance lease costs		$	18.5	$	17.7	$	16.9

(1)Includes short-term lease payments, variable lease payments and office lease payments reflected in general and administrative expense as set forth in the following table for the periods presented:

		Year Ended December 31,
Lease Cost	Classification	2021		2022		2023
Operating lease costs
Equipment - Short-term and variable lease payments	Utilities and other	$	1.8	$	3.9	$	3.6
Real Estate - Variable lease payments (1)	Facility lease expense	$	11.8	$	36.4	$	68.3
Real Estate - Office leases	General and administrative	$	1.3	$	1.3	$	1.4

(1) Represents lease payments that are based on a change in index, such as CPI or inflation, variable payments based on revenue or attendance and variable common area maintenance costs.

Schedule of Maturity of Lease Liabilities by Lease Classification

The following table represents the maturity of lease liabilities, by lease classification, as of December 31, 2023.

	Operating		Finance
Years Ending	Leases		Leases
2024	$	267.2	$	18.0
2025		237.4		16.4
2026		199.6		12.0
2027		158.5		11.9
2028		121.9		11.6
Thereafter		295.4		35.1
Total lease payments	$	1,280.0	$	105.0
Less: Interest		214.2		17.2
Present value of lease liabilities	$	1,065.8	$	87.8

Schedule of Weighted-Average Remaining Lease Term and Discount Rate

The following table represents the weighted-average remaining lease term and discount rate, disaggregated by lease classification, as of December 31, 2023.

	As of
Lease Term and Discount Rate	December 31, 2023
Weighted-average remaining lease term (years) (1)
Operating leases - equipment		3.3
Operating leases - real estate		6.4
Finance leases - equipment		2.6
Finance leases - real estate		7.6
Weighted-average discount rate (2)
Operating leases - equipment		6.3	%
Operating leases - real estate		11.5	%
Finance leases - equipment		3.6	%
Finance leases - real estate		4.9	%

(1)The lease assets and liabilities recorded on the Company’s consolidated balance sheets generally do not include renewal options that have not yet been executed. The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord after consideration of market conditions and performance of the theatre.

(2)The discount rate for each lease represents the incremental borrowing rate at which the Company would borrow funds, on a collateralized basis, over a similar term and at an amount equal to the lease payments in a similar economic environment.

Schedule of Minimum Cash Lease Payments

The following table represents the minimum cash lease payments included in the measurement of lease liabilities and the non-cash addition of right-of-use assets for the periods presented.

	Year Ended December 31,
Other Information	2021		2022		2023
Cash paid for amounts included in the measurement of lease liabilities
Cash outflows for operating leases	$	269.7	$	279.8	$	280.8
Cash outflows for finance leases - operating activities	$	5.9	$	5.3	$	4.9
Cash outflows for finance leases - financing activities	$	14.7	$	14.3	$	14.4
Non-cash amount of leased assets obtained in exchange for:
Operating lease liabilities	$	180.1	$	114.1	$	87.0
Finance lease liabilities	$	0.7	$	—	$	—

XML

REVENUE RECOGNITION (Tables)

12 Months Ended

Dec. 31, 2023

Revenue from Contract with Customer [Abstract]

Summary of Revenues Disaggregated Based on Type of Good Or Service By Reportable Operating Segment and On Timing of Revenue Recognition

The following tables present revenue for the periods indicated, disaggregated based on major type of good or service and by reportable operating segment.

	Year Ended December 31, 2023
	U.S.		International
	Operating		Operating
Major Goods/Services	Segment (1)		Segment		Consolidated
Admissions Revenue	$	1,236.0	$	319.6	$	1,555.6
Concession Revenue		952.0		240.0		1,192.0
Screen advertising, screen rental and promotional revenue		91.0		53.6		144.6
Other Revenue		136.3		38.2		174.5
Total Revenue	$	2,415.3	$	651.4	$	3,066.7

	Year Ended December 31, 2022
	U.S.		International
	Operating		Operating
Major Goods/Services	Segment (1)		Segment		Consolidated
Admissions Revenue	$	1,010.2	$	236.7	$	1,246.9
Concession Revenue		763.0		175.3		938.3
Screen advertising, screen rental and promotional revenue		81.7		45.3		127.0
Other Revenue		115.3		27.2		142.5
Total Revenue	$	1,970.2	$	484.5	$	2,454.7

	Year Ended December 31, 2021
	U.S.		International
	Operating		Operating
Major Goods/Services	Segment (1)		Segment		Consolidated
Admissions Revenue	$	671.7	$	108.3	$	780.0
Concession Revenue		482.8		78.9		561.7
Screen advertising, screen rental and promotional revenue		66.2		17.9		84.1
Other Revenue		72.9		11.8		84.7
Total Revenue	$	1,293.6	$	216.9	$	1,510.5

(1)U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 22 for additional information on intercompany eliminations.

The following tables present revenue for the periods indicated, disaggregated based on timing of revenue recognition (as discussed above) and by reportable segment.

	Year Ended December 31, 2023
	U.S.		International
	Operating		Operating
	Segment (1)		Segment		Consolidated
Goods and services transferred at a point in time	$	2,327.9	$	588.9	$	2,916.8
Goods and services transferred over time		87.4		62.5		149.9
Total	$	2,415.3	$	651.4	$	3,066.7

	Year Ended December 31, 2022
	U.S.		International
	Operating		Operating
	Segment (1)		Segment		Consolidated
Goods and services transferred at a point in time	$	1,856.5	$	428.3	$	2,284.8
Goods and services transferred over time		113.7		56.2		169.9
Total	$	1,970.2	$	484.5	$	2,454.7

	Year Ended December 31, 2021
	U.S.		International
	Operating		Operating
	Segment (1)		Segment		Consolidated
Goods and services transferred at a point in time	$	1,201.2	$	193.7	$	1,394.9
Goods and services transferred over time		92.4		23.2		115.6
Total	$	1,293.6	$	216.9	$	1,510.5

(1)U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 22 for additional information on intercompany eliminations.

Changes in Deferred Revenues

The following table presents changes in the Company’s deferred revenue for the periods indicated:

Deferred Revenue	NCM Screen Advertising Advances (2)			Other Deferred Revenue (3)
Balance at January 1, 2022	$	346.0		$	160.3
Amounts recognized as accounts receivable		—			1.8
Cash received from customers in advance		—			241.1
Common units received from NCM (see Note 9)		1.3			—
Interest accrued related to significant financing component		23.2			—
Revenue recognized during period		(32.3	)		(206.9	)
Foreign currency translation adjustments		—			(1.4	)
Balance at December 31, 2022		338.2			194.9
Amounts recognized as accounts receivable		—			4.6
Cash received from customers in advance		—			327.4
Dispositions (1)		—			(0.4	)
Interest accrued related to significant financing component		22.6			—
Revenue recognized during period		(32.4	)		(299.5	)
Foreign currency translation adjustments		—			(5.4	)
Balance at December 31, 2023	$	328.4		$	221.6

(1)Relates to the sale of the Company’s Ecuador subsidiary. See Note 8.

(2)See Significant Financing Component in Note 9 for discussion of NCM screen advertising advances and maturity of balances as of December 31, 2023.

(3)Includes liabilities associated with outstanding gift cards and discount ticket vouchers, points or rebates outstanding under the Company’s loyalty and membership programs and revenue not yet recognized for screen advertising and other promotional activities. Amount is classified as accounts payable and accrued expenses or other long-term liabilities on the consolidated balance sheets.

Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized

The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied for other deferred revenue in the table above as of December 31, 2023 and when the Company expects to recognize this revenue.

	Year Ended December 31,
Remaining Performance Obligations	2024		2025		Thereafter		Total
Other deferred revenue	$	195.2		26.4		—	$	221.6

XML

EARNINGS (LOSS) PER SHARE (Tables)

12 Months Ended

Dec. 31, 2023

Earnings Per Share [Abstract]

Schedule of computations of basic and diluted loss per share

The following table presents computations of basic and diluted earnings (loss) per share for Holdings under the two class method:

	Year Ended December 31,
	2021			2022			2023
Numerator:
Net (loss) income attributable to Cinemark Holdings, Inc.	$	(422.8	)	$	(271.2	)	$	188.2
Loss (income) allocated to participating share-based awards (1)		6.1			3.8			(3.3	)
Basic net (loss) income attributable to common stockholders	$	(416.7	)	$	(267.4	)	$	184.9
Add: Interest expense on convertible notes, net of tax (3)		—			—		$	18.2
Diluted net (loss) income attributable to common stockholders	$	(416.7	)	$	(267.4	)	$	203.1
Denominator:
Basic weighted average shares outstanding		117.3			118.2			119.1
Common equivalent shares for restricted performance stock units (2)		—			—			0.9
Common equivalent shares for convertible notes (3)		—			—			32.0
Common equivalent shares for warrants (4)		—			—			—
Diluted weighted average shares outstanding		117.3			118.2			152.0
Basic (loss) earnings per share attributable to common stockholders	$	(3.55	)	$	(2.26	)	$	1.55
Diluted (loss) earnings per share attributable to common stockholders	$	(3.55	)	$	(2.26	)	$	1.34

(1)For the years ended December 31, 2021, 2022 and 2023, a weighted average of approximately 1.7 shares, 1.7 shares and 2.1 shares of unvested restricted stock, respectively, are considered participating securities.

(2)For the years ended December 31, 2021 and 2022, approximately 0.0 and 0.4 common equivalent shares for performance stock units were excluded because they were anti-dilutive.

(3)For the years ended December 31, 2021 and 2022, diluted loss per share excludes the assumed conversion of the 4.50% Convertible Senior Notes into 32.0 shares of common stock, as they would have been anti-dilutive. See further discussion below.

(4)For all periods presented, diluted earnings (loss) per share excludes the warrants, as they would be anti-dilutive.

XML

THEATRE PROPERTIES AND EQUIPMENT (Tables)

12 Months Ended

Dec. 31, 2023

Property, Plant and Equipment, Net [Abstract]

Schedule Of Properties And Equipment

Properties and equipment consisted of the following as of the periods presented:

	December 31,
	2022			2023
Theatre properties and equipment
Land	$	99.7		$	97.8
Buildings		528.9			530.6
Property under finance lease		130.3			129.6
Theatre furniture and equipment		1,429.5			1,432.8
Leasehold interests and improvements		1,206.9			1,300.2
Total		3,395.3			3,491.0
Less: accumulated depreciation and amortization (1)		(2,163.2	)		(2,329.3	)
Theatre properties and equipment, net	$	1,232.1		$	1,161.7

(1)Amortization of finance lease assets is included in depreciation and amortization expense on the consolidated statements of income (loss). Accumulated amortization of finance lease assets as of December 31, 2022 and 2023 was $62.5 and $73.9, respectively.

Schedule of Carrying Value of Subsidiary's Significant Assets and Liabilities

The following table presents the carrying value of Ecuador’s significant assets and liabilities as of the periods presented:

	December 31,
	2022		2023
Theatre property and equipment, net	$	5.4	$	—
Operating lease right-of-use asset, net		2.9		—
Goodwill		4.2		—
Total assets	$	15.3	$	—
Total liabilities	$	8.5	$	—

Schedule of Total Revenue and Operating Income

The table below summarizes total revenue and operating income for the Ecuador subsidiary for the periods presented:

	Year Ended December 31,
	2022			2023
Total revenue	$	13.3		$	13.5
Operating (loss) income	$	(1.2	)	$	2.0

XML

INVESTMENT IN NATIONAL CINEMEDIA, INC/NATIONAL CINEMEDIA LLC (Tables)

12 Months Ended

Dec. 31, 2023

Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized

The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied for other deferred revenue in the table above as of December 31, 2023 and when the Company expects to recognize this revenue.

	Year Ended December 31,
Remaining Performance Obligations	2024		2025		Thereafter		Total
Other deferred revenue	$	195.2		26.4		—	$	221.6

NCM Screen Advertising Advances

Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized

The recognition of revenue related to the NCM screen advertising advances is recorded on a straight-line basis over the new term of the amended ESA through February 2041.

	Year Ended December 31,
Remaining Maturity	2024		2025		2026		2027		2028		Thereafter		Total
NCM screen advertising advances (1)	$	10.5	$	11.2	$	12.0	$	12.8	$	13.7	$	268.2	$	328.4

(1)Amounts are net of the estimated interest to be accrued for the periods presented.

NCM

Summary of Activity With Equity Investee Included in the Company's Consolidated Financial Statements

Summary of Activity with NCMI/NCM

Below is a summary of activity with NCMI and NCM included in each of Holdings’ and CUSA’s consolidated financial statements for the periods indicated. See Note 5 for discussion of revenue recognition.

	Investment  in NCMI/NCM			NCM Screen Advertising Advances			Distributions from NCM (5)			Equity in Loss (3)		Other Revenue			Interest Expense - NCM		Cash Received
Balance as of January 1, 2021	$	152.0		$	(344.3	)
Receipt of common units due to annual common unit adjustment		10.2			(10.2	)		—			—		—			—		—
Screen rental revenues earned under ESA (1)		—			—			—			—		(12.0	)		—		12.0
Interest accrued related to significant financing component		—			(23.6	)		—			—		—			23.6		—
Receipt under tax receivable agreement		(0.2	)		—			(0.1	)		—		—			—		0.3
Equity in loss		(26.6	)		—			—			26.6		—			—		—
Amortization of screen advertising advances		—			32.1			—			—		(32.1	)		—		—
Balance as of and for the year ended December 31, 2021	$	135.4		$	(346.0	)	$	(0.1	)	$	26.6	$	(44.1	)	$	23.6	$	12.3
Receipt of common units due to annual common unit adjustment		1.3			(1.3	)		—			—		—			—		—
Screen rental revenues earned under ESA (1)		—			—			—			—		(19.9	)		—		19.9
Interest accrued related to significant financing component		—			(23.2	)		—			—		—			23.2		—
Equity in loss		(13.9	)		—			—			13.9		—			—		—
Impairment of investment in NCM (2)		(113.2	)		—			—			—		—			—		—
Amortization of screen advertising advances		—			32.3			—			—		(32.3	)		—		—
Balance as of and for the year ended December 31, 2022	$	9.6		$	(338.2	)	$	—		$	13.9	$	(52.2	)	$	23.2	$	19.9
Screen rental revenues earned under ESA (1)		—			—			—			—		(20.9	)		—		20.9
Interest accrued related to significant financing component		—			(22.6	)		—			—		—			22.6		—
Redemption of common units of NCM for common stock of NCMI (2)		—			—			—			—		—			—		—
Equity in loss (3)		(3.2	)		—			—			3.2		—			—		—
Impairment of investment in NCMI (4)		(0.7	)		—			—			—		—			—		—
Unrealized gain on fair market value adjustment of investment in NCMI (2)		12.4			—			—			—		—			—		—
Amortization of screen advertising advances		—			32.4			—			—		(32.4	)		—		—
Balance as of and for the year ended December 31, 2023	$	18.1		$	(328.4	)	$	—		$	3.2	$	(53.3	)	$	22.6	$	20.9

(1)Amounts include the per patron and per digital screen theatre access fees, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire were approximately $4.9, $7.5 and $8.9 for the years ended December 31, 2021, 2022 and 2023, respectively. Amounts unpaid and reflected in accounts receivable were $4.9 and $4.9 as of December 31, 2022 and 2023, respectively.

(2)See Investment in National CineMedia below.

(3)Equity in loss was recorded through April 11, 2023, the date NCM filed its bankruptcy petition, after which the Company applied the fair value accounting method as discussed below.

(4)Reflected in impairment of long-lived and other assets on the consolidated income statement for the year indicated. See further discussion at Investment in National CineMedia below.

(5)Excess cash distributions from NCM to its members were restricted through December 2023 in accordance with the credit agreement amendment NCM entered into with its lenders and as a result of their bankruptcy filing. NCMI also suspended its dividend.

Summary of Common Units Received Under Common Unit Adjustment Agreement

Below is a summary of common units received by the Company under the Common Unit Adjustment (“CUA”) Agreement during the years ended December 31, 2021 and 2022:

Event	Date Common Units Received	Number of Common Units Received		Fair Value of Common Units Received (1)
2021 annual common unit adjustment	4/14/2021		2.3	$	10.2
2022 annual common unit adjustment	4/13/2022		0.5	$	1.3

(1) The fair value of the common units received was estimated based on the market price of NCMI common stock (Level 1 input as defined in FASB ASC Topic 820) at the time the common units were determined, adjusted for volatility associated with the estimated time period it would take to convert the common units and register the respective shares.

Summary Financial Information

Summary Financial Information for NCMI/NCM

The tables below present summary financial information for NCMI/NCM for its fiscal periods indicated:

	Year Ended						Three Months Ended
	December 30, 2021			December 29, 2022			March 30, 2023 (1)
Revenue	$	114.6		$	249.2		$	34.9
Operating income (loss)	$	(68.6	)	$	10.9		$	(30.6	)
Net loss	$	(134.6	)	$	(69.8	)	$	(54.0	)

(1)Financial information for NCMI is presented for the latest reporting period available through which the Company accounted for its investment in NCMI under the equity method.

	As of
	December 29, 2022			March 30, 2023 (1)
Current assets	$	148.6		$	121.7
Noncurrent assets	$	628.2		$	618.5
Current liabilities	$	97.5		$	1,204.8
Noncurrent liabilities	$	1,161.6		$	67.2
Members'/Total deficit	$	(482.3	)	$	(531.8	)

(1)Financial information for NCMI is presented for the latest reporting period available through which the Company accounted for its investment in NCMI under the equity method.

XML

INVESTMENTS IN AFFILIATES (Tables)

12 Months Ended

Dec. 31, 2023

Summary of Activity for Each of Company's Other Investments

Below is a summary of activity for each of the Company’s affiliates for the periods indicated:

	AC JV, LLC			DCDC		FE Concepts			Other (1)			Total
Balance at January 1, 2021	$	3.7		$	1.3	$	18.3		$	0.5		$	23.8
Equity in income		—			0.5		1.0			—			1.5
Other (1)		—			—		—			(0.1	)		(0.1	)
Balance at December 31, 2021	$	3.7		$	1.8	$	19.3		$	0.4		$	25.2
Equity in income		3.4			—		1.2			—			4.6
Cash distributions received		(2.9	)		—		(4.0	)		—			(6.9	)
Other (1)		—			—		—			(0.3	)		(0.3	)
Balance at December 31, 2022	$	4.2		$	1.8	$	16.5		$	0.1		$	22.6
Equity in income		4.9			0.3		1.6			—			6.8
Cash distributions received		(5.7	)		—		—			—			(5.7	)
Other (1)		—			—		—			(0.1	)		(0.1	)
Balance at December 31, 2023	$	3.4		$	2.1	$	18.1		$	-		$	23.6

(1)Consists primarily of mark-to-market adjustment on an investment in marketable securities.

XML

GOODWILL AND INTANGIBLE ASSETS, NET (Tables)

12 Months Ended

Dec. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Summary of Goodwill

The Company’s goodwill was as follows for the periods presented:

	U.S. Operating Segment		International Operating Segment			Total
Balance at December 31, 2021 (1)	$	1,182.9	$	65.9		$	1,248.8
Foreign currency translation adjustments		—		2.1			2.1
Balance at December 31, 2022 (1)	$	1,182.9	$	68.0		$	1,250.9
Disposition (2)		—	$	(4.2	)		(4.2	)
Foreign currency translation adjustments		—		4.3			4.3
Balance at December 31, 2023 (1)	$	1,182.9	$	68.1		$	1,251.0

(1)Balances are presented net of accumulated impairment losses of $214.0 for the U.S. operating segment and $43.8 for the international operating segment.

(2)Relates to the sale of the Company’s Ecuador subsidiary. See Note 8.

Intangible Assets

Intangible assets activity and balances consisted of the following for the periods indicated:

	Balance at January 1, 2022			Additions		Amortization			Foreign Currency Translation Adjustments and Other (1)			Balance at December 31, 2022
Intangible assets with finite lives:
Gross carrying amount	$	81.7		$	—	$	—		$	(4.0	)	$	77.7
Accumulated amortization		(71.0	)		—		(2.4	)		0.2			(73.2	)
Total intangible assets with finite lives, net	$	10.7		$	—	$	(2.4	)	$	(3.8	)	$	4.5
Intangible assets with indefinite lives:
Tradename and other		300.1			—		—			—			300.1
Total intangible assets, net	$	310.8		$	—	$	(2.4	)	$	(3.8	)	$	304.6

	Balance at January 1, 2023			Additions (2)		Disposals (3)			Amortization			Foreign Currency Translation Adjustments and Other (4)		Balance at December 31, 2023
Intangible assets with finite lives:
Gross carrying amount	$	77.7		$	—	$	—		$	—		$	0.1	$	77.8
Accumulated amortization		(73.2	)		—		—			(2.1	)		—		(75.3	)
Total intangible assets with finite lives, net	$	4.5		$	—	$	—		$	(2.1	)	$	0.1	$	2.5
Intangible assets with indefinite lives:
Tradename and other		300.1			0.4		(0.4	)		—			0.2		300.3
Total intangible assets, net	$	304.6		$	0.4	$	(0.4	)	$	(2.1	)	$	0.3	$	302.8

(1)Includes foreign currency translation adjustments and an impairment recorded for a U.S. intangible asset during 2022. See Note 12 for discussion of impairment evaluations performed during the year ended December 31, 2022.

(2)Amount represents licenses acquired to sell alcoholic beverages for certain locations.

(3)Relates to the sale of the Company’s Ecuador subsidiary. See Note 8.

Includes foreign currency translation adjustments.

Estimated Aggregate Future Amortization Expense for Intangible Assets

Estimated aggregate future amortization expense for intangible assets is as follows:

Year ended December 31, 2024	$	2.0
Year ended December 31, 2025		0.5
Year ended December 31, 2026		—
Year ended December 31, 2027		—
Year ended December 31, 2028		—
Total	$	2.5

XML

IMPAIRMENT OF LONG-LIVED AND OTHER ASSETS (Tables)

12 Months Ended

Dec. 31, 2023

Impairment or Disposal of Tangible Assets Disclosure [Abstract]

Long-Lived Asset Impairment Losses

Below is a summary of impairment charges for the periods indicated:

	Year Ended
	December 31,
	2021	2022	2023
U.S. segment
Theatre properties	$6.4	$19.7	$6.6
Theatre operating lease right-of-use assets	6.8	34.0	7.1
Investment in NCM (1)	—	113.2	0.7
Other	—	3.9	—
U.S. total	13.2	170.8	14.4
International segment
Theatre properties	4.0	2.2	0.7
Theatre operating lease right-of-use assets	3.2	1.1	1.5
Intangible assets, net	0.4	—	—
International total	7.6	3.3	2.2
Total impairment	$20.8	$174.1	$16.6

(1)See discussion at Investment in National CineMedia in Note 9.

XML

ACCRUED OTHER CURRENT LIABILITIES (Tables)

12 Months Ended

Dec. 31, 2023

Payables and Accruals [Abstract]

Schedule of Accrued Other Current Liabilities

Accrued other current liabilities consisted of the following as of the periods presented:

	December 31,
	2022		2023
Gift card liability (1)	$	64.5	$	73.6
Subscription membership program liability (1)		58.4		77.3
Discount vouchers liability (1)		32.8		31.9
Other (2)		44.7		56.4
Total	$	200.4	$	239.2

(1)See discussion at Revenue Recognition Policy in Note 5.

(2)The only difference between accrued other current liabilities for Holdings, as presented above, and CUSA is an additional $0.3 and $0.1 in other as of December 31, 2022 and 2023, respectively.

XML

LONG-TERM DEBT (Tables)

12 Months Ended

Dec. 31, 2023

Debt Disclosure [Abstract]

Components of Long-Term Debt

Long-term debt of Holdings and CUSA consisted of the following for the periods presented:

	December 31,
	2022		2023
Cinemark Holdings, Inc. 4.50% convertible senior notes due 2025	$	460.0	$	460.0
Cinemark USA, Inc. term loan due 2030 (see Senior Secured Credit Facility below)		626.5		645.1
Cinemark USA, Inc. 8.75% senior secured notes due 2025		250.0		150.0
Cinemark USA, Inc. 5.875% senior notes due 2026		405.0		405.0
Cinemark USA, Inc. 5.25% senior notes due 2028		765.0		765.0
Other		10.1		7.0
Total long-term debt carrying value (1)	$	2,516.6	$	2,432.1
Less: Current portion		10.7		7.8
Less: Debt issuance costs and original issue discount, net of accumulated amortization (1)		31.9		33.0
Long-term debt, less current portion, net of unamortized debt issuance costs and original issue discount (1)	$	2,474.0	$	2,391.3

(1) The only differences between the long-term debt for Holdings, as presented above, and the long-term debt for CUSA are the $460.0 million 4.50% Convertible Senior Notes due 2025 and the related debt issuance costs. The following table sets forth, as of the periods indicated, the total long-term debt carrying value, current portion of long-term debt and debt issuance costs, net of amortization for CUSA:

	December 31,
	2022		2023
Total long-term debt carrying value	$	2,056.6	$	1,972.1
Less: Current portion		10.7		7.8
Less: Debt issuance costs, net of accumulated amortization and original issue discount		22.9		27.5
Long-term debt, less current portion, net of unamortized debt issuance costs and original issue discount	$	2,023.0	$	1,936.8

Schedule of carrying values and fair values of debt instruments

The table below presents the fair value of the Company's long-term debt as of the periods presented:

	As of
	December 31, 2022		December 31, 2023
Holdings fair value (1)	$	2,210.5	$	2,460.3
CUSA fair value	$	1,771.3	$	1,903.8

(1)The fair value of the 4.50% convertible notes was $439.2 and $556.5 as of December 31, 2022 and
2023, respectively.

Maturities of Long-Term Debt, Excluding Unamortized Debt Issuance Costs

Holdings' long-term debt, excluding unamortized debt issuance costs, at December 31, 2023 matures as follows:

2024	$	7.8
2025		617.7
2026		412.7
2027		7.7
2028		772.7
Thereafter		613.5
Total (1)	$	2,432.1

(1)The only difference between the long-term debt maturity payments for Holdings, as presented above, and those for CUSA is the $460.0 repayment of Holdings’ 4.50% Convertible Senior Notes in 2025.

Summary of Company's Interest Rate Swap Agreements Designated as Cash Flow Hedges

Below is a summary of the Company’s interest rate swap agreements designated as cash flow hedges as of December 31, 2023:

						Estimated
						Fair Value at
Notional						December 31,
Amount			Pay Rate	Receive Rate	Expiration Date	2023 (1)
$	137.5	(2)	2.15%	1-Month Term SOFR	December 31, 2024	$	3.5
$	137.5	(3)	2.08%	1-Month Term SOFR	December 31, 2024		3.5
$	175.0		3.20%	1-Month Term SOFR	December 31, 2026		2.9
					Total	$	9.9

(1)Approximately $9.7 of the total is included in prepaid expenses and other and $0.2 is included in deferred charges on the consolidated balance sheet as of December 31, 2023.

(2)In January 2024, the Company amended and extended one of its two then existing $137.5 notional amount interest rate swap agreements to amend the pay rate to 3.17% and extend the maturity date to December 31, 2027, effective January 31, 2024.

(3)In February 2024, the Company amended and extended the second of its two then existing $137.5 notional amount interest rate swap agreements to amend the pay rate to 3.21% and extend the maturity date to December 31, 2026, effective February 29, 2024.

XML

FAIR VALUE MEASUREMENTS (Tables)

12 Months Ended

Dec. 31, 2023

Fair Value Disclosures [Abstract]

Summary of Liabilities Measured at Fair Value on a Recurring Basis

Below is a summary of assets measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of the periods presented:

	As of	Carrying		Fair Value
Description	December 31,	Value		Level 1		Level 2		Level 3
Interest rate swap assets (1)	2022	$	20.4	$	—	$	20.4	$	—
Interest rate swap assets (1)	2023	$	9.9	$	—	$	9.9	$	—
Investment in NCMI (2)	2023	$	18.1	$	—	$	18.1	$	—

(1) See further discussion of interest rate swaps at Note 14.

(2) See further discussion of investment in NCMI at Note 9.

XML

FOREIGN CURRENCY TRANSLATION (Tables)

12 Months Ended

Dec. 31, 2023

Fair Value Disclosures [Abstract]

Summary of Impact of Translating Financial Statements of Company's International Subsidiaries

Below is a summary of the impact of translating the financial statements of the Company’s international subsidiaries for the periods presented.

							Other Comprehensive
							Income (Loss)
	Exchange Rate as of December 31,						Year Ended December 31,
Country	2021		2022		2023		2021			2022		2023
Brazil		5.57		5.29		4.85	$	(4.7	)	$	2.7	$	5.5
Colombia		3,981.16		4,810.19		3,885.85		(0.1	)		—		1.20
Chile		852.02		852.00		879.54		(10.9	)		0.3		(3.1	)
Peru		4.02		3.81		3.75		(2.8	)		1.3		0.3
All other								(0.3	)		0.3		1.0
							$	(18.8	)	$	4.6	$	4.9

XML

NONCONTROLLING INTERESTS IN SUBSIDIARIES (Tables)

12 Months Ended

Dec. 31, 2023

Noncontrolling Interest [Abstract]

Noncontrolling Interests in Subsidiaries

Noncontrolling interests in subsidiaries of the Company were as follows as of the periods presented:

	December 31,
	2022		2023
Cinemark Partners II	$	7.7	$	7.4
Laredo Theatres		0.2		0.3
Greeley Ltd.		0.9		0.8
Other		0.5		0.5
Total	$	9.3	$	9.0

XML

CAPITAL STOCK (Tables)

12 Months Ended

Dec. 31, 2023

Summary of Treasury Stock Activity

Below is a summary of Holdings’ treasury stock activity for the years ended December 31, 2021, 2022 and 2023.

	Number of Treasury Shares		Cost
Balance at January 1, 2021		5.05	$	87.0
Restricted stock withholdings (1)		0.24		4.1
Restricted stock forfeitures (2)		0.06		—
Balance at December 31, 2021		5.35	$	91.1
Restricted stock withholdings (1)		0.26		4.3
Restricted stock forfeitures (2)		0.07		—
Balance at December 31, 2022		5.68	$	95.4
Restricted stock withholdings (1)		0.22		2.9
Restricted stock forfeitures (2)		0.10		—
Balance at December 31, 2023		6.00	$	98.3

(1)Holdings withheld shares as a result of the election by certain employees to satisfy their tax liabilities upon vesting in restricted stock and restricted stock units. Holdings determined the number of shares to be withheld based upon market values of the common stock of Holdings on the vest dates. Below is a summary of the range of market values per share on the vest dates for the years indicated:

	Year Ended December 31,
	2021	2022	2023
Market Values	$15.21 to $24.14	$12.11 to $18.33	$11.16 to $18.36

(2)Holdings repurchased forfeited restricted shares at a cost of $0.001 per share in accordance with the 2017 Omnibus Plan.

Summary of Restricted Stock Activity

Below is a summary of restricted stock activity for the years ended December 31, 2021, 2022 and 2023:

	Year Ended					Year Ended					Year Ended
	December 31, 2021					December 31, 2022					December 31, 2023
	Shares of Restricted Stock			Weighted Average Grant Date Fair Value		Shares of Restricted Stock			Weighted Average Grant Date Fair Value		Shares of Restricted Stock			Weighted Average Grant Date Fair Value
Outstanding at January 1		1.43		$	21.11		1.99		$	21.73		1.85		$	20.64
Granted		1.24		$	21.91		0.88		$	16.40		1.38		$	12.07
Vested		(0.62	)	$	20.92		(0.95	)	$	19.13		(0.78	)	$	21.04
Forfeited		(0.06	)	$	18.96		(0.07	)	$	18.91		(0.10	)	$	16.40
Outstanding at December 31		1.99		$	21.73		1.85		$	20.64		2.35		$	15.67

Summary of Restricted Stock and Restricted Stock Unit Award Activity

Below is a summary of restricted stock award activity recorded for the periods indicated.

	Year Ended December 31,
	2021		2022		2023
Compensation expense recognized during the period:
CUSA employees (1)	$	22.0	$	14.8	$	15.1
Holdings directors		0.9		1.0		1.2
Total recognized by Holdings	$	22.9	$	15.8	$	16.3
Fair value of vested restricted stock held by:
CUSA employees	$	9.7	$	15.3	$	9.1
Holdings directors		1.3		0.6		1.3
Holdings total	$	11.0	$	15.9	$	10.4
Income tax benefit recognized upon vesting of restricted stock awards held by:
CUSA employees	$	0.8	$	2.7	$	0.6
Holdings directors		0.3		0.1		0.3
Holdings total income tax benefit	$	1.1	$	2.8	$	0.9

(1)The former CEO of Holdings retired on December 31, 2021, and all of his outstanding unvested shares vested upon his retirement in accordance with his employment agreement. The Company recorded incremental compensation expense of $4.3 related to the accelerated vesting of these awards during the year ended December 31, 2021.

Schedule of Estimated Remaining expense

As of December 31, 2023, the estimated remaining unrecognized compensation expense related to the unvested restricted stock awards was as follows:

	Estimated
	Remaining
	Expense
CUSA employees (1)	$	17.8
Holdings directors		0.6
Total remaining - Holdings (1)	$	18.4

(1) The weighted average period over which this remaining compensation expense will be recognized by both Holdings and CUSA is approximately 1.5 years.

Summary of Performance Metrics and Measurement Period of Performance Award

Below is a summary of the performance metrics and measurement period for these performance awards:

Performance Measurement Period	Three years with additional service requirement to the third anniversary of the date of the grant
Maximum Performance Target Level	200% of target level
Percentage of maximum performance stock units that vest if performance metrics meet the threshold level (1)	25% or 0.37 PSUs
Percentage of maximum performance stock units that vest if performance metrics are at target (1)	50% or 0.73 PSUs
Percentage of maximum performance stock units that vest if performance metrics are at the maximum (1)	100% or 1.47 PSUs
Most likely performance metrics outcome estimated to be achieved at the time performance stock units were issued	Target
Assumed forfeiture rate for performance stock unit awards	5%

(1)Number of PSUs that vest based on maximum amount of PSUs that could vest of 1.47.

Restricted Stock Units (RSUs)

Summary of Restricted Stock and Restricted Stock Unit Award Activity

Below is a summary of performance stock unit activity for the periods presented:

	Year Ended December 31,
	2021		2022		2023
Number of performance stock unit awards that vested during the period		0.23		0.10		0.14
Fair value of performance stock unit awards that vested during the period	$	4.1	$	1.7	$	1.8
Accumulated dividends paid upon vesting of performance stock unit awards	$	0.1	$	0.3	$	0.2
Compensation expense recognized during the period (1)	$	6.4	$	5.7	$	8.7
Income tax benefit (expense) related to stock unit awards	$	0.7	$	—	$	(0.8	)

(1)The former CEO of Holdings retired on December 31, 2021 and all of his outstanding unvested restricted stock units vested upon his retirement in accordance with his employment agreement. Holdings recorded incremental compensation expense of $2.4 related to the accelerated vesting of these awards during the year ended December 31, 2021.

XML

SUPPLEMENTAL CASH FLOW INFORMATION (Tables)

12 Months Ended

Dec. 31, 2023

Supplemental Cash Flow Elements [Abstract]

Supplemental Information to Consolidated Statements of Cash Flows

The following is provided as supplemental information to the consolidated statements of cash flows:

	Year Ended December 31,
	2021			2022			2023
Cash paid for interest by Holdings (1)	$	108.2		$	140.7		$	151.3
Cash paid for interest by CUSA	$	87.8		$	109.1		$	130.6
(Refunds received) cash paid for income taxes, net	$	(136.5	)	$	4.6		$	22.3
Cash deposited in (transferred from) restricted accounts (2)	$	11.9		$	(14.9	)	$	(10.8	)
Noncash operating activities:
Interest expense - NCM (see Note 9)	$	(23.6	)	$	(23.2	)	$	(22.6	)
Noncash investing activities:
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (3)	$	20.1		$	(3.8	)	$	5.4
Theatre properties acquired under finance leases	$	0.7		$	—		$	—
Investment in NCMI/NCM – receipt of common units (see Note 9)	$	10.2		$	1.3		$	—

(1)Includes the cash interest paid by CUSA.

(2)Represents cash deposited in (transferred out) of collateral account during the period to support the issuance of letters of credit to lenders, net of returned deposits from such accounts upon the repayment of related debt.

(3)Additions to theatre properties and equipment included in accounts payable as of December 31, 2022 and 2023 were $12.0 and $6.6 respectively.

XML

INCOME TAXES (Tables)

12 Months Ended

Dec. 31, 2023

Income Taxes [Line Items]

Provision for Federal and Foreign Income Tax Expense for Continuing Operations

The provision for federal and foreign income tax expense for continuing operations of Holdings consisted of the following:

	Year Ended December 31,
	2021			2022			2023
(Loss) income before income taxes:
U.S.	$	(389.2	)	$	(286.9	)	$	151.4
Foreign		(49.8	)		21.9			70.0
Total	$	(439.0	)	$	(265.0	)	$	221.4

Current and Deferred Income Taxes

Current and deferred income taxes for Holdings were as follows:

	Year Ended December 31,
	2021			2022			2023
Current:
Federal	$	4.0		$	1.9		$	2.2
Foreign		0.8			9.2			14.2
State		1.0			1.2			2.9
Total current expense		5.8			12.3			19.3
Deferred:
Federal	$	(20.2	)	$	(2.7	)	$	15.8
Foreign		0.4			(2.4	)		(5.7	)
State		(2.8	)		(4.2	)		0.5
Total deferred taxes		(22.6	)		(9.3	)		10.6
Income taxes	$	(16.8	)	$	3.0		$	29.9

Reconciliation Between Income Tax Expense and Taxes Computed

A reconciliation between Holdings’ income tax expense and taxes computed by applying the applicable statutory federal income tax rate to income before income taxes is as follows:

	Year Ended December 31,
	2021			2022			2023
Computed statutory tax expense	$	(92.2	)	$	(55.7	)	$	46.5
State and local income taxes, net of federal income tax impact		(1.4	)		(2.2	)		5.4
Changes in valuation allowance		76.3			60.6			(63.9	)
Foreign tax rate differential		(4.5	)		1.3			1.4
Foreign tax credits		—			(4.0	)		(13.0	)
Changes in uncertain tax positions		7.5			1.6			(0.9	)
U.S. tax impact of foreign operations		0.8			(1.6	)		10.3
Return to provision		(5.1	)		1.4			(3.3	)
Expiration of attribute carryforwards		0.6			—			37.1
Permanent differences		5.4			4.6			8.6
Other, net		(4.2	)		(3.0	)		1.7
Income taxes	$	(16.8	)	$	3.0		$	29.9

Tax Effects of Significant Temporary Differences and Tax Loss and Tax Credit Carryforwards

The tax effects of significant temporary differences and tax loss and tax credit carryforwards comprising the net long-term deferred income tax liabilities for Holdings as of the periods presented consisted of the following:

	December 31,
	2022			2023
Deferred liabilities:
Theatre properties and equipment	$	76.9		$	68.4
Finance lease assets		16.0			13.3
Operating lease right-of-use assets		274.3			248.8
Intangible asset – other		49.6			55.8
Intangible asset – tradenames		68.9			69.5
Total deferred liabilities		485.7			455.8
Deferred assets:
Deferred revenue – NCM and Other		82.6			82.2
Prepaid rent		4.1			2.7
Gift cards		8.8			9.7
Investment in partnerships		5.2			1.4
Operating lease obligations		296.1			269.0
Finance lease obligations		21.6			18.6
Tax impact of items in accumulated other comprehensive income and additional paid-in-capital		16.4			13.4
Restricted stock		5.1			4.5
Accrued expenses		3.7			2.9
Other tax loss carryforwards		126.1			82.7
Other tax credit and attribute carryforwards		193.5			179.3
Other expenses, not currently deductible for tax purposes		14.9			11.7
Total deferred assets		778.1			678.1
Net deferred income tax (asset) liability before valuation allowance		(292.4	)		(222.3	)
Valuation allowance against deferred assets – non-current		326.1			266.3
Net deferred income tax liability	$	33.7		$	44.0
Net deferred tax (asset) liability – Foreign	$	4.7		$	(0.1	)
Net deferred tax liability – U.S.		29.0			44.1
Total	$	33.7		$	44.0

Valuation Allowance For Deferred Tax Assets

Holdings’ valuation allowance for deferred tax assets, which includes CUSA’s valuation allowance for deferred tax assets, and CUSA’s valuation for deferred tax assets, for the periods presented were as follows:

	Valuation Allowance for Deferred Taxes
	Holdings			CUSA
Balance at January 1, 2021	$	203.6		$	203.6
Additions		69.1			52.5
Deductions		(4.3	)		(10.9	)
Currency translation		(4.3	)		(4.3	)
Balance at December 31, 2021	$	264.1		$	240.9
Additions		67.0			47.0
Deductions		(5.3	)		(4.9	)
Currency translation		0.3			0.2
Balance at December 31, 2022	$	326.1		$	283.2
Additions		16.6			5.9
Deductions		(83.0	)		(77.2	)
Currency translation		6.6			6.6
Balance at December 31, 2023	$	266.3		$	218.5

Reconciliation of Total Amounts of Unrecognized Tax Benefits Excluding Interest and Penalties

The following is a reconciliation of the total amounts of unrecognized tax benefits excluding interest and penalties for Holdings for the periods presented:

	Year Ended December 31,
	2021			2022			2023
Balance at January 1,	$	46.5		$	55.9		$	55.8
Gross increases - tax positions in prior periods		7.7			—			2.2
Gross decreases - tax positions in prior periods		(1.6	)		(0.2	)		(5.1	)
Gross increases - current period tax positions		3.4			0.1			0.2
Statute of limitations expiration		(0.1	)		—			(0.2	)
Balance at December 31,	$	55.9		$	55.8		$	52.9

CUSA

Income Taxes [Line Items]

Provision for Federal and Foreign Income Tax Expense for Continuing Operations

The provision for federal and foreign income tax expense for continuing operations of CUSA consisted of the following:

	Year Ended December 31,
	2021			2022			2023
(Loss) income before income taxes:
U.S.	$	(362.6	)	$	(263.7	)	$	167.0
Foreign		(49.8	)		21.9			70.0
Total	$	(412.4	)	$	(241.8	)	$	237.0

Current and Deferred Income Taxes

Current and deferred income taxes for CUSA were as follows:

	Year Ended December 31,
	2021			2022			2023
Current:
Federal	$	4.0		$	1.9		$	2.8
Foreign		0.8			9.2			14.2
State		1.0			1.2			2.9
Total current expense		5.8			12.3			19.9
Deferred:
Federal	$	(36.7	)	$	(16.2	)	$	13.8
Foreign		0.4			(2.4	)		(5.7	)
State		(1.8	)		(6.8	)		0.4
Total deferred taxes		(38.1	)		(25.4	)		8.5
Income taxes	$	(32.3	)	$	(13.1	)	$	28.4

Reconciliation Between Income Tax Expense and Taxes Computed

A reconciliation between CUSA’s income tax expense and taxes computed by applying the applicable statutory federal income tax rate to income before income taxes is as follows:

	Year Ended December 31,
	2021			2022			2023
Computed statutory tax expense	$	(86.6	)	$	(50.8	)	$	49.8
State and local income taxes, net of federal income tax impact		(0.7	)		(4.2	)		5.9
Changes in valuation allowance		54.3			41.8			(68.6	)
Foreign tax rate differential		(4.5	)		1.3			1.4
Foreign tax credits		—			(4.0	)		(12.9	)
Changes in uncertain tax positions		5.7			1.6			(0.9	)
U.S. tax impact of foreign operations		0.8			(1.6	)		10.4
Return to provision		(3.2	)		1.2			(3.3	)
Expiration of attribute carryforwards		0.6			—			36.4
Permanent differences		5.5			4.5			8.6
Other, net		(4.2	)		(2.9	)		1.6
Income taxes	$	(32.3	)	$	(13.1	)	$	28.4

Tax Effects of Significant Temporary Differences and Tax Loss and Tax Credit Carryforwards

The tax effects of significant temporary differences and tax loss and tax credit carryforwards comprising the net long-term deferred income tax liabilities for CUSA as of the periods presented consisted of the following:

	December 31,
	2022			2023
Deferred liabilities:
Theatre properties and equipment	$	76.7		$	68.2
Finance lease assets		15.9			13.2
Operating lease right-of-use assets		273.9			248.1
Intangible asset – other		49.5			55.7
Intangible asset – tradenames		68.8			69.3
Tax impact of items in accumulated other comprehensive income and additional paid-in-capital		5.3			1.4
Total deferred liabilities		490.1			455.9
Deferred assets:
Deferred revenue – NCM and Other		82.4			82.0
Prepaid rent		4.1			2.7
Gift Cards		8.8			9.7
Investment in partnerships		5.2			1.4
Operating lease obligations		295.6			268.3
Finance lease obligations		21.6			18.6
Restricted stock		4.9			4.3
Accrued expenses		3.7			2.9
Other tax loss carryforwards		122.0			80.0
Other tax credit and attribute carryforwards		174.1			149.0
Other expenses, not currently deductible for tax purposes		14.8			11.5
Total deferred assets		737.2			630.4
Net deferred income tax (asset) liability before valuation allowance		(247.1	)		(174.5	)
Valuation allowance against deferred assets – non-current		283.2			218.5
Net deferred income tax liability	$	36.1		$	44.0
Net deferred tax (asset) liability – Foreign	$	4.7		$	(0.1	)
Net deferred tax liability – U.S.		31.4			44.1
Total	$	36.1		$	44.0

Reconciliation of Total Amounts of Unrecognized Tax Benefits Excluding Interest and Penalties

The following is a reconciliation of the total amounts of unrecognized tax benefits excluding interest and penalties for CUSA for the periods presented:

	Year Ended December 31,
	2021			2022			2023
Balance at January 1,	$	46.5		$	54.0		$	53.9
Gross increases - tax positions in prior periods		5.8			—			2.2
Gross decreases - tax positions in prior periods		(1.6	)		(0.2	)		(5.1	)
Gross increases - current period tax positions		3.4			0.1			0.2
Statute of limitations expiration		(0.1	)		—			(0.2	)
Balance at December 31,	$	54.0		$	53.9		$	51.0

XML

SEGMENTS - HOLDINGS (Tables)

12 Months Ended

Dec. 31, 2023

Segment Reporting [Abstract]

Selected Financial Information by Reportable Operating Segment

The following table is a breakdown of selected financial information by reportable operating segment for Holdings for the periods presented:

	Year Ended December 31,
	2021			2022			2023
Revenue
U.S.	$	1,296.3		$	1,977.9		$	2,428.1
International		216.9			484.5			651.4
Eliminations		(2.7	)		(7.7	)		(12.8	)
Total Revenue	$	1,510.5		$	2,454.7		$	3,066.7
Adjusted EBITDA (1)
U.S.	$	84.2		$	255.7		$	463.9
International		(4.2	)		80.8			130.2
Total Adjusted EBITDA	$	80.0		$	336.5		$	594.1
Capital expenditures
U.S.	$	78.3		$	87.2		$	111.5
International		17.2			23.5			38.0
Total capital expenditures	$	95.5		$	110.7		$	149.5

Distributions from equity investees are reported entirely within the U.S. operating segment

Reconciliation of Net (loss) Income to Adjusted EBITDA

The following table sets forth a reconciliation of net (loss) income to Adjusted EBITDA for Holdings for the periods presented:

	Year Ended December 31,
	2021			2022			2023
Net (loss) income	$	(422.2	)	$	(268.0	)	$	191.5
Add (deduct):
Income tax (benefit) expense		(16.8	)		3.0			29.9
Interest expense (1)		149.7			155.3			150.4
Other expense (income), net (2)		43.5			23.6			(19.6	)
Cash distributions from equity investees (3)		0.2			6.9			5.7
Depreciation and amortization		265.4			238.2			209.5
Impairment of long-lived and other assets		20.8			174.1			16.6
Restructuring costs		(1.0	)		(0.5	)		—
(Gain) loss on disposal of assets and other		8.0			(6.8	)		(7.7	)
Loss on debt extinguishment and refinancing		6.5			—			10.7
Non-cash rent expense		(3.4	)		(10.8	)		(17.9	)
Share-based awards compensation expense		29.3			21.5			25.0
Adjusted EBITDA	$	80.0		$	336.5		$	594.1

(1)Includes amortization of debt issuance costs, amortization of original issue discount, and amortization of accumulated (gains) losses for amended swap agreements.

(2)Includes interest income, foreign currency exchange and other related loss, interest expense – NCM and equity in income (loss) of affiliates and unrealized gain on investment in NCMI. Excludes distributions from NCM and DCIP.

(3)Reflects cash distributions received from equity investees that were recorded as a reduction of the respective investment balances (see Note 10). These distributions are reported entirely within the U.S. operating segment.

Selected Financial Information by Geographic Area

The following table sets forth a breakdown of select financial information for Holdings by geographic area for the periods presented:

	Year Ended December 31,
	2021	2022	2023
Revenue
U.S.	$1,296.3	$1,977.9	$2,428.1
Brazil	73.5	179.0	233.4
Other international countries	143.4	305.5	418.0
Eliminations	(2.7)	(7.7)	(12.8)
Total	$1,510.5	$2,454.7	$3,066.7

	As of December 31,
	2022	2023
Theatre properties and equipment, net
U.S.	$1,075.3	$1,002.1
Brazil	49.5	54.7
Other international countries	107.3	104.9
Total	$1,232.1	$1,161.7

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($) Segments	Dec. 31, 2022 USD ($) Segments	Dec. 31, 2021 Segments	Dec. 31, 2020 USD ($)
Summary Of Significant Accounting Policies [Line Items]
Unpaid and accrued restructuring costs	$ 0.0	$ 0.0
Operating revenues comprise	100.00%
Operating expenses comprise	100.00%
Description of motion picture exhibition industry	We operate in the motion picture exhibition industry, with theatres in the United States (“U.S.”) and in 13 countries in Latin America as of December 31, 2023.
General liability claim per occurrence, cap	$ 0.3
Aggregate annual cap per policy year				$ 0.0
Pre-funding claims and covers claims annual cap	5.0
Medical claim per occurrence, cap	0.3
Insurance Reserves	$ 11.4	$ 10.0
Minimum Percentage for Tax position measure as largest amount of benefit	50.00%
Reportable operating segments | Segments	2	2	2
Minimum | Cinemark Holdings Inc
Summary Of Significant Accounting Policies [Line Items]
Equity method investment, ownership percentage	20.00%
Fair value method investment, ownership percentage	20.00%
Maximum
Summary Of Significant Accounting Policies [Line Items]
Cost method investment, ownership Percentage	20.00%
Pre-funding claims and covers claims per occurrence	$ 0.3
Maximum | Cinemark Holdings Inc
Summary Of Significant Accounting Policies [Line Items]
Equity method investment, ownership percentage	50.00%
Fair value method investment, ownership percentage	50.00%

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Estimated Useful Lives of Assets (Detail)	Dec. 31, 2023
Buildings On Owned Land
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	40 years
Buildings On Leased Land
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	40 years
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]	Property, Plant and Equipment, Net
Land And Buildings Under Finance Leases
Property, Plant and Equipment [Line Items]
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]	Property, Plant and Equipment, Net
Theatre furniture and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	3 years
Theatre furniture and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	15 years
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]	Property, Plant and Equipment, Net

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Intangible Assets and Amortization Method (Detail)	12 Months Ended
	Dec. 31, 2023
Finite Lived Intangible Assets [Line Items]
Goodwill	Indefinite-lived
Tradename	Indefinite-lived and definite-lived. Definite-lived tradename asset has a remaining useful life of approximately one year.
Other Intangible Assets
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Method	Straight-line method over the terms of the underlying agreement. The remaining useful lives of these intangible assets is two years.
Other Intangible Assets | Maximum
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	2 years
Trade Names
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	1 year

XML

IMPACT OF THE COVID-19 PANDEMIC - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Unusual Or Infrequent Item [Line Items]
Government assistance received	$ 2.8	$ 2.8
Government Assistance, Statement of Income or Comprehensive Income [Extensible Enumeration]	Other Cost and Expense, Operating	Other Cost and Expense, Operating

XML

IMPACT OF THE COVID-19 PANDEMIC - Schedule of Restructuring Plan (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Unusual Or Infrequent Item [Line Items]
Restructuring Reserve, Beginning Balance		$ 0.0
Restructuring costs		0.0	$ (0.5)	$ (1.0)
Restructuring Reserve, Ending Balance		0.0	0.0
2020 Restructuring Plan | U.S. Operating Segment
Unusual Or Infrequent Item [Line Items]
Restructuring Reserve, Beginning Balance		0.0	1.3	6.6
Amounts paid			(0.9)	(4.3)
Reserve adjustments	[1]		(0.4)	(1.0)
Restructuring Reserve, Ending Balance			0.0	1.3
2020 Restructuring Plan | U.S. Operating Segment | Employee Related
Unusual Or Infrequent Item [Line Items]
Restructuring Reserve, Beginning Balance		0.0	0.4	0.9
Amounts paid			(0.4)	(0.4)
Reserve adjustments	[1]		0.0	(0.1)
Restructuring Reserve, Ending Balance			0.0	0.4
2020 Restructuring Plan | U.S. Operating Segment | Facility Closure Costs
Unusual Or Infrequent Item [Line Items]
Restructuring Reserve, Beginning Balance		0.0	0.9	5.7
Amounts paid			(0.5)	(3.9)
Reserve adjustments	[1]		(0.4)	(0.9)
Restructuring Reserve, Ending Balance			0.0	0.9
2020 Restructuring Plan | International Operating Segment
Unusual Or Infrequent Item [Line Items]
Restructuring Reserve, Beginning Balance		0.0	0.1	0.1
Amounts paid			0.0	0.0
Reserve adjustments	[1]		(0.1)	0.0
Restructuring Reserve, Ending Balance			0.0	0.1
2020 Restructuring Plan | International Operating Segment | Employee Related
Unusual Or Infrequent Item [Line Items]
Restructuring Reserve, Beginning Balance		0.0	0.0	0.0
Amounts paid			0.0	0.0
Reserve adjustments	[1]		0.0	0.0
Restructuring Reserve, Ending Balance			0.0	0.0
2020 Restructuring Plan | International Operating Segment | Facility Closure Costs
Unusual Or Infrequent Item [Line Items]
Restructuring Reserve, Beginning Balance		0.0	0.1	0.1
Amounts paid			0.0	0.0
Reserve adjustments	[1]		(0.1)	0.0
Restructuring Reserve, Ending Balance			0.0	0.1
2020 Restructuring Plan | Consolidated
Unusual Or Infrequent Item [Line Items]
Restructuring Reserve, Beginning Balance		0.0	1.4	6.7
Amounts paid			(0.9)	(4.3)
Reserve adjustments	[1]		(0.5)	(1.0)
Restructuring Reserve, Ending Balance			0.0	1.4
2020 Restructuring Plan | Consolidated | Employee Related
Unusual Or Infrequent Item [Line Items]
Restructuring Reserve, Beginning Balance		0.0	0.4	0.9
Amounts paid			(0.4)	(0.4)
Reserve adjustments	[1]		0.0	(0.1)
Restructuring Reserve, Ending Balance			0.0	0.4
2020 Restructuring Plan | Consolidated | Facility Closure Costs
Unusual Or Infrequent Item [Line Items]
Restructuring Reserve, Beginning Balance		$ 0.0	1.0	5.8
Amounts paid			(0.5)	(3.9)
Reserve adjustments	[1]		(0.5)	(0.9)
Restructuring Reserve, Ending Balance			$ 0.0	$ 1.0

[1] Amounts were primarily adjustments based on final facility lease payments for certain closed theatres as compared with original estimates recorded.

XML

LEASE ACCOUNTING - Additional Information (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($)
Theatres
Lease [Line Items]
Contractual minimum lease payments payable under operating lease, lease not yet commenced	$ 44.8
Minimum | Theatres
Lease [Line Items]
Noncancelable operating and finance leases, term	10 years
Minimum | Equipment
Lease [Line Items]
Noncancelable operating leases, term	1 year
Maximum | Theatres
Lease [Line Items]
Noncancelable operating and finance leases, term	25 years
Maximum | Equipment
Lease [Line Items]
Noncancelable operating leases, term	7 years

XML

LEASE ACCOUNTING - Schedule of Operating and Finance Right-of-Use Assets and Lease Liabilities (Detail) - USD ($) $ in Millions		Dec. 31, 2023	Dec. 31, 2022
Assets
Operating lease assets	[1]	$ 986.4	$ 1,102.7
Finance lease assets	[1],[2]	$ 55.7	$ 67.8
Finance Lease Right Of Use Asset Statement Of Financial Position [Extensible List]		Theatre properties and equipment, net of accumulated depreciation	Theatre properties and equipment, net of accumulated depreciation
Total lease assets	[1]	$ 1,042.1	$ 1,170.5
Liabilities, Current
Operating	[1]	212.5	219.3
Current portion of finance lease obligations	[1]	14.0	14.4
Liabilities, Noncurrent
Operating	[1]	853.3	970.6
Finance lease obligations, less current portion	[1]	73.8	88.0
Total lease liabilities	[1]	$ 1,153.6	$ 1,292.3

[1] The operating lease right-of-use assets and liabilities recorded on the Company’s consolidated balance sheets generally do not include renewal options that have not yet been exercised.

[2] Finance lease assets are net of accumulated amortization of $62.5 and $73.9 as of December 31, 2022 and 2023, respectively.

XML

LEASE ACCOUNTING - Schedule of Operating and Finance Right-of-Use Assets and Lease Liabilities (Parenthetical) (Detail) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Finance lease assets, accumulated amortization	$ 73.9	$ 62.5

XML

LEASE ACCOUNTING - Schedule of Aggregate Lease Costs by Lease Classification (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Operating lease costs
Total operating lease costs		$ 352.7	$ 320.1	$ 283.3
Finance lease costs
Depreciation of leased assets		73.9	62.5
Total finance lease costs		0.0	17.7	18.5
Depreciation and Amortization
Finance lease costs
Depreciation of leased assets		12.0	12.4	12.6
Interest Expense
Finance lease costs
Interest on lease liabilities		4.9	5.3	5.9
Equipment | Utilities and Other
Operating lease costs
Total operating lease costs	[1]	4.1	4.4	2.3
Real Estate | Facility Lease Expense
Operating lease costs
Total operating lease costs	[1]	$ 348.6	$ 315.7	$ 281.0

[1] Includes short-term lease payments, variable lease payments and office lease payments reflected in general and administrative expense as set forth in the following table for the periods presented:     Year Ended December 31,   Lease Cost Classification 2021   2022   2023   Operating lease costs               Equipment - Short-term and variable lease payments Utilities and other $ 1.8   $ 3.9   $ 3.6   Real Estate - Variable lease payments (1) Facility lease expense $ 11.8   $ 36.4   $ 68.3   Real Estate - Office leases General and administrative $ 1.3   $ 1.3   $ 1.4   (1) Represents lease payments that are based on a change in index, such as CPI or inflation, variable payments based on revenue or attendance and variable common area maintenance costs.

XML

LEASE ACCOUNTING - Schedule of Aggregate Lease Costs by Lease Classification (Parenthetical) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Lease Cost [Line Items]
Office leases	$ 280.8	$ 279.8	$ 269.7
Equipment | Utilities and Other
Lease Cost [Line Items]
Short term lease payments	3.6	3.9	1.8
Real Estate | Facility Lease Expense
Lease Cost [Line Items]
Variable lease payments	68.3	36.4	11.8
Office leases	$ 1.4	$ 1.3	$ 1.3

XML

LEASE ACCOUNTING - Schedule of Maturity of Lease Liabilities by Lease Classification (Detail) $ in Millions	Dec. 31, 2023 USD ($)
Leases [Abstract]
Operating Leases, 2024	$ 267.2
Operating Leases, 2025	237.4
Operating Leases, 2026	199.6
Operating Leases, 2027	158.5
Operating Leases, 2028	121.9
Operating Leases, Thereafter	295.4
Operating Leases, Total lease payments	1,280.0
Operating Leases, Less: Interest	214.2
Operating Leases, Present value of lease liabilities	1,065.8
Finance Leases, 2024	18.0
Finance Leases, 2025	16.4
Finance Leases, 2026	12.0
Finance Leases, 2027	11.9
Finance Leases, 2028	11.6
Finance Leases, Thereafter	35.1
Finance Leases, Total lease payments	105.0
Finance Leases, Less: Interest	17.2
Finance Leases, Present value of lease liabilities	$ 87.8

XML

LEASE ACCOUNTING - Schedule of Weighted-Average Remaining Lease Term and Discount Rate (Detail)	Dec. 31, 2023
Equipment
Lease [Line Items]
Weighted-average remaining lease term - Operating leases	3 years 3 months 18 days	[1]
Weighted-average remaining lease term - Finance leases	2 years 7 months 6 days	[1]
Weighted-average discount rate - Operating leases	6.30%	[2]
Weighted-average discount rate - Finance leases	3.60%	[2]
Real Estate
Lease [Line Items]
Weighted-average remaining lease term - Operating leases	6 years 4 months 24 days	[1]
Weighted-average remaining lease term - Finance leases	7 years 7 months 6 days	[1]
Weighted-average discount rate - Operating leases	11.50%	[2]
Weighted-average discount rate - Finance leases	4.90%	[2]

[1] The lease assets and liabilities recorded on the Company’s consolidated balance sheets generally do not include renewal options that have not yet been executed. The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord after consideration of market conditions and performance of the theatre.

[2] The discount rate for each lease represents the incremental borrowing rate at which the Company would borrow funds, on a collateralized basis, over a similar term and at an amount equal to the lease payments in a similar economic environment.

XML

LEASE ACCOUNTING - Schedule of Minimum Cash Lease Payments (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash paid for amounts included in the measurement of lease liabilities
Cash outflows for operating leases	$ 280.8	$ 279.8	$ 269.7
Cash outflows for finance leases - operating activities	4.9	5.3	5.9
Cash outflows for finance leases - financing activities	14.4	14.3	14.7
Non-cash amount of leased assets obtained in exchange for:
Operating lease liabilities	87.0	114.1	180.1
Finance lease liabilities	$ 0.0	$ 0.0	$ 0.7

XML

REVENUE RECOGNITION - Additional Information (Detail) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Receivables related to contracts with customers	$ 31.6	$ 22.9
Assets related to costs to obtain or fulfill contract with customers	$ 0.0	$ 0.0

XML

REVENUE RECOGNITION - Summary of Revenues Disaggregated Based on Major Type of Good or Service and by Reportable Operating Segment (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Total revenue		$ 3,066.7	$ 2,454.7	$ 1,510.5
Admissions Revenues
Disaggregation of Revenue [Line Items]
Total revenue		1,555.6	1,246.9	780.0
Concession Revenues
Disaggregation of Revenue [Line Items]
Total revenue		1,192.0	938.3	561.7
Screen Advertising, Screen Rental and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenue		144.6	127.0	84.1
Other Revenues
Disaggregation of Revenue [Line Items]
Total revenue		174.5	142.5	84.7
U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenue	[1],[2]	2,415.3	1,970.2	1,293.6
U.S. Operating Segment | Admissions Revenues
Disaggregation of Revenue [Line Items]
Total revenue	[1]	1,236.0	1,010.2	671.7
U.S. Operating Segment | Concession Revenues
Disaggregation of Revenue [Line Items]
Total revenue	[1]	952.0	763.0	482.8
U.S. Operating Segment | Screen Advertising, Screen Rental and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenue	[1]	91.0	81.7	66.2
U.S. Operating Segment | Other Revenues
Disaggregation of Revenue [Line Items]
Total revenue	[1]	136.3	115.3	72.9
International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenue		651.4	484.5	216.9
International Operating Segment | Admissions Revenues
Disaggregation of Revenue [Line Items]
Total revenue		319.6	236.7	108.3
International Operating Segment | Concession Revenues
Disaggregation of Revenue [Line Items]
Total revenue		240.0	175.3	78.9
International Operating Segment | Screen Advertising, Screen Rental and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenue		53.6	45.3	17.9
International Operating Segment | Other Revenues
Disaggregation of Revenue [Line Items]
Total revenue		$ 38.2	$ 27.2	$ 11.8

[1] U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 22 for additional information on intercompany eliminations.

[2] U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 22 for additional information on intercompany eliminations

XML

REVENUE RECOGNITION - Summary of Revenues Disaggregated Based on Timing of Revenue Recognition (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Total revenue		$ 3,066.7	$ 2,454.7	$ 1,510.5
U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenue	[1],[2]	2,415.3	1,970.2	1,293.6
International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenue		651.4	484.5	216.9
Goods and Services Transferred at a Point in Time
Disaggregation of Revenue [Line Items]
Total revenue		2,916.8	2,284.8	1,394.9
Goods and Services Transferred at a Point in Time | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenue	[2]	2,327.9	1,856.5	1,201.2
Goods and Services Transferred at a Point in Time | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenue		588.9	428.3	193.7
Goods and Services Transferred Over Time
Disaggregation of Revenue [Line Items]
Total revenue		149.9	169.9	115.6
Goods and Services Transferred Over Time | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenue	[2]	87.4	113.7	92.4
Goods and Services Transferred Over Time | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenue		$ 62.5	$ 56.2	$ 23.2

[1] U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 22 for additional information on intercompany eliminations.

[2] U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 22 for additional information on intercompany eliminations

XML

REVENUE RECOGNITION - Changes in Deferred Revenues (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2023		Dec. 31, 2022		Dec. 31, 2021
Change in Contract with Customer Liability [Line Items]
Amounts recognized as accounts receivable		$ 4.9		$ 4.9
NCM Screen Advertising Advances
Change in Contract with Customer Liability [Line Items]
Beginning Balance	[1]	338.2		346.0
Amounts recognized as accounts receivable	[1]	0.0		0.0
Cash received from customers in advance	[1]	0.0		0.0
Dispositions	[1],[2]	0.0
Common units received from NCM (see Note 9)				(1.3)		$ (10.2)
Interest accrued related to significant financing component		22.6	[1]	23.2	[1]	23.6
Revenue recognized during period	[1]	(32.4)		(32.3)
Foreign currency translation adjustments	[1]	0.0		0.0
Ending Balance	[1]	328.4		338.2		346.0
NCM Screen Advertising Advances | NCM
Change in Contract with Customer Liability [Line Items]
Common units received from NCM (see Note 9)	[1]			(1.3)
Other Deferred Revenues
Change in Contract with Customer Liability [Line Items]
Beginning Balance	[3]	194.9		160.3
Amounts recognized as accounts receivable	[3]	4.6		1.8
Cash received from customers in advance	[3]	327.4		241.1
Dispositions	[2],[3]	(0.4)
Interest accrued related to significant financing component	[3]	0.0		0.0
Revenue recognized during period	[3]	(299.5)		(206.9)
Foreign currency translation adjustments	[3]	(5.4)		(1.4)
Ending Balance	[3]	$ 221.6		194.9		$ 160.3
Other Deferred Revenues | NCM
Change in Contract with Customer Liability [Line Items]
Common units received from NCM (see Note 9)	[3]			$ 0.0

[1] See Significant Financing Component in Note 9 for discussion of NCM screen advertising advances and maturity of balances as of December 31, 2023.

[2] Relates to the sale of the Company’s Ecuador subsidiary. See Note 8

[3] Includes liabilities associated with outstanding gift cards and discount ticket vouchers, points or rebates outstanding under the Company’s loyalty and membership programs and revenue not yet recognized for screen advertising and other promotional activities. Amount is classified as accounts payable and accrued expenses or other long-term liabilities on the consolidated balance sheets.

XML

REVENUE RECOGNITION - Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized (Details) $ in Millions	Dec. 31, 2023 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligations	$ 221.6
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Remaining performance obligations	$ 195.2
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Remaining performance obligations	$ 26.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Remaining performance obligations	$ 0.0

XML

EARNINGS (LOSS) PER SHARE - Computations of Basic and Diluted Earnings Per Share (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Earnings Per Share Disclosure [Line Items]
Net Income (Loss)		$ 188.2	$ (271.2)	$ (422.8)
Income (loss) allocated to participating share-based awards	[1]	(3.3)	3.8	6.1
Basic net (loss) income attributable to common stockholders		184.9	(267.4)	(416.7)
Interest expense on convertible notes, net of tax	[2]	18.2	0.0	0.0
Diluted net (loss) income attributable to common stockholders		$ 203.1	$ (267.4)	$ (416.7)
Basic weighted average shares outstanding		119.1	118.2	117.3
Common equivalent shares for restricted stock units	[3]	0.9	0.0	0.0
Common equivalent shares for convertible notes	[2]	32.0	0.0	0.0
Common equivalent shares for warrants	[4]	0.0	0.0	0.0
Diluted weighted average shares outstanding		152.0	118.2	117.3
Basic (loss) earnings per share attributable to common stockholders		$ 1.55	$ (2.26)	$ (3.55)
Diluted (loss) earnings per share attributable to common stockholders		$ 1.34	$ (2.26)	$ (3.55)
Restricted Stock Units (RSUs)
Earnings Per Share Disclosure [Line Items]
Common equivalent shares for restricted stock units			0.4	0.0

[1] For the years ended December 31, 2021, 2022 and 2023, a weighted average of approximately 1.7 shares, 1.7 shares and 2.1 shares of unvested restricted stock, respectively, are considered participating securities.

[2] For the years ended December 31, 2021 and 2022, diluted loss per share excludes the assumed conversion of the 4.50% Convertible Senior Notes into 32.0 shares of common stock, as they would have been anti-dilutive. See further discussion below.

[3] For the years ended December 31, 2021 and 2022, approximately 0.0 and 0.4 common equivalent shares for performance stock units were excluded because they were anti-dilutive.

[4] For all periods presented, diluted earnings (loss) per share excludes the warrants, as they would be anti-dilutive.

XML

EARNINGS (LOSS) PER SHARE - Computations of Basic and Diluted Earnings Per Share (Parenthetical) (Detail) - shares shares in Millions		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Aug. 21, 2020
Earnings Per Share Disclosure [Line Items]
Weighted average shares of participating unvested restricted stock		2.1	1.7	1.7
Common equivalent shares for restricted stock units	[1]	0.9	0.0	0.0
Debt instrument, interest rate, stated percentage		4.50%	4.50%
4.50 % Convertible Senior Notes
Earnings Per Share Disclosure [Line Items]
Debt instrument, interest rate, stated percentage			4.50%	4.50%	4.50%
Common shares issued			32.0	32.0
Restricted Stock Units (RSUs)
Earnings Per Share Disclosure [Line Items]
Common equivalent shares for restricted stock units			0.4	0.0

[1] For the years ended December 31, 2021 and 2022, approximately 0.0 and 0.4 common equivalent shares for performance stock units were excluded because they were anti-dilutive.

XML

EARNINGS (LOSS) PER SHARE - Additional Information (Detail) $ / shares in Units, $ in Millions		12 Months Ended
	Aug. 21, 2020 Tradingday $ / shares	Dec. 31, 2023 USD ($) Tradingday $ / shares shares	Dec. 31, 2022 shares	Dec. 31, 2021 shares
Earnings Per Share Disclosure [Line Items]
Interest rate		4.50%	4.50%
Convertible senior note, if-converted value in excess of outstanding principal value | $		$ 23.3
4.50 % Convertible Senior Notes
Earnings Per Share Disclosure [Line Items]
Interest rate	4.50%		4.50%	4.50%
Common stock, strike price		$ 18.66
Debt Instrument, Convertible, Associated Derivative Transactions, Description		The converted value of the 4.50% Convertible Senior Notes, based on the weighted average closing price of Holdings’ common stock for 2023, exceeded the aggregate outstanding principal of the notes by $23.3 as of December 31, 2023.
Debt instrument convertible conversion, percentage		130.00%
Exercise price	$ 14.35	$ 14.35
Debt instrument, convertible, threshold trading days | Tradingday	20
ShareBased Compensation Arrangements By ShareBased Payment Award Options Grants In Period Weighted Average Exercise Price		$ 14.35
ShareBased Compensation Arrangement By ShareBased Payment Award Options Grants In Period Gross | shares		32,000,000
Common Stock Convertible Conversion Price Increase		$ 22.08
CommonStock Convertible Conversion Price		$ 18.66
Common shares issued | shares			32,000,000	32,000,000
4.50 % Convertible Senior Notes | Minimum
Earnings Per Share Disclosure [Line Items]
Debt instrument, convertible, threshold trading days | Tradingday		20
4.50 % Convertible Senior Notes | Maximum
Earnings Per Share Disclosure [Line Items]
Debt instrument, convertible, threshold trading days | Tradingday		30
Warrant | 4.50 % Convertible Senior Notes
Earnings Per Share Disclosure [Line Items]
ShareBased Compensation Arrangements By ShareBased Payment Award Options Grants In Period Weighted Average Exercise Price		$ 22.08
ShareBased Compensation Arrangement By ShareBased Payment Award Options Grants In Period Gross | shares		32,000,000

XML

THEATRE PROPERTIES AND EQUIPMENT - Schedule Of Properties And Equipment (Detail) - USD ($) $ in Millions		Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Total		$ 3,491.0	$ 3,395.3
Less: accumulated depreciation and amortization	[1]	(2,329.3)	(2,163.2)
Theatre properties and equipment, net		1,161.7	1,232.1
Land
Property, Plant and Equipment [Line Items]
Total		97.8	99.7
Building
Property, Plant and Equipment [Line Items]
Total		530.6	528.9
Property Under Finance Lease
Property, Plant and Equipment [Line Items]
Total		129.6	130.3
Theatre furniture and equipment
Property, Plant and Equipment [Line Items]
Total		1,432.8	1,429.5
Leasehold interests and improvements
Property, Plant and Equipment [Line Items]
Total		$ 1,300.2	$ 1,206.9

[1] Amortization of finance lease assets is included in depreciation and amortization expense on the consolidated statements of income (loss). Accumulated amortization of finance lease assets as of December 31, 2022 and 2023 was $62.5 and $73.9, respectively.

XML

THEATRE PROPERTIES AND EQUIPMENT - Schedule Of Properties And Equipment (Parenthetical) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Accumulated amortization of finance lease assets	$ 73.9	$ 62.5

XML

THEATRE PROPERTIES AND EQUIPMENT (Additional Information) (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($)
Long-Lived Assets Held-for-Sale [Line Items]
Gain (loss) on disposal of assets and other	$ 6.9

XML

THEATRE PROPERTIES AND EQUIPMENT - Summary of Carrying Value of Ecuador's Significant Assets and Liabilities (Details) - USD ($) $ in Millions		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Theatre properties and equipment, net of accumulated depreciation		$ 1,161.7	$ 1,232.1
Operating lease right-of-use assets, net	[1]	986.4	1,102.7
Goodwill	[2]	1,251.0	1,250.9	$ 1,248.8
Theatre Assets Held for Sale [Member]
Property, Plant and Equipment [Line Items]
Theatre properties and equipment, net of accumulated depreciation		0.0	5.4
Operating lease right-of-use assets, net		0.0	2.9
Goodwill		0.0	4.2
Assets		0.0	15.3
Liabilities		$ 0.0	$ 8.5

[1] The operating lease right-of-use assets and liabilities recorded on the Company’s consolidated balance sheets generally do not include renewal options that have not yet been exercised.

[2] Balances are presented net of accumulated impairment losses of $214.0 for the U.S. operating segment and $43.8 for the international operating segment.

XML

THEATRE PROPERTIES AND EQUIPMENT - Summary of Total Revenue and Operating Income for the Ecuador Subsidiary (Details) - Theatre Assets Held for Sale [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Revenues	$ 13.5	$ 13.3
Operating (loss) income	$ 2.0	$ (1.2)

XML

INVESTMENT IN NATIONAL CINEMEDIA, INC / NATIONAL CINEMEDIA LLC - Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2023		Dec. 31, 2022		Dec. 31, 2021
Schedule Of Equity Method Investments [Line Items]
Impairment of long-lived and other assets		$ (16.6)		$ (174.1)		$ (20.8)
Investment In NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance		9.6		135.4		152.0
Receipt of common units due to annual common unit adjustment				1.3		10.2
Receipt under tax receivable agreement						(0.2)
Equity in income (loss) of affiliates				(13.9)		(26.6)
Impairment of long-lived and other assets		(0.7)		(113.2)	[1]
Ending Balance				9.6		135.4
Investment in NCMI [Member]
Schedule Of Equity Method Investments [Line Items]
Equity in income (loss) of affiliates	[2]	(3.2)
Impairment of long-lived and other assets	[3]	0.7
Unrealized Gain (Loss) on Investments	[1]	12.4
Ending Balance		18.1
NCM Screen Advertising Advances
Schedule Of Equity Method Investments [Line Items]
Beginning Balance		(338.2)		(346.0)		(344.3)
Receipt of common units due to annual common unit adjustment				(1.3)		(10.2)
Interest accrued on NCM screen advertising advances		(22.6)	[4]	(23.2)	[4]	(23.6)
Amortization of screen advertising advances		32.4		32.3		32.1
Ending Balance		(328.4)		(338.2)		(346.0)
NCM Screen Advertising Advances | NCM
Schedule Of Equity Method Investments [Line Items]
Receipt of common units due to annual common unit adjustment	[4]			(1.3)
Distributions from NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance	[5]			(0.1)
Receipt under tax receivable agreement	[5]					(0.1)
Ending Balance	[5]					(0.1)
Equity in Loss
Schedule Of Equity Method Investments [Line Items]
Beginning Balance	[2]	13.9		26.6
Equity in income (loss) of affiliates	[2]	3.2		13.9		26.6
Ending Balance	[2]	3.2		13.9		26.6
Other Revenue
Schedule Of Equity Method Investments [Line Items]
Beginning Balance		(52.2)		(44.1)
Revenues earned under ESA	[6]	(20.9)		(19.9)		(12.0)
Amortization of screen advertising advances		(32.4)		(32.3)		(32.1)
Ending Balance		(53.3)		(52.2)		(44.1)
Interest Expense - NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance		23.2		23.6
Interest accrued on NCM screen advertising advances		22.6		23.2		23.6
Ending Balance		22.6		23.2		23.6
Cash Received
Schedule Of Equity Method Investments [Line Items]
Beginning Balance		19.9		12.3
Revenues earned under ESA	[6]	20.9		19.9		12.0
Receipt under tax receivable agreement						0.3
Ending Balance		$ 20.9		$ 19.9		$ 12.3

[1] See Investment in National CineMedia below.

[2] Equity in loss was recorded through April 11, 2023, the date NCM filed its bankruptcy petition, after which the Company applied the fair value accounting method as discussed below.

[3] Reflected in impairment of long-lived and other assets on the consolidated income statement for the year indicated. See further discussion at Investment in National CineMedia below

[4] See Significant Financing Component in Note 9 for discussion of NCM screen advertising advances and maturity of balances as of December 31, 2023.

[5] Excess cash distributions from NCM to its members were restricted through December 2023 in accordance with the credit agreement amendment NCM entered into with its lenders and as a result of their bankruptcy filing. NCMI also suspended its dividend.

[6] Amounts include the per patron and per digital screen theatre access fees, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire were approximately $4.9, $7.5 and $8.9 for the years ended December 31, 2021, 2022 and 2023, respectively. Amounts unpaid and reflected in accounts receivable were $4.9 and $4.9 as of December 31, 2022 and 2023, respectively.

XML

INVESTMENT IN NATIONAL CINEMEDIA, INC / NATIONAL CINEMEDIA LLC - Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Parenthetical) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Schedule Of Equity Method Investments [Line Items]
Company's beverage concessionaire advertising costs	$ 8.9	$ 7.5	$ 4.9
Amounts recognized as accounts receivable	$ 4.9	$ 4.9

XML

INVESTMENT IN NATIONAL CINEMEDIA, INC / NATIONAL CINEMEDIA LLC - Summary of Recognition of Revenue Related To Deferred Revenue (Detail) $ in Millions	Dec. 31, 2023 USD ($)
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue remaining performance obligation, amount	$ 221.6
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue remaining performance obligation, amount	$ 195.2
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue remaining performance obligation, amount	$ 26.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2026-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue remaining performance obligation, amount	$ 0.0
NCM Screen Advertising Advances
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue remaining performance obligation, amount	$ 328.4
NCM Screen Advertising Advances | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue remaining performance obligation, amount	$ 10.5
NCM Screen Advertising Advances | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue remaining performance obligation, amount	$ 11.2
NCM Screen Advertising Advances | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2026-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue remaining performance obligation, amount	$ 12.0
NCM Screen Advertising Advances | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2027-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue remaining performance obligation, amount	$ 12.8
NCM Screen Advertising Advances | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2028-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue remaining performance obligation, amount	$ 13.7
NCM Screen Advertising Advances | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2029-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period
Revenue remaining performance obligation, amount	$ 268.2

XML

INVESTMENT IN NATIONAL CINEMEDIA, INC / NATIONAL CINEMEDIA LLC - Summary of Recognition of Revenue Related To Deferred Revenue (Detail1) $ in Millions	Dec. 31, 2023 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 221.6
N C M Screen Advertising Advances [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 328.4

XML

INVESTMENT IN NATIONAL CINEMEDIA, INC / NATIONAL CINEMEDIA LLC - Additional Information (Detail) - USD ($) shares in Millions, $ in Millions				12 Months Ended
		Mar. 20, 2023	Feb. 17, 2023	Dec. 31, 2023		Dec. 31, 2022		Dec. 31, 2021	Aug. 03, 2023	Jan. 01, 2023	Dec. 31, 2020
Schedule Of Equity Method Investments [Line Items]
Number of additional common units of NCM received under common unit adjustment agreement				4.8
Value of common units received from NCM				$ 0.0	[1]	$ 1.3		$ 10.2
Impairment of long-lived and other assets				(16.6)		(174.1)		(20.8)
Noncontrolling interests				9.0		9.3
Investment In Ncm [Member]
Schedule Of Equity Method Investments [Line Items]
Number of NCM to Redeem Shares			42.0
Common Share Units in Ncm in Exchange		1.7	43.7
Interest in common units of NCM acquired by Company										25.40%
Number of common units of NCM owned by Company										43.7
Carrying value						9.6		$ 135.4			$ 152.0
Impairment of long-lived and other assets				$ (0.7)		$ (113.2)	[2]
Deferred revenue or NCM screen advertising advances extended term				2041-02
Investment in NCMI [Member]
Schedule Of Equity Method Investments [Line Items]
Stock Issued During Period, Shares, New Issues		1.7	42.0
Unrealized Gain (Loss) on Investments	[2]			$ 12.4
Number of Common Shares Held in N C M I									4.4
Interest in common units of NCM acquired by Company				5.00%
Carrying value				$ 18.1
Impairment of long-lived and other assets	[3]			0.7
Ncm [Member]
Schedule Of Equity Method Investments [Line Items]
Remaining performance obligations				$ 174.0
Deferred revenue amortization year and month				2041-02
Ncm [Member] | Minimum [Member]
Schedule Of Equity Method Investments [Line Items]
Percentage Of Incremental Borrowing Rates				4.40%
Ncm [Member] | Maximum [Member]
Schedule Of Equity Method Investments [Line Items]
Percentage Of Incremental Borrowing Rates				8.30%

[1] Additions to theatre properties and equipment included in accounts payable as of December 31, 2022 and 2023 were $12.0 and $6.6 respectively.

[2] See Investment in National CineMedia below.

[3] Reflected in impairment of long-lived and other assets on the consolidated income statement for the year indicated. See further discussion at Investment in National CineMedia below

XML

INVESTMENT IN NATIONAL CINEMEDIA, INC / NATIONAL CINEMEDIA LLC - Summary of Common Units Received Under Adjustment Agreement (Detail) - USD ($) shares in Millions, $ in Millions		3 Months Ended		12 Months Ended
		Apr. 13, 2022	Apr. 14, 2021	Dec. 31, 2023		Dec. 31, 2022	Dec. 31, 2021
Schedule Of Equity Method Investments [Line Items]
Number of Common Units Received				4.8
Value Of Common Units Received From Company One				$ 0.0	[1]	$ 1.3	$ 10.2
Annual Common Unit Adjustment [Member]
Schedule Of Equity Method Investments [Line Items]
Date Common Units Received		Apr. 13, 2022	Apr. 14, 2021
Number of Common Units Received		0.5	2.3
Value Of Common Units Received From Company One	[2]	$ 1.3	$ 10.2

[1] Additions to theatre properties and equipment included in accounts payable as of December 31, 2022 and 2023 were $12.0 and $6.6 respectively.

[2] The fair value of the common units received was estimated based on the market price of NCMI common stock (Level 1 input as defined in FASB ASC Topic 820) at the time the common units were determined, adjusted for volatility associated with the estimated time period it would take to convert the common units and register the respective shares

XML

INVESTMENT IN NATIONAL CINEMEDIA, INC / NATIONAL CINEMEDIA LLC - Summary Financial Information for National CineMedia (Detail) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2023		Dec. 31, 2023	Dec. 31, 2022	Dec. 29, 2022	Dec. 31, 2021	Dec. 30, 2021
Schedule Of Equity Method Investments [Line Items]
Net Income (Loss)			$ 188.2	$ (271.2)		$ (422.8)
N C M I [Member]
Schedule Of Equity Method Investments [Line Items]
Revenues	$ 34.9	[1]			$ 249.2		$ 114.6
Operating (loss) income	(30.6)	[1]			10.9		(68.6)
Net Income (Loss)	(54.0)	[1]			(69.8)		$ (134.6)
Current assets	121.7	[2]			148.6
Noncurrent assets	618.5	[2]			628.2
Current liabilities	1,204.8	[2]			97.5
Noncurrent liabilities	67.2	[2]			1,161.6
Members' deficit	$ (531.8)	[2]			$ (482.3)

[1] Financial information for NCMI is presented for the latest reporting period available through which the Company accounted for its investment in NCMI under the equity method.

[2] Financial information for NCMI is presented for the latest reporting period available through which the Company accounted for its investment in NCMI under the equity method.

XML

INVESTMENTS IN AFFILIATES - Additional Information (Detail) - USD ($) $ in Millions		12 Months Ended
	Apr. 30, 2018	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
AC JV, LLC [Member]
Schedule Of Equity Method Investments [Line Items]
Cash distributions from equity investees		$ 5.7	$ 2.9
AC JV, LLC [Member] | Film rentals and advertising
Schedule Of Equity Method Investments [Line Items]
Event fees		$ 16.0	13.3	$ 6.2
Digital Cinema Distribution Coalition
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest		14.60%
Payments for content delivery services		$ 0.6	0.5	0.6
F E Concepts L L C [Member]
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest		50.00%
F E Concepts L L C [Member] | AWSR Investments, LLC
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest	50.00%
Cash distributions from equity investees		$ 0.0	4.0
Payments to Acquire Equity Method Investments	$ 20.0
Management fee revenues		$ 0.1	$ 0.1	$ 0.1

XML

INVESTMENTS IN AFFILIATES - Summary of Activity for Each of Company's Other Investments (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance		$ 22.6	$ 25.2	$ 23.8
Equity in income of affiliates		6.8	4.6	1.5
Cash distributions received		(5.7)	(6.9)
Other	[1]	(0.1)	(0.3)	(0.1)
Investments, ending balance		23.6	22.6	25.2
AC JV, LLC [Member]
Schedule Of Equity Method Investments [Line Items]
Cash distributions received		(5.7)	(2.9)
AC JV, LLC [Member] | Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance		4.2	3.7	3.7
Equity in income of affiliates		4.9	3.4	0.0
Cash distributions received		(5.7)	(2.9)
Other	[1]	0.0	0.0	0.0
Investments, ending balance		3.4	4.2	3.7
Digital Cinema Distribution Coalition | Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance		1.8	1.8	1.3
Equity in income of affiliates		0.3	0.0	0.5
Cash distributions received		0.0	0.0
Other	[1]	0.0	0.0	0.0
Investments, ending balance		2.1	1.8	1.8
FE Concepts, LLC | Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance		16.5	19.3	18.3
Equity in income of affiliates		1.6	1.2	1.0
Cash distributions received		0.0	(4.0)
Other	[1]	0.0	0.0	0.0
Investments, ending balance		18.1	16.5	19.3
Other Investments | Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance	[1]	0.1	0.4	0.5
Equity in income of affiliates	[1]	0.0	0.0	0.0
Cash distributions received	[1]	0.0	0.0
Other	[1]	(0.1)	(0.3)	(0.1)
Investments, ending balance	[1]	$ 0.0	$ 0.1	$ 0.4

[1] Consists primarily of mark-to-market adjustment on an investment in marketable securities.

XML

GOODWILL AND INTANGIBLE ASSETS, NET - Summary of Goodwill (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Goodwill [Line Items]
Beginning Balance	[1]	$ 1,250.9	$ 1,248.8
Foreign currency translation adjustments		4.3	2.1
Goodwill, Transfers	[2]	(4.2)
Ending Balance	[1]	1,251.0	1,250.9
U.S. Operating Segment
Goodwill [Line Items]
Beginning Balance	[1]	1,182.9	1,182.9
Foreign currency translation adjustments		0.0	0.0
Goodwill, Transfers	[2]	0.0
Ending Balance	[1]	1,182.9	1,182.9
International Operating Segment
Goodwill [Line Items]
Beginning Balance	[1]	68.0	65.9
Foreign currency translation adjustments		4.3	2.1
Goodwill, Transfers	[2]	(4.2)
Ending Balance	[1]	$ 68.1	$ 68.0

[1] Balances are presented net of accumulated impairment losses of $214.0 for the U.S. operating segment and $43.8 for the international operating segment.

[2] Relates to the sale of the Company’s Ecuador subsidiary. See Note 8.

XML

GOODWILL AND INTANGIBLE ASSETS, NET - Summary of Goodwill (Parenthetical) (Detail) $ in Millions	Dec. 31, 2023 USD ($)
U.S. Operating Segment
Goodwill [Line Items]
Accumulated impairment losses	$ 214.0
International Operating Segment
Goodwill [Line Items]
Accumulated impairment losses	$ 43.8

XML

GOODWILL AND INTANGIBLE ASSETS, NET - Intangible Assets-Net (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2023		Dec. 31, 2022
Intangible Assets [Line Items]
Intangible assets with finite lives, Beginning balance		$ 77.7		$ 81.7
ForeignCurrencyTranslationAdjustmentsAndOtherGross carrying amount		0.1	[1]	(4.0)	[2]
Intangible assets with finite lives, Ending balance		77.8		77.7
Intangible assets with finite lives, Accumulated amortization, Beginning balance		(73.2)		(71.0)
Accumulated amortization		(2.1)		(2.4)
Foreign Currency Translation Adjustments And Other Accumulated Amortization	[2]			0.2
Intangible assets with finite lives, Accumulated amortization, Ending balance		(75.3)		(73.2)
Net intangible assets with finite lives, Beginning balance		4.5		10.7
Foreign Currency Translation Adjustments and Other, Total intangible assets with finite lives, net		0.1	[1]	(3.8)	[2]
Foreign Currency Translation Adjustments And Other Indefinite Lived Intangible Assets		0.2	[1]	0.0	[2]
Net intangible assets with finite lives, Ending balance		2.5		4.5
Indefinite-lived Intangible Assets, Tradename and Other, Beginning Balance		300.1		300.1
Indefinite-Lived Intangible Assets Acquired		0.4	[3]	0.0
Indefinite-Lived Intangible Assets (Excluding Goodwill), Total				0.0
Intangible assets with indefinite lives, Disposals	[4]	(0.4)
Indefinite-lived Intangible Assets, Tradename and Other, Ending Balance		300.3		300.1
Total intangible assets - net, Beginning balance		304.6		310.8
Amortization, intangible assets		(2.1)		(2.4)
Other, Total intangible assets - net		0.3	[1]	(3.8)	[2]
Total intangible assets - net, Ending balance		302.8		$ 304.6
Tradename and Other [Member]
Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets Acquired	[3]	0.4
Intangible assets with indefinite lives, Disposals	[4]	$ (0.4)

[1] Includes foreign currency translation adjustments

[2] Includes foreign currency translation adjustments and an impairment recorded for a U.S. intangible asset during 2022. See Note 12 for discussion of impairment evaluations performed during the year ended December 31, 2022.

[3] Amount represents licenses acquired to sell alcoholic beverages for certain locations.

[4] Relates to the sale of the Company’s Ecuador subsidiary. See Note 8

XML

GOODWILL AND INTANGIBLE ASSETS - NET Estimated Aggregate Future Amortization Expense for Intangible Assets (Detail) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets, Net [Abstract]
Year ended December 31, 2024	$ 2.0
Year ended December 31, 2025	0.5
Year ended December 31, 2026	0.0
Year ended December 31, 2027	0.0
Year ended December 31, 2028	0.0
Total	$ 2.5	$ 4.5	$ 10.7

XML

IMPAIRMENT OF LONG-LIVED AND OTHER ASSETS - Summary of Long-Lived Asset Impairment Losses (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022		Dec. 31, 2021
Impaired Long Lived Assets Held And Used [Line Items]
Total impairment		$ 16.6	$ 174.1		$ 20.8
Investment In Ncm [Member]
Impaired Long Lived Assets Held And Used [Line Items]
Total impairment		0.7	113.2	[1]
Us Operating Segment [Member]
Impaired Long Lived Assets Held And Used [Line Items]
Theatre properties		6.6	19.7		6.4
Theatre operating lease right-of-use assets		7.1	34.0		6.8
Investment	[2]	0.7	113.2		0.0
Other		0.0	3.9		0.0
Total impairment		14.4	170.8		13.2
International Operating Segment [Member]
Impaired Long Lived Assets Held And Used [Line Items]
Theatre properties		0.7	2.2		4.0
Theatre operating lease right-of-use assets		1.5	1.1		3.2
Intangible assets		0.0	0.0		0.4
Total impairment		$ 0.0	$ 3.3		$ 7.6

[1] See Investment in National CineMedia below.

[2] See discussion at Investment in National CineMedia in Note 9.

XML

ACCRUED OTHER CURRENT LIABILITIES - Schedule of Accrued Other Current Liabilities (Detail) - USD ($) $ in Millions		Dec. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Gift card liability	[1]	$ 73.6	$ 64.5
Subscription membership program liability	[1]	77.3	58.4
Discount vouchers (Supersavers) liability	[1]	31.9	32.8
Other	[2]	56.4	44.7
Total		$ 239.2	$ 200.4

[1] See discussion at Revenue Recognition Policy in Note 5.

[2] The only difference between accrued other current liabilities for Holdings, as presented above, and CUSA is an additional $0.3 and $0.1 in other as of December 31, 2022 and 2023, respectively.

XML

ACCRUED OTHER CURRENT LIABILITIES - Schedule of Accrued Other Current Liabilities (Parenthetical) (Detail) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Accrued other current liabilities, including accounts payable to subsidiaries	$ 239.2	$ 200.4
Additional gap amount	$ 0.1	$ 0.3

XML

LONG-TERM DEBT - Components of Long-Term Debt (Detail) - USD ($) $ in Millions		Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Total long-term debt carrying value	[1]	$ 2,432.1
CUSA [Member]
Debt Instrument [Line Items]
Total long-term debt carrying value		1,972.1	$ 2,056.6
Less: Current portion		7.8	10.7
Less: Debt issuance costs, net of accumulated amortization and original issue discount		27.5	22.9
Long-term debt, less current portion, net of unamortized debt issuance costs and original issue discount		1,936.8	2,023.0
CNK [Member]
Debt Instrument [Line Items]
Cinemark USA, Inc. term loan due 2025		645.1	626.5
Other			10.1
Total long-term debt carrying value	[2]	2,432.1	2,516.6
Less: Current portion		7.8	10.7
Less: Debt issuance costs, net of accumulated amortization and original issue discount	[2]	33.0	31.9
Long-term debt, less current portion, net of unamortized debt issuance costs and original issue discount	[2]	2,391.3	2,474.0
4.500% convertible senior notes due 2025 | CNK [Member]
Debt Instrument [Line Items]
Senior notes		460.0	460.0
8.750% Senior Secured Notes Due 2025 | CNK [Member]
Debt Instrument [Line Items]
Senior notes		150.0	250.0
5.875% senior notes due 2026 | CNK [Member]
Debt Instrument [Line Items]
Senior notes		405.0	405.0
5.250% senior notes due 2028 | CNK [Member]
Debt Instrument [Line Items]
Senior notes		765.0	$ 765.0
Other		$ 7.0

[1] The only difference between the long-term debt maturity payments for Holdings, as presented above, and those for CUSA is the $460.0 repayment of Holdings’ 4.50% Convertible Senior Notes in 2025.

[2] The only differences between the long-term debt for Holdings, as presented above, and the long-term debt for CUSA are the $460.0 million 4.50% Convertible Senior Notes due 2025 and the related debt issuance costs.

XML

LONG-TERM DEBT - Components of Long-Term Debt (Parenthetical) (Detail) - Parent Company [Member] - USD ($) $ in Millions	Dec. 31, 2023	Aug. 21, 2020
Debt Instrument [Line Items]
Aggregate principal amount	$ 460.0	$ 460.0
Convertible senior notes percentage	4.50%	4.50%

XML

LONG-TERM DEBT - Schedule of Carrying Values and Fair Values of Debt Instruments (Detail) - USD ($) $ in Millions		Dec. 31, 2023	Dec. 31, 2022
CNK [Member]
Debt Instrument [Line Items]
Long-Term Debt, Fair Value	[1]	$ 2,460.3	$ 2,210.5
CUSA [Member]
Debt Instrument [Line Items]
Long-Term Debt, Fair Value		$ 1,903.8	$ 1,771.3

[1] The fair value of the 4.50% convertible notes was $439.2 and $556.5 as of December 31, 2022 and
2023, respectively.

XML

LONG-TERM DEBT - Schedule of Carrying Values and Fair Values of Debt Instruments (Parenthetical) (Detail) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Interest rate	4.50%	4.50%
Convertible Senior Notes [Member]
Debt Instrument [Line Items]
Long-Term Debt, Fair Value	$ 556.5	$ 439.2

XML

LONG-TERM DEBT - Additional Information (Detail) $ / shares in Units, $ in Millions				1 Months Ended				12 Months Ended
	May 01, 2023 USD ($)	Aug. 21, 2020 USD ($) Tradingday $ / shares	Apr. 20, 2020 USD ($)	May 26, 2023 USD ($)	Jun. 15, 2021 USD ($)	May 21, 2021 USD ($)	Mar. 16, 2021 USD ($)	Dec. 31, 2023 USD ($) Tradingday Agreement $ / shares	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($) Tradingday
Debt Instrument [Line Items]
Interest rate								4.50%	4.50%
Legal and other fees								$ 0.5
Average interest rate on outstanding borrowings								7.10%
Multiple Consolidated Interest Expense Under Subcondition Two Of Condition Two Under Dividend Restriction								0.0175
Loss accumulated on swaps prior to the amendments								$ 5.1
Amortization of accumulated losses for amended swap agreements								(6.4)	$ 4.5	$ 4.5
Loss on debt extinguishment and refinancing								(10.7)	0.0	(6.5)
Loans Amount										35.8	$ 35.8
Restricted payments available amount								599.1
CUSA [Member]
Debt Instrument [Line Items]
Repayments of long-term debt								10.6	28.1	10.3
Payment of debt issuance costs								$ 7.5	0.0	17.3
Total Leverage Ratio, Percentage								0.25%
Debt instrument, maturity date								May 24, 2030
Proceeds, Net From Long Term Borrowing								$ 632.7
Fair value of long-term debt								1,903.8	1,771.3
Debt issuance costs								27.5	22.9
Loss on debt extinguishment and refinancing								$ 10.7	$ 0.0	$ 6.5
Interest Rate Swap
Debt Instrument [Line Items]
Number of Interest Rate Swap Agreements Amended | Agreement								3
Interest Rate Swap Agreements Three
Debt Instrument [Line Items]
Maturity Date								Dec. 31, 2026
Derivative, Notional Amount								$ 175.0
Minimum
Debt Instrument [Line Items]
Net Total Leverage Ratio								1.00%
Net Total Leverage Ratio Minimum								1.00%
Net Total Leverage Ratio Maximum								1.00%
Minimum | CUSA [Member]
Debt Instrument [Line Items]
Percentage of variable margin rate added to Eurodollar rate								0.20%
Maximum
Debt Instrument [Line Items]
Net Total Leverage Ratio								2.75%
Net Total Leverage Ratio Minimum								2.75%
Net Total Leverage Ratio Maximum								5.00%
Maximum | CUSA [Member]
Debt Instrument [Line Items]
Percentage of variable margin rate added to Eurodollar rate								0.375%
Senior Secured Credit Facility | CUSA [Member]
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes				$ 775.0
Amended Senior Secured Credit Facility | Minimum
Debt Instrument [Line Items]
Senior secured leverage ratio required								1.00%
Amended Senior Secured Credit Facility | Maximum
Debt Instrument [Line Items]
Senior secured leverage ratio required								3.50%
4.50 % Convertible Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes		$ 460.0
Interest rate		4.50%							4.50%	4.50%
Debt instrument, maturity date		Aug. 15, 2025
Conversion price per share, percentage		130.00%
Initial conversion price | $ / shares		$ 14.35						$ 14.35
Trading price per principal amount of notes		$ 1,000.0
Percentage of product of last reported sale price of common stock and conversion rate		98.00%
Debt conversion, description								(1) during the five business day period after any five consecutive trading day period, or the measurement period, in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of Holdings’ common stock and the conversion rate on each such trading day; (2) if Holdings distributes to all or substantially all stockholders (i) rights options or warrants entitling them to purchase shares at a discount to the recent average trading price of Holdings’ common stock (including due to a stockholder rights plan) or (ii) Holdings’ assets or securities or rights, options or warrants to purchase the same with a per share value exceeding 10% of the trading price of Holdings’ stock, (3) upon the occurrence of specified corporate events as described further in the indenture, or (4) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of Holdings’ common stock for at least 20 trading days during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to $18.66 per share (130% of the initial conversion price of $14.35 per share), on each applicable trading day. Beginning May 15, 2025, holders may convert their 4.50% Convertible Senior Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date. Upon conversion of the 4.50% Convertible Senior Notes, Holdings will pay or deliver cash, shares of Holdings’ common stock or a combination of cash and shares of Holdings’ common stock, at Holdings’ election.
Debt instrument, convertible, latest date								May 15, 2025
Debt instrument, convertible, threshold trading days | Tradingday		20
Debt instrument, convertible, threshold consecutive trading days | Tradingday											30
Debt instrument, convertible, conversion ratio per 1000 principal amount		69.6767
Total cost of the Hedge Transactions		$ 142.1
Warrants, per share | $ / shares		$ 22.08
Cash proceeds from the sale of the warrants		$ 89.4
4.50 % Convertible Senior Notes | Minimum
Debt Instrument [Line Items]
Sale price per share | $ / shares		$ 18.66
Debt instrument, convertible, threshold trading days | Tradingday								20
4.50 % Convertible Senior Notes | Maximum
Debt Instrument [Line Items]
Debt instrument, convertible, threshold trading days | Tradingday								30
4.875 % Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes					$ 755.0
Interest rate					4.875%
Tender offer amount						$ 755.0
Remaining principal amount of optional redemption						$ 755.0
Outstanding principal at the redemption price percentage						100.00%
Loss on debt extinguishment and refinancing										$ (3.9)
4.875 % Senior Notes | Unamortized Debt Issuance Costs
Debt Instrument [Line Items]
Unamortized debt issuance costs										3.3
4.875 % Senior Notes | Payment of Fees
Debt Instrument [Line Items]
Unamortized debt issuance costs										0.6
5.125% Senior Notes
Debt Instrument [Line Items]
Tender offer amount							$ 334.0
Remaining principal amount of optional redemption							$ 66.0
Outstanding principal at the redemption price percentage							100.00%
Loss on debt extinguishment and refinancing										(2.6)
5.125% Senior Notes | Unamortized Debt Issuance Costs
Debt Instrument [Line Items]
Unamortized debt issuance costs										1.2
5.125% Senior Notes | Payment of Fees
Debt Instrument [Line Items]
Unamortized debt issuance costs										$ 1.4
5.250% Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes					$ 765.0
Interest rate				5.25%	5.25%
Debt instrument, maturity date					Jul. 15, 2028
Debt Instrument Issue Discount					101.00%
Debt issuance costs					$ 10.7
5.875% Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes							$ 405.0
Interest rate				5.875%			5.875%
Disclosure of dividend restrictions associated with the debt agreement								$ 3,556.8
Debt instrument, maturity date							Mar. 15, 2026
Debt Instrument Issue Discount							101.00%	101.00%
Debt issuance costs							$ 6.0
5.875% Senior Notes | Minimum
Debt Instrument [Line Items]
Debt covenants, required minimum coverage ratio								1.00%
Actual coverage ratio								1.00%
5.875% Senior Notes | Maximum
Debt Instrument [Line Items]
Debt covenants, required minimum coverage ratio								2.00%
Actual coverage ratio								5.50%
8.750 % Senior Notes
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes	$ 100.0		$ 250.0
Interest rate	8.75%		8.75%	8.75%
Premium Paid on the Redemption of Bond								$ 2.2
Loss on extinguishment of debt	$ 3.4
Debt Instrument Accrued Interest								106.6
Debt instrument, maturity date			May 01, 2025
Debt Instrument Issue Discount	101.00%
Remaining principal amount of optional redemption								150.0
Unamortized debt issuance costs								1.2
8.750 % Senior Notes | CUSA [Member]
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes	$ 100.0
Senior Secured Notes Due 2025
Debt Instrument [Line Items]
Interest rate					8.75%
Convertible Senior Notes Due 2025
Debt Instrument [Line Items]
Interest rate					4.50%
Convertible Senior Notes
Debt Instrument [Line Items]
Fair value of long-term debt								$ 556.5	$ 439.2
8.75 % Senior Notes Due June 1, 2024 | CUSA [Member]
Debt Instrument [Line Items]
Option rates	100.00%
International Segment
Debt Instrument [Line Items]
Interest rate								4.00%
Repayments of principal loan amount								$ 4.1	$ 21.5
Prior | 8.75 % Senior Notes Due June 1, 2024 | CUSA [Member]
Debt Instrument [Line Items]
Option rates	102.188%
Revolving Credit Facility [Member] | CUSA [Member]
Debt Instrument [Line Items]
Revolving credit line, maturity date				May 26, 2028
Revolving Credit Facility [Member] | Amended Senior Secured Credit Facility | Minimum
Debt Instrument [Line Items]
Senior secured leverage ratio required								1.00%
Revolving Credit Facility [Member] | Amended Senior Secured Credit Facility | Maximum
Debt Instrument [Line Items]
Senior secured leverage ratio required								0.30%
Term Loan Credit facility
Debt Instrument [Line Items]
Percentage of variable margin rate added to Eurodollar rate								2.75%
Amount outstanding under the term loan								$ 645.1
Percentage of Variable Rate added to Secured Overnight Financing Rate								0.50%
Term Loan Credit facility | CUSA [Member]
Debt Instrument [Line Items]
Unamortized Debt Issuance Expense								$ 4.7
Lender Fees Paid on Debt Extinguishment								2.1
Debt Issuance Costs Capitalized								7.5
Original issue discount								9.8
Repayments of long-term debt								628.3
Debt issuance costs								$ 10.1
Term Loan Credit facility | Minimum
Debt Instrument [Line Items]
Net Total Leverage Ratio								1.00%
Term Loan Credit facility | Maximum
Debt Instrument [Line Items]
Net Total Leverage Ratio								2.13%
Term Loan Credit facility | Senior Secured Credit Facility
Debt Instrument [Line Items]
Quarterly principal payments due								$ 1.6
Debt instrument description of interest								SOFR for a period of 1, 3, or 6 months (depending upon the Interest Period (as defined in the Credit Agreement) chosen by CUSA) (the "Term SOFR Rate"), subject to a floor of 0.50% per annum, plus an applicable margin of 3.75% per annum
Term Loan Credit facility | Senior Secured Credit Facility | CUSA [Member]
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes				$ 650.0
Final principal payment due date				May 24, 2030
Last quarterly payment date				Dec. 31, 2030
Term Loan Credit facility | Amended Senior Secured Credit Facility
Debt Instrument [Line Items]
Percentage of variable margin rate added to Eurodollar rate								3.75%
Percentage of Variable Rate added to Federal Reserve Bank Effective Rate								1.00%
Percentage of Variable Rate added to Alternate Base Rate								1.00%
Term Loan Credit facility | 5.250% Senior Notes
Debt Instrument [Line Items]
Interest rate				5.25%
Revolving Credit Line
Debt Instrument [Line Items]
Percentage of Variable Rate added to Alternate Base Rate								1.00%
Revolving Credit Line | Senior Secured Credit Facility | CUSA [Member]
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes				$ 125.0
Revolving Credit Line | Amended Senior Secured Credit Facility
Debt Instrument [Line Items]
Percentage of variable margin rate added to Eurodollar rate								3.25%
Percentage of Variable Rate added to Alternate Base Rate								1.50%
Amount outstanding under the revolving credit line								$ 0.0
Revolving Credit Line | Amended Senior Secured Credit Facility | Minimum
Debt Instrument [Line Items]
Percentage of Variable Rate added to Secured Overnight Financing Rate								3.00%
Percentage of Variable Rate added to Alternate Base Rate								2.00%
Revolving Credit Line | Amended Senior Secured Credit Facility | Maximum
Debt Instrument [Line Items]
Percentage of Variable Rate added to Secured Overnight Financing Rate								3.50%
Percentage of Variable Rate added to Alternate Base Rate								2.50%

XML

LONG-TERM DEBT - Summary of Borrowings of International Subsidiaries (Detail)	Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Interest rate	4.50%	4.50%

XML

LONG-TERM DEBT - Maturities of Long-Term Debt, Excluding Unamortized Debt Issuance Costs (Detail) $ in Millions	Dec. 31, 2023 USD ($)
Debt Disclosure [Abstract]
2024	$ 7.8
2025	617.7
2026	412.7
2027	7.7
2028	772.7
Thereafter	613.5
Total	$ 2,432.1	[1]

[1] The only difference between the long-term debt maturity payments for Holdings, as presented above, and those for CUSA is the $460.0 repayment of Holdings’ 4.50% Convertible Senior Notes in 2025.

XML

LONG-TERM DEBT - Maturities of Long-Term Debt, Excluding Unamortized Debt Issuance Costs (Parenthetical) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Interest rate	4.50%	4.50%
CNK [Member]
Debt Instrument [Line Items]
Repayments of holding's	$ 460.0
Interest rate	4.50%

XML

LONG-TERM DEBT - Summary of Company's Interest Rate Swap Agreements Designated as Cash Flow Hedges (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2023	Feb. 29, 2024	Jan. 31, 2024
Interest Rate Swap Agreement 1
Debt Instrument [Line Items]
Effective Date		Feb. 29, 2024
Pay Rate			3.21%
Expiration Date		Dec. 31, 2026
Interest Rate Swap Agreement 2
Debt Instrument [Line Items]
Effective Date		Jan. 31, 2024
Pay Rate				3.17%
Expiration Date		Dec. 31, 2027
Designated as Hedging Instrument | Cash Flow Hedging
Debt Instrument [Line Items]
Estimated Fair Value	[1]	$ 9.9
Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Swap Agreement 1
Debt Instrument [Line Items]
Notional Amount	[2]	$ 137.5
Pay Rate	[2]	2.08%
Receive Rate	[2]	1-Month Term SOFR
Expiration Date	[2]	Dec. 31, 2024
Estimated Fair Value	[1],[2]	$ 3.5
Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Swap Agreement 2
Debt Instrument [Line Items]
Notional Amount	[3]	$ 137.5
Pay Rate	[3]	2.15%
Receive Rate	[3]	1-Month Term SOFR
Expiration Date	[3]	Dec. 31, 2024
Estimated Fair Value	[1],[3]	$ 3.5
Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Swap Agreement 3
Debt Instrument [Line Items]
Notional Amount		$ 175.0
Pay Rate		3.20%
Receive Rate		1-Month Term SOFR
Expiration Date		Dec. 31, 2026
Estimated Fair Value	[1]	$ 2.9

[1] Approximately $9.7 of the total is included in prepaid expenses and other and $0.2 is included in deferred charges on the consolidated balance sheet as of December 31, 2023.

[2] In February 2024, the Company amended and extended the second of its two then existing $137.5 notional amount interest rate swap agreements to amend the pay rate to 3.21% and extend the maturity date to December 31, 2026, effective February 29, 2024.

[3] In January 2024, the Company amended and extended one of its two then existing $137.5 notional amount interest rate swap agreements to amend the pay rate to 3.17% and extend the maturity date to December 31, 2027, effective January 31, 2024.

XML

LONG-TERM DEBT - Summary of Company's Interest Rate Swap Agreements Designated as Cash Flow Hedges (Parenthetical) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Feb. 29, 2024	Jan. 31, 2024
Interest Rate Swap Agreement 1
Debt Instrument [Line Items]
Pay Rate		3.21%
Effective Date	Feb. 29, 2024
Maturity Date	Dec. 31, 2026
Interest Rate Swap Agreement 2
Debt Instrument [Line Items]
Existing Notional Amount		$ 137.5	$ 137.5
Pay Rate			3.17%
Effective Date	Jan. 31, 2024
Maturity Date	Dec. 31, 2027
prepaid Expenses and Other
Debt Instrument [Line Items]
Estimated Fair Value	$ 9.7
Other Assets
Debt Instrument [Line Items]
Estimated Fair Value	$ 0.2

XML

FAIR VALUE MEASUREMENTS (Detail) - Fair Value Measurements, Recurring - USD ($) $ in Millions		Dec. 31, 2023	Dec. 31, 2022
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Interest rate swap assets	[1]	$ 9.9	$ 20.4
Investment In NCMI	[2]	18.1
Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Interest rate swap assets	[1]	0.0	0.0
Investment In NCMI	[2]	0.0
Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Interest rate swap assets	[1]	9.9	20.4
Investment In NCMI	[2]	18.1
Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Interest rate swap assets	[1]	0.0	$ 0.0
Investment In NCMI	[2]	$ 0.0

[1] See further discussion of interest rate swaps at Note 14.

[2] See further discussion of investment in NCMI at Note 9.

XML

FAIR VALUE MEASUREMENTS - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Fair value, asset transfers out of Level 3	$ 0	$ 0	$ 0

XML

FOREIGN CURRENCY TRANSLATION - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Foreign Currency Translation [Line Items]
Cumulative foreign currency losses	$ (384.9)	$ (389.8)
Cumulative inflation rate	100.00%
Cumulative inflation period	3 years
Blue Chip Swap [Member]
Foreign Currency Translation [Line Items]
Foreign currency exchange and other related loss	$ 12.4
Argentina
Foreign Currency Translation [Line Items]
Foreign currency exchange and other related loss	(24.2)	8.5	$ 0.2
CNK [Member]
Foreign Currency Translation [Line Items]
Accumulated other comprehensive loss	(363.9)	(353.2)
Foreign currency exchange and other related loss	(28.8)	(11.5)	(1.3)
CUSA [Member]
Foreign Currency Translation [Line Items]
Accumulated other comprehensive loss	(366.7)	(356.3)
Foreign currency exchange and other related loss	$ (28.8)	$ (11.5)	$ (1.3)

XML

FOREIGN CURRENCY TRANSLATION - Summary of Impact of Translating Financial Statements of Company's International Subsidiaries (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)	$ 4,900	$ 4,600	$ (18,800)
Brazil
Foreign Currency Translation [Line Items]
Exchange Rate	4.85	5.29	5.57
Other comprehensive Income (Loss)	$ 5,500	$ 2,700	$ (4,700)
Colombia
Foreign Currency Translation [Line Items]
Exchange Rate	3,885.85	4,810.19	3,981.16
Other comprehensive Income (Loss)	$ 1,200	$ 0	$ (100)
Chile
Foreign Currency Translation [Line Items]
Exchange Rate	879.54	852	852.02
Other comprehensive Income (Loss)	$ (3,100)	$ 300	$ (10,900)
Peru
Foreign Currency Translation [Line Items]
Exchange Rate	3.75	3.81	4.02
Other comprehensive Income (Loss)	$ 300	$ 1,300	$ (2,800)
Other foreign countries
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)	$ 1,000	$ 300	$ (300)

XML

NON-CONTROLLING INTEREST IN SUBSIDIARIES (Detail) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Noncontrolling Interest [Line Items]
Noncontrolling interests	$ 9.0	$ 9.3
Cinemark Partners Second
Noncontrolling Interest [Line Items]
Noncontrolling interests	7.4	7.7
Laredo Theatre
Noncontrolling Interest [Line Items]
Noncontrolling interests	0.3	0.2
Greeley Ltd
Noncontrolling Interest [Line Items]
Noncontrolling interests	0.8	0.9
Other
Noncontrolling Interest [Line Items]
Noncontrolling interests	$ 0.5	$ 0.5

XML

NON-CONTROLLING INTEREST IN SUBSIDIARIES - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Noncontrolling Interest [Abstract]
Changes in ownership interest in subsidiaries	$ 0	$ 0	$ 0

XML

CAPITAL STOCK - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Stockholders Equity Note [Line Items]
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0
CUSA
Stockholders Equity Note [Line Items]
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0
Preferred stock shares authorized	1,000,000
Preferred stock par value	$ 1
CUSA | Class A Common Stock
Stockholders Equity Note [Line Items]
Common stock, shares outstanding	1,500
Common stock voting rights	Holders of Class A common stock have exclusive voting rights
CUSA | Class B Common Stock
Stockholders Equity Note [Line Items]
Common stock, shares outstanding	182,600
Common stock voting rights	Holders of Class B common stock have no voting rights except upon any proposed amendments to the articles of incorporation
Restricted Stock
Stockholders Equity Note [Line Items]
Number of restricted shares granted	1,380,000	880,000	1,240,000
Market value of common stock on the dates of grant	$ 12.07	$ 16.4	$ 21.91
Number of restricted stock unit awards that vested during the period	780,000	950,000	620,000
Restricted Stock | CUSA Employees and Holdings Directors
Stockholders Equity Note [Line Items]
Number of restricted shares granted	1,400,000
Restricted Stock | Minimum | CUSA Employees and Holdings Directors
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant	$ 11.19
Forfeiture rate for restricted stock awards	0.00%
Award vesting period for restricted stock	1 year
Restricted Stock | Maximum | CUSA Employees and Holdings Directors
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant	$ 19.07
Forfeiture rate for restricted stock awards	10.00%
Award vesting period for restricted stock	3 years
Restricted Stock Units (RSUs)
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant	$ 11.68	$ 16.65
Number of restricted stock unit awards that vested during the period	140,000	100,000	230,000
Unrecognized compensation expense	$ 12.6
Remaining Compensation Expense recognition period (in years)	1 year 8 months 12 days
Number of hypothetical shares of common stock	1,500,000	800,000
Number of hypothetical shares of common stock at maximum IRR level	1,700,000

XML

CAPITAL STOCK - Summary of Treasury Stock Activity (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Treasury Stock, Number of Shares and Restriction Disclosures [Abstract]
Treasury Stock Shares		6,000,000	5,680,000	5,350,000	5,050,000.00
Restricted stock withholdings	[1]	220,000	260,000	240,000
Restricted stock forfeitures	[2]	100,000	70,000.00	60,000.00
Beginning Balance, Cost		$ 95.4	$ 91.1	$ 87.0
Restricted stock withholdings	[1]	2.9	4.3	4.1
Restricted stock forfeitures	[2]	0.0	0.0	0.0
Ending Balance, Cost		$ 98.3	$ 95.4	$ 91.1

[1] Holdings withheld shares as a result of the election by certain employees to satisfy their tax liabilities upon vesting in restricted stock and restricted stock units. Holdings determined the number of shares to be withheld based upon market values of the common stock of Holdings on the vest dates. Below is a summary of the range of market values per share on the vest dates for the years indicated:

[2] Holdings repurchased forfeited restricted shares at a cost of $0.001 per share in accordance with the 2017 Omnibus Plan.

XML

CAPITAL STOCK - Summary of Treasury Stock Activity (Detail) (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Schedule of Treasury Stock [Line Items]
Common stock repurchased value as result of restricted stock forfeitures			$ 0.001
Minimum
Schedule of Treasury Stock [Line Items]
Market Value of Restricted Shares	$ 11.16	$ 12.11	15.21
Maximum
Schedule of Treasury Stock [Line Items]
Market Value of Restricted Shares	$ 18.36	$ 18.3	$ 24.14

XML

CAPITAL STOCK - Summary of Restricted Stock Activity (Detail) - Restricted Stock - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Shares of Restricted Stock
Shares of Restricted Stock, Beginning balance	1,850,000	1,990,000	1,430,000
Shares of Restricted Stock, Granted	1,380,000	880,000	1,240,000
Shares of Restricted Stock, Vested	(780,000)	(950,000)	(620,000)
Shares of Restricted Stock, Forfeited	(100,000)	(70,000.00)	(60,000.00)
Shares of Restricted Stock, Ending balance	2,350,000	1,850,000	1,990,000
Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value Outstanding, Beginning	$ 20.64	$ 21.73	$ 21.11
Weighted Average Grant Date Fair Value, Granted	12.07	16.4	21.91
Weighted Average Grant Date Fair Value, Vested	21.04	19.13	20.92
Weighted Average Grant Date Fair Value, Forfeited	16.4	18.91	18.96
Weighted Average Grant Date Fair Value Outstanding, Ending	$ 15.67	$ 20.64	$ 21.73

XML

CAPITAL STOCK - Schedule of Estimated Remaining Expense (Detail) - Restricted Stock Units (RSUs) [Member] $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Estimated remaining expense	$ 18.4	[1]
Cinemark Partners Second [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Estimated remaining expense	17.8	[1]
Cinemark Holdings Inc [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Estimated remaining expense	$ 0.6

[1] The weighted average period over which this remaining compensation expense will be recognized by both Holdings and CUSA is approximately 1.5 years.

XML

CAPITAL STOCK - Schedule of Estimated Remaining Expense (Parenthetical) (Detail)	12 Months Ended
	Dec. 31, 2023
Cinemark Partners Second [Member] | Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted average period remaining	1 year 6 months

XML

CAPITAL STOCK - Summary of Performance Metrics and Measurement Period of Performance Award (Detail)	12 Months Ended
	Dec. 31, 2023 $ / shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Restricted stock units that vest at maximum performance targets	$ 1.47
If performance metrics are at the maximum
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Restricted stock units that vest at maximum performance targets	$ 1.47	[1]
Restricted Stock Units (RSUs)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Performance Measurement Period	Three years with additional service requirement to the third anniversary of the date of the grant
Maximum Performance Target Level	200% of target level
Percentage of maximum restricted stock units vest	50.00%	[1]
Restricted stock units that vest at maximum performance targets	$ 0.73	[1]
Estimated forfeiture rates	5.00%
Restricted Stock Units (RSUs) | If performance metrics meet the target level
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Percentage of maximum restricted stock units vest	25.00%	[1]
Restricted Stock Units (RSUs) | Stock units vest if performance metrics meet the threshold level
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Restricted stock units that vest at maximum performance targets	$ 0.37	[1]
Restricted Stock Units (RSUs) | If performance metrics are at the maximum
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Percentage of maximum restricted stock units vest	100.00%	[1]
Restricted Stock Units (RSUs) | Estimated to be achieved at the time units were issued
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Most likely performance metrics outcome estimated	Target

[1] Number of PSUs that vest based on maximum amount of PSUs that could vest of 1.47.

XML

CAPITAL STOCK - Summary of Performance Metrics and Measurement Period of Performance Award (Parenthetical) (Details)	12 Months Ended
	Dec. 31, 2023 $ / shares
Share-Based Payment Arrangement [Abstract]
Restricted stock units that vest at maximum performance targets	$ 1.47

XML

CAPITAL STOCK - Summary of Restricted Stock Units Granted (Detail)	12 Months Ended
	Dec. 31, 2023
Restricted Stock Units (RSUs)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Estimated forfeiture rates	5.00%

XML

CAPITAL STOCK - Summary of Restricted Stock and Restricted Stock Unit Award Activity (Detail) - USD ($)		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized during the period		$ 16,300,000	$ 15,800,000	$ 22,900,000
Fair value of vested restricted stock held by:		10,400,000	15,900,000	11,000,000
Income tax benefit recognized upon vesting of restricted stock awards held by:		$ 900,000	$ 2,800,000	$ 1,100,000
Number of restricted stock unit awards that vested during the period		780,000	950,000	620,000
Restricted Stock | CUSA Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized during the period	[1]	$ 15,100,000	$ 14,800,000	$ 22,000,000
Fair value of vested restricted stock held by:		9,100,000	15,300,000	9,700,000
Income tax benefit recognized upon vesting of restricted stock awards held by:		600,000	2,700,000	800,000
Restricted Stock | Holdings Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized during the period		1,200,000	1,000,000	900,000
Fair value of vested restricted stock held by:		1,300,000	600,000	1,300,000
Income tax benefit recognized upon vesting of restricted stock awards held by:		300,000	100,000	300,000
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized during the period	[1]	8,700,000	5,700,000	6,400,000
Fair value of vested restricted stock held by:		1,800,000	1,700,000	4,100,000
Income tax benefit recognized upon vesting of restricted stock awards held by:		$ (800,000)	$ 0	$ 700,000
Number of restricted stock unit awards that vested during the period		140,000	100,000	230,000
Accumulated dividends paid upon vesting of restricted stock unit awards		$ 200,000	$ 300,000	$ 100,000

[1] The former CEO of Holdings retired on December 31, 2021 and all of his outstanding unvested restricted stock units vested upon his retirement in accordance with his employment agreement. Holdings recorded incremental compensation expense of $2.4 related to the accelerated vesting of these awards during the year ended December 31, 2021.

XML

CAPITAL STOCK - Summary of Restricted Stock and Restricted Stock Unit Award Activity (Detail) (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Restricted Stock
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Incremental compensation expense			$ 4.3
Restricted Stock Units (RSUs)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Dividends payable to former CEO	$ 0.2	$ 0.3	0.1
Incremental compensation expense			$ 2.4

XML

SUPPLEMENTAL CASH FLOW INFORMATION - Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2023		Dec. 31, 2022	Dec. 31, 2021
Schedule Of Cash Flow Supplemental [Line Items]
Cash paid for interest by Holdings	[1]	$ 151.3		$ 140.7	$ 108.2
(Refunds received) cash paid for income taxes, net		22.3		4.6	(136.5)
Cash deposited in (transferred from) restricted accounts	[2]	(10.8)		(14.9)	(11.9)
Noncash investing and financing activities:
Interest expense - NCM		(22.6)		(23.2)	(23.6)
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment	[3]	5.4		(3.8)	20.1
Theatre properties acquired under finance leases		0.0	[3]	0.0	0.7
Investment in NCMI/NCM - receipt of common units		0.0	[3]	1.3	10.2
CUSA
Schedule Of Cash Flow Supplemental [Line Items]
Cash paid for interest by CUSA		$ 130.6		$ 109.1	$ 87.8

[1] Includes the cash interest paid by CUSA.

[2] Represents cash deposited in (transferred out) of collateral account during the period to support the issuance of letters of credit to lenders, net of returned deposits from such accounts upon the repayment of related debt.

[3] Additions to theatre properties and equipment included in accounts payable as of December 31, 2022 and 2023 were $12.0 and $6.6 respectively.

XML

SUPPLEMENTAL CASH FLOW INFORMATION - Supplemental Information to Condensed Consolidated Statements of Cash Flows (Parenthetical) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Supplemental Cash Flow Elements [Abstract]
Additions to theatre properties and equipment included in accounts payable	$ 6.6	$ 12.0

XML

INCOME TAXES - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Taxes [Line Items]
Tax credit carryforwards expiring year description	the Company remained in a three-year cumulative pre-tax loss domestically and in certain foreign jurisdictions. This is heavily weighted as objectively verifiable negative evidence and, as a result, the Company is unable to include future projected earnings in assessing the recoverability of its deferred tax assets in these jurisdictions
Deferred tax assets valuation allowance	$ 266.3	$ 326.1
Gross unrecognized tax benefits, including interest and penalties	64.1	64.3
Unrecognized tax benefit that if recognized would impact effective tax rate	64.1	64.3
Reduction in existing unrecognized tax benefits	52.9	55.8	$ 55.9	$ 46.5
Maximum
Income Taxes [Line Items]
Reduction in unrecognized tax benefits is reasonably possible	35.9
CUSA
Income Taxes [Line Items]
Deferred tax assets valuation allowance	218.5	283.2
Gross unrecognized tax benefits, including interest and penalties	62.2	62.5
Unrecognized tax benefit that if recognized would impact effective tax rate	62.2	62.5
Accrued for interest and penalties	11.1	8.5
Reduction in existing unrecognized tax benefits	51.0	$ 53.9	$ 54.0	$ 46.5
Curacao Subsidiary
Income Taxes [Line Items]
Accumulated undistributed earnings and profits	2.0
Foreign
Income Taxes [Line Items]
Accumulated undistributed earnings and profits	157.6
One-time transition tax accumulated undistributed earnings and profits	$ 159.3
Tax credits carryforward period	10 years

XML

INCOME TAXES - Summary of Provision for Federal and Foreign Income Tax Expense for Continuing Operations (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Taxes [Line Items]
U.S	$ 151.4	$ (286.9)	$ (389.2)
Foreign	70.0	21.9	(49.8)
Total	221.4	(265.0)	(439.0)
CUSA
Income Taxes [Line Items]
U.S	167.0	(263.7)	(362.6)
Foreign	70.0	21.9	(49.8)
Total	$ 237.0	$ (241.8)	$ (412.4)

XML

INCOME TAXES - Summary of Current and Deferred Income Taxes (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Current:
Federal	$ 2.2	$ 1.9	$ 4.0
Foreign	14.2	9.2	0.8
State	2.9	1.2	1.0
Total current expense	19.3	12.3	5.8
Deferred:
Federal	15.8	(2.7)	(20.2)
Foreign	(5.7)	(2.4)	0.4
State	(0.5)	(4.2)	(2.8)
Total deferred taxes	10.6	(9.3)	(22.6)
Income taxes	29.9	3.0	(16.8)
CUSA
Current:
Federal	2.8	1.9	4.0
Foreign	14.2	9.2	0.8
State	2.9	1.2	1.0
Total current expense	19.9	12.3	5.8
Deferred:
Federal	13.8	(16.2)	(36.7)
Foreign	(5.7)	(2.4)	0.4
State	0.4	(6.8)	(1.8)
Total deferred taxes	8.5	(25.4)	(38.1)
Income taxes	$ 28.4	$ (13.1)	$ (32.3)

XML

INCOME TAXES - Summary of Reconciliation Between Income Tax Expenses (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Taxes [Line Items]
Computed statutory tax expense	$ 46.5	$ (55.7)	$ (92.2)
State and local income taxes, net of federal income tax impact	5.4	(2.2)	(1.4)
Changes in valuation allowance	(63.9)	60.6	76.3
Foreign tax rate differential	1.4	1.3	(4.5)
Foreign tax credits	(13.0)	(4.0)	0.0
Changes in uncertain tax positions	(0.9)	1.6	7.5
U.S. tax impact of foreign operations	10.3	(1.6)	0.8
Return to provision	3.3	1.4	5.1
Expiration of attribute carryforwards	37.1	0.0	0.6
Permanent Differences	8.6	4.6	5.4
Other, net	1.7	(3.0)	(4.2)
Income taxes	29.9	3.0	(16.8)
CUSA
Income Taxes [Line Items]
Computed statutory tax expense	49.8	(50.8)	(86.6)
State and local income taxes, net of federal income tax impact	5.9	(4.2)	(0.7)
Changes in valuation allowance	(68.6)	41.8	54.3
Foreign tax rate differential	1.4	1.3	(4.5)
Foreign tax credits	(12.9)	(4.0)	0.0
Changes in uncertain tax positions	(0.9)	1.6	5.7
U.S. tax impact of foreign operations	10.4	(1.6)	0.8
Return to provision	(3.3)	1.2	(3.2)
Expiration of attribute carryforwards	36.4	0.0	0.6
Permanent Differences	8.6	4.5	5.5
Other, net	1.6	(2.9)	(4.2)
Income taxes	$ 28.4	$ (13.1)	$ (32.3)

XML

INCOME TAXES - Summary of Valuation Allowance For Deferred Tax Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Taxes [Line Items]
Beginning Balance	$ 326.1	$ 264.1	$ 203.6
Additions	16.6	67.0	69.1
Deductions	83.0	5.3	4.3
Currency translation	(6.6)	(0.3)	4.3
Ending Balance	266.3	326.1	264.1
CUSA
Income Taxes [Line Items]
Beginning Balance	283.2	240.9	203.6
Additions	5.9	47.0	52.5
Deductions	77.2	4.9	10.9
Currency translation	(6.6)	(0.2)	4.3
Ending Balance	$ 218.5	$ 283.2	$ 240.9

XML

INCOME TAXES - Tax Effects of Significant Temporary Differences and Tax Loss and Tax Credit Carryforwards (Detail) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]
Theatre properties and equipment	$ 68.4	$ 76.9
Finance lease assets	13.3	16.0
Operating lease right-of-use assets	248.8	274.3
Intangible asset — other	55.8	49.6
Intangible asset — tradenames	69.5	68.9
Total deferred liabilities	455.8	485.7
Prepaid rent	2.7	4.1
Gift Cards	9.7	8.8
Investment in partnerships	1.4	5.2
Operating lease obligations	269.0	296.1
Finance lease obligations	18.6	21.6
Tax impact of items in accumulated other comprehensive income and additional paid-in-capital	13.4	16.4
Restricted stock	4.5	5.1
Accrued expenses	2.9	3.7
Other tax loss carryforwards	82.7	126.1
Other tax credit and attribute carryforwards	179.3	193.5
Other expenses, not currently deductible for tax purposes	11.7	14.9
Total deferred assets	678.1	778.1
Net deferred income tax (asset) liability before valuation allowance	(222.3)	(292.4)
Valuation allowance against deferred assets – non-current	266.3	326.1
Net deferred income tax liability	44.0	33.7
CUSA
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]
Theatre properties and equipment	68.2	76.7
Finance lease assets	13.2	15.9
Operating lease right-of-use assets	248.1	273.9
Intangible asset — other	55.7	49.5
Intangible asset — tradenames	69.3	68.8
Tax impact of items in accumulated other comprehensive income and additional paid-in-capital	1.4	5.3
Total deferred liabilities	455.9	490.1
Deferred revenue - NCM and other	82.0	82.4
Prepaid rent	2.7	4.1
Gift Cards	9.7	8.8
Investment in partnerships	1.4	5.2
Operating lease obligations	268.3	295.6
Finance lease obligations	18.6	21.6
Restricted stock	4.3	4.9
Accrued expenses	2.9	3.7
Other tax loss carryforwards	80.0	122.0
Other tax credit and attribute carryforwards	149.0	174.1
Other expenses, not currently deductible for tax purposes	11.5	14.8
Total deferred assets	630.4	737.2
Net deferred income tax (asset) liability before valuation allowance	(174.5)	(247.1)
Valuation allowance against deferred assets – non-current	218.5	283.2
Net deferred income tax liability	44.0	36.1
NCM
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]
Deferred revenue - NCM and other	82.2	82.6
Foreign
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]
Net deferred Income tax (asset) liability	0.1	4.7
Foreign | CUSA
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]
Net deferred Income tax (asset) liability	0.1	4.7
U.S.
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]
Net deferred income tax liability	44.1	29.0
U.S. | CUSA
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]
Net deferred income tax liability	$ 44.1	$ 31.4

XML

INCOME TAXES - Reconciliation of Total Amounts of Unrecognized Tax Benefits Excluding Interest and Penalties (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Taxes [Line Items]
Beginning Balance	$ 55.8	$ 55.9	$ 46.5
Gross increases - tax positions in prior periods	2.2	0.0	7.7
Gross decreases - tax positions in prior periods	(5.1)	(0.2)	(1.6)
Gross increases - current period tax positions	0.2	0.1	3.4
Statute of limitations expiration	(0.2)	0.0	(0.1)
Ending Balance	52.9	55.8	55.9
CUSA
Income Taxes [Line Items]
Beginning Balance	53.9	54.0	46.5
Gross increases - tax positions in prior periods	2.2	0.0	5.8
Gross decreases - tax positions in prior periods	(5.1)	(0.2)	(1.6)
Gross increases - current period tax positions	0.2	0.1	3.4
Statute of limitations expiration	(0.2)	0.0	(0.1)
Ending Balance	$ 51.0	$ 53.9	$ 54.0

XML

COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Commitments and Contingencies Disclosure [Line Items]
Employer matching contribution payments	$ 6.4	$ 5.7
Liability recorded for employer contribution payments	$ 0.9
Messrs. Thomas, Gamble, Fernandes and Cavalier
Commitments and Contingencies Disclosure [Line Items]
Employment agreements term extension	1 year

XML

SEGMENTS - HOLDINGS - Selected Financial Information by Reportable Operating Segment (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Revenue		$ 3,066.7	$ 2,454.7	$ 1,510.5
Adjusted EBITDA	[1]	594.1	336.5	80.0
Total capital expenditures		149.5	110.7	95.5
U.S. Operating Segment
Segment Reporting Information [Line Items]
Revenue	[2],[3]	2,415.3	1,970.2	1,293.6
International Operating Segment
Segment Reporting Information [Line Items]
Revenue		651.4	484.5	216.9
Operating Segments | U.S. Operating Segment
Segment Reporting Information [Line Items]
Revenue		2,428.1	1,977.9	1,296.3
Adjusted EBITDA	[1]	463.9	255.7	84.2
Total capital expenditures		111.5	87.2	78.3
Operating Segments | International Operating Segment
Segment Reporting Information [Line Items]
Revenue		651.4	484.5	216.9
Adjusted EBITDA	[1]	130.2	80.8	(4.2)
Total capital expenditures		38.0	23.5	17.2
Eliminations
Segment Reporting Information [Line Items]
Revenue		$ (12.8)	$ (7.7)	$ (2.7)

[1] Distributions from equity investees are reported entirely within the U.S. operating segment

[2] U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 22 for additional information on intercompany eliminations.

[3] U.S. segment revenues exclude intercompany transactions with the international operating segment. See Note 22 for additional information on intercompany eliminations

XML

SEGMENTS - HOLDINGS - Reconciliation of Net Income to Adjusted EBITDA (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Net (loss) income		$ 191.5	$ (268.0)	$ (422.2)
Add (deduct):
Income tax benefit (expense)		29.9	3.0	(16.8)
Interest expense	[1]	150.4	155.3	149.7
Other expense (income), net	[2]	(19.6)	23.6	43.5
Depreciation and amortization		209.5	238.2	265.4
Impairment of long-lived and other assets		16.6	174.1	20.8
Restructuring costs		0.0	(0.5)	(1.0)
(Gain) loss on disposal of assets and other		(7.7)	(6.8)	8.0
Loss on debt extinguishment and refinancing		10.7	0.0	6.5
Non-cash rent expense		(17.9)	(10.8)	(3.4)
Share based awards compensation expense		25.0	21.5	29.3
Adjusted EBITDA	[3]	594.1	336.5	80.0
Other Cash Distributions From Equity Investees [Member]
Add (deduct):
Cash distributions from equity investees	[4]	$ 5.7	$ 6.9	$ 0.2

[1] Includes amortization of debt issuance costs, amortization of original issue discount, and amortization of accumulated (gains) losses for amended swap agreements.

[2] Includes interest income, foreign currency exchange and other related loss, interest expense – NCM and equity in income (loss) of affiliates and unrealized gain on investment in NCMI. Excludes distributions from NCM and DCIP.

[3] Distributions from equity investees are reported entirely within the U.S. operating segment

[4] Reflects cash distributions received from equity investees that were recorded as a reduction of the respective investment balances (see Note 10). These distributions are reported entirely within the U.S. operating segment.

XML

SEGMENTS - HOLDINGS - Selected Financial Information by Geographic Area (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 3,066.7	$ 2,454.7	$ 1,510.5
Theatre properties and equipment, net of accumulated depreciation	1,161.7	1,232.1
Reportable Geographical Components
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	3,066.7	2,454.7	1,510.5
Theatre properties and equipment, net of accumulated depreciation	1,161.7	1,232.1
Reportable Geographical Components | U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	2,428.1	1,977.9	1,296.3
Theatre properties and equipment, net of accumulated depreciation	1,002.1	1,075.3
Reportable Geographical Components | Brazil
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	233.4	179.0	73.5
Theatre properties and equipment, net of accumulated depreciation	54.7	49.5
Reportable Geographical Components | Other international countries
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	418.0	305.5	143.4
Theatre properties and equipment, net of accumulated depreciation	104.9	107.3
Reportable Geographical Components | Eliminations
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ (12.8)	$ (7.7)	$ (2.7)

XML

RELATED PARTY TRANSACTIONS - Additional Information (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2023 USD ($) Theatre	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
FE Concepts, LLC
Related Party Transaction [Line Items]
Service fees	$ 0.1	$ 0.1	$ 0.1
Percentage of voting interest	50.00%
Cash distributions from affiliate/equity investment		4.0
Laredo Theatre, Ltd
Related Party Transaction [Line Items]
Company's interest in Laredo	75.00%
Lone Star Theatre's interest in Laredo	25.00%
Ownership interest held by David Roberts	100.00%
Percentage of stock owned by founder	8.50%
Percentage of management fees based on theatre revenues	5.00%
Management fee revenues	$ 0.7	0.6	0.4
Distribution Made to Limited Partner, Cash Distributions Paid	1.3	2.7
Walter Hebert
Related Party Transaction [Line Items]
Consulting services paid		0.2	0.1
Copper Beech Capital LLC
Related Party Transaction [Line Items]
Amount paid for the use of aircraft	0.1	0.1	0.1
Syufy Enterprises, LP
Related Party Transaction [Line Items]
Management fee revenues	$ 0.0	0.0	0.1
Number of theatres leased | Theatre	12
Total rent paid to Syufy	$ 22.1	$ 22.3	$ 23.3

XML

VALUATION AND QUALIFYING ACCOUNTS - Valuation Allowance of Deferred Tax Assets (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Valuation and Qualifying Accounts Disclosure [Line Items]
Beginning Balance	$ 326,100,000	$ 264,100,000	$ 203,600,000
Additions	0
Deductions	83,000,000	5,300,000	4,300,000
Ending Balance	266,300,000	326,100,000	264,100,000
CUSA
Valuation and Qualifying Accounts Disclosure [Line Items]
Beginning Balance	283,200,000	240,900,000	203,600,000
Deductions	77,200,000	4,900,000	10,900,000
Ending Balance	$ 218,500,000	$ 283,200,000	$ 240,900,000

XML

QUARTERLY FINANCIAL INFORMATION (Detail) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Quarterly Financial Information Disclosure [Abstract]
Revenue	$ 3,066.7	$ 2,454.7	$ 1,510.5
Net (loss) income	191.5	(268.0)	(422.2)
Net income attributable to Cinemark USA, Inc.	$ 188.2	$ (271.2)	$ (422.8)
Net income per share attributable to Cinemark Holdings, Inc.’s common stockholders:
Basic	$ 1.55	$ (2.26)	$ (3.55)
Diluted	$ 1.34	$ (2.26)	$ (3.55)

XML

SUBSEQUENT EVENTS - Additional Information (Details) shares in Millions	Jan. 01, 2023 shares
Investment In NCM
Subsequent Event [Line Items]
Number of common units of NCM owned by Company	43.7

XML

Condensed Parent Company Balance Sheets (Detail) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Liabilities
Accrued other current liabilities, including accounts payable to subsidiaries	$ 239.2	$ 200.4
Commitments and contingencies (see Note 6)
Equity
Treasury stock shares	(98.3)	(95.4)	$ (91.1)	$ (87.0)
Cinemark Holdings, Inc.
Assets
Cash and cash equivalents	236.8	247.2
Interest receivable and other current assets	2.6	0.6
Investment in subsidiaries	591.2	372.5
Total assets	830.6	620.3
Liabilities
Accrued other current liabilities, including accounts payable to subsidiaries	66.5	61.5
Long-term debt	454.4	451.0
Other long-term liabilities	(0.1)	(2.4)
Total liabilities	520.8	510.1
Commitments and contingencies (see Note 6)
Equity
Common stock value	0.1	0.1
Additional paid-in-capital	1,244.3	1,219.3
Treasury stock shares	(98.3)	(95.4)
Accumulated deficit	(472.4)	(660.6)
Accumulated other comprehensive loss	(363.9)	(353.2)
Total equity	309.8	110.2
Total liabilities and equity	$ 830.6	$ 620.3

XML

Condensed Parent Company Balance Sheets (Parenthetical) (Detail) - Cinemark Holdings, Inc. - $ / shares	Dec. 31, 2023	Dec. 31, 2022
Condensed Financial Statements, Captions [Line Items]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	127,598,774	126,082,187
Common stock, shares outstanding	121,596,206	120,403,833
Treasury stock, shares	6,002,568	5,678,354

XML

Condensed Parent Company Statements of Income (Loss) (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Condensed Financial Statements, Captions [Line Items]
Revenue		$ 3,066.7	$ 2,454.7	$ 1,510.5
Interest expense	[1]	150.4	155.3	149.7
Income tax benefit (expense)		(29.9)	(3.0)	16.8
Net Income (Loss)		188.2	(271.2)	(422.8)
Cinemark Holdings, Inc.
Condensed Financial Statements, Captions [Line Items]
Revenue		0.0	0.0	0.0
Cost of operations		3.3	2.9	2.6
Operating (loss) income		(3.3)	(2.9)	(2.6)
Interest expense		(24.1)	(24.1)	(24.1)
Interest income		11.8	3.8	0.1
Loss before income taxes and equity in loss of subsidiaries		(15.6)	(23.2)	(26.6)
Income tax benefit (expense)		(1.5)	(16.1)	5.7
Equity in income (loss) of affiliates		205.3	(231.9)	(401.9)
Net Income (Loss)		$ 188.2	$ (271.2)	$ (422.8)

[1] Includes amortization of debt issuance costs, amortization of original issue discount, and amortization of accumulated (gains) losses for amended swap agreements.

XML

Condensed Parent Company Statements of Comprehensive Income (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Condensed Statement of Income Captions [Line Items]
Net (loss) income	$ 191.5	$ (268.0)	$ (422.2)
Other comprehensive income (loss), net of tax
Foreign currency translation adjustments	4.9	4.6	(18.8)
Cinemark Holdings, Inc.
Condensed Statement of Income Captions [Line Items]
Net (loss) income	188.2	(271.2)	(422.8)
Other comprehensive income (loss), net of tax
Unrealized gain (loss) due to fair value adjustments on interest rate swap agreements, net of taxes and settlements	(9.2)	32.2	18.5
Foreign currency translation adjustments	4.9	4.6	(18.8)
Total other comprehensive (loss) income, net of tax	(4.3)	36.8	(0.3)
Comprehensive (loss) income attributable to Cinemark, Inc.	$ 183.9	$ (234.4)	$ (423.1)

XML

Condensed Parent Company Statements of Comprehensive Income (Parenthetical) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cinemark Holdings, Inc.
Condensed Statement of Income Captions [Line Items]
Unrealized gain due to fair value adjustments on interest rate swap agreements, tax	$ 1.2	$ (2.8)	$ (0.7)

XML

Condensed Parent Company Statements of Cash Flows (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Operating Activities
Net (loss) income	$ 191.5	$ (268.0)	$ (422.2)
Adjustments to reconcile net (loss) income to cash used for operating activities:
Share based awards compensation expense	25.0	21.5	29.3
Cinemark Holdings, Inc.
Operating Activities
Net (loss) income	188.2	(271.2)	(422.8)
Adjustments to reconcile net (loss) income to cash used for operating activities:
Share based awards compensation expense	1.2	1.0	0.9
Amortization of debt issuance costs	3.5	3.4	3.5
Equity in loss (income) of affiliates	(205.3)	231.9	401.9
Changes in other assets and liabilities	4.9	21.7	10.5
Net cash used for operating activities	(7.5)	(13.2)	(6.0)
Investing Activities
Contributions to subsidiaries	0.0	0.0	(120.0)
Net cash (used for) provided by investing activities	0.0	0.0	(120.0)
Financing Activities
Restricted stock withholdings for payroll taxes	(2.9)	(4.3)	(4.1)
Net cash used for financing activities	(2.9)	(4.3)	(4.1)
Decrease in cash and cash equivalents	(10.4)	(17.5)	(130.1)
Cash and cash equivalents:
Beginning of period	247.2	264.7	394.8
End of period	$ 236.8	$ 247.2	$ 264.7

XML

Schedule 1 Basis of Presentation - Additional Information (Detail) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	May 24, 2013	Dec. 18, 2012
Organization and Summary of Significant Accounting Policies Disclosure [Line Items]
Interest rate	4.50%	4.50%
Cinemark Holdings, Inc.
Organization and Summary of Significant Accounting Policies Disclosure [Line Items]
Restricted net assets as a percentage of consolidated net assets	25.00%
Cinemark Holdings, Inc. | 4.875 % Senior Notes Due June 1, 2023
Organization and Summary of Significant Accounting Policies Disclosure [Line Items]
Interest rate				5.25%
Cinemark Holdings, Inc. | 5.125% Senior Notes Due 2022
Organization and Summary of Significant Accounting Policies Disclosure [Line Items]
Interest rate					5.875%
Cinemark Holdings, Inc. | 8.750% Senior Secured Notes Due 2025
Organization and Summary of Significant Accounting Policies Disclosure [Line Items]
Interest rate			8.75%
Senior Notes [Member] | Cinemark Holdings, Inc.
Organization and Summary of Significant Accounting Policies Disclosure [Line Items]
Restricted net assets	$ 427.8

XML

Schedule 1 Dividends and Distributions with Subsidiaries - Additional Information (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2021 USD ($)
Cinemark Holdings, Inc.
Dividends [Line Items]
Dividends Paid to Cinemark USA, Inc.	$ 120.0

XML

Long-term Debt - Additional Information (Details) - Cinemark Holdings, Inc. - USD ($) $ in Millions	Dec. 31, 2023	Aug. 21, 2020
Debt Instrument [Line Items]
Aggregate principal amount	$ 460.0	$ 460.0
Convertible senior notes percentage	4.50%	4.50%

XML

SUBSIDIARIES - CONDENSED CONSOLIDATING BALANCE SHEET (Detail) - USD ($) $ in Millions		Dec. 31, 2023	Dec. 31, 2022
Current assets
Theatre properties and equipment, net of accumulated depreciation		$ 1,161.7	$ 1,232.1
Operating lease right-of-use assets, net	[1]	986.4	1,102.7
Current liabilities
Current portion of operating lease obligations	[1]	212.5	219.3
Current portion of finance lease obligations	[1]	14.0	14.4
Long-term liabilities
Operating lease obligations, less current portion	[1]	853.3	970.6
Finance lease obligations, less current portion	[1]	73.8	$ 88.0
Commitments and Contingencies
CINEMARK USA, INC. AND SUBSIDIARIES
Current assets
Cash and cash equivalents		612.4
Other current assets		266.7
Total current assets		879.1
Theatre properties and equipment, net of accumulated depreciation		1,161.7
Operating lease right-of-use assets, net		986.4
Other assets		1,628.7
Total assets		4,655.9
Current liabilities
Current portion of long-term debt		7.8
Current portion of operating lease obligations		212.5
Current portion of finance lease obligations		14.0
Current income tax payable		4.2
Accounts payable and accrued expenses		483.9
Total current liabilities		722.4
Long-term liabilities
Long-term debt, less current portion		1,936.8
Operating lease obligations, less current portion		853.3
Finance lease obligations, less current portion		73.8
Other long-term liabilities and deferrals		469.3
Total long-term liabilities		3,333.2
Equity		600.3
Total liabilities and equity		4,655.9
Restricted Group [Member] | CINEMARK USA, INC. AND SUBSIDIARIES
Current assets
Cash and cash equivalents		496.3
Other current assets		393.4
Total current assets		889.7
Theatre properties and equipment, net of accumulated depreciation		1,161.7
Operating lease right-of-use assets, net		986.4
Other assets		1,718.1
Total assets		4,755.9
Current liabilities
Current portion of long-term debt		7.8
Current portion of operating lease obligations		212.5
Current portion of finance lease obligations		14.0
Current income tax payable		4.2
Accounts payable and accrued expenses		494.8
Total current liabilities		733.3
Long-term liabilities
Long-term debt, less current portion		2,199.0
Operating lease obligations, less current portion		853.3
Finance lease obligations, less current portion		73.8
Other long-term liabilities and deferrals		468.7
Total long-term liabilities		3,594.8
Equity		427.8
Total liabilities and equity		4,755.9
Unrestricted Group [Member] | CINEMARK USA, INC. AND SUBSIDIARIES
Current assets
Cash and cash equivalents		116.1
Other current assets		(115.8)
Total current assets		0.3
Theatre properties and equipment, net of accumulated depreciation		0.0
Operating lease right-of-use assets, net		0.0
Other assets		285.8
Total assets		286.1
Current liabilities
Current portion of long-term debt		0.0
Current portion of operating lease obligations		0.0
Current portion of finance lease obligations		0.0
Current income tax payable		0.0
Accounts payable and accrued expenses		0.0
Total current liabilities		0.0
Long-term liabilities
Long-term debt, less current portion		0.0
Operating lease obligations, less current portion		0.0
Finance lease obligations, less current portion		0.0
Other long-term liabilities and deferrals		0.6
Total long-term liabilities		0.6
Equity		285.5
Total liabilities and equity		286.1
Eliminations [Member] | CINEMARK USA, INC. AND SUBSIDIARIES
Current assets
Cash and cash equivalents		0.0
Other current assets		(10.9)
Total current assets		(10.9)
Theatre properties and equipment, net of accumulated depreciation		0.0
Operating lease right-of-use assets, net		0.0
Other assets		(375.2)
Total assets		(386.1)
Current liabilities
Current portion of long-term debt		0.0
Current portion of operating lease obligations		0.0
Current portion of finance lease obligations		0.0
Current income tax payable		0.0
Accounts payable and accrued expenses		10.9
Total current liabilities		10.9
Long-term liabilities
Long-term debt, less current portion		(262.2)
Operating lease obligations, less current portion		0.0
Finance lease obligations, less current portion		0.0
Other long-term liabilities and deferrals		0.0
Total long-term liabilities		(262.2)
Equity		(113.0)
Total liabilities and equity		$ (386.1)

[1] The operating lease right-of-use assets and liabilities recorded on the Company’s consolidated balance sheets generally do not include renewal options that have not yet been exercised.

XML

SUBSIDIARIES - CONDENSED CONSOLIDATING STATEMENT OF INCOME (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenue		$ 3,066.7	$ 2,454.7	$ 1,510.5
Cost of operations
Depreciation and amortization		2.1	2.4
Depreciation and amortization		209.5	238.2	265.4
Gain on disposal of assets and other		7.7	6.8	(8.0)
Interest expense	[1]	150.4	155.3	149.7
Loss on debt extinguishment and refinancing		10.7	0.0	6.5
Interest expense - NCM		(22.6)	(23.2)	(23.6)
Other income	[2]	19.6	(23.6)	(43.5)
Income before income taxes		151.4	(286.9)	(389.2)
Income tax expense		29.9	3.0	(16.8)
Net income (loss)		191.5	(268.0)	(422.2)
Less: Net income attributable to noncontrolling interests		3.3
Net income attributable to Cinemark USA, Inc.		188.2	$ (271.2)	$ (422.8)
Cinemark USA, Inc. [Member]
Cost of operations
Net income attributable to Cinemark USA, Inc.		205.3
CINEMARK USA, INC. AND SUBSIDIARIES
Revenue		3,066.7
Cost of operations
Theatre operating costs		2,286.6
General and administrative expenses		195.5
Depreciation and amortization		209.5
Impairment of long-lived assets		16.6
Gain on disposal of assets and other		(7.7)
Total cost of operations		2,700.5
Operating income (loss)		366.2
Interest expense		(126.3)
Loss on debt extinguishment and refinancing		10.7
Equity in income of affiliates		3.6
Interest expense - NCM		(22.6)
Other income		(26.8)
Total other (expense) income		(129.2)
Income before income taxes		237.0
Income tax expense		28.4
Net income (loss)		208.6
Net income attributable to Cinemark USA, Inc.		208.6
Restricted Group [Member]
Revenue		3,066.7
Cost of operations
Theatre operating costs		2,286.6
General and administrative expenses		195.5
Depreciation and amortization		209.5
Impairment of long-lived assets		15.9
Gain on disposal of assets and other		(7.7)
Total cost of operations		2,699.8
Operating income (loss)		366.9
Interest expense		(129.1)
Loss on debt extinguishment and refinancing		10.7
Equity in income of affiliates		1.6
Other income		(9.3)
Total other (expense) income		(151.5)
Income before income taxes		215.4
Income tax expense		24.0
Net income (loss)		191.4
Less: Net income attributable to noncontrolling interests		3.3
Restricted Group [Member] | Cinemark USA, Inc. [Member]
Cost of operations
Net income attributable to Cinemark USA, Inc.		188.1
Restricted Group [Member] | CINEMARK USA, INC. AND SUBSIDIARIES
Cost of operations
Net income attributable to Cinemark USA, Inc.		191.4
Restricted Group [Member] | NCM
Cost of operations
Interest expense - NCM		(22.6)
Unrestricted Group [Member] | Cinemark USA, Inc. [Member]
Cost of operations
Net income attributable to Cinemark USA, Inc.		17.2
Unrestricted Group [Member] | CINEMARK USA, INC. AND SUBSIDIARIES
Revenue		0.0
Cost of operations
Theatre operating costs		0.0
Depreciation and amortization		0.0
Impairment of long-lived assets		0.7
Total cost of operations		0.7
Operating income (loss)		(0.7)
Interest expense		0.0
Loss on debt extinguishment and refinancing		0.0
Equity in income of affiliates		2.0
Interest expense - NCM		0.0
Other income		(20.3)
Total other (expense) income		22.3
Income before income taxes		21.6
Income tax expense		4.4
Net income (loss)		17.2
Less: Net income attributable to noncontrolling interests		0.0
Net income attributable to Cinemark USA, Inc.		17.2
Eliminations [Member] | Cinemark USA, Inc. [Member]
Cost of operations
Net income attributable to Cinemark USA, Inc.		0.0
Eliminations [Member] | CINEMARK USA, INC. AND SUBSIDIARIES
Revenue		0.0
Cost of operations
Theatre operating costs		0.0
General and administrative expenses		0.0
Depreciation and amortization		0.0
Impairment of long-lived assets		0.0
Gain on disposal of assets and other		0.0
Total cost of operations		0.0
Operating income (loss)		0.0
Interest expense		(2.8)
Loss on debt extinguishment and refinancing		0.0
Equity in income of affiliates		0.0
Interest expense - NCM		0.0
Other income		2.8
Total other (expense) income		0.0
Income before income taxes		0.0
Income tax expense		0.0
Net income (loss)		0.0
Less: Net income attributable to noncontrolling interests		0.0
Net income attributable to Cinemark USA, Inc.		$ 0.0

[1] Includes amortization of debt issuance costs, amortization of original issue discount, and amortization of accumulated (gains) losses for amended swap agreements.

[2] Includes interest income, foreign currency exchange and other related loss, interest expense – NCM and equity in income (loss) of affiliates and unrealized gain on investment in NCMI. Excludes distributions from NCM and DCIP.

XML

SUBSIDIARIES - CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Net Income (Loss)	$ 188.2	$ (271.2)	$ (422.8)
Other comprehensive income, net of tax
Foreign currency translation adjustments	4.9	$ 4.6	$ (18.8)
CINEMARK USA, INC. AND SUBSIDIARIES
Net Income (Loss)	208.6
Other comprehensive income, net of tax
Unrealized gain (loss) due to fair value adjustments on interest rate swap agreements, net of taxes and settlements	(8.9)
Foreign currency translation adjustments	4.9
Total other comprehensive (loss) income, net of tax	(4.0)
Total comprehensive (loss) income, net of tax	204.6
Comprehensive income attributable to noncontrolling interests	(3.3)
Comprehensive (loss) income attributable to Cinemark, Inc.	201.3
Restricted Group [Member] | CINEMARK USA, INC. AND SUBSIDIARIES
Net Income (Loss)	191.4
Other comprehensive income, net of tax
Unrealized gain (loss) due to fair value adjustments on interest rate swap agreements, net of taxes and settlements	(8.9)
Foreign currency translation adjustments	4.9
Total other comprehensive (loss) income, net of tax	(4.0)
Total comprehensive (loss) income, net of tax	187.4
Comprehensive income attributable to noncontrolling interests	(3.3)
Comprehensive (loss) income attributable to Cinemark, Inc.	184.1
Unrestricted Group [Member] | CINEMARK USA, INC. AND SUBSIDIARIES
Net Income (Loss)	17.2
Other comprehensive income, net of tax
Unrealized gain (loss) due to fair value adjustments on interest rate swap agreements, net of taxes and settlements	0.0
Foreign currency translation adjustments	0.0
Total other comprehensive (loss) income, net of tax	0.0
Total comprehensive (loss) income, net of tax	17.2
Comprehensive income attributable to noncontrolling interests	0.0
Comprehensive (loss) income attributable to Cinemark, Inc.	17.2
Eliminations [Member] | CINEMARK USA, INC. AND SUBSIDIARIES
Net Income (Loss)	0.0
Other comprehensive income, net of tax
Unrealized gain (loss) due to fair value adjustments on interest rate swap agreements, net of taxes and settlements	0.0
Foreign currency translation adjustments	0.0
Total other comprehensive (loss) income, net of tax	0.0
Total comprehensive (loss) income, net of tax	0.0
Comprehensive income attributable to noncontrolling interests	0.0
Comprehensive (loss) income attributable to Cinemark, Inc.	$ 0.0

XML

SUBSIDIARIES - CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (Parenthetical) (Detail) - CUSA [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax	$ 1.5	$ (3.4)	$ (3.3)
CINEMARK USA, INC. AND SUBSIDIARIES
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax	$ (1.5)

XML

SUBSIDIARIES - CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Operating activities
Net Income (Loss)	$ 188.2	$ (271.2)	$ (422.8)
Investing activities
Investments and loans to affiliates	0.0
Financing activities
Payments on finance leases	(14.4)	(14.3)	$ (14.7)
CINEMARK USA, INC. AND SUBSIDIARIES
Operating activities
Net Income (Loss)	208.6
Adjustments to reconcile net income to cash provided by operating activities	223.7
Changes in assets and liabilities	22.5
Net cash provided by operating activities	454.8
Investing activities
Additions to theatre properties and equipment	(149.5)
Proceeds from Divestiture of Interest in Consolidated Subsidiaries	14.8
Net proceeds from sale of subsidiary	2.9
Net cash (used for) provided by investing activities	(131.8)
Financing activities
Redemption Of Senior Notes	(102.2)
Proceeds from Issuance of Secured Debt	640.2
Repayments of Secured Debt	(624.9)
Payment of debt issuance costs	(7.5)
Payment of fees on refinancing of senior secured credit facility	(2.6)
Restricted stock withholdings for payroll taxes	(2.9)
Other repayments on long-term debt	(10.6)
Payments on finance leases	14.4
Proceeds from (Payments for) Other Financing Activities	(0.5)
Net cash used for financing activities	(125.4)
Effect of exchange rate changes on cash and cash equivalents	(12.5)
Increase in cash and cash equivalents	185.1
Cash and cash equivalents:
Beginning of period	427.3
End of period	612.4	427.3
Restricted Group [Member] | CINEMARK USA, INC. AND SUBSIDIARIES
Operating activities
Net Income (Loss)	191.4
Adjustments to reconcile net income to cash provided by operating activities	219.3
Changes in assets and liabilities	36.5
Net cash provided by operating activities	447.2
Investing activities
Additions to theatre properties and equipment	(149.5)
Proceeds from Divestiture of Interest in Consolidated Subsidiaries	14.8
Net proceeds from sale of subsidiary	2.9
Investments and loans to affiliates	(2.3)
Net cash (used for) provided by investing activities	(134.1)
Financing activities
Redemption Of Senior Notes	(102.2)
Proceeds from Issuance of Secured Debt	640.2
Repayments of Secured Debt	(624.9)
Payment of debt issuance costs	(7.5)
Payment of fees on refinancing of senior secured credit facility	(2.6)
Restricted stock withholdings for payroll taxes	(2.9)
Other repayments on long-term debt	(10.6)
Payments on finance leases	(14.4)
Proceeds from (Payments for) Other Financing Activities	(0.5)
Net cash used for financing activities	(125.4)
Effect of exchange rate changes on cash and cash equivalents	(12.5)
Increase in cash and cash equivalents	175.2
Cash and cash equivalents:
Beginning of period	321.1
End of period	496.3	321.1
Unrestricted Group [Member] | CINEMARK USA, INC. AND SUBSIDIARIES
Operating activities
Net Income (Loss)	17.2
Adjustments to reconcile net income to cash provided by operating activities	4.4
Changes in assets and liabilities	(14.0)
Net cash provided by operating activities	7.6
Investing activities
Additions to theatre properties and equipment	0.0
Proceeds from Divestiture of Interest in Consolidated Subsidiaries	0.0
Net proceeds from sale of subsidiary	0.0
Investments and loans to affiliates	2.3
Net cash (used for) provided by investing activities	2.3
Financing activities
Redemption Of Senior Notes	0.0
Proceeds from Issuance of Secured Debt	0.0
Repayments of Secured Debt	0.0
Payment of debt issuance costs	0.0
Payment of fees on refinancing of senior secured credit facility	0.0
Restricted stock withholdings for payroll taxes	0.0
Other repayments on long-term debt	0.0
Payments on finance leases	0.0
Proceeds from (Payments for) Other Financing Activities	0.0
Net cash used for financing activities	0.0
Effect of exchange rate changes on cash and cash equivalents	0.0
Increase in cash and cash equivalents	9.9
Cash and cash equivalents:
Beginning of period	106.2
End of period	116.1	106.2
Eliminations [Member] | CINEMARK USA, INC. AND SUBSIDIARIES
Operating activities
Net Income (Loss)	0.0
Adjustments to reconcile net income to cash provided by operating activities	0.0
Changes in assets and liabilities	0.0
Net cash provided by operating activities	0.0
Investing activities
Additions to theatre properties and equipment	0.0
Proceeds from Divestiture of Interest in Consolidated Subsidiaries	0.0
Net proceeds from sale of subsidiary	0.0
Net cash (used for) provided by investing activities	0.0
Financing activities
Redemption Of Senior Notes	0.0
Proceeds from Issuance of Secured Debt	0.0
Repayments of Secured Debt	0.0
Payment of debt issuance costs	0.0
Payment of fees on refinancing of senior secured credit facility	0.0
Restricted stock withholdings for payroll taxes	0.0
Other repayments on long-term debt	0.0
Payments on finance leases	0.0
Proceeds from (Payments for) Other Financing Activities	0.0
Net cash used for financing activities	0.0
Effect of exchange rate changes on cash and cash equivalents	0.0
Increase in cash and cash equivalents	0.0
Cash and cash equivalents:
Beginning of period	0.0
End of period	$ 0.0	$ 0.0

XML

SUBSIDIARIES - CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS (Parenthetical) (Details) - USD ($) $ in Millions	May 01, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Condensed Cash Flow Statements, Captions [Line Items]
Debt instrument, interest rate, stated percentage		4.50%	4.50%
8.75% Secured Notes
Condensed Cash Flow Statements, Captions [Line Items]
Debt instrument, face amount	$ 100.0
Debt instrument, redemption price, percentage	102.20%
Debt instrument, interest rate, stated percentage		8.75%	8.75%	8.75%